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Chapter 1
Design of Agrochemicals Based on Fluorine-Containing
Nitrogen-Based Heterocycles. The Importance of the F, CF3, 
SF5 and SCF3 Groups 
General Introduction
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ABSTRACT: The development of new agrochemicals is crucial to achieve food security to everyone in 
a society where the worldwide population is increasing rapidly. In this chapter, the importance of 
agrochemical lead discovery is described. In addition, the biological importance of fluorinated
nitrogenous heterocycles in the agrochemical sector is emphasized. Finally, the importance and 
properties of the F, CF3, SF5 and SCF3 groups and their incorporation into potentially active 
molecules via building blocks are also described.
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1.1 Introduction
Adequate access to food is a universal right. The fulfillment, however, of this right is an 
ambitious goal, only achievable with the eradication of malnutrition and the accomplishment of 
reaching global food security. Unfortunately, current trends in population growth,1 urbanization, 
poverty, climate change, water stress and food waste are putting global food systems at risk. With 
the population and food consumption increasing over the coming decades, achieving food 
security to everyone will require action on many fronts.2
1.2 Agrochemical Lead Discovery
Continuous improvement in the production of food crops and fiber represent a constant 
challenge because of the expansion of the world population and the reduction of the arable 
farmland.3
In this regard, agrochemicals, including insecticides, acaricides, herbicides, and fungicides 
among others, play a key role in crop protection. An agrochemical or agrichemical (contraction 
of agricultural chemical) can be defined as a chemical used in agriculture, such as a pesticide or 
fertilizer, or a chemical employed to improve the quality and quantity of farm products.
Moreover, agrochemicals provide an effective approach for the control of a wide array of the 
world’s crop pests. The development of new pest control options, including new agrochemicals,4
is crucial because of the existence of a dynamic agricultural environment with new weeds and 
plant diseases, together with the presence of resistance to pesticides.5
It can take approximately 10 years and around $300 million to bring a new agrochemical from 
the initial synthesis phase to final registration, with an estimated success rate of agrochemical 
discovery at 1/140,000.4,6 Roughly, 37% of the overall cost is dedicated to total research 
(discovery of a new product) and about 12% to registration. The bulk 51% involves the total 
development costs being development and environmental chemistry, toxicology and field trials.4,7
A graphic representation is depicted in Figure 1.1.
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Figure 1.1 Distributions of Costs for the Discovery of a New Agrochemical.
1.2.1 Development of Crop Protection
The global agriculture should double the food production and the productivity of the farm 
would need to increase by 1.8% every year in order to adequately feed the worldwide population 
by 2050, which is projected to be around 9–10 thousand million people. Natural resources 
(water, land and biodiversity) are simultaneously diminishing and degrading. As an example of 
this fact, 30% of crop production will be at risk by 2025 due to water availability.8 This 
magnitude of sustained increase in global food production is unprecedented and requires
substantial changes in the methods to improve the agronomic and crop production practices.9
The development of sustainable methods for crop protection are crucial to achieve food 
security, as they would increase the yields of food crops (required because of the increase of 
world population), reduce losses during periods of drought or heat caused by climate change, 
and increase yields of industrial crops that may be required for biofuels or industrial 
biotechnologies.
In this regard, the European Training Network ECHONET (Expanding Capability in 
Heterocyclic Organic Synthesis Network)10 was funded under the Marie Skłodowska-Curie 
actions by the European Commission under the FP7 “People” Programme. The network 
comprises seven full partners (six academic and one industrial) and two associated industrial 
partners (Figure 1.2). The scientific objectives of ECHONET (implying therefore the goals of 
this thesis) are the following: 
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a) Exploit novel synthetic methodologies to prepare small molecules of high societal value.
b) Exploit state-of-the-art HTS for the synthesis of functionalized compounds.
c) Develop new biologically active compounds, with specific attention to those compounds 
that address current agrochemical challenges in food production.
Figure 1.2 Partnership of ECHONET Project.
Agricultural practices greatly increase crops yields, but extensive rely on these practices can lead 
to serious consequences. Thus, it is worth noting the importance of additional requirements that 
need to be taken into account for the development of agrochemicals, such as the interaction 
between the soil and the chemicals added to it. As the soil serves many vital functions in our 
society, especially for food production, it is of extreme importance to protect it and, additionally, 
to ensure its sustainability. The contamination and degradation of the soil can occur by an 
overuse of chemical fertilizers and pesticides that have also effects on the soil organisms. 
Therefore, persistency and movement of pesticides (and their transformation products) should 
be monitored in soil by measuring certain parameters such as water solubility, soil-sorption 
constant, octanol/water partition coefficient and half-life in soil.11
Other hazards that should be considered when using pesticides are (1) the impact on humans
(direct or through food commodities) and on the environment, and (2) contamination of water, 
air, and non-target vegetation.
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1.3 Fluorine-Containing Nitrogenous Agrochemicals
The presence of halogen atoms or halogen-containing substituents is an essential tool for the 
development of more efficacious agrochemicals, with environmentally more favorable 
physicochemical properties and higher economic viability.
Since 1940 to date, there has been a clear expansion in the synthesis and use of halogenated 
compounds in the agrochemical research and development fields. The incorporation of halogens 
into active ingredients (AIs) has become an important concept in the research of modern 
agrochemicals. The importance of the presence of halogens into molecules could be attributed to 
steric and electronic effects, physicochemical properties, polarity of the carbon–halogen bonds, 
improvements in the metabolic, oxidative and thermal stability and lastly, by shifts in the 
biological activity.12
Among the halogens, fluorine has earned a key place in the agrochemical sector in the search
of developing safer and more environmentally friendly, cost-effective halogenated agrochemicals.
A clear evidence of the importance of fluorine in the agrochemical sector is the drastic growth of 
fluorinated compounds, which has increased from 4% in 1977,13 to 14% in 2003,14 and more 
than 17% in 2004.15 Furthermore, in the past six years there has been a significant increase of 
fluorinated commercial pesticides (herbicides, fungicides, insecticides and acaricides), becoming 
approximately 52%, and around a quarter to be chlorine/fluorine substituted.16 Figure 1.3 
depicts examples of new agricultural nitrogenous heterocycles (N-heterocycles) that contain one 
or more fluorine atoms in their structures. Saflufenacil (inhibitor of protoporphyrinogen IX 
oxidase (PPO) developed by BASF)17 and pyroxasulfone (for use in corn, soybeans, cotton and 
wheat)18 are two examples of herbicides containing both CF3 and F groups.
Indaziflam (a cellulose-biosynthesis-inhibiting (CBI) herbicide developed by Bayer 
CropScience)19 and halauxifen-methyl (a low-use rate herbicide for the control of broadleaf 
weeds)20 represent two herbicides that contain one aliphatic and one aromatic fluorine atom in 
their structure, respectively. Finally, bicyclopyrone21 is a representative example of a new corn 
herbicide bearing an aromatic CF3 group in its structure.
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Figure 1.3 Fluorine-Containing Nitrogenous Agricultural Heterocyclic Products Launched between 2010 and 2016.
The effects caused by the presence of fluorine in agrochemicals, and in general in 
commercialized products,22 can be attributed to the physicochemical effects of having fluorine or 
fluorinated substituents in biologically active molecules. There are four main properties observed 
by incorporation of fluorine:15,23
a) Steric Effect: the replacement of hydrogen by fluorine is a common bioisosteric replacement 
because the size of the fluorine atom (van der Waals radius 1.47 Å) is the smallest after 
hydrogen’s (1.20 Å), thus fluorine can resemble hydrogen in a bioactive compound with respect 
to the steric requirements for binding to an active site.
b) Electronic Effect: the high electronegativity of fluorine can influence the electron distribution 
of part of a molecule, modifying therefore the physical properties and the chemical reactivity 
(affecting for instance the acidity or basicity of neighboring groups and creating a large dipole 
moment).
c) Stability: the C–F bond is stronger than the C–H bond, resulting in a significant influence on 
metabolic, oxidative and thermal stability. The presence of the CF3 or the OCF3 group provides
increased stability towards degradation in biologically active molecules because the CF3 and 
OCF3 groups are very unreactive to nucleophilic attack.
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d) Lipophilicity: the presence of fluorinated groups increases the lipophilicity of biologically 
active molecules (with functional groups such as CF3, OCF3 and SCF3 among the most lipophilic 
groups known), and plays a crucial role in the vivo uptake and transport of active ingredients 
through plant and insect cuticles.
Finally, substitution of functional groups by suitable halogenated residues, or more specifically 
fluorine-containing residues, can sometimes result in what it is known as “shift” of biological 
activity.12 A representative example of this “shift” can be explained with the herbicidal 1-aryl
pyrazole 1 (Scheme 1.1). The NO2-substituted pyrazole 1 is an active compound with herbicidal 
activity. A “shift” in activity takes place when the NO2 group is replaced by the SCF3 group, 
leading to the highly active insecticidal derivative 2, which shows a structural similarity with the 
commercial insecticide fipronil (3; a broad-spectrum insecticide that selectively acts by blocking 
GABA-gated chloride channels of neurons in the central nervous system and causes neural 
excitation and convulsions in insects, resulting in their death).24
Scheme 1.1 An Example of “Shift” of Biological Activity.
1.4 F, CF3, OCF3, SF5 and SCF3: a Comparison of Physicochemical Properties
The development of fluorination chemistry began more than 100 years ago, with the first 
examples reported in the second half of the 19th century.25 A few decades ago, the discovery of 
fluorinating reagents such as Selectfluor26 and DAST (diethylaminosulfur trifluoride)27 led to a
rapid development of new fluorinating methods. Since then, and in particular in the past ten 
years, the merger of fluorination chemistry and synthetic organic chemistry has resulted in 
advances for the introduction of not only fluorine, but also of fluorinated groups, such as the 
CF3 (trifluoromethyl), OCF3 (trifluoromethoxy), SF5 (pentafluorosulfanyl, also known as the 
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“super-trifluoromethyl group”) and SCF3 (trifluoromethylsulfanyl) groups. A comparison of the 
physicochemical properties of the F, CF3, OCH3, SF5 and SCF3 groups is described in this 
section.
Figure 1.4 shows the comparative pKa values of benzoic acid derivatives substituted in the 3-
position with the F, CF3, OCF3, SF5 or SCF3 group, compared to the NO2-substituted derivative 
(σm = 0.73). Among these fluorinated derivatives, the 3-SF5-substituted derivative is ranked as 
the strongest benzoic acid derivative, followed by the 3-CF3-substituted and the 3-SCF3- and 3-
OCF3-substituted benzoic acid compounds. The least electron-withdrawing group is the fluorine 
substituent (σm = 0.28).28
Figure 1.4 Electron-Withdrawing Effect of the NO2, SF5, CF3, SCF3, OCF3 and F Groups. 
As was described before, compounds with fluorine(s) in their structure show greater 
lipophilicity. The comparative values of lipophilicity by varying fluorinated substituents in the 
same molecule are shown in Figure 1.5.23,29
Figure 1.5 Values of Lipophilicity of the NO2, F, CF3, OCF3, SF5, SCF3 and Groups.
In this case, the SCF3 group has the highest lipophilicity value (πx = 1.44) followed by the SF5
(πx = 1.23), OCF3 (πx = 1.04), CF3 (πx = 0.88) and F (πx = 0.14) groups. Compounds with higher 
lipophilicity show generally higher permeation across biological membranes. Thus, the 
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incorporation of a SCF3 group can enhance bioavailability, which is of great interest in 
agrochemical and pharmaceutical research.30
1.5 Introduction of the F, CF3, SF5 and SCF3 Groups
The introduction of fluorinated groups such as F, CF3, SF5 and SCF3 has been developed over 
many years.31 In general terms, the introduction of these groups into molecules could be 
achieved via two different methodologies, either incorporation by a direct transformation or 
incorporation by fluorine-containing building blocks (Scheme 1.2).
Scheme 1.2 Schematic Representation of (a) Direct and (b) Building Blocks Incorporation of the F, CF3, SF5 and 
SCF3 Groups.
Direct incorporation of the F, CF3, SF5 and SCF3 groups (Scheme 1.2a) is one of the main 
challenges for organic chemists. The direct introduction of these groups has been extensively 
described for many years, especially for the F and CF3 groups. The direct incorporation of these
two functionalities by electrophilic, nucleophilic and radical pathways has been widely studied 
and is well developed.32 The chemistry of the SCF3 group is less evolved and therefore is one of 
the main targets of study nowadays. CF3S-Containing compounds can be synthesized by direct 
C–S bond formation (for example via trifluoromethylsulfanylation) or trifluoromethylation of 
sulfur-containing compounds.33 Finally, in the case of the SF5 group, its introduction into 
molecules is more limited compared to the other groups (there is only a radical pathway known) 
and is less explored. The only useful sources of this group are the highly toxic gases SF5Br and
SF5Cl.34 The direct incorporation of these functionalities is beyond the scope of this thesis.
The other strategy that could be used for the incorporation of these fluorinated groups into 
molecules is based on the use of fluorinated building blocks. A building block refers to the use of 
chemical reagents from which drugs or drug candidates might be synthetically prepared (Scheme 
1.2b). The use of building blocks is a useful tool in medicinal and agrochemical sectors for the 
construction of libraries of compounds used for biological screening. This method represents 
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one of the major strategies for pharmaceutical industries involved in drug discovery. In this 
context, fluorine-containing building blocks are widely used in drug design because they increase 
the probability of finding drug leads.
The spectrum of F-, F3C-, F5S- and CF3S-containing building blocks and their applications in 
the synthesis of compounds is extremely broad. Therefore, a compilation of only a few examples 
of F-, F3C-, F5S- and CF3S-containing (hetero)aromatic, vinylic and acetylenic building blocks is 
described here.
1.5.1 (Hetero)Aromatic Building Blocks
The use of fluorinated building blocks is one of the most useful strategies for the construction 
of fluorine-, trifluoromethyl-, pentafluorosulfanyl- and (trifluoromethyl)sulfanyl-containing 
(hetero)aromatic molecules and therefore the most widely used methodology for the synthesis of 
potential bioactive compounds.
2,6-Difluorobenzoyl urea 4 is an example of fluorine-containing aromatic building block. Urea 
4 was used as framework for the synthesis of new acyl ureas, resulting in different molecules with 
different potencies and insect spectrum control, such as hexaflumuron, lufenuron, novaluron,
and noviflumuron (Scheme 1.3).3 In all cases, the 2,6-difluorobenzoyl urea 4 remained constant
and only the N-aryl portion of the molecule was changed.
Scheme 1.3 2,6-Difluorobenzoyl Urea Building Block 4 and Insecticide Derivatives.
3-(Trifluoromethyl)aniline (5), is another example of the use of fluorinated building blocks for 
the synthesis of bioactive compounds. 3-(Trifluoromethyl)aniline (5), directly or indirectly, was 
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the precursor for the synthesis of four herbicides: norflurazon, flurochloridone, fluridone and 
diflufenican (Scheme 1.4). For example, norflurazon was synthesized from its precursor 
compound 5, which was converted into the corresponding hydrazine via diazotization and 
reduction.3
Scheme 1.4 3-(Trifluoromethyl)anilline Building Block 5.
Another remarkable example of using building blocks for the synthesis of fluorine-containing 
heterocycles is the F5S-substituted aniline 6, precursor of F5S-fipronil analog 8, which was
synthesized in five steps (Scheme 1.5). In biological tests, the SF5 analog of fipronil was superior 
in activity compared to its CF3 analog and also showed no loss of potency towards the resistant 
strain of housefly.35
Scheme 1.5 Synthesis of F5S-Fipronil Analog 8.
Regarding CF3S-containing building blocks, compound 12 was synthesized from the CF3S-
derivative 9, which reacted with propargyl alcohol 10 by a Sonogashira coupling to yield 
compound 11 in 71% yield (Scheme 1.6). Further transformation of compound 11 gave the 
enantiomerically enriched (91% ee) compound 12.36
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Scheme 1.6 Synthesis of Compound 12 from CF3S-Building Block 9.
1.5.2 Vinylic and Acetylenic Building Blocks
Vinylic and acetylenic building blocks possess an essential importance concerning the synthesis 
of (hetero)cycles because of their intrinsic potential in the chemistry of cycloaddition reactions. 
Both monosubstituted vinylic and acetylenic derivatives represent the simplest building blocks 
that could be used for the synthesis of new F-, F3C-, F5S- and CF3S-containing compounds 
(Figure 1.6). The bare fluorinated alkene and alkyne building blocks could be used for the 
synthesis of heterocycles containing only the F, CF3, SF5 and SCF3 substituents, whereas the 
highly substituted analogs of those would lead to the formation of the substituted counterparts.
Figure 1.6 Monosubstituted Vinylic and Acetylenic Derivatives of F, CF3, SF5 and SCF3 Groups.
This section describes the reactivity of fluorinated vinylic and acetylenic building blocks with 
F-, F3C-, F5S- and CF3S-substitutents on the synthesis of F-, F3C-, F5S- and CF3S-containing 
heterocycles.
1.5.2.1 Fluoroethene and Fluoroacetylene
The reactivity of fluoroethene (13) and fluoroacetylene (17) for the synthesis of heterocycles is 
unknown. One of the reasons may be the fact that they are gases (boiling points: 13 −72.2 °C
and 17 −80.0 °C), which implies a difficulty to work with them in a laboratory and requires 
special techniques for their synthesis and isolation.
Another reason could be the fact that fluoroacetylene (17) is not commercially available. There 
are no reactions reported regarding any C–C bond formation or other types of reactions that 
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could lead to the formation of any product. Interestingly, there are a few computational studies 
regarding the use of fluoroethene (13) and fluoroacetylene (17), but no reactivity has been 
described.37,38
1.5.2.2 3,3,3-Trifluoroprop-1-ene and 3,3,3-Trifluoroprop-1-yne
Addition, oxidation, substitution or C–C bond formation reactions are only a few examples of
known reactions that have been reported with 3,3,3-trifluoroprop-1-ene (14). The chemistry of 
alkene 14 towards the synthesis of (hetero)cycles is also rather limited. The synthesis of 
isoxazolines represents one of the few examples of the synthesis of N-heterocycles that has been 
reported using alkene 14. The most common method used to synthesize isoxazolines is by
1,3-dipolar cycloaddition reactions between nitrile oxides and alkenes.
In 2000, Jiang et al. reported the synthesis of the steroidal trifluoromethyl isoxazoline 22 (1:1 
ratio of stereoisomers) in 80% yield by the 1,3-dipolar cycloaddition reaction between the nitrile 
oxide formed from the precursor hydroximoyl chloride 21 and 3,3,3-trifluoroprop-1-ene 14 in 
the presence of Et3N (Scheme 1.7).39
Scheme 1.7 1,3-Dipolar Cycloaddition Reaction of a Steroidal Nitrile Oxide and Alkene 14.
Three years later, several aryl isoxazoline derivatives (24) were patented as potential agents for 
their use as control animal pests, in particular arthropods, such as insects, Acarina and 
helminths.40 In this case, various aromatic oximes (23) were converted to their N-
hydroxybenzimidoyl chloride derivatives in the presence of N-chlorosuccinimide. The reactions 
of the corresponding nitrile oxides with alkene 14 yielded compounds 24 (Scheme 1.8).
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Scheme 1.8 1,3-Dipolar Cycloaddition Reaction of Nitrile Oxides and Alkene 14.
In 2013, Hilpert et al. performed the reaction of a nitrile oxide and 3,3,3-trifluoroprop-1-ene 14
to give 4,5-dihydroisoxazole ester 26 in quantitative yield (Scheme 1.9). The nitrile oxide was 
slowly generated in situ from chloro hydroxyimino ester 25 in a heterogeneous mixture of 
NaHCO3 in AcOEt.41
Scheme 1.9 1,3-Dipolar Cycloaddition Reaction of a Nitrile Oxide and Alkene 14.
The synthesis of triazoles via reaction of alkyne 18 with azides represents the only reaction 
used for 3,3,3-trifluoroprop-1-yne 18. In 2010, Shreeve and co-workers published the synthesis 
of 1,4-disubstituted 1,2,3-triazoles containing the CF3 group. They performed the click 
cycloadditions by in situ generation of the F5S-containing alkyl azides (from compounds 27) that 
reacted with F3C-alkyne 18 (Scheme 1.10). They also observed for the first time the nucleophilic 
substitution of the SF5 group by an azide (while heating up to 80 °C), and were able to isolate 
compound 29 in 10% yield (for n = 2).42
Scheme 1.10 Synthesis of Triazoles 28 by the Reaction of Azides and Alkyne 18.
Soon thereafter, the same research group published the synthesis of poly(F3C-substituted 1,2,3-
triazole) compounds as dense stable energetic materials.43
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Two years later, Ferreira et al. synthesized the new 1,2,3-triazole nucleoside ribavirin analog 32
containing the CF3 group, which was also synthesized via a click cycloaddition of benzyl azide 30
and the F3C-acetylene 18 (Scheme 1.11). They also tested the antiviral activity of compound 32
against Influenza A and HSV-1 replication as well as reverse transcriptase (RT) from human 
immunodeficiency virus type 1 (HIV-1 RT). Unfortunately, compound 32 was not as effective as 
the most potent drugs.44
Scheme 1.11 Synthesis of Ribavirin Analog 32 from F3C-Acetylene 18 and Benzyl Azide 30. 
F3C-acetylene 18 was also used under Cu-catalyzed conditions with ethyl 2-azidoacetate (33) to 
give triazole 34.45 Compound 34 was used as a starting material for the synthesis of the analog 
35, after hydrolysis and coupling with several amines (Scheme 1.12).46
Scheme 1.12 Synthesis of 35 from F3C-Acetylene 18.
Scheme 1.13 depicts another example of the synthesis of F3C-containing triazoles. Anilines 36
were converted into the corresponding azides by treatment with isoamyl nitrite and TMSN3, 
which reacted with alkyne 18 to yield compounds 37 (Scheme 1.13).47
Scheme 1.13 Synthesis of Triazoles 37 from Anilines 36.
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Finally, the importance of the CF3 group has been demonstrated as a sensitive 19F NMR sensor 
for the detection of oligonucleotide secondary structures. Granqvist and Virta reported in 2014 
the synthesis and application of 4′‑C‑[(4-trifluoromethyl‑1H‑1,2,3-triazol-1-yl)methyl]thymidine, 
of which the required phosphoramidite building block 40 was synthesized via reaction of 
F3C-acetylene 18 with azide 39 (Scheme 1.14).48 Two years later, and following the same strategy, 
Granqvist and Virta reported the synthesis of the corresponding cytidine, adenosine, and 
guanosine building blocks.49
Scheme 1.14 Synthesis of F3C-containing Triazole 40 from Alcohol 38.
1.5.2.3 (Pentafluoro)vinyl-6-sulfane and Ethynyl(pentafluoro)-6-sulfane
The radical addition of the SF5Cl or SF5Br gases to double or triple bonds and the following 
dehydrohalogenation of the corresponding intermediates provide F5S-substituted alkenes and 
alkynes. These alkenes and alkynes are precursors of F5S-containing heterocycles, such as 
pyrrolines and pyrroles,50 thiophenes51 and furanes.52 However, the use of (pentafluoro)vinyl-6-
sulfane (15) and ethynyl(pentafluoro)-6-sulfane (19) in the synthesis of heterocycles is rather 
limited. There are no examples where the bare (pentafluoro)vinyl-6-sulfane (15) is used in the 
synthesis of heterocycles, and the only reactivity known involves bromination,53 chlorination54
and reactions with N2F4,55 among others.
The first synthesis of a F5S-subsituted pyrazole using ethynyl(pentafluoro)-6-sulfane (19) was 
published by Hoover and Coffman in 1964.53 The cycloaddition of diazomethane with alkyne 19
yielded a mixture of the tautomeric pyrazoles 41 and 42 in a 3:2 ratio (Scheme 1.15). In 2007, 
Shreeve and co-workers reinvestigated this cycloaddition reaction and also confirmed the 
inseparable nature of the mixture of regioisomers 41 and 42.56
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Scheme 1.15 Synthesis of Pyrazoles 41 and 42 from Alkyne 19. 
Shreeve and co-workers also performed the reaction of alkyne 19 with diazo compound 43, 
which provided imidazole 44 as a single regioisomer in 59% yield (Scheme 1.16).57
Scheme 1.16 Synthesis of Compound 44 from F5S-Acetylene 19 and Diazomethane Derivative 43. 
These researchers also synthesized different triazoles via Cu-catalyzed 1,3-dipolar cycloaddition 
reactions. The reaction of alkyne 19 with azides 45a–d yielded the desired triazoles 46a–d in 
moderate to good yields (Scheme 1.17).
Scheme 1.17 “Click-Chemistry” Reaction of Alkyne 19 with Azides 45.
They expanded their work towards the synthesis of compound 4958 and derivatives (Scheme 
1.18) by using similar methodology as described above. Compound 49 was synthesized from the 
reaction of azide 48 (previously prepared from compound 47)59 and F5S-acetylene 19.
Scheme 1.18 “Click-Chemistry” Reaction of Alkyne 19 with Azide 48.
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Afterwards in 2011, they published the synthesis of poly(F5S-substituted 1,2,3-triazole) 
compounds (as previously mentioned for acetylene 18) as dense stable energetic materials.43
Finally, there are two additional known reactions with F5S-acetylene 19 (Scheme 1.19).
Scheme 1.19 Synthesis of Acetylene 52 and Benzene 55.
The first reaction, published by Berry et al., described the synthesis and characterization of the 
novel compound bis(pentafluorosulfanyl)acetylene (52), which was synthesized from the addition 
of SF5Br 50 to F5S-acetylene 19 upon dehydrobromination by KOH (Scheme 1.19a).60 The 
second reaction was a Diels–Alder reaction, also described by Hoover and Coffman, of alkyne 19
and butadienes 53 (Scheme 1.19b) to give cycloadducts 54, which were submitted to further 
dehydrogenation to give compounds 55.53
1.5.2.4 Trifluoromethyl Vinyl Sulfide and Ethynyl Trifluoromethyl Sulfide
The chemistries of trifluoromethyl vinyl sulfide (16) and ethynyl trifluoromethyl sulfide (20) are
barely known. Harris described in 1967 the addition of chlorine, bromine, trifluoromethanethiol 
and trifluoromethylsulfanyl chloride to CF3S-ethene 16 to give compounds 56, 57, 58 and 
mixtures of 2-chloro-1,1-bis[(trifluoromethyl)sulfanyl]ethane and unidentified compounds, 
respectively (Scheme 1.20).61
In 2010, Sokolenko et al. reported the oxidation of sulfide 16 with MCPBA to the 
corresponding sulfoxide 59.62 The reactivity of trifluoromethyl vinyl sulfide 16 in cycloaddition 
reactions has been reported only twice, but has never been applied to the synthesis of 
heterocycles.
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Scheme 1.20 Reactions of Alkene 16. 
In 1967, Harris reported a Diels–Alder cycloaddition of alkene 16 and compound 53b,61 which 
led to the formation of cyclohexene 60 (Scheme 1.21).
Scheme 1.21 Example of a Cycloaddition Reaction of Trifluoromethyl Vinyl Sulfide (16).
Another example of a cycloaddition reaction of alkene 16 is the cyclopropanation reaction with 
compound 61 to yield cyclopropanes 6263 (Scheme 1.22).
Scheme 1.22 Synthesis of Cyclopropanes 62.
There is no reaction reported in the literature of ethynyl trifluoromethyl sulfide (20), which 
renders investigation of its synthesis and applications more appealing.64
520586-L-bw-Riesco
Processed on: 8-8-2018 PDF page: 35
1
Design of Agrochemicals Based on Fluorine-Containing Nitrogen-Based Heterocycles
35
1.6 Purpose and Outline of the Investigation
This thesis deals with the design and synthesis of scaffolds or building blocks for the synthesis 
of libraries of novel compounds based on fluorinated N-heterocycles, as they represent a key 
role in the agrochemical sector. The F, CF3, SF5 and SCF3 groups were chosen, among the 
different fluorinated groups that are known, to improve the biological profile of small molecules,
to be present in the majority of molecules presented in this thesis.
The synthetic content described in this thesis is divided in three parts:
a) The first part, Chapters 2 and 3, deals with the synthesis of two libraries of compounds 
based on derivatives of the piperidin-4-one scaffold that already contain the F, the CF3 or the 
SF5 group.
Chapter 2 describes the synthesis of three piperidin-4-one scaffolds that are the starting point 
of the thesis. These piperidin-4-ones were synthesized from readily available starting materials 
(with the fluorinated substituent F, CF3 or SF5 in aromatic building blocks) via an 
enantioselective multicomponent organocatalytic Mannich reaction. The further derivatization of 
the ketone after condensation with several tryptamine derivatives via a diastereoselective 
Pictet−Spengler cyclization generated a new small library of compounds based on the 
spiro[piperidine-pyridoindole] core.
Chapter 3 deals with the derivatization of the amino group of the three fluorinated piperidin-4-
ones described in Chapter 2 using flow chemistry. The reaction of the amino group with several 
isocyanates in flow yielded a new library of ureas in excellent yields. The diastereoselective 
reduction of the ketone was performed in flow and further derivatization of the amino alcohols 
was also achieved.
b) The second part, Chapter 4, describes the synthesis and selective functionalization of two 
new scaffolds based on the spiro[piperidine-pyridoindole] and spiro[piperidine-pyrrolopyridine] 
cores, following the methodology described in Chapter 2. This research was linked to research in
the European Lead Factory whose aim is to produce new drug-like molecules.
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c) The third part, Chapters 5 and 6, involves novel methodology for the incorporation of the 
SCF3 group via building blocks. The synthesis of trifluoromethyl vinyl sulfide and ethynyl 
trifluoromethyl sulfide and their application in the synthesis of two families of drug- and 
agrochemical-like compounds are described.
Chapter 5 describes the synthesis of the trifluoromethyl vinyl sulfide building block. The 
reactivity of this alkene was studied and the first 1,3-dipolar cycloaddition reaction was 
developed. The high-pressure promoted reaction of nitrones and trifluoromethyl vinyl sulfide 
yielded a new class of CF3S-containing isoxazolidines in a regio- and stereoselective manner.
Chapter 6 deals with the synthesis of ethynyl trifluoromethyl sulfide as a building block for the 
synthesis of CF3S-containing heterocycles. Ethynyl trifluoromethyl sulfide was synthesized from 
trifluoromethyl vinyl sulfide and used in copper-catalyzed cycloaddition reactions to yield 1,4-
disubstituted CF3S-containing triazoles.
Finally, future perspectives that could be further investigated as a result of this thesis are
presented in Chapter 7.
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An Enantio- and Diastereoselective Mannich/ 
Pictet−Spengler Sequence to Form Spiro[piperidine-
pyridoindoles] and Application to Library Synthesis
This chapter has been adapted from “Riesco-Domínguez, A.; van der Zwaluw, N.; Blanco-Ania, 
D.; Rutjes, F. P. J. T. Eur. J. Org. Chem. 2017, 662–670”.
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ABSTRACT: A new tandem strategy based on a Mannich/Pictet−Spengler sequence has been 
developed and additionally applied to the synthesis of a new library (14 examples) of privileged 
compounds based on the spiro[piperidine-pyridoindole] core. The sequence proceeds via a 
diastereoselective Pictet−Spengler cyclization, after condensation of several tryptamine derivatives 
with three novel piperidin-4-ones containing the fluorinated substituents F, CF3 or SF5. The 
piperidin-4-ones were synthesized from readily available starting materials via an enantioselective 
multicomponent organocatalytic Mannich reaction.
520586-L-bw-Riesco
Processed on: 8-8-2018 PDF page: 43
43
2
An Enantio- and Diastereoselective Mannich/Pictet−Spengler Sequence for Library Synthesis
2.1 Introduction
Spirocyclic compounds have been increasingly exploited as lead compounds in early phases of 
drug discovery because of their unique properties, such as the intrinsic three-dimensionality, the 
conformational restriction that enhances binding to a target and the structural patentability.1
Over the past few years, various examples of natural compounds and synthetic drugs containing 
spiro-fused heterocycles that possess relevant biological activities have been discovered (Figure 
2.1).2 In particular, nitrogen-containing spiro heterocycles have been identified to play a key role 
in biological and pharmaceutical processes,3 rendering this framework an attractive building 
block for further research. Examples of compounds with a spiro-piperidine moiety include 
iboluteine, an iboga-type indole alkaloid isolated from the Apocynaceae family; fenspiride 
hydrochloride, an antitussive drug; and fluspirilene, an antipsychotic drug used for the treatment 
of schizophrenia.
Figure 2.1 Natural and Synthetic Active Compounds Containing the Spiro-Piperidine Moiety.
In this regard, substituents at the 2- and 6-positions of the piperidine ring could be vital to 
modulate biological activity.4 Furthermore, and previously mentioned in Chapter 1, the presence 
of fluorine atoms can greatly enhance the drug-likeness of small molecules. Due to properties 
such as electronegativity, atom size and lipophilicity, the introduction of fluorine into small 
molecules can effectively alter their biological activity and bioavailability in comparison to the 
non-fluorinated counterparts.5,6 Inspired by previous piperidinone syntheses from our group7
and in conjunction with contemporary work on spirocyclic compound libraries in the framework 
of the European Lead Factory,8 we herewith report an enantio- and diastereoselective reaction 
sequence for the synthesis of spiro[piperidine-pyridoindole] structures 7 and their utilization to 
the synthesis of a focused compound library containing a variety of fluorine functionalities.
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2.2 Results and Discussion
From a retrosynthetic point of view, the spiro[piperidine-pyridoindole] core of compounds 7
could be generated from piperidin-4-one 4 and substituted indole derivatives by a 
diastereoselective Pictet−Spengler reaction (Scheme 2.1). The enantiopure piperidin-4-one 4
could itself be diastereoselectively obtained from β-amino ketone 3 via an intramolecular 
organocatalyzed Mannich reaction. Lastly, amino ketone 3 should be accessible by an 
enantioselective organocatalyzed three-component Mannich reaction of commercially available p-
anisidine, 3,4-dimethoxybenzaldehyde and acetone.
Scheme 2.1 Retrosynthesis of the Spiro[piperidine-4,1′-pyrido[3,4-b]indole Framework.
2.2.1 Synthesis of the Scaffolds
The forward synthesis commenced with the preparation of protected β-amino ketone 1, as 
previously reported by our group.7 Compound 1 was obtained in 61% yield and >99% ee by a 
multi-component L-proline-catalyzed Mannich reaction.7,9 We selected compound 1 for the 
synthesis of this library because of the high relevance of the 3,4-dimethoxyphenyl group in 
nature and active drugs.10 From compound 1, two possible synthetic routes for the synthesis of 
2,6-disubstituted piperidin-4-ones were envisioned (Scheme 2.2). Early efforts were focused on 
the synthesis of 4-methoxyphenyl (PMP)-protected piperidinones 2 in a one-pot procedure by a 
Mannich cyclization.
This approach involved the challenging synthesis of a scaffold with high steric hindrance as a 
result of the three contiguous substituents.11 In our efforts to synthesize product 2, protected 
amine 1 was reacted with several aldehydes, in the presence of various catalysts and under a range 
of temperatures (see Experimental Section). Unfortunately, none of the conditions led to the 
desired N-protected piperidin-4-one 2. Due to these difficulties, we then chose to synthesize the 
unprotected scaffold 4 with reduced steric hindrance (Scheme 2.2). To this end, the deprotection 
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of N-PMP amine 1 was carried out employing H5IO6 under acidic conditions to afford the 
corresponding product 3 in 46% yield.12 Subsequently, the amino ketone 3 was treated with 
triethylamine and 4-fluorobenzaldehyde to afford imine 5 (R = F). 1H NMR data of the reaction
mixture showed not only imine formation, but also a side product, which could not be 
characterized, and the cyclized product 4A.
Scheme 2.2 Synthetic Route for the Piperidin-4-one Synthesis. 
Several reaction conditions were investigated to obtain full conversion of imine 5 into the 
desired product 4A (Table 2.1). The conditions previously reported by us7 for these types of 
cyclizations were unsuccessful (entry 4). After further investigation, we were pleased to find that 
full conversion to the cyclized product 4A could be achieved when using L-proline as catalyst.
Table 2.1 Conditions for the Synthesis of 4A.
Entry Reagent (equiv) Solvent t (°C) Ratio 5/4A
1 Et3N (1) Et3N/1,2-DCE 21−60 3.3:1 
2 KOtBu (0.2) THF 21–70 2:1
3 Et3N (0.5) 1,2-DCE 40 3.3:1
4 CSA (1.2) 1,2-DCE 60 1.7:1
5 TFA (1.2) CH2Cl2 21 0.3:1 
6 L-proline (0.2) MeCN 21 0:1
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In addition, 1H NMR analysis of the reaction mixtures showed the existence of a slow 
equilibrium between imines 5 and 6, and cyclized product 4A under certain conditions, which led 
to different ratios of products depending on the temperature. In this manner, we observed that 
at low temperatures the formation of 4A was favored, whereas at room temperature imines 5 and 
6 were the major compounds in the reaction mixture. The presence of 5 and 6, 
4-fluorobenzaldehyde and 3,4-dimethoxybenzaldehyde confirmed the existence of the 
equilibrium between compounds 4A, 5 and 6 (Scheme 2.3).
Scheme 2.3 Equilibrium between 4a and Imines 5 and 6.
Following the optimization of the two-step synthesis of 4A, a one-pot procedure was 
investigated in order to obtain the cyclized product directly from 3. Thus, amine hydrochloride 3
was treated with Et3N and anhydrous Na2SO4 in the presence of catalytic amounts of L-proline, 
to afford the cyclized product 4A in 75% yield. In the same way, two additional cis-2,6-
diarylpiperidin-4-ones 4B and 4C, containing the CF3 and SF5 groups, were synthesized in 38 
and 28% yield, respectively.13 A clarification of the mechanism for this diastereoselective 
cyclization by an intramolecular Mannich reaction is depicted in Scheme 2.4. Firstly, the iminium 
ion species formed by reaction of amine 3 and the corresponding aldehyde is positioned close to 
a chair conformation with the lowest energy, in which the two hydrogens are placed in pseudo-
axial positions. Secondly, the enamine, formed by L-proline and the ketone, attacks the iminium 
ion giving the final piperidin-4-one with a cis-configuration, having the two bulky aryl groups in 
equatorial positions. The cis-stereochemistry of the products was confirmed by NOESY studies.
Scheme 2.4 Mechanism for the Diastereoselective Cyclization.
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2.2.2 Pictet–Spengler Cyclization
With the core scaffolds 4A−C in hand, we focused on the development of a new library of 
spiro compounds based on derivatization of the ketone by the classic Pictet−Spengler reaction.14
Initially, 3-methoxy-, 3-fluoro-, and 3,4-dimethoxyphenethylamine were selected as test 
substrates (Scheme 2.5).15
Scheme 2.5 Reactions with 2-Phenylethyl Amines.
Test reactions without catalyst did not reach full conversion to the corresponding 
imines. However, after thorough investigation (see Experimental Section), complete 
imine formation was obtained in the presence of Ti(OiPr)4. When performing the 
subsequent Pictet−Spengler reaction using TFA or TfOH as promoters, however, no 
cyclized product was observed in any of these cases.
Due to these preliminary results, the more reactive tryptamine was chosen as the model 
substrate (Table 2.2). The reactions of 4A−C with tryptamine were carried out in 
dichloromethane in the presence of molecular sieves (4 Å), which smoothly afforded the imine 
intermediate. Addition of TFA at 0 °C then led to the diastereoselective formation of 
compounds 7Aa−Ca in moderate yields (Table 2.2, method A).
Further screening of reaction conditions (Table 2.9, Experimental Section) led us to 
conclude that optimal conversion to the imine was achieved by reaction of the selected 
amine with Ti(OiPr)4 (1.3 equiv), in the presence of Et3N (1.2 equiv, only for substrates 
delivered as the hydrochloride) in THF at 21 °C. As previously stated, addition of TFA at 
0 °C then successfully delivered the desired Pictet−Spengler cyclization products. It is 
important to note that initially a mixture of the piperidin-4-one and imine was formed in 
all cases, which could not be driven to full conversion into the imine. Following these 
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conditions, compounds 7Ab−Cd were synthesized in an average yield of 67% (BORSM).
It is worth mentioning that TfOH was used as the acid in the synthesis of compounds 
7Ad−Cd.
Table 2.2 Scope of the Pictet−Spengler Cyclization.
aMethod A: reaction carried out in CH2Cl2 and in the presence of molecular sieves (4 Å), followed by addition 
of TFA. bMethod B: Ti(OiPr)4 (1.3 equiv) in THF followed by addition of TFA. cYield given based on 
recovered starting material (BORSM) for compounds 7Ab−Cd.
In these instances, the use of TFA in different amounts (2.2, 4.0 and 7.0 equiv) was not 
sufficient for the cyclization to take place.16 The resulting molecules, containing three 
NH groups, are difficult to purify through standard silica gel column chromatography.
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For this reason, isolation was performed by inactivation of the silica gel with Et3N. 
Moreover, after column chromatography, an additional washing step with aqueous 
ammonia (25% in water) was performed in order to remove residual triethylammonium 
salts.
We propose a rationale to explain the diastereoselectivity that is in accordance with the 
known reactivity of cyclohexanones towards nucleophiles.17 The cyclization presumably 
proceeds through a piperidinimine chairlike conformation, in which the indole ring 
exclusively attacks from the equatorial direction, which is the least hindered side (Scheme 
2.6). 2D NMR studies (NOESY) confirmed the stereochemistry of products 7Aa−Cd.
Scheme 2.6 Rationale for the Diastereoselectivity of the Pictet−Spengler Cyclization.
2.2.3 Pictet–Spengler Cyclization: Synthesis of Compounds 12 and 13
We synthesized compound 12 from indole-2-carbaldehyde, and compound 13 using a 
smaller pyrrole-based heterocycle to extend this library of compounds and to further 
expand the scope of the synthetic strategy (Scheme 2.8).
Scheme 2.7 Henry Reaction and Subsequent Reduction for the Synthesis of Amines 9 and 11. 
Firstly, the Pictet−Spengler precursors 9 and 11 (Scheme 2.7) were synthesized from 
commercially available indole-2-carbaldehyde and pyrrole-2-carbaldehyde via a Henry reaction 
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with nitromethane,18 followed by reduction of the nitro alkenes 8 and 10, using LiAlH4 in Et2O 
for the synthesis of 9, and NaBH4 in MeOH followed by the use of a mixture of NaBH4/NiCl2
for the synthesis of 11.19
Finally, precursors 9 and 11 were subjected to the previously optimized conditions in the 
presence of piperidin-4-one 4A to completely diastereoselectively afford the corresponding 
Pictet−Spengler products 12 and 13, in 52% yield in both cases (Scheme 2.8).
Scheme 2.8 Synthesis of Spiro Compounds 12 and 13.
2.3 Conclusion
An enantio- and diastereoselective route for the synthesis of a new class of spiro piperidine 
structures via a Mannich/Pictet−Spengler reaction sequence was developed. Three new 
cis-2,6-disubstituted piperidin-4-one analogues containing fluorine functionalities were
synthesized and incorporated into the synthetic route. Finally, this methodology was 
implemented to the synthesis of a compound library consisting of a total of 14 examples all 
being single stereoisomers.
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2.5 Experimental Section
Reagents were obtained from commercial suppliers and were used without purification. 
Standard syringe techniques were applied for the transfer of dry solvents and air- or moisture-
sensitive reagents. Reactions were followed, and RF values were obtained, using thin layer 
chromatography (TLC) on silica gel-coated plates (Merck 60 F254) with the indicated solvent 
mixture. Detection was performed with UV light, and/or by charring at ca. 150 °C after dipping 
into a solution of either 2% anisaldehyde in ethanol/H2SO4, KMnO4 or ninhydrin. Infrared 
spectra were recorded on an IR-ATR Bruker TENSOR 27 spectrometer. High-resolution or 
accurate mass measurement (ΔM < 3 mmu or 5 ppm) were recorded on a JEOL AccuTOF-CS 
JMS-T100CS for electrospray (spectra recorded in infusion in MeOH containing 50 nM PPG-
475 as internal mass-drift compensation standard) or JEOL AccuTOF-GCv JMS-T100GCv 
(GC/electron ionization MS, column bleeding at high temperature used as internal mass drift 
compensation standard). Optical rotations were determined with a Perkin Elmer 241 polarimeter. 
NMR spectra were recorded at 298 K on a Varian Inova 400 (400 MHz), Bruker Avance III 400 
MHz or Bruker Avance III 500 MHz spectrometer in the solvent indicated. Chemical shifts are 
given in parts per million (ppm) with respect to tetramethylsilane (0.00 ppm), or CHD2OD (3.31 
ppm) as internal standard for 1H NMR; and CDCl3 (77.16 ppm), or CD3OD (49.00 ppm) as 
internal standard for 13C NMR. NMR characterization was done according to the appearance of 
the signals. Coupling constants are reported as J values in hertz (Hz). 1H NMR data are reported 
as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, t = triplet, quint = quintet, 
dd = doublet of doublets, dt = doublet of triplets, dq = doublet of quartets, td = triplet of 
doublets, tt = triplet of triplets, ddd = doublet of doublet of doublets, ddt = doublet of doublets 
of triplets, ddquint = doublet of doublet of quintets, dddd = doublet of doublets of doublets of 
doublets, dddquint = doublet of doublet of doublet of quintets, dtdq = doublet of triplet of 
doublet of quartets, m = multiplet, b = broad), coupling constants (Hz), integration and 
assignment. Compounds were fully characterized by 1H and 13C spectra and 2D COSY, HSQC, 
HMBC, NOESY and HOESY spectra. Column or flash chromatography was carried out using 
ACROS silica gel (0.035–0.070 mm, and 60 Å pore diameter).
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Conditions for the Synthesis of 1,2,6-Trisubstituted Piperidin-4-ones
Reaction conditions using alkyl aldehydes: the protected amine 1a reacted with several 
electrophiles in the presence of a catalyst in order to obtain 1,2,6-trisubstituted piperidin-4-one 
derivatives (Table 2.3). Unfortunately, no piperidin-4-one 2 could be detected under any 
circumstances.
Table 2.3 Conditions Used for the Synthesis of 1,2,6-Trisubstituted Piperidin-4-ones 2.a
Entry Electrophile R1 Catalyst t (°C) Solvent
1 HCHO H AcOH 130 MeCN 
2 HCHO H AcOH 21 MeCN 
3 (E)-PhCH=CHCHO (E)-PhCH=CH TFA 21 MeCN
4 (CH2O)n H TFA 21 MeCN
5 [Me2N=CH2]I H – 21 MeCN
6 (CH2O)n H HCO2H 21 MeCN
7 OHCCO2Et CO2Et HCO2H 21 MeCN
8 (CH2O)n H HCO2H 21 HCO2H
9b OHCCO2Et CO2Et HCO2H 21 HCO2H
aThe reactions were followed by TLC, mass spectrometry and 1H NMR. bThe mass of the corresponding 
product was found but unfortunately the final compound was not isolated.
Reaction conditions using aromatic aldehydes: The intramolecular Mannich reaction was also 
performed with compound 1a and 4-fluorobenzaldehyde in the presence of L-proline in different 
solvents (mixtures of MeCN/EtOH and CH2Cl2/EtOH) at 21 °C (Scheme 2.9).
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Scheme 2.9 Synthesis of 1,2,6-Trisubstituted Piperidin-4-one 2a with 1 and 4-Fluorobenzaldehyde.
The same reaction was also carried out employing different starting materials with different 
substituents (R1 = F, NO2), which were previously synthesized (Table 2.4).
Table 2.4 Conditions Used for the Synthesis of 1,2,6-Trisubstituted Piperidin-4-ones 2.a
aAll reactions were performed on small scale (0.06–0.15 mmol) and the products 
were not isolated. bThe compound was obtained in a one-pot process from the 
multicomponent Mannich reaction after a second addition of aldehyde and after 
column chromatography (300 mg scale). cThe reaction was performed at −78 °C.
Entry Substrate R1 R2 Product(s) Solvent
1 1b F SF5 2e CH2Cl2/EtOH
2b 1b F F 2f EtOH
3
1b F SF5 2g +
EtOH 
– SF5 2l
4 1b F F 2f CH2Cl2
5 1b F NO2 2h EtOH
6 
1b F CN 2i +
EtOH 
– CN 2m
7 
1c NO2 CN 2j +
CH2Cl2/EtOH– NO2 2n
8c 1c NO2 CN 2k EtOH
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Only -amino ketones 1b and 1c gave very low conversion to products under these conditions. 
Symmetric cyclized product 2f could be isolated in 2% yield after column chromatography (entry 
2). Interestingly, 1H NMR and mass spectrometry confirmed scrambling of aryl groups for the 
reactions of 1b and 1c with benzaldehydes substituted with electron-withdrawing groups on the 
4-position. Thus, compound 1b afforded a mixture of piperidin-4-ones 2g and 2l when R2 = SF5
(entry 3) and gave only 2m when R2 = CN (entry 6). In the same way, -amino ketone 1c
afforded a mixture of piperidin-4-ones 2j and 2n when R2 = CN (entry 7).
Optimization of the Pictet−Spengler Cyclization
Conditions for the imine formation with 2-phenylethyl amines:
Scheme 2.10 Imine Formation for 2-Arylethyl Amines.
Table 2.5 Reaction Conditions for Non-Catalytic Imine Formation.
Entry SM Amine (equiv) Solvent t (°C) time
1 4A 14a (1.0) CH2Cl2 21 48 h
2 4A 14c (1.0) CH2Cl2 21 24 h
3 4A 14b (1.2) MeOH 21 22 h
* Dry CH2Cl2 and distilled MeOH were used.
Table 2.6 Reaction Conditions for Imine Formation Using AcOH.
Entry SM Amine Solvent t (°C) AcOH (equiv) MSa time
1 4A 14b CH2Cl2 21 0.5 Yes 72 h
2 4B 14b 1,2-DCE 21 0.5 Yes 48 h
3 4B 14b 1,2-DCE 80 0.5 No 24 h
4 4B 14b CH2Cl2 40 1.0 Yes 72 h
5 4B 14b MeOH 21 1.0 Yes 24 h
6 4A 14c CH2Cl2 35 5.0 Yes 95 h
7 4A 14c CH2Cl2 21 0.5 Yes 66 h
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8b 4B 14a 1,2-DCE 40 0.5 No Rotavap
aMolecular sieves (4 Å). For all reactions 1.2 equivalents of amine were used. b1.3 equivalents of
amine were used.
Table 2.7 Reaction Conditions for Imine Formation Using Ti(OiPr)4 and Cyclization.a
Entry SM Amine (equiv) Solvent t (°C) Acid (equiv)
1b 4B 14b (1.2) MeOH 40 TFA (2.2)
2 4C 14b (3.0) MeOH 21 TFA (2.2)
3 4A 14c (3.0) MeOH 21 TFA (2.2)
4 4A 14a (3.0) MeOH 21 TFA (2.2)
5 4A 14a (3.0) CH2Cl2 21 TFA (11)
6 4A 14a (3.0) CH2Cl2 21 TFA (2.2)
7 4A 14a (2.0) CH2Cl2 21 TfOH (5)
8 4A 14a (4.0) CH2Cl2 21 TfOH (100)
aFor all reactions 1.3 equivalents of Ti(OiPr)4 were used. Imine was formed but 
no cyclization was observed. b1.7 equivalents of Ti(OiPr)4.
Conditions for the imine formation with tryptamine derivatives:
Table 2.8 Reaction Conditions for the Synthesis of 7Aa−Ca, 7Ab and 7Cb.
Entry SM R1 Product Amine (equiv) Promotor timine (h) Yield (%)
1 4A H 7Aa 1.0 – 24 52 
2 4B H 7Ba 1.1 – 5 41
3 4C H 7Ca 1.0 – 5 47
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4 4A OMe 7Ab 1.0 AcOH 7 31
5 4C OMe 7Cb 2.2 AcOH 53 61
Table 2.9 Reaction Conditions for the Synthesis of 7Ab−Cd. 
Entry SM Product R1 R2 Acid (equiv) Yield (%) BORSMa (%)
1 4A 7Ab H OMe TFA (2.2) 55 74
2 4B 7Bb H OMe TFA (2.2) 77 77
3 4C 7Cb H OMe TFA (2.2) 26 56
4 4A 7Ac OH H TFA (2.2) 50 80
5 4B 7Bc OH H TFA (2.2) 39 74
6 4C 7Cc OH H TFA (2.2) 48 76
7 4A 7Ad F H TfOH (3.0) 62 74
8 4B 7Bd F H TfOH (3.0) 31 37
9 4C 7Cd F H TfOH (3.0) 40 52
aBased on recovery of starting material.
Precursors for the Synthesis of Piperidin-4-one 1, 3 and 5
(S)-4-(3,4-Dimethoxyphenyl)-4-[(4-methoxyphenyl)amino]butan-2-one 120
3,4-Dimethoxybenzaldehyde (10.5 g, 63.2 mmol), p-anisidine (7.78 g, 63.2 
mmol) and L-proline (1.5 g, 12.64 mmol) were added to a mixture of DMSO 
(45 mL) and acetone (180 mL). The resulting reaction mixture was stirred 
for 23 h. The reaction mixture was quenched with 100 mL potassium 
phosphate buffer (0.5 M, pH 7, 100 mL). Subsequently, a total of 150 mL of potassium 
phosphate buffer (0.5 M, pH 7) was added in portions. The reaction mixture was cooled to 0 °C 
and the product started to precipitate. After stirring for 20 min, the suspension was filtered off 
and the residue was washed with water (0 °C, 50 mL). The product was dried in vacuo. The 
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product was obtained as an off-white powder (19 g). The product was recrystallized from AcOEt
and obtained as white crystals (12.7 g, 38.5 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 6.91–
6.86 (m, 2 H, 2′-CH + 6′-CH), 6.83–6.77 (m, 1 H, 5′-CH), 6.72–6.66 (m, 2 H, 3″-CH + 5″-CH), 
6.55–6.48 (m, 2 H, 2″-CH + 6″-CH), 4.69 (t, J = 6.5 Hz, 1 H, 4-CH), 3.84 (s, 6 H, 3′-OCH3 + 
4′-OCH3), 3.69 (s, 3 H, 4″-OCH3), 2.88 (d, J = 6.5 Hz, 2 H, 3-CH2), 2.10 (s, 3 H, 1-CH3). 13C 
NMR [101 MHz, δ (ppm), CDCl3]: 207.5 (2-C), 152.5 (4″-C), 149.3 (3′-C), 148.2 (4′-C), 141.1 
(1″-C), 135.5 (1′-C), 118.3 (6′-C), 115.5 (3″-C + 5″-C), 114.8 (2″-C + 6″-C), 111.3 (5′-C), 109.6 
(2′-C), 56.0 (3′-OCH3 or 4′-OCH3), 55.9 (3′-OCH3 or 4′-OCH3), 55.7 (4″-OCH3), 55.3 (4-C), 51.5 
(3-C), 30.9 (1-C). FTIR [?̅?𝜈 (cm−1)]: 3385, 1708, 1510, 1253, 1235, 1139, 1027, 821. HRMS [ESI 
(m/z)] calcd for C38H46N2O8Na (M + Na)+ = 352.15248, found 352.15248. HPLC: ee > 99%, 
Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, heptane/propan-2-ol 4:1, retention time: 1: 
18.7 min, ent-(1): 15.7 min. Mp: 147–151 °C. [α]D20 +2.4 (c 0.41, CHCl3).7 Yield: 61%.
(S)-4-Amino-4-(3,4-dimethoxyphenyl)butan-2-one hydrochloride 3
Aqueous H2SO4 (1 M, 12.1 mL, 12.1 mmol) and H5IO6 (2.87 g, 12.6 mmol) 
were added to a solution of compound 1 (4 g, 12.1 mmol) in MeCN/H2O 
(120 mL, 1:1). The mixture was stirred for 1.5 h at 21 °C. The mixture was 
washed with CH2Cl2 (3 × 60 mL) and the aqueous phase was diluted with 
CH2Cl2 (60 mL). The pH of the aqueous layer was brought to 9 by addition of 5 M aqueous 
KOH under vigorous stirring. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (3 × 60 mL). The combined organic layers were dried over Na2SO4 and 
HCl/AcOEt (9.5 mL) was added. The resulting mixture was concentrated until the product 
precipitated. The product was isolated by filtration and dried in vacuo to afford 3 (1.44 g, 5.54 
mmol) as a pale yellow solid. 1H NMR [400 MHz, δ (ppm), CD3OD]: 7.03 (d, J = 1.8 Hz, 1 H, 
2′-CH), 7.00–6.96 (m, 2 H, 5′-CH + 6′-CH), 4.64 (t, J = 6.8 Hz, 1 H, 4-CH), 3.87 (s, 3 H, 
3′-OCH3), 3.84 (s, 3 H, 4′-OCH3), 3.20 (d, J = 6.8 Hz, 2 H, 3-CH2), 2.20 (s, 3 H, 1-CH3). 13C 
NMR [101 MHz, δ (ppm), CD3OD]: 207.5 (2-C), 151.2 (3′-C), 150.9 (4′-C), 130.3 (1′-C), 121.1 
(6′-C), 113.1 (5′-C), 112.1 (2′-C), 56.7 (3′-OCH3), 56.5 (4′-OCH3), 52.2 (4-C), 47.6 (3-C), 30.1 
(1-C). FTIR [?̅?𝜈 (cm−1)]: 3395, 2936, 1709, 1515, 1264, 1143, 1018. HRMS [ESI (m/z)] calcd for 
(C12H18NO3 + H)+ = 224.12867, found 224.13151 (|Δ| = 12.69 ppm). Yield: 46%.21
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(S)-4-(3,4-Dimethoxyphenyl)-4-[(E)-(4-fluorobenzylidene)amino]butan-2-one 5
Triethylamine (0.44 mL, 3.18 mmol) and 4-fluorobenzaldehyde (0.34 mL, 
3.18 mmol) were added to a solution of 3 (1.65 g, 6.36 mmol) in dry 1,2-
dichloroethane (115 mL). The mixture was concentrated in vacuo. Dry 1,2-
dichloroethane (110 mL) was added to the residue and the mixture was 
concentrated again in vacuo. Dry 1,2-dichloroethane (110 mL) and 
triethylamine (0.44 mL, 3.18 mmol) were added to the resulting residue and 
the mixture was concentrated in vacuo. The mixture was dissolved in dry 1,2-dichloroethane 
(113 mL) and triethylamine (0.44 mL, 3.18 mmol) and 4-fluorobenzaldehyde (0.03 mL, 0.32 
mmol) were added. The resulting mixture was concentrated in vacuo to afford the crude imine. 
1H NMR [400 MHz, δ (ppm), CD3OD]: 8.33 (s, 1 H, HCN), 7.77–7.70 (m, 2 H, 2″-CH + 6″-
CH), 7.10–7.04 (m, 2 H, 3″-CH + 5″-CH), 6.98–6.93 (m, 2 H, 2′-CH + 6′-CH), 6.85–6.82 (m, 
1 H, 5′-CH), 4.85 (dd, J = 8.9, 4.2 Hz, 1 H, 4-CH), 3.90 (s, 3 H, 3′-OCH3 or 4′-OCH3), 3.86 (s, 3 
H, 3′-OCH3 or 4′-OCH3), 3.21 (dd, J = 16.3, 8.9 Hz, 1 H, 3-CHH), 2.89 (dd, J = 16.3, 4.2 Hz,
1 H, 3-CHH), 2.11 (s, 3 H, 1-CH3).
Cyclized Piperidin-4-ones 4A−C
General Procedure for the Synthesis of Compounds 4A–C
A mixture of 3 (1.00 equiv), triethylamine (1.00 equiv), the corresponding aldehyde (1.00 
equiv), L-proline (0.20 equiv) and anhydrous Na2SO4 (0.28 equiv) in EtOH was stirred at 21 °C
under inert atmosphere for 3–4 h. Then, the mixture was quenched with a saturated NH4Cl
solution (75 mL) and the aqueous layer was extracted with AcOEt (3 × 200 mL). The organic 
layers were combined and extracted with a solution 0.1 M HCl (3 × 200 mL). The combined 
extracted aqueous layers were washed with AcOEt and neutralized with 1.0 M aqueous sodium 
hydroxide to pH 7–8. The aqueous layer was extracted with AcOEt (3 × 200 mL) and the 
organic layers were separated. The combined organic layers were washed with saturated brine 
solution. Then, the organic layers were dried over anhydrous Na2SO4, filtered off and 
concentrated under reduced pressure to afford compounds 4A–C.
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(2S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)piperidin-4-one 4A
According to the general procedure, the reaction of amino ketone 
hydrochloride 3 (2.5 g, 9.63 mmol) afforded 4A (2.4 g, 7.28 mmol) as 
an orange solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.48–7.41 (m, 
2 H, 2″-CH + 6″-CH), 7.08–7.02 (m, 2 H, 3″-CH + 5″-CH), 7.02–6.96 
(m, 2 H, 2′-CH + 6′-CH), 6.85 (d, J = 8.1 Hz, 1 H, 5′-CH), 4.05 (dd, J = 10.2, 4.5 Hz, 1 H, 
6-CH), 4.01 (dd, J = 10.9, 3.7 Hz, 1 H, 2-CH), 3.92 (s, 3 H, 3′-OCH3), 3.88 (s, 3 H, 4′-OCH3), 
2.66–2.50 (m, 4 H, 3-CH2 + 5-CH2). 13C NMR [101 MHz, δ (ppm), CDCl3]: 208.1 (4-C), 162.4 
(d, J = 246.2 Hz, 4″-C), 149.3 (3′-C), 148.8 (4′-C), 138.6 (d, J = 3.1 Hz, 1″-C), 135.4 (1′-C), 128.3 
(d, J = 8.1 Hz, 2″-C + 6″-C), 118.8 (6′-C), 115.7 (d, J = 21.3 Hz, 3″-C + 5″-C), 111.3 (5′-C), 109.7 
(2′-C), 61.1 (2-C), 60.6 (6-C), 56.1 (3′-OCH3 or 4′-OCH3), 56.1 (3′-OCH3 or 4′-OCH3), 50.7 (3-C
or 5-C), 50.6 (3-C or 5-C). FTIR [?̅?𝜈 (cm−1)]: 3305, 1710, 1509, 1264, 1232. HRMS [ESI (m/z)] 
calcd for (C19H20FNO3 + H)+ = 330.15055, found 330.15190 (|Δ| = 4.11 ppm). RF: 0.50 
(heptane/AcOEt, 1:1). Yield: 75%.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(trifluoromethyl)phenyl]piperidin-4-one 4B
According to the general procedure, the reaction of amino ketone 
hydrochloride 3 (2.5 g, 9.63 mmol) afforded 4B (1.4 g, 3.70 mmol) 
as an orange solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.66–7.56 
(m, 4 H, 2″-CH + 3″-CH + 5″-CH + 6″-CH), 7.03–6.97 (m, 2 H, 
2′-CH + 6′-CH), 6.85 (d, J = 8.1 Hz, 1 H, 5′-CH), 4.14 (dd, J = 8.6, 7.0 Hz, 1 H, 6-CH), 4.03 (dd,
J = 11.0, 3.6 Hz, 1 H, 2-CH), 3.92 (s, 3 H, 3′-OCH3), 3.88 (s, 3 H, 4′-OCH3), 2.68–2.53 (m, 4 H, 
3-CH2 + 5-CH2). 13C NMR [101 MHz, δ (ppm), CDCl3]: 207.5 (4-C), 149.4 (3′-C), 148.9 (4′-C), 
146.7 (q, J = 1.2 Hz, 1″-C), 135.2 (1′-C), 130.3 (q, J = 32.5 Hz, 4″-C), 127.1 (2″-C + 6″-C), 125.9 
(q, J = 3.7 Hz, 3″-C + 5″-C), 122.7 (CF3, indirect observation), 118.8 (6′-C), 111.3 (5′-C), 109.7 
(2′-C), 61.1 (2-C), 60.8 (6-C), 56.1 (3′-OCH3 + 4′-OCH3), 50.6 (3-C), 50.3 (5-C). HRMS [ESI 
(m/z)] calcd for (C20H21F3NO3 + H)+ = 380.14735, found 380.14778 (|Δ| = 1.13 ppm). RF:
0.60 (heptane/AcOEt, 1:1). Yield: 38%.
520586-L-bw-Riesco
Processed on: 8-8-2018 PDF page: 60
60
Chapter 2
(2S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(pentafluoro-λ6-sulfanyl)phenyl]piperidin-4-one 4C
According to the general procedure, the reaction of amino ketone 
hydrochloride 3 (2.2 g, 8.61 mmol) afforded 4C (1.07 g, 2.45 mmol) 
as a yellow solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.79–7.74 
(m, 2 H, 3″-CH + 5″-CH), 7.61–7.56 (m, 2 H, 2″-CH + 6″-CH), 
7.03–6.96 (m, 2 H, 2′-CH + 6′-CH), 6.86 (d, J = 7.9 Hz, 1 H, 5′-CH), 4.15 (dd, J = 8.3, 6.5 Hz, 1 
H, 6-CH), 4.04 (dd, J = 11.0, 3.3 Hz, 1 H, 2-CH), 3.92 (s, 3 H, 3′-OCH3), 3.88 (s, 3 H, 4′-OCH3), 
2.69–2.50 (m, 4 H, 3-CH2 + 5-CH2). 13C NMR [101 MHz, δ (ppm), CDCl3]: 207.2 (4-C), 153.7 
(4″-C, indirect observation), 149.4 (3′-C), 148.9 (4′-C), 146.6–146.5 (m, 1″-C), 135.1 (1′-C), 127.1 
(2″-C + 6″-C), 126.7–126.5 (m, 3″-C + 5″-C), 118.8 (6′-C), 111.3 (5′-C), 109.7 (2′-C), 61.1 (2-C), 
60.5 (6-C), 56.1 (3′-OCH3 + 4′-OCH3), 50.6 (3-C), 50.2 (5-C). FTIR [?̅?𝜈 (cm−1)]: 1714, 1517, 829. 
HRMS [ESI (m/z)] calcd for (C19H21F5NO3S + H)+ = 438.11623, found 438.11611 (|Δ| = 0.27 
ppm). RF: 0.60 (heptane/AcOEt, 1:1). Yield: 28%.
Cyclized Pictet−Spengler Products 7Aa−Cd, 12 and 13
General Procedure for the Synthesis of Compounds 7Aa−Ca
A mixture of piperidin-4-one 4A−C (1.00 equiv) and tryptamine (1.00 equiv for the synthesis 
of 7Aa and 7Ca and 1.60 equiv for the synthesis of 7Ba) dissolved in CH2Cl2 was stirred at 
21 °C under inert atmosphere for the time indicated in each case. Then, the solution was cool 
down to 0 °C, TFA (2.2 equiv) was added and the reaction mixture was warmed to 21 °C and 
stirred for the time indicated in each case. The reaction mixture was quenched with a saturated 
NaHCO3 solution and the aqueous layer was extracted with CH2Cl2 (three times). The combined 
organic layers were washed with brine, dried over Na2SO4, filtered off and concentrated in 
vacuo.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-2′,3′,4′,9′-tetrahydrospiro[piperi-
dine-4,1′-pyrido[3,4-b]indole] 7Aa 
According to the general procedure, the reaction of piperidin-4-one 
4A (51.5 mg, 0.16 mmol) was stirred overnight in 2.5 mL of CH2Cl2
for the imine formation. TFA (27 µl, 0.34 mmol) in CH2Cl2 (0.14 mL) 
was added and the reaction mixture was stirred for 48 h. The crude 
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mixture was purified by column chromatography (heptane/AcOEt 4:1→AcOEt) and ion 
exchange column chromatography (ISOLUTE SCX-2) to afford compound 7Aa (38.5 mg, 0.08 
mmol) as a yellow solid. 1H NMR [500 MHz, δ (ppm), CDCl3): 7.86 (bs, 1 H, 9′-NH), 7.49–7.44 
(m, 3 H, 5′-CH + 2′′′-CH + 6′′′-CH), 7.29 (d, J = 8.0 Hz, 1 H, 8′-CH), 7.13 (ddd, J = 8.1, 7.1, 1.3 
Hz, 1 H, 7′-CH), 7.10–7.06 (m, 1 H, 6′-CH), 7.06–6.98 (m, 4 H, 2″-CH, 6″-CH + 3′′′-CH + 5′′′-
CH), 6.83 (d, J = 8.2 Hz, 1 H, 5″-CH), 4.50–4.43 (m, 1 H, 6-CH), 4.40 (dd, J = 10.9, 3.1 Hz, 1 H, 
2-CH), 3.92 (s, 3 H, 3″-OCH3), 3.86 (s, 3 H, 4″-OCH3), 3.26 (t, J = 5.7 Hz, 2 H, 3′-CH2), 2.75 (t, 
J = 5.7 Hz, 2 H, 4′-CH2), 2.08–1.93 (m, 4 H, 3-CH2 + 5-CH2). 13C NMR [126 MHz, δ (ppm), 
CDCl3]: 162.1 (d, J = 244.7 Hz, 4′′′-C), 149.1 (3″-C), 148.4 (4″-C), 140.5 (1′′′-C), 139.4 (9′a-C), 
137.3 (1″-C), 135.6 (8′a-C), 128.4 (d, J = 7.9 Hz, 2′′′-C + 6′′′-C), 127.6 (4′b-C), 121.9 (7′-C), 119.5 
(6′-C), 119.0 (6″-C), 118.3 (5′-C), 115.4 (d, J = 21.1 Hz, 3′′′-C + 5′′′-C), 111.3 (5″-C), 110.9 (8′-C), 
110.2 (2″-C), 108.9 (4′a-C), 56.6 (2-C), 56.3 (6-C), 56.13 (3″-OCH3 or 4″-OCH3), 56.11 (3″-OCH3
or 4″-OCH3), 53.3 (4-C), 45.12 (3-C or 5-C), 45.08 (3-C or 5-C), 39.4 (3′-C), 23.3 (4′-C). FTIR [?̅?𝜈
(cm−1)]: 3364, 2933, 2835, 1603, 1507, 1223, 1136, 1025, 804. HRMS [ESI (m/z)] calcd for 
(C29H30FN3O2 + H)+ = 472.23985, found 472.24003 (|Δ| = 0.4 ppm). RF: 0.43 (AcOEt). Yield: 
52%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(trifluoromethyl)phenyl]-2′,3′,4′,9′-tetrahydro-
spiro[piperidine-4,1′-pyrido[3,4-b]indole] 7Ba
According to the general procedure, the reaction of piperidin-4-one 
4B (100 mg, 0.26 mmol) was stirred for 5 h, in the presence of 
molecular sieves (4 Å), in CH2Cl2 (5 mL) for the imine formation. 
TFA (44 µl, 0.57 mmol) in CH2Cl2 (0.25 mL) was added and the 
reaction mixture was stirred for 24 h. The crude mixture was 
purified by two columns of chromatography (heptane/AcOEt 3:1→AcOEt/MeOH 10:1) and 
(heptane/AcOEt 2:3→AcOEt/MeOH 10:1) to afford compound 7Ba (56.6 mg, 0.11 mmol). 1H 
NMR [400 MHz, δ (ppm), CDCl3]: 7.84 (bs, 1 H, 9′-NH), 7.67–7.55 (m, 4 H, 2′′′-CH + 3′′′-CH + 
5′′′-CH + 6′′′-CH,), 7.47 (d, J = 7.7 Hz, 1 H, 5′-CH), 7.27 (dt, J = 8.0, 0.9 Hz, 1 H, 8′-CH), 7.13 
(ddd, J = 8.1, 7.1, 1.3 Hz, 1 H, 7′-CH), 7.10–7.01 (m, 3 H, 2″-CH + 6′-CH + 6″-CH), 6.84 (d, J = 
8.1 Hz, 1 H, 5″-CH), 4.54 (dd, J = 10.5, 3.5 Hz, 1 H, 6-CH), 4.42 (dd, J = 10.4, 3.4 Hz, 1 H, 
2-CH), 3.92 (s, 3 H, 3″-OCH3), 3.87 (s, 3 H, 4″-OCH3), 3.34–3.20 (m, 2 H, 3′-CH2), 2.75 (t, J = 
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5.7 Hz, 2 H, 4′-CH2), 2.08–1.90 (m, 4 H, 3-CH2 + 5-CH2). 13C NMR [101 MHz, δ (ppm), 
CDCl3]: 149.1 (3″-C), 149.0 (q, J = 1.0 Hz, 1′′′-C), 148.4 (4″-C), 139.2 (9′a-C), 137.3 (1″-C), 135.6 
(8′a-C), 129.6 (q, J = 32.3 Hz, 4′′′-C), 127.5 (4′b-C), 127.2 (2′′′-C + 6′′′-C), 125.6 (q, J = 3.7 Hz, 
3′′′-C + 5′′′-C), 124.3 (q, J = 272.2 Hz, CF3), 122.0 (7′-C), 119.6 (6′-C), 118.9 (6″-C), 118.4 (5′-C), 
111.3 (5″-C), 110.9 (8′-C), 110.1 (2″-C), 109.0 (4′a-C), 56.6 (6-C), 56.4 (2-C), 56.1 (3″-OCH3 + 4″-
OCH3), 53.2 (4-C), 45.2 (3-C or 5-C), 45.0 (3-C or 5-C), 39.4 (3′-C), 23.3 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 
3367, 2931, 2838, 1618, 1516, 1261, 1118, 1017, 806. HRMS [ESI (m/z)] calcd for 
(C30H30F3N3O2 + H)+ = 522.23708, found 522.23684 (|Δ| = 0.5 ppm). RF: 0.22 
(heptane/AcOEt, 2:3). Yield: 41%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(pentafluoro-λ6-sulfanyl)phenyl]-2′,3′,4′,9′-tetra-
hydrospiro[piperidine-4,1′-pyrido[3,4-b]indole] 7Ca
According to the general procedure, the reaction of piperidin-4-one 
4C (40 mg, 0.09 mmol) was stirred for 5 h, in the presence of 
molecular sieves (4 Å), in CH2Cl2 (1.5 mL) for the imine formation. 
TFA (20 µl, 0.20 mmol) was added and the reaction mixture was 
stirred 16 h. The crude mixture was purified by column 
chromatography (heptane/AcOEt 4:1→AcOEt) to afford compound 7Ca (24.4 mg, 0.042 
mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.89 (s, 1 H, 9′-NH), 7.75–7.69 (m, 2 H, 3′′′-CH + 
5′′′-CH), 7.62–7.57 (m, 2 H, 2′′′-CH + 6′′′-CH), 7.48 (d, J = 7.7 Hz, 1 H, 5′-CH), 7.27 (d, J = 7.4 
Hz, 1 H, 8′-CH), 7.14 (t, J = 7.5 Hz, 1 H, 7′-CH), 7.11–7.01 (m, 3 H, 6′-CH + 2″-CH + 6″-CH), 
6.85 (d, J = 8.1 Hz, 1 H, 5″-CH), 4.55 (dd, J = 10.3, 2.9 Hz, 1 H, 6-CH), 4.43 (dd, J = 10.6, 2.7 
Hz, 1 H, 2-CH), 3.92 (s, 3 H, 3″-OCH3), 3.87 (s, 3 H, 4″-OCH3), 3.37–3.17 (m, 2 H, 3′-CH2), 
2.76 (t, J = 5.5 Hz, 2 H, 4′-CH2), 2.12–1.91 (m, 4 H, 3-CH2 + 5-CH2), 1.86 (bs, 1 H, 1-NH or 2′-
NH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 152.9 (quint, J = 17.1 Hz, 4′′′-C), 149.1 (3″-C), 
148.8 (1′′′-C), 148.4 (4″-C), 139.1 (9′a-C), 137.1 (1″-C), 135.6 (8′a-C), 127.5 (4′b-C), 127.1 (2′′′-C + 
6′′′-C), 126.3 (quint, J = 4.6 Hz, 3′′′-C + 5′′′-C), 122.0 (7′-C), 119.5 (6′-C), 118.9 (6″-C), 118.4 (5′-
C), 111.3 (5″-C), 110.9 (8′-C), 110.1 (2″-C), 109.0 (4′a-C), 56.3 (6-C + 2-C), 56.14 (3″-OCH3), 
56.09 (4″-OCH3), 53.2 (4-C), 45.1 (3-C or 5-C), 44.8 (3-C or 5-C), 39.4 (3′-C), 23.2 (4′-C). FTIR 
[?̅?𝜈 (cm−1)]: 3373, 2934, 2838, 1592, 1515, 1232, 1138, 1027, 840. HRMS [ESI (m/z)] calcd for 
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(C29H31F5N3O2S + H)+ = 580.20571, found 580.20471 (|Δ| = 1.73 ppm). RF: 0.34 
(heptane/AcOEt, 2:3). Yield: 47%.
General Procedure for the Synthesis of Compounds 7Ab−Cb
A solution of Ti(OiPr)4 (1.30 equiv) in dry THF (0.5 mL) was added to a mixture of piperidin-
4-one 4A−C (1.00 equiv) and 6-methoxytryptamine (1.20 equiv) in dry THF (2 mL) at 21 °C 
under an argon atmosphere. After 6 h, TFA (2.20 equiv) dissolved in dry THF (0.5 mL) was 
added at 0 °C; the reaction mixture was warmed to 21 °C and stirred for 19−24 h. The reaction
mixture was quenched with a saturated NaHCO3 solution and diluted with AcOEt. The layers 
were separated and the aqueous phase was extracted with AcOEt (3 ×). The combined organic 
layers were washed with brine, dried over Na2SO4, filtered off and concentrated in vacuo. The 
crude mixture was purified by column chromatography (heptane/AcOEt 2:1→AcOEt/MeOH 
10:1). The dried product was dissolved in CH2Cl2 (5 mL) and washed with aqueous ammonia 
(25%, 5 mL). The aqueous phase was extracted with CH2Cl2 (3 × 5 mL) and the combined 
organic layers were washed with brine, dried over Na2SO4, filtered off and dried in vacuo to 
afford compounds 7Ab−Cb.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-7′-methoxy-2′,3′,4′,9′-tetrahydro-
spiro[piperidine-4,1′-pyrido[3,4-b]indole] 7Ab
According to the general procedure, the reaction of piperidin-4-
one 4A (50 mg, 0.152 mmol) afforded 7Ab (41.5 mg, 0.083 mmol).
1H NMR [400 MHz, δ (ppm), CDCl3]: 7.79 (bs, 1 H, 9′-NH), 
7.48–7.44 (m, 2 H, 2′′′-CH + 6′′′-CH), 7.33 (d, J = 8.6 Hz, 1 H, 5′-
CH), 7.05 (d, J = 1.9 Hz, 1 H, 2″-CH), 7.03–6.98 (m, 3 H, 6″-CH
+ 3′′′-CH + 5′′′-CH), 6.82 (d, J = 8.3 Hz, 1 H, 5″-CH), 6.80 (d, J = 2.2 Hz, 1 H, 8′-CH), 6.74 (dd,
J = 8.6, 2.2 Hz, 1 H, 6′-CH), 4.44 (dd, J = 9.1, 4.9 Hz, 1 H, 6-CH), 4.39 (dd, J = 11.0, 2.9 Hz, 1 
H, 2-CH), 3.91 (s, 3 H, 3″-OCH3), 3.86 (s, 3 H, 4″-OCH3), 3.81 (s, 3 H, 7′-OCH3), 3.24 (t, J = 5.7 
Hz, 2 H, 3′-CH2), 2.70 (t, J = 5.7 Hz, 2 H, 4′-CH2), 2.06–1.92 (m, 4 H, 3-CH2 + 5-CH2), 1.72 (bs, 
2 H, 1-NH + 2′-NH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 162.1 (d, J = 245.0 Hz, 4′′′-C), 
156.4 (7′-C), 149.1 (3″-C), 148.3 (4″-C), 140.5 (1′′′-C), 138.2 (9′a-C), 137.3 (1″-C), 136.4 (8′a-C), 
128.4 (d, J = 7.9 Hz, 2′′′-C + 6′′′-C), 122.0 (4′b-C), 118.9 (6″-C), 118.8 (5′-C), 115.4 (d, J = 21.2 
Hz, 3′′′-C + 5′′′-C), 111.2 (5″-C), 110.1 (2″-C), 108.9 (6′-C), 108.7 (4′a-C), 95.1 (8′-C), 56.6 (2-C), 
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56.3 (6-C), 56.1 (3″-OCH3 + 4″-OCH3), 55.9 (7′-OCH3), 53.2 (4-C), 45.1 (3-C or 5-C), 45.0 (5-C 
or 3-C), 39.4 (3′-C), 23.3 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3366, 2931, 2835, 1628, 1507, 1223, 1153, 
1025, 764. HRMS [ESI (m/z)] calcd for (C30H32FN3O3 + H)+ = 502.25093, found 502.25059 
(|Δ| = 0.7 ppm). RF: 0.30 (heptane/AcOEt/Et3N, 4:4:1). Yield (BORSM): 74%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-7′-methoxy-6-[4-(trifluoromethyl)phenyl]-2′,3′,4′,9′-
tetrahydrospiro[piperidine-4,1′-pyrido[3,4-b]indole] 7Bb
According to the general procedure, the reaction of piperidin-4-
one 4B (50 mg, 0.132 mmol) afforded 7Bb (56.0 mg, 0.102 mmol). 
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.69 (bs, 1 H, 9′-NH), 
7.64–7.55 (m, 4 H, 2′′′-CH + 3′′′-CH + 5′′′-CH + 6′′′-CH), 7.34 (d, 
J = 8.6 Hz, 1 H, 5′-CH), 7.06–7.01 (m, 2 H, 2″-CH + 6″-CH), 6.84 
(d, J = 8.2 Hz, 1 H, 5″-CH), 6.80 (d, J = 2.2 Hz, 1 H, 8′-CH), 6.75 (dd, J = 8.6, 2.2 Hz, 1 H, 6′-
CH), 4.53 (dd, J = 11.1, 2.3 Hz, 1 H, 6-CH), 4.41 (dd, J = 10.3, 3.5 Hz, 1 H, 2-CH), 3.92 (s, 3 H, 
3″-OCH3), 3.87 (s, 3 H, 4″-OCH3), 3.81 (s, 3 H, 7′-OCH3), 3.28–3.22 (m, 2 H, 3′-CH2), 2.71 (t, 
J = 5.6 Hz, 2 H, 4′-CH2), 2.05–1.89 (m, 4 H, 3-CH2 + 5-CH2), 1.62 (bs, 2 H, 1-NH + 2′-NH). 13C 
NMR [126 MHz, δ (ppm), CDCl3]: 156.4 (7′-C), 149.1 (3″-C), 149.0 (1′′′-C), 148.4 (4″-C), 138.1 
(9′a-C), 137.3 (1″-C), 136.4 (8′a-C), 129.6 (q, J = 32.3 Hz, 4′′′-C), 127.2 (2′′′-C + 6′′′-C), 125.5 (q, 
J = 3.7 Hz, 3′′′-C + 5′′′-C), 124.3 (q, J = 272.0 Hz, CF3), 122.0 (4′b-C), 118.9 (6″-C), 118.8 (5′-C), 
111.3 (5″-C), 110.2 (2″-C), 108.8 (6′-C), 108.7 (4′a-C), 95.2 (8′-C), 56.6 (6-C), 56.4 (2-C), 56.1 (3″-
OCH3 + 4″-OCH3), 55.9 (7′-OCH3), 53.2 (4-C), 45.1 (3-C), 44.9 (5-C), 39.4 (3′-C), 23.3 (4′-C).
FTIR [?̅?𝜈 (cm−1)]: 3369, 2926, 2835, 1619, 1515, 1260, 1097, 1066, 797. HRMS [ESI (m/z)] calcd 
for (C31H32F3N3O3 + H)+ = 552.24737, found 552.24740 (|Δ| = 0.1 ppm). RF: 0.32
(heptane/AcOEt/Et3N, 4:4:1). Yield: 77%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-7′-methoxy-6-[4-(pentafluoro-6-sulfanyl)phenyl]-
2′,3′,4′,9′-tetrahydrospiro[piperidine-4,1′-pyrido[3,4-b]indole] 7Cb
According to the general procedure, the reaction of piperidin-4-
one 4C (50 mg, 0.114 mmol) afforded 7Cb (18.1 mg, 0.030 
mmol). In this case, after following the general procedure, the 
crude mixture was purified by a second column chromatography 
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(heptane/AcOEt 2:1→AcOEt/MeOH 10:1) and an ion exchange column chromatography 
(ISOLUTE SCX-2). The dried product was dissolved again in CH2Cl2 (5 mL) and washed with 
aqueous ammonia (25%, 5 mL). The combined aqueous layers were extracted with CH2Cl2 (3 × 
5 mL) and the organic layers were washed with brine, dried over Na2SO4, filtered off and dried in 
vacuo. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.73–7.70 (m, 2 H, 3′′′-CH + 5′′′-CH), 7.68 (bs, 1 
H, 9′-NH), 7.61–7.57 (m, 2 H, 2′′′-CH + 6′′′-CH), 7.34 (d, J = 8.6 Hz, 1 H, 5′-CH), 7.04 (d, J = 
2.0 Hz, 1 H, 2″-CH), 7.02 (dd, J = 8.2, 2.0 Hz, 1 H, 6″-CH), 6.84 (d, J = 8.2 Hz, 1 H, 5″-CH), 
6.79 (d, J = 2.2 Hz, 1 H, 8′-CH), 6.75 (dd, J = 8.6, 2.2 Hz, 1 H, 6′-CH), 4.53 (dd, J = 11.1, 2.2 Hz, 
1 H, 6-CH), 4.41 (dd, J = 10.4, 3.5 Hz, 1 H, 2-CH), 3.92 (s, 3 H, 3″-OCH3), 3.87 (s, 3 H, 4″-
OCH3), 3.81 (s, 3 H, 7′-OCH3), 3.28–3.21 (m, 2 H, 3′-CH2), 2.71 (t, J = 5.7 Hz, 2 H, 4′-CH2), 
2.04–1.87 (m, 4 H, 3-CH2 + 5-CH2), 1.62 (bs, 2 H, 1-NH + 2′-NH). 13C NMR [101 MHz, δ 
(ppm), CDCl3]: 156.5 (7′-C), 152.9 (quint, J = 17.6 Hz, 4′′′-C), 149.1 (3″-C), 148.8 (1′′′-C), 148.5 
(4″-C), 137.9 (9′a-C), 137.1 (1″-C), 136.4 (8′a-C), 127.1 (2′′′-C + 6′′′-C), 126.3 (quint, J = 4.4 Hz, 
3′′′-C + 5′′′-C), 122.0 (4′b-C), 118.9 (6″-C), 118.9 (5′-C), 111.3 (5″-C), 110.1 (2″-C), 108.9 (6′-C), 
108.8 (4′a-C), 95.2 (8′-C), 56.3 (2-C + 6-C), 56.14 (3″-OCH3), 56.09 (4″-OCH3), 55.9 (7′-OCH3), 
53.2 (4-C), 45.1 (3-C or 5-C), 44.8 (5-C or 3-C), 39.4 (3′-C), 23.3 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3371, 
2938, 2837, 1629, 1516, 1262, 1154, 1027, 823, 729. HRMS [ESI (m/z)] calcd for 
(C30H32F5N3O3S + H)+ = 610.21561, found 610.21628 (|Δ| = 1.1 ppm). RF: 0.28 
(heptane/AcOEt/Et3N, 4:4:1). Yield (BORSM): 56%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-2′,3′,4′,9′-tetrahydrospiro[piperi-
dine-4,1′-pyrido[3,4-b]indol]-6′-ol 7Ac
Triethylamine (25 µL, 0.182 mmol) dissolved in dry THF (0.25 mL) 
and Ti(OiPr)4 (58 µL, 0.197 mmol) dissolved in dry THF (0.25 mL) 
were added to a mixture of 4A (50 mg, 0.152 mmol) and serotonin
hydrochloride (38.7 mg, 0.182 mmol) dissolved in dry THF (0.5 mL). 
After 30 min, additional Et3N (25 µL, 0.182 mmol) and THF (16.5 
mL) were added. After 4.5 h, TFA (52 µL, 0.668 mmol) dissolved in 
dry THF (0.5 mL) was added at 0 °C and the reaction mixture was warmed to 21 °C and stirred 
for 21 h. The reaction mixture was quenched with an aqueous saturated NaHCO3 solution and 
diluted with AcOEt. The organic and aqueous phases were separated and the aqueous phase was 
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extracted with AcOEt (4 ×). The combined organic layers were washed with brine, dried with 
Na2SO4, filtered and dried in vacuo. The crude was dissolved in dry THF (2 mL) and serotonin 
hydrochloride (15.5 mg, 0.073 mmol), Et3N (10 µL, 0.073 mmol) in dry THF (0.5 mL) and 
Ti(OiPr)4 (23.2 µL, 0.079 mmol) were added. After 3 h, TFA (10.4 µL, 0.134 mmol) was added at 
0 °C, the reaction mixture was warmed to 21 °C and stirred for 20.5 h. The reaction mixture was 
quenched with an aqueous saturated NaHCO3 solution and diluted with AcOEt. The organic 
and aqueous phases were separated and the aqueous phase was extracted with AcOEt (4 ×). The 
combined organic layers were washed with brine, dried with Na2SO4, filtered and dried in vacuo. 
The crude was purified by column chromatography (AcOEt→AcOEt/MeOH 10:1). The dried 
product was dissolved in CH2Cl2 (5 mL) and washed with aqueous ammonia (25%, 2 × 5 mL). 
The combined aqueous layers were extracted with CH2Cl2 (3 × 10 mL) and the combined 
organic layers were washed with brine, dried over Na2SO4, filtered off and dried in vacuo to 
afford 7Ac (37.0 mg, 0.076 mmol) as a yellow solid. 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.81 
(bs, 1 H, 9′-NH), 7.45 (m, 2 H, 2′′′-CH + 6′′′-CH), 7.09 (d, J = 8.6 Hz, 1 H, 8′-CH), 7.05 (d, J = 
2.0 Hz, 1 H, 2″-CH), 7.03–6.96 (m, 3 H, 6″-CH + 3′′′-CH + 5′′′-CH), 6.84 (d, J = 2.4 Hz, 1 H, 5′-
CH), 6.81 (d, J = 8.2 Hz, 1 H, 5″-CH), 6.67 (dd, J = 8.6, 2.4 Hz, 1 H, 7′-CH), 4.44 (dd, J = 10.4, 
3.6 Hz, 1 H, 6-CH), 4.39 (dd, J = 11.1, 2.6 Hz, 1 H, 2-CH), 3.87 (s, 3 H, 3″-OCH3), 3.85 (s, 3 H, 
4″-OCH3), 3.22 (t, J = 5.7 Hz, 2 H, 3′-CH2), 2.63 (t, J = 5.7 Hz, 2 H, 4′-CH2), 2.10–1.93 (m, 4 H, 
3-CH2 + 5-CH2). 13C NMR [126 MHz, δ (ppm), CDCl3]: 162.1 (d, J = 245.2 Hz, 4′′′-C), 149.6 
(6′-C), 149.1 (3″-C), 148.4 (4″-C), 140.6 (9′a-C), 140.2 (d, J = 2.9 Hz, 1′′′-C), 137.1 (1″-C), 130.9 
(8′a-C), 128.5 (d, J = 7.9 Hz, 2′′′-C + 6′′′-C), 128.3 (4′b-C), 119.0 (6″-C), 115.4 (d, J = 21.2 Hz, 3′′′-
C + 5′′′-C), 111.5 (7′-C), 111.5 (8′-C), 111.3 (5″-C), 110.2 (2″-C), 108.4 (4′a-C), 103.4 (5′-C), 56.7 
(2-C), 56.4 (6-C), 56.14 (3″-OCH3 or 4″-OCH3), 56.11 (3″-OCH3 or 4″-OCH3), 53.4 (4-C), 44.8 
(3-C + 5-C), 39.3 (3′-C), 23.2 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3367, 2931, 2838, 1591, 1515, 1261, 1118, 
1016, 800. HRMS [ESI (m/z)] calcd for (C29H30FN3O3 + H)+ = 488.23454, found 488.23494 
(|Δ| = 0.8 ppm). RF: 0.32 (AcOEt/Et3N, 8:1). Yield (BORSM): 80%.
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(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(trifluoromethyl)phenyl]-2′,3′,4′,9′-tetrahydro-
spiro[piperidine-4,1′-pyrido[3,4-b]indol]-6′-ol 7Bc 
Triethylamine (22 µL, 0.158 mmol) dissolved in dry THF (0.50 mL)
and Ti(OiPr)4 (50 µL, 0.171 mmol) dissolved in dry THF (0.50 mL)
were added to a mixture of 4B (50 mg, 0.132 mmol) and serotonin
hydrochloride (33.6 mg, 0.158 mmol) dissolved in dry THF (2 mL).
After 7 h, TFA (22 µL, 0.290 mmol) dissolved in dry THF (0.5 mL)
was added at 0 °C and the reaction mixture was warmed to 21 °C
and stirred for 23 h. The reaction mixture was quenched with an aqueous saturated NaHCO3
solution and diluted with AcOEt. The organic and aqueous phases were separated and the 
aqueous phase was extracted with AcOEt (4 h). The combined organic layers were washed with 
brine, dried with Na2SO4, filtered and dried in vacuo. The crude mixture was dissolved in dry 
THF (1.5 mL) and serotonin hydrochloride (33.6 mg, 0.158 mmol), Et3N (22 µL, 0.158 mmol) in 
dry THF (0.5 mL) and Ti(OiPr)4 (50 µL, 0.171 mmol) were added. After 7 h, TFA (22 µL, 0.290 
mmol) dissolved in dry THF (0.5 mL) was added at 0 °C, the reaction mixture was warmed to 
21 °C and stirred for 24.5 h. The reaction mixture was quenched with an aqueous saturated 
NaHCO3 solution and diluted with AcOEt. The organic and aqueous phases were separated and 
the aqueous phase was extracted with AcOEt (3 ×). The combined organic layers were washed 
with brine, dried with Na2SO4, filtered and dried in vacuo. The crude was purified by column 
chromatography (heptane/AcOEt 1:1→AcOEt/MeOH 10:1). The dried product was dissolved 
in CH2Cl2 (5 mL) and washed with aqueous ammonia (25%, 5 mL). The aqueous layer was 
extracted with CH2Cl2 (3 × 5 mL) and the combined organic layers were washed with brine, 
dried over Na2SO4, filtered off and dried in vacuo to afford 7Bc (27.5 mg, 0.051 mmol) as a 
purple solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.70 (bs, 1 H, 9′-NH), 7.62–7.55 (m, 4 H, 
2′′′-CH + 3′′′-CH + 5′′′-CH + 6′′′-CH), 7.10 (d, J = 8.6 Hz, 1 H, 8′-CH), 7.04 (d, J = 1.8 Hz, 1 H, 
2″-CH), 7.02 (dd, J = 8.2, 1.9 Hz, 1 H, 6″-CH), 6.86 (d, J = 2.4 Hz, 1 H, 5′-CH), 6.83 (d, J = 8.2 
Hz, 1 H, 5″-CH), 6.68 (dd, J = 8.6, 2.4 Hz, 1 H, 7′-CH), 4.53 (dd, J = 10.7, 3.0 Hz, 1 H, 6-CH), 
4.41 (dd, J = 10.7, 3.0 Hz, 1 H, 2-CH), 3.90 (s, 3 H, 3″-OCH3), 3.86 (s, 3 H, 4″-OCH3), 3.34–
3.16 (m, 2 H, 3′-CH2), 2.66 (t, J = 5.7 Hz, 2 H, 4′-CH2), 2.19–1.91 (m, 5 H, 3-CH2 + 5-CH2, 1-
NH or 2′-NH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 149.6 (6′-C), 149.1 (3″-C), 148.5 (4″-C), 
148.3 (1′′′-C), 140.3 (9′a-C), 136.7 (1″-C), 130.9 (8′a-C), 129.6 (q, J = 32.4 Hz, 4′′′-C), 128.2 (4′b-C), 
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127.3 (2′′′-C + 6′′′-C), 125.6 (q, J = 3.7 Hz, 3′′′-C + 5′′′-C), 124.3 (q, J = 272.0 Hz, CF3), 119.1 (6″-
C), 111.7 (8′-C), 111.5 (7′-C), 111.3 (5″-C), 110.2 (2″-C), 108.3 (4′a-C), 103.5 (5′-C), 56.7 (6-C), 
56.6 (2-C), 56.1 (3″-OCH3 or 4″-OCH3), 56.0 (3″-OCH3 or 4″-OCH3), 53.4 (4-C), 44.5 (3-C or 5-
C), 44.3 (3-C or 5-C), 39.3 (3′-C), 23.1 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3364, 3305, 2931, 2836, 1591, 
1509, 1223, 1140, 1024, 800. HRMS [ESI (m/z)] calcd for (C30H30F3N3O3 + H)+ = 538.23216, 
found 538.23175 (|Δ| = 0.8 ppm). RF: 0.32 (AcOEt/Et3N, 8:1). Yield (BORSM): 74%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(pentafluoro-λ6-sulfanyl)phenyl]-2′,3′,4′,9′-tetra-
hydrospiro[piperidine-4,1′-pyrido[3,4-b]indol]-6′-ol 7Cc
Triethylamine (19 µL, 0.137 mmol) dissolved in dry THF (0.5 mL) 
and Ti(OiPr)4 (44 µL, 0.149 mmol) dissolved in dry THF (0.5 mL) 
were added to a mixture of 4A (50 mg, 0.114 mmol) and serotonin
hydrochloride (29.2 mg, 0.137 mmol) in dry THF (2 mL). After 6 h, 
TFA (19 µL, 0.251 mmol) dissolved in dry THF (0.5 mL) was added 
at 0 °C and the reaction mixture was warmed to 21 °C and stirred 
for 20 h. The reaction mixture was quenched with NaHCO3 and diluted with AcOEt. The 
organic layer was separated and the aqueous phase was extracted with AcOEt (4 ×). The 
combined organic layers were washed with brine, dried over Na2SO4, filtered off and dried in 
vacuo. The crude was purified by column chromatography (heptane/AcOEt
1:1→AcOEt/MeOH 10:1) and the dried product was dissolved in CH2Cl2 (5 mL) and washed 
with aqueous ammonia (25%, 5 mL). The aqueous phase was extracted with CH2Cl2 (3 × 5 mL) 
and the combined organic layers were washed with brine, dried over Na2SO4, filtered off and 
dried in vacuo to afford 7Cc (32.4 mg, 0.054 mmol) as a purple solid. 1H NMR [500 MHz, δ 
(ppm), CDCl3]: 7.81 (bs, 1 H, 9′-NH), 7.71–7.66 (m, 2 H, 3′′′-CH + 5′′′-CH), 7.59–7.54 (m, 2 H, 
2′′′-CH + 6′′′-CH), 7.08 (d, J = 8.6 Hz, 1 H, 8′-CH), 7.04 (d, J = 1.9 Hz, 1 H, 2″-CH), 7.01 (dd,
J = 8.2, 1.9 Hz, 1 H, 6″-CH), 6.84 (d, J = 2.4 Hz, 1 H, 5′-CH), 6.82 (d, J = 8.3 Hz, 1 H, 5″-CH), 
6.67 (dd, J = 8.6, 2.4 Hz, 1 H, 7′-CH), 4.54–4.50 (m, 1 H, 6-CH), 4.41 (dd, J = 11.2, 2.2 Hz, 1 H, 
2-CH), 3.87 (s, 3 H, 3″-OCH3), 3.85 (s, 3 H, 4″-OCH3), 3.29–3.16 (m, 2 H, 3′-CH2), 2.62 (t, J = 
5.6 Hz, 2 H, 4′-CH2), 2.13–1.90 (m, 5 H, 3-CH2 + 5-CH2, 1-NH or 2′-NH). 13C NMR [126 
MHz, δ (ppm), CDCl3]: 153.0 (quint, J = 16.9 Hz, 4′′′-C), 149.6 (6′-C), 149.2 (3″-C), 148.5 (4″-C), 
148.3 (1′′′-C), 140.2 (9′a-C), 136.7 (1″-C), 130.9 (8′a-C), 128.2 (4′b-C), 127.2 (2′′′-C + 6′′′-C), 126.3 
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(quint, J = 4.2 Hz, 3′′′-C + 5′′′-C), 119.1 (6″-C), 111.7 (7′-C), 111.5 (8′-C), 111.3 (5″-C), 110.2 (2″-
C), 108.4 (4′a-C), 103.5 (5′-C), 56.5 (2-C), 56.4 (6-C), 56.14 (3″-OCH3 or 4″-OCH3), 56.12 (3″-
OCH3 or 4″-OCH3), 53.3 (4-C), 44.6 (3-C), 44.3 (5-C), 39.3 (3′-C), 23.1 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 
3367, 2961, 2839, 1592, 1516, 1260, 103, 799. HRMS [ESI (m/z)] calcd for (C29H30F5N3O3S + 
H)+ = 596.20116, found 596.20063 (|Δ| = 0.9 ppm). RF: 0.37 (AcOEt/Et3N, 8:1). Yield 
(BORSM): 76%.
General Procedure for the Synthesis of Compounds 7Ad−Cd
A solution of triethylamine (1.20 equiv) in dry THF (0.5 mL) and a solution of Ti(OiPr)4 (1.30 
equiv) in dry THF (0.5 mL) were added to a mixture of piperidin-4-one 4A−C (1.00 equiv) and 
5-fluorotryptamine hydrochloride (1.20 equiv) in dry THF (2 mL) at 21 °C under an argon 
atmosphere. After 4−7 h, TfOH (3.00 equiv for 7Ad−7Bd and 3.50 equiv for 7Cd) dissolved in 
dry THF (0.5 mL) was added at 0 °C, the reaction mixture was warmed to 21 °C and stirred for 
22−25 h. The reaction mixture was quenched with a saturated NaHCO3 solution and diluted 
with AcOEt. The layers were separated and the aqueous phase was extracted with AcOEt (3 ×). 
The combined organic layers were washed with brine, dried over Na2SO4, filtered off and 
concentrated in vacuo. The crude mixture was purified by column chromatography 
(heptane/AcOEt 2:1→AcOEt/MeOH 10:1) and the dried product was dissolved in CH2Cl2
(5 mL) and washed with aqueous ammonia (25%, 5 mL). The aqueous phase was extracted with 
CH2Cl2 (3 × 5 mL) and the combined organic layers were washed with brine, dried over Na2SO4, 
filtered off and dried in vacuo to afford compounds 7Ad−Cd.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6′-fluoro-6-(4-fluorophenyl)-2′,3′,4′,9′-tetrahydrospi-
ro[piperidine-4,1′-pyrido[3,4-b]indole] 7Ad
According to the general procedure, the reaction of piperidin-4-one 
4A (50 mg, 0.152 mmol) afforded 7Ad (46.1 mg, 0.094 mmol) as a 
yellow solid. 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.93 (bs, 1 H, 9′-
NH), 7.50–7.43 (m, 2 H, 2′′′-CH + 6′′′-CH), 7.20–7.16 (m, 1 H, 8′-CH), 
7.10 (dd, J = 9.4, 2.5 Hz, 1 H, 5′-CH), 7.04 (d, J = 2.0 Hz, 1 H, 2″-
CH), 7.02–6.98 (m, 3 H, 6″-CH + 3′′′-CH + 5′′′-CH), 6.86 (td, J = 9.2, 
2.5 Hz, 1 H, 7′-CH), 6.82 (d, J = 8.2 Hz, 1 H, 5″-CH), 4.46–4.43 (m, 1 H, 6-CH), 4.40 (dd, J = 
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10.8, 3.1 Hz, 1 H, 2-CH), 3.91 (s, 3 H, 3″-OCH3), 3.86 (s, 3 H, 4″-OCH3), 3.25 (t, J = 5.8 Hz, 2 
H, 3′-CH2), 2.69 (t, J = 5.8 Hz, 2 H, 4′-CH2), 2.09–1.93 (m, 4 H, 3-CH2 + 5-CH2), 1.72 (bs, 2 H, 
1-NH + 2′-NH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 162.1 (d, J = 245.2 Hz, 4′′′-C), 157.9 (d, 
J = 234.3 Hz, 6′-C), 149.1 (3″-C), 148.4 (4″-C), 141.4 (9′a-C), 140.4 (1′′′-C), 137.1 (1″-C), 132.1 
(8′a-C), 128.4 (d, J = 7.9 Hz, 2′′′-C + 6′′′-C), 127.9 (d, J = 9.8 Hz, 4′b-C), 119.0 (6″-C), 115.4 (d, 
J = 21.1 Hz, 3′′′-C + 5′′′-C), 111.4 (d, J = 9.4 Hz, 8′-C), 111.2 (5″-C), 110.1 (2″-C), 109.9 (d, J = 
26.0 Hz, 7′-C), 109.1 (d, J = 4.3 Hz, 4′a-C), 103.4 (d, J = 23.2 Hz, 5′-C), 56.6 (2-C), 56.3 (6-C), 
56.14 (3″-OCH3 or 4″-OCH3), 56.10 (3″-OCH3 or 4″-OCH3), 53.3 (4-C), 45.04 (3-C or 5-C), 
45.02 (3-C or 5-C), 39.3 (3′-C), 23.2 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3362, 2930, 2838, 1601, 1508, 1225, 
1139, 1025, 798. HRMS [ESI (m/z)] calcd for (C29H29F2N3O2 + H)+ = 490.23155, found 
490.23061 (|Δ| = 0.9 ppm). RF: 0.37 (heptane/AcOEt/Et3N, 4:4:1). Yield (BORSM): 74%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6′-fluoro-6-[4-(trifluoromethyl)phenyl]-2′,3′,4′,9′-tet-
rahydrospiro[piperidine-4,1′-pyrido[3,4-b]indole] 7Bd
According to the general procedure, the reaction of piperidin-4-one 
4B (50 mg, 0.132 mmol) afforded 7Bd (21.9 mg, 0.041 mmol) as a 
yellow solid. In this case, after following the general procedure, the 
crude was purified for a second time by an ion exchange column 
(ISOLUTE SCX-2); the dried product was dissolved in CH2Cl2
(5 mL) and washed with aqueous ammonia (25%, 5 mL). The aqueous phase was extracted with 
CH2Cl2 (3 × 5 mL) and the combined organic layers were washed with brine, dried over Na2SO4, 
filtered off and dried in vacuo. 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.94 (bs, 1 H, 9′-NH), 
7.65–7.55 (m, 4 H, 2′′′-CH + 3′′′-CH + 5′′′-CH + 6′′′-CH), 7.20-7.15 (m, 1 H, 8′-CH), 7.10 (dd, J = 
9.4, 2.4 Hz, 1 H, 5′-CH), 7.08–7.04 (m, 1 H, 2″-CH), 7.06–7.00 (m, 1 H, 6″-CH), 6.86 (td, J = 9.2, 
2.6 Hz, 1 H, 7′-CH), 6.83 (d, J = 8.3 Hz, 1 H, 5″-CH), 4.57–4.52 (m, 1 H, 6-CH), 4.45–4.41 (m, 1 
H, 2-CH), 3.91 (s, 3 H, 3″-OCH3), 3.86 (s, 3 H, 4″-OCH3), 3.29–3.22 (m, 2 H, 3′-CH2), 2.70 (t, 
J = 5.5 Hz, 2 H, 4′-CH2), 2.09–1.92 (m, 4 H, 3-CH2 + 5-CH2), 1.80 (bs, 2 H, 1-NH + 2′-NH).
13C NMR [126 MHz, δ (ppm), CDCl3]: 157.9 (d, J = 234.3 Hz, 6′-C), 149.2 (3″-C), 148.5 (4″-C), 
148.4 (1′′′-C), 141.1 (9′a-C), 136.8 (1″-C), 132.1 (8′a-C), 129.7 (q, J = 32.6 Hz, 4′′′-C), 127.9 (d, J = 
9.6 Hz, 4′b-C), 127.3 (2′′′-C + 6′′′-C), 125.6 (q, J = 3.4 Hz, 3′′′-C + 5′′′-C), 124.3 (q, J = 271.5 Hz, 
CF3), 119.0 (6″-C), 111.4 (d, J = 9.6 Hz, 8′-C), 111.3 (5″-C), 110.2 (2″-C), 110.0 (d, J = 26.0 Hz, 
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7′-C), 109.1 (d, J = 4.5 Hz, 4′a-C), 103.4 (d, J = 23.2 Hz, 5′-C), 56.6 (6-C), 56.5 (2-C), 56.13 (3″-
OCH3 or 4″-OCH3), 56.11 (3″-OCH3 or 4″-OCH3), 53.2 (4-C), 44.6 (3-C), 44.4 (5-C), 39.3 (3′-C), 
23.1 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3362, 2935, 2837, 1586, 1514, 1261, 1017, 799. HRMS [ESI (m/z)] 
calcd for (C30H29F4N3O2 + H)+ = 540.22734, found 540.22741 (|Δ| = 0.1 ppm). RF: 0.41 
(heptane/AcOEt/Et3N, 4:4:1). Yield (BORSM): 37%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6′-fluoro-6-[4-(pentafluoro-λ6-sulfanyl)phenyl]-
2′,3′,4′,9′-tetrahydrospiro[piperidine-4,1′-pyrido[3,4-b]indole] 7Cd
According to the general procedure, the reaction of piperidin-4-one 
4C (50 mg, 0.114 mmol) afforded 7Cd (27.6 mg, 0.046 mmol) as a 
yellow solid. 1H NMR [500 MHz, δ (ppm), CDCl3]: 8.02 (bs, 1 H, 
9′-NH), 7.72–7.69 (m, 2 H, 3′′′-CH + 5′′′-CH), 7.61–7.56 (m, 2 H, 2′′′-
CH + 6′′′-CH), 7.20–7.15 (m, 1 H, 8′-CH), 7.10 (dd, J = 9.5, 2.5 Hz, 
1 H, 5′-CH), 7.04 (d, J = 2.0 Hz, 1 H, 2″-CH), 7.02 (dd, J = 8.2, 2.0 
Hz, 1 H, 6″-CH), 6.87 (td, J = 9.1, 2.6 Hz, 1 H, 7′-CH), 6.83 (d, J = 8.2 Hz, 1 H, 5″-CH), 4.54 
(dd, J = 7.6, 6.1 Hz, 1 H, 6-CH), 4.42 (dd, J = 11.0, 2.2 Hz, 1 H, 2-CH), 3.91 (s, 3 H, 3″-OCH3), 
3.86 (s, 3 H, 4″-OCH3), 3.31–3.20 (m, 2 H, 3′-CH2), 2.69 (t, J = 5.7 Hz, 2 H, 4′-CH2), 2.13–1.96 
(m, 4 H, 3-CH2 + 5-CH2). 13C NMR [126 MHz, δ (ppm), CDCl3]: 157.9 (d, J = 234.4 Hz, 6′-C), 
153.0 (quint, J = 16.9 Hz, 4′′′-C), 149.2 (3″-C), 148.5 (4″-C), 148.4 (1′′′-C), 141.0 (9′a-C), 136.8 (1″-
C), 132.1 (8′a-C), 127.9 (d, J = 9.6 Hz, 4′b-C), 127.2 (2′′′-C + 6′′′-C), 126.3 (quint, J = 4.5 Hz, 3′′′-C
+ 5′′′-C), 119.0 (6″-C), 111.4 (d, J = 9.8 Hz, 8′-C), 111.3 (5″-C), 110.1 (2″-C), 110.0 (d, J = 26.6 
Hz, 7′-C), 109.2 (d, J = 4.5 Hz, 4′a-C), 103.4 (d, J = 23.4 Hz, 5′-C), 56.4 (2-C), 56.3 (6-C), 56.1 
(3″-OCH3 + 4″-OCH3), 53.2 (4-C), 44.9 (3-C), 44.6 (5-C), 39.3 (3′-C), 23.2 (4′-C). FTIR [?̅?𝜈
(cm−1)]: 3367, 2962, 2839, 1588, 1515, 1260, 1022, 795. HRMS [ESI (m/z)] calcd for 
(C29H29F6N3O2S + H)+ = 598.19536, found 598.19629 (|Δ| = 1.6 ppm). RF: 0.25 
(heptane/AcOEt/Et3N, 4:4:1). Yield (BORSM): 52%.
General Procedure for the Synthesis of Compounds 12 and 13
Ti(OiPr)4 was added to a mixture of piperidin-4-one 4A (1.00 equiv) and the amine (1.20 equiv; 
2-(1H-indol-2-yl)ethan-1-amine for 12 and 2-(1H-pyrrol-2-yl)ethan-1-amine for 13) in dry THF 
(3 mL) at 21 °C under an argon atmosphere. After 6 h, TFA (2.20 equiv) was added at 0 °C; the 
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reaction mixture was warmed to 21 °C and stirred overnight. The reaction mixture was quenched 
with a saturated NaHCO3 solution (3 mL) and diluted with AcOEt. The layers were separated 
and the aqueous phase was extracted with AcOEt (4 × 6 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, filtered off and concentrated in vacuo. The crude was 
purified by column chromatography (heptane/AcOEt 2:1→AcOEt). The dried product was 
dissolved in CH2Cl2 (5 mL) and washed with aqueous ammonia (25%, 5 mL). The aqueous phase 
was extracted with CH2Cl2 (3 × 5 mL) and the combined organic layers were washed with brine, 
dried over Na2SO4, filtered off and dried in vacuo to afford compounds 12 and 13.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-2',3',4',5'-tetrahydrospiro[piperi-
dine-4,1'-pyrido[4,3-b]indole] 12
According to the general procedure, the reaction of piperidin-4-one 
4A (15 mg, 0.05 mmol) afforded 12 (12 mg, 0.03 mmol). 1H NMR
[400 MHz, δ (ppm), CDCl3]: 7.88–7.75 (m, 2 H, 5-NH + 9′-CH) 
7.51−7.47 (m, 2 H, 2′′′-CH + 6′′′-CH), 7.31–7.27 (m, 1 H, 6′-CH), 
7.14–7.09 (m, 2 H, 7′-CH or 8′-CH), 7.08–7.03 (m, 2 H, 2″-CH + 6″-
CH), 7.03–6.95 (m, 2 H, 3′′′-CH + 5′′′-CH), 6.85−6.80 (m, 1 H, 5″-CH), 4.47–4.41 (m, 1 H, 6-
CH), 4.40 (dd, J = 12.2, 2.2 Hz, 1 H, 2-CH), 3.90 (s, 3 H, 3″-OCH3), 3.85 (s, 3 H, 4″-OCH3), 
3.26 (t, J = 5.6 Hz, 2 H, 3′-CH2), 2.74 (t, J = 5.6 Hz, 2 H, 4′-CH2), 2.60–2.39 (m, 2 H, 3-CHH or 
5-CHH), 1.92–1.82 (m, 2 H, 3-CHH or 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 162.0 
(4′′′-C, indirect observation), 149.0 (3″-OCH3), 148.2 (4″-OCH3), 140.0 (1′′′-C, indirect 
observation), 137.9 (1″-C, indirect observation), 132.5 (4′a-C), 131.1 (5′a-C), 128.5 (d, J = 7.8 Hz, 
2′′′-C + 6′′′-C), 125.1 (9′a-C), 121.2 (7′ or 8′ or 9′-C), 119.5 (7′ or 8′ or 9′-C), 119.4 (7′ or 8′ or 9′-C), 
119.0 (6″-C), 116.4 (9′b-C), 115.2 (d, J = 21.1 Hz, 3′′′-C + 5′′′-C), 111.3 (5″-C), 110.9 (6′-C), 110.4 
(2″-C), 56.9 (2-C), 56.6 (6-C), 56.1 (3″-OCH3 + 4″-OCH3), 54.2 (4-C), 44.8 (3-C or 5-C), 44.6 
(3-C or 5-C), 38.7 (3′-C), 24.8 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3366, 2957, 2856, 1602, 1508, 1229, 1156, 
1026, 763. HRMS [ESI (m/z)] calcd for (C29H31F1N3O2 + H)+ = 472.24003, found 472.24094 
(|Δ| = 1.92 ppm). RF: 0.35 (AcOEt/Et3N, 8:1). Yield: 52%.
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(2S,4S,6R)-2-(3,4-dimethoxyphenyl)-6-(4-fluorophenyl)-1',5',6',7'-tetrahydrospiro[piperi-
dine-4,4'-pyrrolo[3,2-c]pyridine] 13
According to the general procedure, the reaction of piperidin-4-one 
4A (40 mg, 0.12 mmol) afforded 13 (22 mg, 0.062 mmol). 1H NMR
[400 MHz, δ (ppm), CDCl3]: 7.79 (bs, 1 H, 5′-NH), 7.49–7.39 (m, 2 H, 
2′′′-CH + 6′′′-CH), 7.06–6.95 (m, 4 H, 2″-CH + 6″-CH + 3′′′-CH + 5′′′-
CH), 6.82 (d, J = 8.2 Hz, 1 H, 5″-CH), 6.60 (t, J = 2.7 Hz, 1 H, 6′-
CH), 6.06 (t, J = 2.7 Hz, 1 H, 7′-CH), 4.33 (dd, J = 11.3, 3.5 Hz, 1 H, 6-CH), 4.29 (dd, J = 11.6, 
2.9 Hz, 1 H, 2-CH), 3.90 (s, 3 H, 3″-OCH3), 3.86 (s, 3 H, 4″-OCH3), 3.20 (t, J = 5.8 Hz, 2 H, 3′-
CH2), 2.58 (t, J = 5.8 Hz, 2 H, 4′-CH2), 2.07–1.79 (m, 4 H, 3-CH2 + 5-CH2), 1.68 (bs, 1 H, 1-NH
or 2′-NH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 162.0 (d, J = 244.4 Hz, 4′′′-C), 149.0 (3″-C), 
148.1 (4″-C), 141.1 (d, J = 3.0 Hz, 1′′′-C), 138.0 (1″-C), 128.4 (d, J = 7.9 Hz, 2′′′-C + 6′′′-C), 124.8 
(4′a-C), 118.9 (6″-C), 116.0 (6′-C), 115.1 (d, J = 21.1 Hz, 3′′′-C + 5′′′-C), 111.2 (5″-C), 110.9 (7′a-
C), 110.2 (2″-C), 104.5 (7′-C), 56.8 (2-C), 56.5 (6-C), 56.1 (3″-OCH3 + 4″-OCH3), 53.5 (4-C), 46.4 
(3-C or 5-C), 46.3 (3-C or 5-C), 38.9 (3′-C), 24.3 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3379, 2930, 2836, 1604, 
1508, 1227, 1156, 1026, 765. HRMS [ESI (m/z)] calcd for (C25H29F1N3O2 + H)+ = 422.22438, 
found 422.22591 (|Δ| = 3.63 ppm). RF: 0.45 (AcOEt/Et3N, 8:1). Yield: 52%.
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Chapter 3
Continuous Flow Synthesis of Urea-Containing Compound 
Libraries Based on the Piperidin-4-one Scaffold
This chapter has been adapted from “Riesco-Domínguez, A.; Blanco-Ania, D.; Rutjes, F. P. J. T. 
Eur. J. Org. Chem. 2018, 1312–1320”.
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ABSTRACT: The advantages of performing reactions in continuous flow versus the classic batch 
processes render flow chemistry a suitable technique for library synthesis. Inspired by our recent 
work to create fluorine-containing nitrogen heterocycles and by the potential of the urea group in 
drug design, we herewith describe the combination of both aspects in the continuous flow synthesis 
of two libraries of urea derivatives based on the piperidin-4-one scaffold.
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3.1 Introduction
The urea group represents an important functionality in pharmaceutical and agrochemical 
products.1 Urea-containing molecules possess an immense potential in drug design as a result of 
their capability for hydrogen binding to biomolecular targets.2 Moreover, ureas are widely used in 
drug design for the modulation of several factors, such as selectivity, stability, toxicity and 
pharmacokinetic profile of lead molecules.2 Examples of active compounds containing a urea are 
depicted in Figure 3.1. Trimefluor,3 a selective pre- and post-emergence herbicide for use in 
cotton, and triflumuron,4 a broad spectrum insecticide against chewing insects commercialized 
by Bayer CropScience, are examples of bioactive molecules containing a urea group. Another 
example of a urea-containing pharmaceutical is vestipitant,5 a selective antagonist for the NK1
receptor.
Figure 3.1 Biologically Active Compounds Containing a Urea Group.
In Chapter 2, we described an enantio- and diastereoselective synthesis of piperidin-4-ones 
2a–c from the enantiopure amino ketone 1 (Scheme 3.1).6 Compounds 2a–c, containing three 
different fluorine functionalities (F, CF3 and SF5) to enhance their bioactivity and metabolic 
profile,7 were synthesized and further derivatized into a novel library of spirocyclic compounds 
(3 and 4) under classic batch processes through a diastereoselective Pictet–Spengler cyclization.6
The inherent potential of this scaffold (2a–c) for derivatization combined with the advantages 
of flow chemistry for library synthesis8 (including excellent heat exchange and fast mixing for 
better reaction control, automated small-scale optimization and rapid automated compound 
library-preparation) encouraged us to further develop a new class of urea derivatives in flow (5
and 6) based on scaffolds 2a–c (Scheme 3.1).
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Scheme 3.1 Described Work in Chapter 2 (Batch) and this Work (Flow) Based on Scaffolds 2a–c. 
3.2 Results and Discussion
We started our investigations by testing the reactivity of our amines (2b and 2c) with alkyl 
isocyanates (ethyl [7A] or isopropyl isocyanate [7B], 1.5 equiv) varying solvent, temperature and 
reaction time (see Table 3.1 for summarized results and Experimental Section for the entire 
optimization process). All reactions were carried out in a borosilicate glass reactor (channel width 
600 µm, channel depth 500 µm and effective reactor volume 100 µL).9 The microreactor was 
placed into a microreactor holder, which automatically aligns with the fluidic connections and 
makes contact with the temperature controlling metal plate in the microreactor holder. Then, the 
inlet modules were connected through the microreactor holder with the inlet ports of the 
microreactor and the outlet tubing was also placed at the outlet port. The tubing was connected 
to the syringes, which were connected to the pumps. The two solutions, one containing the 
piperidin-4-ones (2b or 2c) and the other one with the isocyanates 7 were pumped and brought 
together inside of the microreactor (Table 3.1).
Initially, we used solvents such as MeCN or 1,2-dichloroethane in a temperature range of 
50–80 °C and reaction times of 10–15 min (entries 1–4). Low conversions to ureas 5bA and 5bB
were obtained in all these cases and only a slightly higher conversion to 5bA (ratio 5bA/2b 1:0.7) 
was achieved when we used MeCN at 50 °C (entry 1). The use of EtOH at 80 °C and a reaction 
time of 10 min provided a ratio of 1:1.2 for 5bB/2b (entry 5). An increase of the reaction time 
to 15 min (entry 6) gave higher conversion into product 5bB (1:0.15). By increasing the amount 
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of isocyanate (2.0 and 2.5 equiv, entries 7 and 8, respectively), nearly full conversion to 5bB and 
full conversion to 5cA were obtained. However, carbamate 8 was also formed in the reaction 
mixture when EtOH was used as solvent, as a result of the nucleophilic attack of EtOH to the 
isocyanate. Therefore, we explored the use of bulkier alcohols as solvent (iPrOH and tBuOH) to 
avoid the formation of 8.
Table 3.1 Optimization Process for the Synthesis of Alkyl and Aryl Ureas 5b and 5c.
Entry 2 
7 
(equiv) Solvent 
t
(°C)
time
(min) 5 8 R R
1
Ratio 
5/2/8a
Flow rate
(µL/min)
1 2b 7A (1.5) MeCN 50 10 5bA – CH3CH2 – 1:0.7:0b 10.00 
2 2b 7A (1.5) MeCN 80 10 5bA – CH3CH2 – 1:10:0 10.00
3 2b 7A (1.5) MeCN 80 15 5bA – CH3CH2 – 1:5.0:0 6.67
4 2b 7B (1.5) 1,2-DCE 80 15 5bB – (CH3)2CH – 1:6.0:0 6.67 
5 2b 7B (1.5) EtOH 80 10 5bB 8a (CH3)2CH CH3CH2 1:1.2:0.14 10.0
6 2b 7B (1.5) EtOH 80 15 5bB 8a (CH3)2CH CH3CH2 1:0.15:0.31 6.67
7 2b 7B (2.0) EtOH 80 17 5bB 8a (CH3)2CH CH3CH2 1:0.08:0.31 5.88
8 2c 7A (2.5) EtOH 80 17 5cA 8b CH3CH2 CH3CH2 1:0:0.92 5.88
9 2c 7A (2.5) iPrOH 80 17 5cA 8c CH3CH2 (CH3)2CH 1:0:0.6 5.88 
10 2c 7A (2.5) tBuOH 80 17 5cA – CH3CH2 – 1:0:010 5.88
11 2c 7A (2.0) tBuOH 25 17 5cA – CH3CH2 – 1:0.12:011 5.88
12 2c 7A (2.0) tBuOH 35 17 5cA – CH3CH2 – 1:0.10:011 5.88
13 2c 7A (2.0) tBuOH 50 17 5cA – CH3CH2 – 1:0:011 5.88
14 2b 7E (1.5) EtOH 80 20 5bE 8d 2,4-F2C6H3 CH3CH2 0:1:0.50 5.00 
15 2b 7E (1.3) 1,2-DCE 80 17 5bE – 2,4-F2C6H3 – 1:0:0 5.88
aCalculated by 1H NMR of the fraction of the collected product. bAnalyzed by 1H NMR of the fraction of 
stabilization time.
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Thus, the reaction of piperidin-4-one 2c with ethyl isocyanate (2.5 equiv) in the presence of 
propan-2-ol gave full conversion to urea 5cA and less formation of the carbamate 8 (entry 9) 
whereas the formation of 8 was completely suppressed when tert-butyl alcohol was used (entry 
10).10 With this result in hands, we tried to decrease the temperature of the reaction and the 
amount of isocyanate used. We confirmed that when using 2.0 equiv of ethyl isocyanate and 
temperatures between 25–35 °C full conversion was not reached (entries 11 and 12). Finally, we 
found that the use of 2.0 equiv of ethyl isocyanate at 50 °C in tBuOH were the suitable 
conditions to obtain full conversion to compound 5cA (entry 13).
Once the conditions for the synthesis of aliphatic ureas were optimized, we attempted the 
synthesis of the aryl derivatives. Therefore, we first explored the reaction of 2b with 
2,4-difluorophenyl isocyanate (7E, 1.5 equiv) at 80 °C in EtOH and a reaction time of 20 min; 
the reaction, however, did not show any conversion to product 5bE and it resulted in a mixture 
of 2b and carbamate 8 (ratio 2b/8d 1:0.50; entry 14). By changing the solvent to 
1,2-dichloroethane, and using 1.3 equiv of isocyanate 7E, full conversion to compound 5bE was 
obtained (entry 15).
3.2.1 Synthesis of the Library of Ureas Based on the Piperidin-4-ones
Five isocyanates 7A–E (alkyl and aryl isocyanates with different substituents on the phenyl 
ring, Figure 3.2) were selected for the generation of a 15-compound library (Table 3.2).
Figure 3.2 Isocyanates Used for the Generation of the Library.
For all experiments, three fractions (stabilization time, collected product and residual) were 
collected in separated vials and final products were analyzed directly by 1H NMR from the 
fraction of collected product. This fraction always started after running three cycles of the 
stabilization time (see Experimental Section for experimental details).12
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The reaction of piperidin-4-ones 2a–c with alkyl isocyanates 7A and 7B gave full conversions 
to products 5aA–cB in very good to excellent yields (83–92%).
Table 3.2 Library of Ureas 5aA–cE Based on the Piperidin-4-one Scaffold.
aReaction carried out in tBuOH at 50 °C in 17 min using 2.0 equiv of isocyanate. bReaction carried out in 1,2-
dicloroethane at 80 °C in 17 min using 1.3 equiv of isocyanate. cConversion calculated by 1H NMR of the 
fraction of collected product. dIsolated yield of the fraction of collected product. Ar = 3,4-(MeO)2C6H3.
We also obtained full conversions to ureas 5aC–cE when aryl isocyanates (7C–E) were used. 
Very good to excellent yields were obtained for compounds 5aC, 5aE, 5bC and 5cC–cE. Good 
yields were obtained for compounds 5aD and 5bD whereas compound 5bE was obtained with a 
moderate yield.
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The excess of isocyanates was removed in vacuo as much as possible so that only small 
amounts of the least volatile isocyanates remained in the reaction mixtures.
The crude mixtures of compounds 5bA and 5bB showed the presence of a minor product in a 
1:0.1 ratio according to their 1H NMR spectra. We attributed these mixtures to be either 
rotamers of the urea group or a possible mixture of atropisomers, with the carbamoyl group 
(almost) perpendicular to the piperidine ring (Figure 3.3), both caused by the congested 2,6-
diphenylpiperidine-1-carboxamide framework. For ureas 5bC and 5bD, the ratio of the isomers 
could not be measured accurately whereas for the rest of ureas only one of both isomers was 
observed.
Figure 3.3 Rotamers and Atropisomers of 5bA and 5bB.
Optimization of these reactions to obtain full conversion was crucial to avoid purification by 
column chromatography. Purifying these poorly soluble ureas generally requires polar solvents 
such as MeOH, but in case of sterically congested ureas methanolysis13 may take place in the 
purification process. In this case, methanolysis occurred because the nitrogen in the piperidine 
ring might not be fully conjugated anymore with the carbonyl and therefore MeOH can form a 
hydrogen bond with the nitrogen. To analyze the reactivity of these ureas in MeOH, we 
dissolved urea 5aC in CD3OD and monitored the mixture by 1H NMR (Scheme 3.2).
Scheme 3.2 Methanolysis of Ureas 5aC and 5cB.
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We observed that compound 5aC was still present after 1–4 h, but after 19 h at room 
temperature compound 5aC transformed into piperidin-4-one 2a (protonated and deuterated 
substrates), phenyl isocyanate 7C and carbamates 9 and 10 (relative abundance 9/10 30:70). 
1H NMR showed a mixture of compounds which was confirmed by GC-MS (Scheme 3.2).
We also studied the decomposition of the aliphatic urea 5cB, which also showed the presence 
of carbamates 9 and 10 (detected by GC-MS) and the starting material 2c (protonated and 
deuterated substrates).
3.2.2 Reduction of the Ketone in Flow
Finally, a diastereoselective reduction of ketone 2c was carried out in flow using LiBH4 as 
reducing reagent to provide full conversion to a 10:1 mixture of piperidinols 11c and 12c
(Scheme 3.3). The workup of this reaction was performed offline after the reaction mixture was 
completely collected in the corresponding vial. The reduction of ketone 2b was performed in 
batch using N-Selectride14 to give alcohol 12b.15
Scheme 3.3 Reduction of 2a and 2c with N-Selectride and LiBH4.
3.2.3 Synthesis of the Library of Ureas Based on the Piperidin-4-ols
Then, we decided to perform the urea synthesis using as starting material amino alcohol 11c
(Table 3.3). Initially, we performed the reaction between 11c and isocyanate 7B using the 
conditions previously developed for aliphatic isocyanates (tBuOH, 17 min and 50 °C). We 
decreased the amount of 7B to 1.0 equiv, to firstly test the reactivity of our hindered amine in 
the presence of the nucleophilic alcohol. We confirmed by 1H NMR that only the amine group 
reacted with the isocyanate and therefore the corresponding carbamate was not observed.
However, while using 1.0 equiv of isocyanate, a ratio 11c/6cB 1:0.5 was obtained. Thus, we 
increased the amount of isocyanate 7B to 1.5 equiv and full conversion to urea 6cB was achieved 
(84% yield). When we applied these conditions using ethyl (7A) and benzyl (7F) isocyanates, 
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amino alcohol 11c was converted with full conversion to ureas 6cA and 6cF16 in 85 and 99% 
yield, respectively.
Finally, two additional examples with aryl isocyanates (7C and 7D) were synthesized. In this 
case, the use of 1.1 equiv of isocyanate in 1,2-DCE at 80 °C was sufficient to reach full 
conversion to ureas 6cC and 6cD. For compounds 6cA–cD and 6cF, a 6:1 ratio of conformers 
was obtained.
Table 3.3 Library of Ureas 6cA–cD and 6cF Based on Amino Alcohol 11c.
aReaction carried out in tBuOH at 50 °C in 17 min using 1.5 equiv of isocyanate. bReaction carried out in 1,2-
dicloroethane at 80 °C in 17 min using 1.1 equiv of isocyanate. cConversion calculated by 1H NMR of the 
fraction of collected product. dIsolated yield of the fraction of collected product.
3.2.4 NMR Analysis
As previously mentioned, the presence of conformers (rotamers or atropisomers) was caused 
by the hindered rotation around one of the single N–CO bonds of the urea.17 NOESY
experiments of compound 13bB (the major product of reaction between alcohol 12b and 
isocyanate 7B) showed correlations between the NH of the urea with both benzylic protons 
(Table 3.4), indicating therefore the existence of atropisomerism (in case of rotamers, each 
rotamer would show only one correlation with one benzylic proton).18 The assignment of the 
characteristic protons is depicted in Table 3.4.
Chemical shifts of compounds 13bB and 13bB′19 present a considerable difference, not only 
for the benzylic protons H2 and H6 (entries 1 and 5), but also for protons H4 and H7 (entries 3 
and 6). We were also able to confirm that the major product of the stereoisomers was compound 
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13bB, which showed a correlation between the NH proton of the urea and both benzylic 
protons, H2 and H6. The clarification of these two products was done by NOESY studies.
Table 3.4 Chemical Shifts (ppm) of Atropisomers 13bB and 13bB′ in CDCl3.
Entry 1H ppm (13bB) ppm (13bB′)
1 H2 4.89 4.36 
2 H3 2.11/1.84 2.20–2.10/2.00–1.89
3 H4 4.43 4.16 
4 H5 2.70/2.00 2.37/2.20–2.10
5 H6 5.65 5.12
6 H7 3.80–3.70 3.58–3.49
7 H8 0.88 0.72
8 H9 0.74 0.60 
3.3 Conclusion
In summary, we have synthesized a small library of ureas in continuous flow. The reactions 
utilized for their syntheses were achieved in a reaction time of 17 min without further need of 
purification rendering drug-like molecules. Moreover, we have also reduced diastereoselectively 
the ketone group in flow in a reaction time of 3 min. Additional urea formation of amino alcohol 
11c was also performed to create five different urea derivatives. NMR studies confirmed the 
formation of conformers caused by the hindered rotation around one of the single N–CO bonds 
of the urea. The elucidation of these species to be identified as either rotamers or atropisomers 
could not be clarified. This methodology could be applied to a wide range of substrates as a tool 
to prepare libraries of potentially bioactive molecules. It is worth noting that the batch synthesis 
of these compounds could also be carried out in case any molecule was active and scalability was 
required.
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3.4 Experimental Section
For general experimental details, see Section 2.5 (p 51).
Reactions were carried out using the FlowStart Evo equipment and microreactors purchased 
by FutureChemistry. At very low flow rates, stabilization and pressure of the equipment may take 
long; therefore, a stabilization time is calculated and run before the collecting product fraction. 
The stabilization time is calculated following equation 1:
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑇𝑇𝑆𝑆𝑇𝑇𝑇𝑇 = 3 × 𝑅𝑅𝑇𝑇𝑆𝑆𝑅𝑅𝑆𝑆𝑆𝑆𝑅𝑅 𝑉𝑉𝑆𝑆𝑆𝑆𝑉𝑉𝑇𝑇𝑇𝑇 𝑇𝑇𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝐹𝐹𝑆𝑆𝑆𝑆𝐹𝐹 𝑅𝑅𝑆𝑆𝑆𝑆𝑇𝑇⁄  (Eq 1)
For all reactions, products were analyzed from the collected fraction and therefore calculations 
and yields are based on this fraction.
Table 3.5 Optimization Process for the Synthesis of Alkyl and Aryl Ureas 5.
Entry 2 
7 
(equiv) Solvent 
t
(°C)
time
(min) 5 8 R R
1
Ratio 
5/2/8a
Flow rate
(µL/min)
1 2b 7A (1.5) MeCN 50 10 5bA – CH3CH2 – 1:0.7:0b 10.00 
2 2b 7A (1.5) MeCN 80 10 5bA – CH3CH2 – 1:10:0 10.00
3 2b 7A (1.5) MeCN 59 15 5bA – CH3CH2 – 1:10:0 6.67 
4c 2b 7A (1.5) MeCN 59 15 5bA – CH3CH2 – – 6.7
5 2b 7A (1.5) MeCN 80 15 5bA – CH3CH2 – 1:5.0:0 6.67 
6 2b 7B (1.5) 1,2-DCE 80 15 5bB – (CH3)2CH – 1:6.0:0 6.67
7 2b 7B (1.5) EtOH 80 10 5bB 8a (CH3)2CH CH3CH2 1:1.2:0.14 10.0
8 2b 7B (1.5) EtOH 80 15 5bB 8a (CH3)2CH CH3CH2 1:0.15:0.31 6.67 
9 2b 7B (1.5) EtOH 80 20 5bB 8a (CH3)2CH CH3CH2 1:0.20:0.29 5.00
10 2b 7B (2.0) EtOH 80 17 5bB 8a (CH3)2CH CH3CH2 1:0.08:0.31 5.88 
11 2c 7A (2.5) EtOH 80 17 5cA 8b CH3CH2 CH3CH2 1:0:0.92 5.88
12 2a 7A (2.5) EtOH 80 17 5aA 8b CH3CH2 CH3CH2 1:0:0.90 5.88
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13 2b 7A (2.5) EtOH 80 17 5bA 8b CH3CH2 CH3CH2 1:0:0.90 5.88 
14 2c 7A (2.5) dry EtOH 80 17 5cA 8b CH3CH2 CH3CH2 1:6:7.40 5.88
15 2c 7A (2.5) iPrOH 80 17 5cA 8c CH3CH2 (CH3)2CH 1:0:0.6 5.88
16 2c 7A (2.5) tBuOH 80 17 5cA – CH3CH2 – 1:0:0d 5.88 
17 2c 7A (1.5) tBuOH 80 17 5cA – CH3CH2 – 1:0.2:0e 5.88
18 2c 7A (1.8) tBuOH 80 17 5cA – CH3CH2 – 1:0.3:0e 5.88 
19 2c 7A (2.0) tBuOH 80 17 5cA – CH3CH2 – 1:0:0e 5.88
20 2c 7A (2.0) CF3CH2OH 80 17 5cA 8e CH3CH2 CF3CH2 1:4.3:7.9 5.88
21 2c 7A (2.0) dry tBuOH 80 17 5cA – CH3CH2 – 1:0.12:0e 5.88 
22 2c 7A (2.2) dry tBuOH 80 17 5cA – CH3CH2 – 1:0.5:0e 5.88
23 2c 7A (2.0) EtOH 21 17 5cA – CH3CH2 – 1:0.25:0 5.88 
24 2c 7A (2.0) EtOH 30 17 5cA – CH3CH2 – 1:0.11:0.6 5.88
25 2c 7A (2.0) tBuOH 25 17 5cA – CH3CH2 – 1:0.12:0e 5.88
26 2c 7A (2.0) tBuOH 35 17 5cA – CH3CH2 – 1:0.10:0e 5.88 
27 2c 7A (2.0) tBuOH 50 17 5cA – CH3CH2 – 1:0:0e 5.88
28 2b 7A (2.0) tBuOH 50 17 5bA – CH3CH2 – 1:0:0e 5.88 
29 2b 7E (1.5) EtOH 80 20 5bE 8d 2,4-F2C6H3 CH3CH2 0:1:0.50 5.00
30 2b 7E (1.3) 1,2-DCE 80 17 5bE – 2,4-F2C6H3 – 1:0:0 5.88
aCalculated by 1H NMR of the fraction of the collected product. bAnalyzed by 1H NMR of the fraction of 
stabilization time. cBack-pressure regulator used in the reaction. d1,3-Diethylurea was obtained as a side 
product in the reaction mixture (ratio 5cA/1,3-diethylurea 1:0.28). eThe presence of 1,3-diethylurea was 
reduced (ratio 5cA or 5bA/1,3-diethyl urea 1:0.1, approximately in all cases).
General Procedure for the Synthesis of Alkyl Ureas 5aA, 5aB, 5bA, 5bB, 5cA and 5cB
Solution A: piperidin-4-one (2a–c, 1.0 equiv) dissolved in tBuOH (99.8–100.2 mM). Solution 
B: alkyl isocyanate (7A or 7B, 2.0 equiv) dissolved in tBuOH (0.1 M).
Solution A (1.96 µL/min) was combined with B (3.92 µL/min) inside the glass microreactor 
(internal volume: 100 µL). The reaction was performed at 50 °C for 17 min.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-ethyl-6-(4-fluorophenyl)-4-oxopiperidine-1-carbox-
amide 5aA
According to the general procedure, the reaction of piperidin-4-one 2a
(3.63 mg, 0.011 mmol) in tBuOH (99.8 mM) with 7A afforded urea 
5aA (3.67 mg, 9.16 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]:
7.39–7.31 (m, 2 H, 2″-CH + 6″-CH), 7.08–7.01 (m, 2 H, 3″-CH + 5″-
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CH), 6.80 (d, J = 8.2 Hz, 1 H, 5′-CH), 6.75 (dd, J = 8.2, 2.1 Hz, 1 H, 6′-CH), 6.64 (d, J = 2.1 Hz, 
1 H, 2′-CH), 6.00 (t, J = 5.4 Hz, 1 H, 6-CH), 5.22 (dd, J = 9.7, 4.9 Hz, 1 H, 2-CH), 4.40 (t, J = 
5.2 Hz, 1 H, NH), 3.86 (s, 3 H, 4′-OCH3), 3.73 (s, 3 H, 3′-OCH3), 3.18–3.07 (m, 3 H, 1′′′-CH2 + 
5-CHH), 2.88–2.73 (m, 2 H, 3-CHH + 5-CHH), 2.60 (dd, J = 17.6, 4.9 Hz, 1 H, 3-CHH), 0.88 (t, 
J = 7.2 Hz, 3 H, 2′′′-CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 207.8 (4-C), 162.1 (d, J = 
247.5 Hz, 4″-C), 159.1 (HNC=O), 150.1 (3′-C), 149.0 (4′-C), 139.0 (d, J = 3.1 Hz, 1″-C), 134.9 
(1′-C), 128.4 (d, J = 8.0 Hz, 2″-C + 6″-C), 117.9 (6′-C), 116.0 (d, J = 21.5 Hz, 3″-C + 5″-C), 111.4 
(5′-C), 108.9 (2′-C), 56.1 (3′-OCH3 + 4′-OCH3), 56.0 (2-C), 52.4 (6-C), 46.1 (3-C), 43.6 (5-C), 36.2 
(1′′′-C), 15.2 (2′′′-C). FTIR [?̅?𝜈 (cm−1)]: 3420, 2967, 1722, 1639, 1511, 1264, 1228, 1025. HRMS
[ESI (m/z)] calcd for (C22H25FN2O4 + Na)+ = 423.16906, found 423.16916 (|Δ| = 1.0 ppm). 
RF: 0.27 (heptane/AcOEt, 1:2). Yield: 83%.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-ethyl-4-oxo-6-[4-(trifluoromethyl)phenyl]piperidine-
1-carboxamide 5bA
According to the general procedure, the reaction of piperidin-4-one 
2b (4.68 mg, 0.012 mmol) in tBuOH (100.2 mM) with 7A afforded 
urea 5bA (4.74 mg, 0.011 mmol). 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 7.66–7.60 (m, 2 H, 3″-CH + 5″-CH), 7.56–7.51 (m, 2 H, 2″-
CH + 6″-CH), 6.80 (d, J = 8.2 Hz, 1 H, 5′-CH), 6.75 (ddd, J = 8.2, 
2.1, 0.5 Hz, 1 H, 6′-CH), 6.54 (d, J = 2.1 Hz, 1 H, 2′-CH), 6.20 (t, J = 5.2 Hz, 1 H, 6-CH), 5.12 
(dd, J = 10.2, 4.9 Hz, 1 H, 2-CH), 4.44 (t, J = 5.2 Hz, 1 H, NH), 3.86 (s, 3 H, 4′-OCH3), 3.67 (s, 3 
H, 3′-OCH3), 3.23–3.11 (m, 3 H, 1′′′-CH2 + 5-CHH), 2.86 (dd, J = 18.4, 5.6 Hz, 1 H, 5-CHH), 
2.74 (dd, J = 17.5, 10.2 Hz, 1 H, 3-CHH), 2.61 (dd, J = 17.5, 4.9 Hz, 1 H, 3-CHH), 0.90 (t, J = 
7.2 Hz, 3 H, 2′′′-CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 207.2 (4-C), 159.1 (HNC=O), 
150.3 (3′-C), 149.2 (4′-C), 147.4 (1″-C), 134.6 (1′-C), 129.9 (4″-C, indirect observation), 127.3 (2″-
C + 6″-C), 126.1 (q, J = 3.6 Hz, 3″-C + 5″-C), 124.0 (q, J = 272.2 Hz, CF3), 117.9 (6′-C), 111.5 
(5′-C), 108.7 (2′-C), 56.6 (2-C), 56.1 (4′-OCH3), 56.0 (3′-OCH3), 52.3 (6-C), 46.6 (3-C), 42.9 (5-C), 
36.2 (1′′′-C), 15.2 (2′′′-C). FTIR [?̅?𝜈 (cm−1)]: 3422, 2970, 1722, 1635, 1517, 1327, 1264, 1238, 1123, 
725. HRMS [ESI (m/z)] calcd for (C23H25F3N2O4 + Na)+ = 473.16586, found 473.16547 (|Δ| 
= 2.0 ppm). RF: 0.28 (heptane/AcOEt, 1:2). Yield: 85%.
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(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-ethyl-4-oxo-6-[4-(pentafluoro-λ6-sulfanyl)phenyl]-
piperidine-1-carboxamide 5cA
According to the general procedure, the reaction of piperidin-4-one 
2c (2.21 mg, 5.05 µmol) in tBuOH (99.9 mM) with 7A afforded urea 
5cA (2.37 mg, 4.66 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]:
7.81–7.71 (m, 2 H, 3″-CH + 5″-CH), 7.55–7.49 (m, 2 H, 2″-CH + 
6″-CH), 6.80 (d, J = 8.2 Hz, 1 H, 5′-CH), 6.76 (dd, J = 8.2, 2.0 Hz, 1 
H, 6′-CH), 6.48 (d, J = 2.0 Hz, 1 H, 2′-CH), 6.25 (t, J = 5.1 Hz, 1 H, 6-CH), 5.07 (dd, 
J = 10.3, 5.0 Hz, 1 H, 2-CH), 4.47 (t, J = 5.2 Hz, 1 H, NH), 3.86 (s, 3 H, 4′-OCH3), 3.66 (s, 3 H, 
3′-OCH3), 3.24–3.09 (m, 3 H, 1′′′-CH2 + 5-CHH), 2.88 (dd, J = 18.5, 5.8 Hz, 1 H, 5-CHH), 2.72 
(dd, J = 17.6, 10.4 Hz, 1 H, 3-CHH), 2.61 (dd, J = 17.6, 5.0 Hz, 1 H, 3-CHH), 0.91 (t, J = 7.2 
Hz, 3 H, 2′′′-CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 206.9 (4-C), 159.0 (HNC=O), 153.1 
(4″-C, indirect observation), 150.4 (3′-C), 149.2 (4′-C), 147.2 (1″-C, indirect observation), 134.4 
(1′-C), 127.3 (2″-C + 6″-C), 126.7 (3″-C + 5″-C, indirect observation), 117.9 (6′-C), 111.5 (5′-C), 
108.5 (2′-C), 56.8 (2-C), 56.1 (4′-OCH3), 55.9 (3′-OCH3), 51.9 (6-C), 46.8 (3-C), 42.7 (5-C), 36.3 
(1′′′-C), 15.2 (2′′′-C). FTIR [?̅?𝜈 (cm−1)]: 3431, 2925, 1723, 1643, 1518, 1264, 1239, 844. HRMS
[ESI (m/z)] calcd for (C22H25F5N2O4S + Na)+ = 531.13474, found 531.13535 (|Δ| = 0.1 ppm). 
RF: 0.26 (heptane/AcOEt, 1:2). Yield: 92%.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-N-isopropyl-4-oxopiperidine-1-car-
boxamide 5aB
According to the general procedure, the reaction of piperidin-4-one 2a
(3.50 mg, 0.01 mmol) in tBuOH (99.8 mM) with 7B afforded 5aB
(3.72 mg, 8.98 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.40–
7.31 (m, 2 H, 2″-CH + 6″-CH), 7.09–7.00 (m, 2 H, 3″-CH + 5″-CH), 
6.80 (d, J = 8.2 Hz, 1 H, 5′-CH), 6.75 (ddd, J = 8.2, 2.1, 0.6 Hz, 1 H, 
6′-CH), 6.67 (d, J = 2.1 Hz, 1 H, 2′-CH), 5.95 (t, J = 5.5 Hz, 1 H, 6-CH), 5.23 (dd, J = 9.6, 4.9 
Hz, 1 H, 2-CH), 4.29 (d, J = 7.2 Hz, 1 H, NH), 3.88–3.80 (m, 1 H, 1′′′-CH), 3.86 (s, 3 H, 4′-
OCH3), 3.74 (s, 3 H, 3′-OCH3), 3.10 (dd, J = 18.2, 5.5 Hz, 1 H, 5-CHH), 2.83 (dd, J = 17.7, 9.5 
Hz, 1 H, 3-CHH), 2.79 (dd, J = 18.2, 5.9 Hz, 1 H, 5-CHH), 2.61 (dd, J = 17.6, 4.9 Hz, 1 H, 3-
CHH), 0.94 (d, J = 6.5 Hz, 3 H, 2′′′-CH3), 0.83 (d, J = 6.5 Hz, 3 H, 3′′′-CH3). 13C NMR [101 
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MHz, δ (ppm), CDCl3]: 207.8 (4-C), 162.2 (d, J = 247.3 Hz, 4″-C), 158.4 (HNC=O), 150.2 (3′-C), 
149.0 (4′-C), 139.1 (d, J = 3.2 Hz, 1″-C), 135.1 (1′-C), 128.5 (d, J = 8.0 Hz, 2″-C + 6″-C), 117.9 
(6′-C), 116.0 (d, J = 21.4 Hz, 3″-C + 5″-C), 111.4 (5′-C), 109.1 (2′-C), 56.1 (3′-OCH3 + 4′-OCH3), 
55.9 (2-C), 52.5 (6-C), 46.0 (3-C), 43.7 (5-C), 43.2 (1′′′-C), 23.3 (2′′′-C), 23.0 (3′′′-C). FTIR [?̅?𝜈
(cm−1)]: 3420, 2969, 1721, 1639, 1605, 1510, 1263, 1228, 1026, 854. HRMS [ESI (m/z)] calcd 
for (C23H27FN2O4 + Na)+ = 437.18471, found 437.18465 (|Δ| = 1.4 ppm). RF: 0.41 
(heptane/AcOEt, 1:2). Yield: 84%.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-isopropyl-4-oxo-6-[4-(trifluoromethyl)phenyl]piperi-
dine-1-carboxamide 5bB
According to the general procedure, the reaction of piperidin-4-one 
2b (4.10 mg, 0.01 mmol) in tBuOH (100.2 mM) with 7B afforded 
5bB (4.48 mg, 9.65 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 
7.66–7.60 (m, 2 H, 3″-CH + 5″-CH), 7.57–7.51 (m, 2 H, 2″-CH + 
6″-CH), 6.80 (d, J = 8.2 Hz, 1 H, 5′-CH), 6.75 (ddd, J = 8.2, 2.2, 0.5 
Hz, 1 H, 6′-CH), 6.55 (d, J = 2.1 Hz, 1 H, 2′-CH), 6.16 (t, J = 5.2 Hz, 1 H, 6-CH), 5.11 (dd, J = 
10.2, 4.9 Hz, 1 H, 2-CH), 4.33 (d, J = 7.2 Hz, 1 H, NH), 3.88–3.82 (m, 1 H, 1′′′-CH), 3.86 (s, 3 H, 
4′-OCH3), 3.68 (s, 3 H, 3′-OCH3), 3.18 (dd, J = 18.4, 4.7 Hz, 1 H, 5-CHH), 2.87 (dd, J = 18.4, 5.7 
Hz, 1 H, 5-CHH), 2.74 (dd, J = 17.5, 10.2 Hz, 1 H, 3-CHH), 2.61 (dd, J = 17.5, 4.9 Hz, 1 H, 3-
CHH), 0.97 (d, J = 6.5 Hz, 3 H, 2′′′-CH3), 0.82 (d, J = 6.5 Hz, 3 H, 3′′′-CH3). 13C NMR [101 
MHz, δ (ppm), CDCl3]: 207.2 (4-C), 158.3 (HNC=O), 150.3 (3′-C), 149.2 (4′-C), 147.5 (1″-C), 
134.8 (1′-C), 129.9 (4″-C, indirect observation), 127.3 (2″-C + 6″-C), 126.1 (q, J = 3.6 Hz, 3″-C + 
5″-C), 122.5 (CF3, indirect observation), 117.9 (6′-C), 111.5 (5′-C), 108.7 (2′-C), 56.5 (2-C), 56.1 
(4′-OCH3), 56.0 (3′-OCH3), 52.3 (6-C), 46.5 (3-C), 43.3 (1′′′-C), 42.9 (5-C), 23.3 (2′′′-C), 23.0 (3′′′-
C). FTIR [?̅?𝜈 (cm−1)]: 3417, 2968, 1722, 1642, 1516, 1326, 1262, 1238, 1123, 767. HRMS [ESI 
(m/z)] calcd for (C24H27F3N2O4 + Na)+ = 487.18151, found 487.18134 (|Δ| = 1.5 ppm). RF: 
0.41 (heptane/AcOEt, 1:2). Yield: 89%.
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(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-isopropyl-4-oxo-6-[4-(pentafluoro-λ6-sulfanyl)phen-
yl]piperidine-1-carboxamide 5cB
According to the general procedure, the reaction of piperidin-4-one 
2c (4.76 mg, 0.01 mmol) in tBuOH (99.9 mM) with 7B afforded 5cB
(5.22 mg, 9.99 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.78–
7.73 (m, 2 H, 3″-CH + 5″-CH), 7.56–7.50 (m, 2 H, 2″-CH + 6″-
CH), 6.80 (d, J = 8.2 Hz, 1 H, 5′-CH), 6.75 (dd, J = 8.2, 2.1 Hz, 1 H, 
6′-CH), 6.49 (d, J = 2.1 Hz, 1 H, 2′-CH), 6.22 (t, J = 5.1 Hz, 1 H, 6-CH), 5.04 (dd, J = 10.4, 5.0 
Hz, 1 H, 2-CH), 4.36 (d, J = 7.2 Hz, 1 H, NH), 3.89–3.80 (m, 1 H, 1′′′-CH), 3.86 (s, 3 H, 4′-
OCH3), 3.66 (s, 3 H, 3′-OCH3), 3.18 (dd, J = 18.4, 4.3 Hz, 1 H, 5-CHH), 2.89 (dd, J = 18.4, 5.7 
Hz, 1 H, 5-CHH), 2.71 (dd, J = 17.5, 10.4 Hz, 1 H, 3-CHH), 2.60 (dd, J = 17.5, 5.0 Hz, 1 H, 3-
CHH), 0.99 (d, J = 6.5 Hz, 3 H, 2′′′-CH3), 0.82 (d, J = 6.5 Hz, 3 H, 3′′′-CH3). 13C NMR [101 
MHz, δ (ppm), CDCl3]: 206.9 (4-C), 158.3 (HNC=O), 152.9 (4″-C, indirect observation), 150.4 
(3′-C), 149.3 (4′-C), 147.4 (1″-C), 134.6 (1′-C), 127.3 (2″-C + 6″-C), 126.8–126.6 (m, 3″-C + 5″-C), 
117.9 (6′-C), 111.5 (5′-C), 108.5 (2′-C), 56.8 (2-C), 56.2 (4′-OCH3), 55.9 (3′-OCH3), 51.8 (6-C), 
46.8 (3-C), 43.3 (1′′′-C), 42.6 (5-C), 23.3 (2′′′-C), 23.0 (3′′′-C). FTIR [?̅?𝜈 (cm−1)]: 3421, 2970, 1723, 
1642, 1517, 1263, 1238, 842. HRMS [ESI (m/z)] calcd for (C23H27F5N2O4S + Na)+ = 
545.15039, found 545.15003 (|Δ| = 1.7 ppm). RF: 0.45 (heptane/AcOEt, 1:2). Yield: 92%.
Synthesis and Full Characterization of Aryl Ureas 5aC–aE, 5bC–bE and 5cC–cE
Solution A: piperidin-4-one (2a–c, 1.0 equiv) dissolved in 1,2-DCE (78.5–102.5 mM). Solution 
B: aryl isocyanate (7C, 7D or 7E, 1.3 equiv) dissolved in 1,2-DCE (0.1 M).
Solution A (2.56 µL/min) was combined with B (3.32 µL/min) inside the glass microreactor 
(internal volume: 100 µL). The reaction was performed at 80 °C for 17 min.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-4-oxo-N-phenylpiperidine-1-carbox-
amide 5aC
According to the general procedure, the reaction of piperidin-4-one 2a
(2.59 mg, 7.86 µmol) in 1,2-DCE (88.9 mM) with 7C afforded 5aC
(3.15 mg, 7.02 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.45–
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7.38 (m, 2 H, 2″-CH + 6″-CH), 7.25–7.18 (m, 2 H, 3′′′-CH + 5′′′-CH), 7.12–7.05 (m, 2 H, 3″-CH
+ 5″-CH), 7.05–6.98 (m, 3 H, 2′′′-CH + 4′′′-CH + 6′′′-CH), 6.89–6.83 (m, 2 H, 5′-CH + 6′-CH), 
6.65 (d, J = 1.7 Hz, 1 H, 2′-CH), 6.60 (s, 1 H, NH), 6.19 (t, J = 5.3 Hz, 1 H, 6-CH), 5.35 (dd, J = 
10.1, 4.9 Hz, 1 H, 2-CH), 3.89 (s, 3 H, 4′-OCH3), 3.72 (s, 3 H, 3′-OCH3), 3.21 (dd, J = 18.4, 4.9 
Hz, 1 H, 5-CHH), 2.95–2.85 (m, 2 H, 3-CHH + 5-CHH), 2.67 (dd, J = 17.6, 4.9 Hz, 1 H, 3-
CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 207.2 (4-C), 162.3 (d, J = 247.8 Hz, 4″-C), 156.6 
(HNC=O), 150.6 (3′-C), 149.5 (4′-C), 138.6 (1′′′-C), 138.5 (d, J = 3.4 Hz, 1″-C), 134.3 (1′-C), 129.1 
(3′′′-C + 5′′′-C), 128.6 (d, J = 8.0 Hz, 2″-C + 6″-C), 123.7 (4′′′-C), 120.0 (2′′′-C + 6′′′-C), 118.1 (6′-
C), 116.3 (d, J = 21.4 Hz, 3″-C + 5″-C), 111.7 (5′-C), 108.9 (2′-C), 56.6 (2-C), 56.2 (4′-OCH3), 
56.1 (3′-OCH3), 52.3 (6-C), 46.3 (3-C), 43.4 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3388, 2924, 1722, 1662, 
1510, 1265, 1235, 1026, 754. HRMS [ESI (m/z)] calcd for (C26H25FN2O4 + Na)+ = 471.16906, 
found 471.16910 (|Δ| = 1.1 ppm). RF: 0.24 (heptane/AcOEt, 2:1). Yield: 89%.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-4-oxo-N-phenyl-6-[4-(trifluoromethyl)phenyl]piperi-
dine-1-carboxamide 5bC
According to the general procedure, the reaction of piperidin-4-one 
2b (2.1 mg, 5.54 µmol) in 1,2-DCE (82.8 mM) with 7C afforded 
5bC (2.43 mg, 4.87 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 
7.69–7.64 (m, 2 H, 3″-CH + 5″-CH), 7.62–7.57 (m, 2 H, 2″-CH + 
6″-CH), 7.25–7.19 (m, 2 H, 3′′′-CH + 5′′′-CH), 7.06–6.99 (m, 3 H, 
2′′′-CH + 4′′′-CH + 6′′′-CH), 6.89–6.85 (m, 2 H, 5′-CH + 6′-CH), 6.64 (s, 1 H, NH), 6.53–6.51 (m, 
1 H, 2′-CH), 6.41 (t, J = 5.0 Hz, 1 H, 6-CH), 5.22 (dd, J = 10.8, 4.8 Hz, 1 H, 2-CH), 3.89 (s, 3 H, 
4′-OCH3), 3.65 (s, 3 H, 3′-OCH3), 3.29 (dd, J = 18.6, 4.1 Hz, 1 H, 5-CHH), 2.98 (dd, J = 18.6, 5.8 
Hz, 1 H, 5-CHH), 2.80 (dd, J = 17.5, 10.8 Hz, 1 H, 3-CHH), 2.66 (dd, J = 17.5, 4.8 Hz, 1 H, 3-
CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 206.6 (4-C), 156.7 (HNC=O), 150.7 (3′-C), 149.7 
(4′-C), 146.7 (1″-C), 138.5 (1′′′-C), 133.9 (1′-C), 130.2 (4″-C, indirect observation), 129.1 (3′′′-C + 
5′′′-C), 127.4 (2″-C + 6″-C), 126.2 (q, J = 3.6 Hz, 3″-C + 5″-C), 125.9 (CF3, indirect observation), 
123.9 (4‴-C), 120.0 (2′′′-C + 6′′′-C), 118.1 (6′-C), 111.7 (5′-C), 108.6 (2′-C), 57.3 (2-C), 56.2 (4′-
OCH3), 56.0 (3′-OCH3), 51.9 (6-C), 46.9 (3-C), 42.6 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3391, 2939, 1722, 
1663, 1597, 1517, 1442, 1327, 1265, 1238, 755. HRMS [ESI (m/z)] calcd for (C27H25F3N2O4 + 
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Na)+ = 521.16586, found 521.16560 (|Δ| = 1.6 ppm). RF: 0.70 (heptane/AcOEt, 1:2). Yield: 
88%.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-4-oxo-6-[4-(pentafluoro-λ6-sulfanyl)phenyl]-N-phenyl-
piperidine-1-carboxamide 5cC
According to the general procedure, the reaction of piperidin-4-one 
2c (2.49 mg, 5.69 µmol) in 1,2-DCE (102.5 mM) with 7C afforded 
5cC (3.22 mg, 5.79 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 
7.81–7.75 (m, 2 H, 3″-CH + 5″-CH), 7.61–7.55 (m, 2 H, 2″-CH + 
6″-CH), 7.25–7.20 (m, 2 H, 3′′′-CH + 5′′′-CH), 7.06–7.02 (m, 3 H, 
2′′′-CH + 4′′′-CH + 6′′′-CH), 6.90–6.86 (m, 2 H, 5′-CH + 6′-CH), 6.67 (s, 1 H, NH), 6.49–6.47 (m, 
1 H, 2′-CH), 6.47–6.43 (m, 1 H, 6-CH), 5.16 (dd, J = 11.0, 4.9 Hz, 1 H, 2-CH), 3.89 (s, 3 H, 4′-
OCH3), 3.63 (s, 3 H, 3′-OCH3), 3.28 (dd, J = 18.7, 3.7 Hz, 1 H, 5-CHH), 3.00 (dd, J = 18.7, 5.9 
Hz, 1 H, 5-CHH), 2.77 (dd, J = 17.5, 11.0 Hz, 1 H, 3-CHH), 2.66 (dd, J = 17.5, 4.9 Hz, 1 H, 3-
CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 206.3 (4-C), 156.6 (HNC=O), 153.4 (4″-C, 
indirect observation), 150.9 (3′-C), 149.7 (4′-C), 146.9 (1″-C), 138.4 (1′′′-C), 133.8 (1′-C), 129.1 (3′′′-
C + 5′′′-C), 127.4 (2″-C + 6″-C), 126.9–126.8 (m, 3″-C + 5″-C), 123.9 (4′′′-C), 120.1 (2′′′-C + 6′′′-
C), 118.1 (6′-C), 111.7 (5′-C), 108.3 (2′-C), 57.6 (2-C), 56.2 (4′-OCH3), 55.9 (3′-OCH3), 51.5 (6-C), 
47.0 (3-C), 42.4 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3389, 2926, 1725, 1663, 1598, 1518, 1265, 1238, 844. 
HRMS [ESI (m/z)] calcd for (C26H25F5N2O4S + Na)+ = 579.13474, found 579.13534 (|Δ| = 
0.1 ppm). RF: 0.22 (heptane/AcOEt, 2:1). Yield: 99%.
(2S,6R)-N-(2-Chlorophenyl)-2-(3,4-dimethoxyphenyl)-6-(4-fluorophenyl)-4-oxopiperi-
dine-1-carboxamide 5aD
According to the general procedure, the reaction of piperidin-4-one 2a
(2.4 mg, 7.28 µmol) in 1,2-DCE (90.2 mM) with 7D afforded 5aD
(2.58 mg, 5.34 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.09 (dd, 
J = 8.2, 1.5 Hz, 1 H, 6′′′-CH), 7.44–7.37 (m, 2 H, 2″-CH + 6″-CH), 
7.25–7.17 (m, 2 H, 3′′′-CH + 5′′′-CH), 7.11–7.04 (m, 2 H, 3″-CH + 5″-
CH), 7.02 (s, 1 H, NH), 6.98–6.90 (m, 1 H, 4′′′-CH), 6.85 (dd, J = 8.2, 1.9 Hz, 1 H, 6′-CH), 6.82 
(d, J = 8.2 Hz, 1 H, 5′-CH), 6.73 (d, J = 1.9 Hz, 1 H, 2′-CH), 6.15 (t, J = 5.6 Hz, 1 H, 6-CH), 5.50 
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(dd, J = 9.3, 5.1 Hz, 1 H, 2-CH), 3.86 (s, 3 H, 4′-OCH3), 3.75 (s, 3 H, 3′-OCH3), 3.17 (dd, J = 
18.3, 5.6 Hz, 1 H, 5-CHH), 2.94 (dd, J = 17.7, 9.3 Hz, 1 H, 3-CHH), 2.88 (dd, J = 18.4, 5.6 Hz, 1 
H, 5-CHH), 2.73 (dd, J = 17.7, 5.1 Hz, 1 H, 3-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]:
207.2 (4-C), 162.3 (d, J = 247.7 Hz, 4″-C), 156.5 (HNC=O), 150.2 (3′-C), 149.3 (4′-C), 138.0 (d, 
J = 3.2 Hz, 1″-C), 135.8 (1′′′-C), 133.7 (1′-C), 129.0 (3′′′-C or 5′′′-C), 128.6 (d, J = 8.1 Hz, 2″-C + 
6″-C), 127.5 (3′′′-C or 5′′′-C), 124.0 (4′′′-C), 123.1 (2′′′-C), 122.3 (6′′′-C), 118.5 (6′-C), 116.3 (d, J = 
21.5 Hz, 3″-C + 5″-C), 111.7 (5′-C), 109.2 (2′-C), 56.2 (2-C), 56.1 (3′-OCH3 + 4′-OCH3), 53.0 (6-
C), 46.2 (3-C), 43.8 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3365, 2931, 1723, 1666, 1510, 1306, 1264, 1026. 
HRMS [ESI (m/z)] calcd for (C26H24ClFN2O4 + Na)+ = 505.13063, found 505.13076 (|Δ| = 
0.3 ppm). RF: 0.35 (heptane/AcOEt, 2:1). Yield: 73%.
(2S,6R)-N-(2-Chlorophenyl)-2-(3,4-dimethoxyphenyl)-4-oxo-6-[4-(trifluoromethyl)phen-
yl]piperidine-1-carboxamide 5bD
According to the general procedure, the reaction of piperidin-4-one 
2b (1.98 mg, 5.22 µmol) in 1,2-DCE (82.8 mM) with 7D afforded 
5bD (2.15 mg, 4.03 µmol). 1H NMR [500 MHz, δ (ppm), CDCl3]:
8.09 (dd, J = 8.3, 1.5 Hz, 1 H, 6′′′-CH), 7.67–7.63 (m, 2 H, 3″-CH + 
5″-CH), 7.60–7.56 (m, 2 H, 2″-CH + 6″-CH), 7.25–7.19 (m, 2 H, 3′′′-
CH + 5′′′-CH), 7.04 (s, 1 H, NH), 6.95 (ddd, J = 8.1, 7.4, 1.5 Hz, 1 H, 4′′′-CH), 6.86 (dd, J = 8.3, 
2.1 Hz, 2 H, 6′-CH), 6.82 (d, J = 8.3 Hz, 1 H, 5′-CH), 6.65 (d, J = 2.1 Hz, 1 H, 2′-CH), 6.31 (t, J
= 5.4 Hz, 1 H, 6-CH), 5.43 (dd, J = 9.7, 5.1 Hz, 1 H, 2-CH), 3.85 (s, 3 H, 4′-OCH3), 3.70 (s, 3 H, 
3′-OCH3), 3.22 (dd, J = 18.5, 5.1 Hz, 1 H, 5-CHH), 2.94 (dd, J = 18.5, 5.7 Hz, 1 H, 5-CHH), 
2.87 (dd, J = 17.6, 9.7 Hz, 1 H, 3-CHH), 2.74 (dd, J = 17.6, 5.1 Hz, 1 H, 3-CHH). 13C NMR
[126 MHz, δ (ppm), CDCl3]: 206.4 (4-C), 156.4 (HNC=O), 150.2 (3′-C), 149.3 (4′-C), 146.3 (1″-
C), 135.6 (1′′′-C), 133.2 (1′-C), 130.2 (q, J = 32.7 Hz, 4″-C), 128.9 (3′′′-C or 5′′′-C), 127.4 (3′′′-C or
5′′′-C), 127.2 (2″-C + 6″-C), 126.1 (q, J = 3.6 Hz, 3″-C + 5″-C), 124.1 (4′′′-C), 123.7 (q, J = 272.5 
Hz, CF3, indirect observation), 123.1 (2′′′-C), 122.2 (6′′′-C), 118.5 (6′-C), 111.7 (5′-C), 108.8 (2′-C), 
56.6 (2-C), 56.0 (4′-OCH3), 55.9 (3′-OCH3), 52.8 (6-C), 46.5 (3-C), 43.0 (5-C). FTIR [?̅?𝜈 (cm−1)]: 
3356, 2961, 1724, 1666, 1593, 1517, 1439, 1327, 1263, 1234, 1124, 754. HRMS [ESI (m/z)] 
calcd for (C27H24ClF3N2O4 + Na)+ = 555.12689, found 555.12901 (|Δ| = 2.8 ppm). RF: 0.33 
(heptane/AcOEt, 2:1). Yield: 77%.
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(2S,6R)-N-(2-Chlorophenyl)-2-(3,4-dimethoxyphenyl)-4-oxo-6-[4-(pentafluoro-λ6-sulfa-
nyl)phenyl]piperidine-1-carboxamide 5cD
According to the general procedure, the reaction of piperidin-4-one 
2c (3.4 mg, 7.77 µmol) in 1,2-DCE (78.5 mM) with 7D afforded 
5cD (4.6 mg, 7.78 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 
8.09–8.05 (m, 1 H, 6′′′-CH), 7.79–7.75 (m, 2 H, 3″-CH + 5″-CH), 
7.58–7.53 (m, 2 H, 2″-CH + 6″-CH), 7.24–7.20 (m, 2 H, 3′′′-CH + 
5′′′-CH), 7.05 (s, 1 H, NH), 6.96 (ddd, J = 8.2, 7.3, 1.5 Hz, 1 H, 4′′′-CH), 6.87 (dd, J = 8.2, 2.1 Hz, 
1 H, 6′-CH), 6.83 (d, J = 8.2 Hz, 1 H, 5′-CH), 6.60 (d, J = 2.1 Hz, 1 H, 2′-CH), 6.32 (t, J = 5.4 
Hz, 1 H, 6-CH), 5.40 (dd, J = 9.7, 5.1 Hz, 1 H, 2-CH), 3.85 (s, 3 H, 4′-OCH3), 3.68 (s, 3 H, 3′-
OCH3), 3.21 (dd, J = 18.6, 5.0 Hz, 1 H, 5-CHH), 2.94 (dd, J = 18.6, 5.8 Hz, 1 H, 5-CHH), 2.86 
(dd, J = 17.6, 9.7 Hz, 1 H, 3-CHH), 2.74 (dd, J = 17.6, 5.1 Hz, 1 H, 3-CHH). 13C NMR [101 
MHz, δ (ppm), CDCl3]: 206.3 (4-C), 156.4 (HNC=O), 153.3 (4″-C, indirect observation), 150.4 
(3′-C), 149.5 (4′-C), 146.4 (1″-C), 135.6 (1′′′-C), 133.2 (1′-C), 129.1 (3′′′-C or 5′′′-C), 127.6 (3′′′-C or
5′′′-C), 127.4 (2″-C + 6″-C), 127.0–126.8 (m, 3″-C + 5″-C), 124.3 (4′′′-C), 123.2 (2′′′-C), 122.4 (6′′′-
C), 118.6 (6′-C), 111.8 (5′-C), 108.7 (2′-C), 56.9 (2-C), 56.2 (4′-OCH3), 56.0 (3′-OCH3), 52.5 (6-C), 
46.7 (3-C), 42.9 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3360, 2961, 2838, 2258, 1725, 1686, 1593, 1517, 1440, 
1306, 1263, 1234, 1145, 1027, 842, 751. HRMS [ESI (m/z)] calcd for (C26H24ClF5N2O4S + Na)+
= 613.09632, found 613.09446 (|Δ| = 3.02 ppm). Yield: 99%.
(2S,6R)-N-(2,4-Difluorophenyl)-2-(3,4-dimethoxyphenyl)-6-(4-fluorophenyl)-4-oxopiperi-
dine-1-carboxamide 5aE
According to the general procedure, the reaction of piperidin-4-one 2a
(2.30 mg, 6.98 µmol) in 1,2-DCE (87.6 mM) with 7E afforded 5aE
(3.28 mg, 6.77 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.01 (td, 
J = 9.1, 5.9 Hz, 1 H, 6′′′-CH), 7.42–7.35 (m, 2 H, 2″-CH + 6″-CH), 
7.12–7.05 (m, 2 H, 3″-CH + 5″-CH), 6.86–6.77 (m, 3 H, 5′-CH + 6′-
CH + 5′′′-CH), 6.74–6.67 (m, 2 H, 3′′′-CH + NH), 6.64 (d, J = 1.8 Hz, 
1 H, 2′-CH), 6.15 (t, J = 5.4 Hz, 1 H, 6-CH), 5.37 (dd, J = 9.9, 4.9 Hz, 1 H, 2-CH), 3.87 (s, 3 H, 
4′-OCH3), 3.72 (s, 3 H, 3′-OCH3), 3.20 (dd, J = 18.5, 5.1 Hz, 1 H, 5-CHH), 2.91 (dd, J = 17.7, 9.9 
Hz, 1 H, 3-CHH), 2.88 (dd, J = 18.5, 5.6 Hz, 1 H, 5-CHH), 2.68 (dd, J = 17.7, 4.9 Hz, 1 H, 3-
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CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 207.0 (4-C), 162.3 (d, J = 248.0 Hz, 4″-C), 158.2 
(dd, J = 245.2, 11.4 Hz, 4′′′-C), 156.4 (HNC=O), 152.6 (dd, J = 246.0, 12.0 Hz, 2′′′-C), 150.3 (3′-
C), 149.4 (4′-C), 138.1 (d, J = 3.3 Hz, 1″-C), 133.6 (1′-C), 128.6 (d, J = 8.1 Hz, 2″-C + 6″-C), 
123.5 (dd, J = 10.4, 3.8 Hz, 1′′′-C), 122.7 (dd, J = 9.0, 2.4 Hz, 6′′′-C), 118.3 (6′-C), 116.3 (d, J = 
21.5 Hz, 3″-C + 5″-C), 111.7 (5′-C), 111.1 (dd, J = 21.6, 3.7 Hz, 5′′′-C), 108.9 (2′-C), 103.4 (dd, J = 
26.7, 23.3 Hz, 3′′′-C), 56.5 (2-C), 56.10 (3′-OCH3 or 4′-OCH3), 56.06 (3′-OCH3 or 4′-OCH3), 52.6 
(6-C), 46.2 (3-C), 43.4 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3379, 2936, 1721, 1665, 1534, 1511, 1256, 1228, 
1025, 962, 849. HRMS [ESI (m/z)] calcd for (C26H23F3N2O4 + Na)+ = 507.15021, found 
507.15113 (|Δ| = 0.7 ppm). RF: 0.29 (heptane/AcOEt, 2:1). Yield: 97%.
(2S,6R)-N-(2,4-Difluorophenyl)-2-(3,4-dimethoxyphenyl)-4-oxo-6-[4-(trifluoromethyl)phen-
yl]piperidine-1-carboxamide 5bE
According to the general procedure, the reaction of piperidin-4-one 
2b (1.37 mg, 3.61 µmol) in 1,2-DCE (82.8 mM) with 7E afforded 
5bE (1.07 g, 2.00 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 
8.01 (td, J = 9.1, 5.9 Hz, 1 H, 6′′′-CH), 7.70–7.64 (m, 2 H, 3″-CH + 
5″-CH), 7.60–7.55 (m, 2 H, 2″-CH + 6″-CH), 6.88–6.79 (m, 3 H, 5′-
CH + 6′-CH + 5′′′-CH), 6.73 (s, 1 H, NH), 6.72 (ddd, J = 11.0, 8.3, 
2.8 Hz, 1 H, 3′′′-CH), 6.54–6.52 (m, 1 H, 2′-CH), 6.35 (t, J = 5.1 Hz, 1 H, 6-CH), 5.26 (dd, J = 
10.5, 4.9 Hz, 1 H, 2-CH), 3.86 (s, 3 H, 4′-OCH3), 3.66 (s, 3 H, 3′-OCH3), 3.27 (dd, J = 18.6, 4.4 
Hz, 1 H, 5-CHH), 2.95 (dd, J = 18.6, 5.8 Hz, 1 H, 5-CHH), 2.82 (dd, J = 17.6, 10.6 Hz, 1 H, 3-
CHH), 2.67 (dd, J = 17.6, 4.9 Hz, 1 H, 3-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 206.5 
(4-C), 156.4 (HNC=O), 158.2 (d, J = 244.4 Hz, 4′′′-C), 152.3 (dd, J = 243.9, 11.6 Hz, 2′′′-C), 150.5 
(3′-C), 149.6 (4′-C), 146.5 (1″-C), 133.2 (1′-C), 130.2 (4″-C, indirect observation), 127.4 (2″-C + 
6″-C), 126.2 (q, J = 3.5 Hz, 3″-C + 5″-C), 123.8 (q, J = 270.3 Hz, CF3, indirect observation), 
123.4 (dd, J = 10.4, 3.9 Hz, 1′′′-C), 122.8 (dd, J = 8.8, 2.3 Hz, 6′′′-C), 118.4 (6′-C), 111.8 (5′-C), 
111.2 (dd, J = 21.6, 3.8 Hz, 5′′′-C), 108.5 (2′-C), 103.5 (dd, J = 26.6, 23.3 Hz, 3′′′-C), 57.2 (2-C), 
56.1 (4′-OCH3), 56.0 (3′-OCH3), 52.3 (6-C), 46.7 (3-C), 42.7 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3381, 2927, 
1723, 1667, 1611, 1535, 1518, 1327, 1257, 1126, 1026. HRMS [ESI (m/z)] calcd for 
(C27H23F5N2O4 + Na)+ = 557.14702, found 557.14825 (|Δ| = 1.2 ppm). RF: 0.31 
(heptane/AcOEt, 2:1). Yield: 55%.
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(2S,6R)-N-(2,4-Difluorophenyl)-2-(3,4-dimethoxyphenyl)-4-oxo-6-[4-(pentafluoro-λ6-sul-
fanyl)phenyl]piperidine-1-carboxamide 5cE
According to the general procedure, the reaction of piperidin-4-one 
2c (1.87 mg, 4.27 µmol) in 1,2-DCE (82.9 mM) with 7E afforded 5cE
(2.2 mg, 3.7 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.00 (td, 
J = 9.1, 5.9 Hz, 1 H, 6′′′-CH), 7.83–7.74 (m, 2 H, 3″-CH + 5″-CH), 
7.60–7.52 (m, 2 H, 2″-CH + 6″-CH), 6.88–6.80 (m, 3 H, 5′-CH + 6′-
CH + 5′′′-CH), 6.79–6.68 (m, 2 H, 3′′′-CH + NH), 6.49 (d, J = 1.2 Hz, 
1 H, 2′-CH), 6.38 (t, J = 5.0 Hz, 1 H, 6-CH), 5.22 (dd, J = 10.7, 4.9 Hz, 1 H, 2-CH), 3.87 (s, 3 H, 
4′-OCH3), 3.65 (s, 3 H, 3′-OCH3), 3.27 (dd, J = 18.6, 4.1 Hz, 1 H, 5-CHH), 2.97 (dd, J = 18.6, 5.8 
Hz, 1 H, 5-CHH), 2.80 (dd, J = 17.6, 10.7 Hz, 1 H, 3-CHH), 2.68 (dd, J = 17.6, 4.9 Hz, 1 H, 3-
CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 206.2 (4-C), 158.3 (dd, J = 245.7, 11.4 Hz, 4′′′-C), 
156.4 (HNC=O), 153.5–153.1 (m, 4″-C), 152.7 (dd, J = 245.7, 11.5 Hz, 2′′′-C), 150.6 (3′-C), 149.7 
(4′-C), 146.5 (1″-C), 133.1 (1′-C), 127.4 (2″-C + 6″-C), 127.0–126.9 (m, 3″-C + 5″-C), 123.4 (dd, J
= 10.5, 3.7 Hz, 1′′′-C), 122.9 (dd, J = 9.0, 2.5 Hz, 6′′′-C), 118.4 (6′-C), 111.8 (5′-C), 111.2 (dd, J = 
21.7, 3.6 Hz, 5′′′-C), 108.3 (2′-C), 103.5 (dd, J = 26.6, 23.3 Hz, 3′′′-C), 57.4 (2-C), 56.2 (4′-OCH3), 
55.9 (3′-OCH3), 51.9 (6-C), 46.9 (3-C), 42.5 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3376, 2962, 1725, 1666, 
1610, 1534, 1517, 1257, 843. HRMS [ESI (m/z)] calcd for (C26H23F7N2O4S + H)+ = 593.13395, 
found 593.13686 (|Δ| = 4.0 ppm). HRMS [ESI (m/z)] calcd for (C26H23F7N2O4S + Na)+ = 
615.11590, found 615.11657 (|Δ| = 0.2 ppm). RF: 0.25 (heptane/AcOEt, 2:1). Yield: 87%.
Synthesis and Full Characterization of Amino Alcohols 11c and 12b
(2S,4R,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(pentafluoro-λ6-sulfanyl)phenyl]piperidin-4-ol 11c
Solution A: piperidin-4-one 2c (8.4 mg, 0.019 mmol) dissolved in THF (50.3 mM). Solution B: 
LiBH4 (2 M solution in THF; 1.5 equiv) dissolved in THF (75 mM).
Solution A (13.33 µL/min) was combined with B (20 µL/min) inside the glass microreactor 
(internal volume: 100 µL). The reaction was performed at 21 °C for 3 min.
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1H NMR [500 MHz, δ (ppm), CDCl3]: 7.75–7.69 (m, 2 H, 3″-CH + 
5″-CH), 7.57–7.52 (m, 2 H, 2″-CH + 6″-CH), 7.00 (d, J = 2.0 Hz, 1 
H, 2′-CH), 6.96 (dd, J = 8.2, 2.0 Hz, 1 H, 6′-CH), 6.83 (d, J = 8.2 
Hz, 1 H, 5′-CH), 3.99–3.92 (m, 2 H, 4-CH + 6-CH), 3.91 (s, 3 H, 3′-
OCH3), 3.87 (s, 3 H, 4′-OCH3), 3.81 (dd, J = 11.3, 2.4 Hz, 1 H, 2-CH), 2.21–2.10 (m, 2 H, 3-
CHH + 5-CHH), 1.62–1.46 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]:
153.0 (4″-C, indirect observation), 149.2 (3′-C), 148.5 (4′-C), 148.2 (1″-C), 136.7 (1′-C), 127.2 (2″-
C + 6″-C), 126.3 (quint, J = 4.0 Hz, 3″-C + 5″-C), 118.9 (6′-C), 111.2 (5′-C), 110.1 (2′-C), 69.9 (4-
C), 59.7 (2-C), 59.4 (6-C), 56.09 (4′-OCH3), 56.07 (3′-OCH3), 43.9 (3-C or 5-C), 43.8 (3-C or 5-C). 
FTIR [?̅?𝜈 (cm−1)]: 2936, 2839, 1517, 1262, 1232, 1027, 845, 815. HRMS [ESI (m/z)] calcd for 
(C19H22F5NO3S + H)+ = 440.13188, found 440.13125 (|Δ| = 1.44 ppm). Yield: 76%.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(trifluoromethyl)phenyl]piperidin-4-ol 12b
N-Selectride (3.95 mL, 3.95 mmol, 1.0 M solution in THF) was 
added to a solution of piperidin-4-one 2b (500 mg, 1.32 mmol) in 
dry THF (96 mL) at −78 °C. The reaction was stirred for 1 h and it 
was quenched with H2O (100 mL). The solution was allowed to 
reach 21 °C and then AcOEt was added. The organic layer was separated and the aqueous layer 
was extracted with AcOEt (3 × 50 mL). The combined organic layers were washed with brine, 
dried over anhydrous Na2SO4, filtered off and concentrated in vacuo. The residue was purified 
by SCX-2 column to afford amino alcohol 12b (456 mg, 1.20 mmol). 1H NMR [400 MHz, δ
(ppm), CDCl3]: 7.66–7.53 (m, 4 H, 2″-CH + 3″-CH + 5″-CH + 6″-CH), 7.04–6.97 (m, 2 H, 2′-
CH + 6′-CH), 6.84 (d, J = 8.1 Hz, 1 H, 5′-CH), 4.40–4.32 (m, 2 H, 4-CH + 6-CH), 4.25 (dd, J = 
11.7, 2.7 Hz, 1 H, 2-CH), 3.91 (s, 3 H, 3′-OCH3), 3.87 (s, 3 H, 4′-OCH3), 1.95–1.87 (m, 2 H, 3-
CHH + 5-CHH), 1.86–1.70 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 
149.4 (1″-C), 149.1 (3′-C), 148.4 (4′-C), 137.5 (1′-C, indirect observation), 129.4 (4″-C, indirect 
observation), 127.3 (2″-C + 6″-C), 125.5 (q, J = 3.7 Hz, 3″-C + 5″-C), 123.0 (CF3, indirect 
observation), 118.9 (6′-C), 111.3 (5′-C), 110.2 (2′-C), 66.2 (4-C), 56.09 (3′-OCH3 or 4′-OCH3), 
56.07 (3′-OCH3 or 4′-OCH3), 56.0 (6-C), 55.7 (2-C), 41.66 (3-C or 5-C), 41.65 (3-C or 5-C). 
FTIR [?̅?𝜈 (cm−1)]: 2936, 1517, 1465, 1326, 1263, 1163, 1123, 1067, 1027, 806. HRMS [ESI 
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(m/z)] calcd for (C20H22F3NO3 + H)+ = 382.16300, found 382.16336 (|Δ| = 0.94 ppm). Yield: 
91%.
Synthesis and Full Characterization of Alkyl Ureas 6cA, 6cB and 6cF
Solution A: compound 11c (1.0 equiv) dissolved in tBuOH (94.3–96.5 mM). Solution B: alkyl 
isocyanate (7A, 7B or 7F, 1.5 equiv) dissolved in tBuOH (0.1 M).
Solution A (2.35 µL/min) was combined with B (3.53 µL/min) inside the glass microreactor 
(internal volume: 100 µL). The reaction was performed at 50 °C for 17 min.
(2S,4R,6R)-2-(3,4-Dimethoxyphenyl)-N-ethyl-4-hydroxy-6-[4-(pentafluoro-λ6-sulfanyl)-
phenyl]piperidine-1-carboxamide 6cA
According to the general procedure, the reaction of amino alcohol 
11c (2.37 mg, 5.39 µmol) in tBuOH (94.6 mM) afforded urea 6cA
(2.33 mg, 4.56 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.74–
7.70 (m, 2 H, 3″-CH + 5″-CH), 7.70–7.65 (m, 2 H, 2″-CH + 6″-
CH), 6.85 (dd, J = 8.3, 2.0 Hz, 1 H, 6′-CH), 6.81 (d, J = 8.3 Hz, 1 
H, 5′-CH), 6.57 (d, J = 2.0 Hz, 1 H, 2′-CH), 5.39 (t, J = 6.2 Hz, 1 H, 6-CH), 4.43 (t, J = 5.8 Hz, 1 
H, NH), 4.40 (dd, J = 11.7, 4.3 Hz, 1 H, 2-CH), 4.27–4.14 (m, 1 H, 4-CH), 3.86 (s, 3 H, 4′-
OCH3), 3.69 (s, 3 H, 3′-OCH3), 2.93 (qd, J = 7.2, 5.4 Hz, 2 H, 1′′′-CH2), 2.43 (dt, J = 13.3, 6.2 
Hz, 1 H, 5-CHH), 2.24–2.10 (m, 2 H, 5-CHH + 3-CHH), 1.94 (dt, J = 13.5, 11.2 Hz, 1 H, 3-
CHH), 1.78 (d, J = 3.7 Hz, 1 H, OH), 0.73 (t, J = 7.2 Hz, 3 H, 2′′′-CH3). 13C NMR [101 MHz, δ
(ppm), CDCl3]: 160.7 (HNC=O), 152.7 (4″-C, indirect observation), 149.9 (3′-C), 148.9 (4′-C), 
148.7 (1″-C, indirect observation), 135.7 (1′-C), 128.1 (2″-C + 6″-C), 126.3–126.1 (m, 3″-C + 5″-
C), 118.7 (6′-C), 111.4 (5′-C), 109.5 (2′-C), 65.8 (4-C), 59.2 (2-C), 56.1 (4′-OCH3), 56.0 (3′-OCH3), 
55.3 (6-C), 41.2 (3-C), 37.8 (5-C), 35.7 (1′′′-C), 14.8 (2′′′-C). FTIR [?̅?𝜈 (cm−1)]: 3414, 2937, 1627, 
1517, 1263, 1140, 1027, 846, 594. HRMS [ESI (m/z)] calcd for (C22H27F5N2O4S + Na)+ = 
533.15094, found 533.15027 (|Δ| = 1.26 ppm). Yield: 85%.
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(2S,4R,6R)-2-(3,4-Dimethoxyphenyl)-4-hydroxy-N-isopropyl-6-[4-(pentafluoro-λ6-sulfa-
nyl)phenyl]piperidine-1-carboxamide 6cB
According to the general procedure, the reaction of amino alcohol 
11c (2.80 mg, 6.37 µmol) in tBuOH (94.3 mM) afforded urea 6cB
(2.76 mg, 5.34 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.73–
7.68 (m, 2 H, 3″-CH + 5″-CH), 7.68–7.63 (m, 2 H, 2″-CH + 6″-
CH), 6.86 (dd, J = 8.3, 2.0 Hz, 1 H, 6′-CH), 6.81 (d, J = 8.2 Hz, 1 H, 
5′-CH), 6.62 (d, J = 2.1 Hz, 1 H, 2′-CH), 5.19 (dd, J = 7.4, 5.1 Hz, 1 H, 6-CH), 4.36–4.28 (m, 2 
H, NH + 2-CH), 4.24–4.12 (m, 1 H, 4-CH), 3.86 (s, 3 H, 4′-OCH3), 3.72 (s, 3 H, 3′-OCH3), 
3.60–3.50 (m, 1 H, 1′′′-CH), 2.46–2.35 (m, 1 H, 5-CHH), 2.21–2.08 (m, 2 H, 3-CHH + 5-CHH), 
1.99–1.87 (m, 1 H, 3-CHH), 0.75 (d, J = 6.5 Hz, 3 H, 2′′′-CH3), 0.61 (d, J = 6.5 Hz, 3 H, 3′′′-CH3). 
13C NMR [101 MHz, δ (ppm), CDCl3]: 160.3 (HNC=O), 152.7 (4″-C, indirect observation), 
149.8 (3′-C), 148.9 (4′-C), 148.4 (1″-C), 135.5 (1′-C), 128.2 (2″-C + 6″-C), 126.2–126.0 (m, 3″-C + 
5″-C), 119.0 (6′-C), 111.4 (5′-C), 109.9 (2′-C), 66.2 (4-C), 59.7 (2-C), 56.2 (3′-OCH3 + 4′-OCH3), 
56.0 (6-C), 42.4 (1′′′-C), 41.4 (3-C), 38.4 (5-C), 22.8 (2′′′-C), 22.5 (3′′′-C). FTIR [?̅?𝜈 (cm−1)]: 3404, 
2967, 1704, 1627, 1517, 1465, 1263, 1140, 1027, 844, 595. HRMS [ESI (m/z)] calcd for 
(C23H29F5N2O4S + H)+ = 525.18464, found 525.18665 (|Δ| = 3.82 ppm). Yield: 84%.
(2S,4R,6R)-N-Benzyl-2-(3,4-dimethoxyphenyl)-4-hydroxy-6-[4-(pentafluoro-λ6-sulfanyl)-
phenyl]piperidine-1-carboxamide 6cF
According to the general procedure, the reaction of amino alcohol 
11c (2.00 mg, 4.55 µmol) in tBuOH (96.5 mM) afforded urea 6cF
(2.60 mg, 4.54 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.76–
7.66 (m, 4 H, 2″-CH + 3″-CH + 5″-CH + 6″-CH), 7.21–7.12 (m, 3 
H, 3′′′-CH + 4′′′-CH + 5′′′-CH), 6.80 (dd, J = 8.2, 2.1 Hz, 1 H, 6′-
CH), 6.77–6.72 (m, 3 H, 5′-CH + 2′′′-CH + 6′′′-CH), 6.54 (d, J = 2.1 Hz, 1 H, 2′-CH), 5.44 (t, J = 
6.1 Hz, 1 H, 6-CH), 4.80 (t, J = 5.6 Hz, 1 H, NH), 4.47 (dd, J = 11.5, 4.2 Hz, 1 H, 2-CH), 4.27–
4.19 (m, 1 H, 4-CH), 4.17 (dd, J = 14.8, 5.8 Hz, 1 H, NCHH), 4.05 (dd, J = 14.8, 5.2 Hz, 1 H, 
NCHH), 3.85 (s, 3 H, 4′-OCH3), 3.63 (s, 3 H, 3′-OCH3), 2.44 (dt, J = 13.1, 6.3 Hz, 1 H, 5-CHH), 
2.24 (dt, J = 14.4, 6.5 Hz, 1 H, 5-CHH), 2.15 (dt, J = 13.5, 5.1 Hz, 1 H, 3-CHH), 1.97 (dt, J = 
13.7, 11.1 Hz, 1 H, 3-CHH), 1.82 (d, J = 3.3 Hz, 1 H, OH). 13C NMR [101 MHz, δ (ppm), 
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CDCl3]: 160.5 (HNC=O), 152.6 (4″-C, indirect observation), 149.9 (3′-C), 148.9 (4′-C), 148.7 (1″-
C), 138.4 (1′′′-C), 135.6 (1′-C), 128.5 (3′′′-C + 5′′′-C), 128.2 (2″-C + 6″-C), 127.3 (4′′′-C), 127.2 (2′′′-
C + 6′′′-C), 126.3–126.2 (m, 3″-C + 5″-C), 118.7 (6′-C), 111.5 (5′-C), 109.4 (2′-C), 65.6 (4-C), 59.0 
(2-C), 56.1 (4′-OCH3), 55.9 (3′-OCH3), 55.2 (6-C), 45.1 (NCH2), 40.9 (3-C), 37.6 (5-C). FTIR [?̅?𝜈
(cm−1)]: 3410, 2936, 1690, 1560, 1541, 1263, 1139, 1027, 842, 750, 595. HRMS [ESI (m/z)] 
calcd for (C27H29F5N2O4S + Na)+ = 595.16659, found 595.16478 (|Δ| = 3.04 ppm). Yield: 
99%.
Synthesis and Full Characterization of Aryl Ureas 6cC and 6cD
Solution A: compound 11c (1.0 equiv) dissolved in 1,2-DCE (95.6–105.0 mM). Solution B: aryl 
isocyanate (7C and 7D, 1.1 equiv) dissolved in 1,2-DCE (0.1 M).
Solution A (2.80 µL/min) was combined with B (3.08 µL/min) inside the glass microreactor 
(internal volume: 100 µL). The reaction was performed at 80 °C for 17 min.
(2S,4R,6R)-2-(3,4-Dimethoxyphenyl)-4-hydroxy-6-[4-(pentafluoro-λ6-sulfanyl)phenyl]-N-
phenylpiperidine-1-carboxamide 6cC
According to the general procedure, the reaction of amino alcohol 
11c (2.57 mg, 5.85 µmol) in 1,2-DCE (95.6 mM) afforded urea 6cC
(3.26 mg, 5.84 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.80–
7.76 (m, 2 H, 2″-CH + 6″-CH), 7.75–7.70 (m, 2 H, 3″-CH + 5″-
CH), 7.20–7.14 (m, 2 H, 3′′′-CH + 5′′′-CH), 6.99–6.90 (m, 4 H, 6′-CH
+ 2′′′-CH + 4′′′-CH + 6′′′-CH), 6.87 (d, J = 8.2 Hz, 1 H, 5′-CH), 6.56 (s, 1 H, NH), 6.51 (d, J = 
2.1 Hz, 1 H, 2′-CH), 5.80 (t, J = 5.8 Hz, 1 H, 6-CH), 4.61 (dd, J = 12.0, 4.3 Hz, 1 H, 2-CH), 
4.36–4.24 (m, 1 H, 4-CH), 3.88 (s, 3 H, 4′-OCH3), 3.62 (s, 3 H, 3′-OCH3), 2.58 (dt, J = 14.3, 6.9 
Hz, 1 H, 5-CHH), 2.37 (dt, J = 14.9, 5.4 Hz, 1 H, 5-CHH), 2.18 (dt, J = 13.6, 5.1 Hz, 1 H, 3-
CHH), 2.03 (dt, J = 13.7, 11.6 Hz, 1 H, 3-CHH), 1.89–1.85 (m, 1 H, OH). 13C NMR [101 MHz, 
δ (ppm), CDCl3]: 157.6 (HNC=O), 152.6 (4″-C, indirect observation), 150.4 (3′-C), 149.3 (4′-C), 
148.9 (1″-C), 138.5 (1′′′-C), 135.3 (1′-C), 129.0 (3′′′-C + 5′′′-C), 128.2 (2″-C + 6″-C), 126.4–126.2 
(m, 3″-C + 5″-C), 123.6 (4′′′-C), 119.8 (2′′′-C + 6′′′-C), 118.5 (6′-C), 111.6 (5′-C), 109.1 (2′-C), 65.1 
(4-C), 59.1 (2-C), 56.2 (4′-OCH3), 55.9 (3′-OCH3), 53.8 (6-C), 41.0 (3-C), 36.6 (5-C). FTIR [?̅?𝜈
(cm−1)]: 3388, 2933, 2841, 1686, 1647, 1501, 1443, 1420, 1264, 1237, 1140, 1027, 843, 754. 
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HRMS [ESI (m/z)] calcd for (C26H27F5N2O4S + Na)+ = 581.15094, found 581.14995 (|Δ| = 
1.70 ppm). Yield: 99%.
(2S,4R,6R)-N-(2-Chlorophenyl)-2-(3,4-dimethoxyphenyl)-4-hydroxy-6-[4-(pentafluoro-λ6-
sulfanyl)phenyl]piperidine-1-carboxamide 6cD
According to the general procedure, the reaction of amino alcohol 
11c (3.40 mg, 7.74 µmol) in 1,2-DCE (105.0 mM) afforded urea 6cD
(3.81 mg, 6.42 µmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.01 
(dd, J = 8.6, 1.6 Hz, 1 H, 6′′′-CH), 7.79–7.75 (m, 2 H, 2″-CH + 6″-
CH), 7.75–7.70 (m, 2 H, 3″-CH + 5″-CH), 7.21–7.14 (m, 2 H, 3′′′-
CH + 5′′′-CH), 6.97 (s, 1 H, NH), 6.95–6.87 (m, 2 H, 6′-CH + 4′′′-CH), 6.82 (d, J = 8.3 Hz, 1 H, 
5′-CH), 6.61 (d, J = 2.2 Hz, 1 H, 2′-CH), 5.83 (t, J = 6.0 Hz, 1 H, 6-CH), 4.85 (dd, J = 11.1, 4.8 
Hz, 1 H, 2-CH), 4.39–4.37 (m, 1 H, 4-CH), 3.84 (s, 3 H, 4′-OCH3), 3.65 (s, 3 H, 3′-OCH3), 2.57 
(dt, J = 14.4, 7.0 Hz, 1 H, 5-CHH), 2.36 (dt, J = 14.9, 5.8 Hz, 1 H, 5-CHH), 2.26 (dt, J = 13.9, 
5.4 Hz, 1 H, 3-CHH), 2.09 (dt, J = 13.9, 10.5 Hz, 1 H, 3-CHH), 1.87 (d, J = 3.6 Hz, 1 H, OH). 
13C NMR [101 MHz, δ (ppm), CDCl3]: 157.1 (HNC=O), 152.6 (4″-C, indirect observation), 
150.1 (3′-C), 149.1 (4′-C), 148.5 (1″-C), 135.8 (1′′′-C), 134.8 (1′-C), 129.0 (3′′′-C or 5′′′-C), 128.2 (2″-
C + 6″-C), 127.5 (3′′′-C or 5′′′-C), 126.5–126.3 (m, 3″-C + 5″-C), 123.9 (4′′′-C), 123.0 (2′′′-C), 122.0 
(6′′′-C), 119.0 (6′-C), 111.8 (5′-C), 109.2 (2′-C), 64.9 (4-C), 58.3 (2-C), 56.2 (4′-OCH3), 56.0 (3′-
OCH3), 54.0 (6-C), 40.8 (3-C), 36.6 (5-C). FTIR [?̅?𝜈 (cm−1)]: 3362, 2936, 2838, 2258, 1735, 1663, 
1517, 1439, 1263, 1140, 1027, 843, 754. HRMS [ESI (m/z)] calcd for (C26H26ClF5N2O4S + H)+
= 593.13002, found 593.12885 (|Δ| = 1.98 ppm). Yield: 83%.
Synthesis and Full Characterization of Ureas 13bB and 13bB′
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-4-hydroxy-N-isopropyl-6-[4-(trifluoromethyl)phen-
yl]piperidine-1-carboxamide 13bB and 13bB′
Isopropyl isocyanate (7B; 0.01 mL, 0.12 mmol) was added to a solution of piperidin-4-ol 12b
(46.2 mg, 0.12 mmol) in CH2Cl2 (1.2 mL) at 21 °C and the reaction was stirred for 20 h. The 
solvent was removed under vacuo and the crude was purified by column chromatography 
(CH2Cl2→CH2Cl2/MeOH, 10:1) to afford compounds 13bB and 13bB′ (21.5 mg, 0.046 mmol)
as separated species. Combined yield: 38%.
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13bB: 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.59–7.49 (m, 4 H, 2″-
CH + 3″-CH + 5″-CH + 6″-CH), 6.84–6.74 (m, 2 H, 5′-CH + 6′-
CH), 6.64 (bs, 1 H, 2′-CH), 5.65 (t, J = 5.4 Hz, 1 H, 6-CH), 4.90 (dd, 
J = 10.0, 4.1 Hz, 1 H, 2-CH), 4.43 (quint, J = 5.2 Hz, 1 H, 4-CH), 
4.33 (d, J = 7.4 Hz, 1 H, NH), 3.83 (s, 3 H, 4′-OCH3), 3.82–3.71 (m, 
1 H, 1′′′-CH), 3.71 (s, 3 H, 3′-OCH3), 2.76–2.64 (m, 1 H, 5-CHH), 2.15–2.07 (m, 1 H, 3-CHH), 
2.00 (dt, J = 15.0, 5.4 Hz, 1 H, 5-CHH), 1.84 (dt, J = 14.9, 3.8 Hz, 1 H, 3-CHH), 0.89 (d, J = 6.5 
Hz, 3 H, 2′′′-CH3), 0.74 (d, J = 6.4 Hz, 3 H, 3′′′-CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 
159.3 (HNC=O), 149.7 (3′-C), 148.65–148.59 (m, 1″-C), 148.5 (4′-C), 136.1 (1′-C), 129.2 (q, J = 
32.6 Hz, 4″-C), 127.4 (2″-C + 6″-C), 125.5 (q, J = 3.7 Hz, 3″-C + 5″-C), 122.8 (CF3, indirect 
observation), 118.3 (6′-C), 111.3 (5′-C), 109.6 (2′-C), 62.4 (4-C), 56.0 (4′-OCH3), 55.9 (3′-OCH3), 
54.1 (2-C), 52.1 (6-C), 42.8 (1′′′-C), 39.6 (3-C), 36.1 (5-C), 23.2 (2′′′-C), 22.9 (3′′′-C). FTIR [?̅?𝜈
(cm−1)]: 3415, 2965, 2937, 1619, 1517, 1465, 1327, 1262, 1164, 1123, 1070, 1019, 808. HRMS
[ESI (m/z)] calcd for (C24H29F3N2O4 + Na)+ = 489.19771, found 489.19701 (|Δ| = 1.43 ppm).
13bB′: 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.69–7.62 (m, 2 H, 
2″-CH + 6″-CH), 7.61–7.54 (m, 2 H, 3″-CH + 5″-CH), 6.90–6.84 
(m, 1 H, 6′-CH), 6.81 (dd, J = 8.2, 0.8 Hz, 1 H, 5′-CH), 6.67 (d, J = 
1.9 Hz, 1 H, 2′-CH), 5.12 (dd, J = 7.3, 5.2 Hz, 1 H, 6-CH), 4.36 (dd, 
J = 11.7, 3.9 Hz, 1 H, 2-CH), 4.32 (d, J = 7.5 Hz, 1 H, NH), 4.23–
4.11 (m, 1 H, 4-CH), 3.86 (s, 3 H, 4′-OCH3), 3.73 (s, 3 H, 3′-OCH3), 3.60–347 (m, 1 H, 1′′′-CH), 
2.41–2.33 (m, 1 H, 5-CHH), 2.20–2.10 (m, 2 H, 5-CHH + 3-CHH), 2.01–1.91 (m, 1 H, 3-CHH), 
0.72 (d, J = 5.9 Hz, 3 H, 2′′′-CH3), 0.61 (d, J = 6.6 Hz, 3 H, 3′′′-CH3). 13C NMR [101 MHz, δ
(ppm), CDCl3]: 160.4 (HNC=O), 149.7 (3′-C), 148.8 (4′-C), 148.4 (1″-C), 135.6 (1′-C), 129.4 (4″-
C, indirect observation), 128.2 (2″-C + 6″-C), 125.4 (3″-C + 5″-C), 122.9 (CF3, indirect 
observation), 119.1 (6′-C), 111.3 (5′-C), 110.0 (2′-C), 66.3 (4-C), 59.6 (2-C), 56.7 (6-C), 56.1 (3′-
OCH3 or 4′-OCH3), 56.0 (3′-OCH3 or 4′-OCH3), 42.4 (1′′′-C), 41.2 (3-C), 38.7 (5-C), 22.8 (2′′′-C), 
22.5 (3′′′-C). FTIR [?̅?𝜈 (cm−1)]: 3414, 2930, 1620, 1517, 1465, 1325, 1263, 1164, 1122, 1027, 842. 
HRMS [ESI (m/z)] calcd for (C24H29F3N2O4 + Na)+ = 489.19771, found 489.19688 (|Δ| = 
1.70 ppm).
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values would be expected if atropisomers were observed, although the absence of examples of this 
phenomenon in the literature makes the prediction of those values difficult).
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Synthesis of Spiro[piperidine-pyridoindole] and 
Spiro[piperidine-pyrrolopyridine] Scaffolds and Their 
Derivatization 
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ABSTRACT: The synthesis of tri- and tetracyclic scaffolds based on the spiro[piperidine-pyridoindole] 
and spiro[piperidine-pyrrolopyridine] cores was developed using the Pictet–Spengler reaction. Both 
scaffolds present three possible derivatization points that could lead to the generation of new 
libraries of compounds within the European Lead Factory. The selective derivatization of the amino 
groups of both scaffolds was achieved in good yields to form drug-like compounds. Finally, the 
elimination reaction of the spiro[piperidine-pyridoindole] derivatives into pyridinyl-indolyl-ethyl ureas 
was evaluated.
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4.1 Introduction
Small molecule therapy remains one of the keystones of modern medicine. Nearly 90% of all 
the currently marketed drugs are based on small molecules.1 More specifically, two thirds of the 
new drugs that were approved in 2015 originated from small molecular entities, which 
demonstrate the relevance of small molecules with respect to drug development. In many 
instances, the starting point for developing new small molecules is derived from collections of 
chemical compounds.1,2
The pharmaceutical industry could not exist nowadays without the help of high-throughput 
screening (HTS): a widely used methodology that assesses the biological effect of individual 
members of large collections of chemical compounds. This methodology has generated more 
new active pharmaceutical ingredients than any other rational drug discovery approach.3
In this regard, the European Lead Factory (ELF) was founded in 2012.4 The ELF is a 
collaborative public–private partnership (PPP) that provides researchers in Europe with a 
platform for translation of innovative biology and chemistry into high-quality starting points for 
drug discovery (Figure 4.1).
Figure 4.1 Schematic Representation of the Goal of the European Lead Factory.
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An integral part of the ELF is a large collection of small molecules that is generated in a 
combined action of academic groups, SMEs and big pharmaceutical companies. Academic 
partners and SMEs produce proposals for new compound libraries, which are validated and 
brought into production if accepted by the Library Proposal Committee.
The main criteria for a library proposal to get accepted by the ELF are molecular properties,5
structural features, novelty, diversity potential, synthetic tractability and innovative library 
design.4
In this context and based on the results described in Chapter 2,6 we proposed two compound 
libraries based on scaffolds 1 and 2 (Figure 4.2a). The three-dimensionality and the presence of 
three potential points of diversification (NH groups) present in 1 and 2 made these compounds 
interesting targets for the ELF. However, the high molecular weights of these compounds (471.6 
for the indole derivative and 421.5 for the pyrrole derivative) would limit their derivatization, 
taking into consideration the Lipinski’s rules.5c,7 The Lipinski’s rule of five states that a drug 
candidate should have a molecular weight lower than 500,8 among other requirements.
Figure 4.2 a) Compounds 1 and 2. b) New Scaffolds 3 and 4 for Library Syntheses.
Thus, we decided to simplify scaffolds 1 and 2 into more drug-like molecules by removing the 
two phenyl groups (and therefore the two chiral centers) at the 2- and 6-positions in the 
piperidine ring and proposed scaffolds 3 and 4 (Figure 4.2b) as frameworks for further
derivatization into libraries of compounds.
From a medicinal chemistry point of view, scaffold 3 combines two interesting features: a spiro
diamine moiety (a diazaspiroalkane)9 and a tetrahydro-γ-carboline10 moiety (Figure 4.3), which 
are relevant in nature and occur in bioactive molecules such as histrionicotoxin derivatives or the 
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antihistamine mebhydrolin. Unification of these two features would lead to the spirocyclic 
compound 3.
Figure 4.3 Scaffold 3, Diazaspiroalkane 5 and Tetrahydro-γ-carboline 6.
Scaffold 3 was submitted as a library proposal to the ELF presenting different substitution 
patterns (aliphatic and aromatic amides, sulfonamides and ureas among others) on the three 
nitrogen atoms. The results of the molecular properties of the final library are shown in Figures 
4.4 and 4.5.
Figure 4.4 Average Molecular Weight and Log P of the Final Library Based on Scaffold 3.
Figure 4.4 shows the average molecular weight and log P of the possible final products of the 
library based on compound 3, both in accordance with Lipinski’s rule of five by having the 
majority of the compounds a molecular weight slightly less than 500 and a log P less than 5.
Figure 4.5 represents an indication of the number of groups that can accept hydrogen atoms to 
form hydrogen bonds. This indication can be estimated by the sum of oxygen and nitrogen 
atoms, being ideally less than ten. As can be seen in Figure 4.5, the majority of the compounds 
could form between five and nine hydrogen bonds.
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Figure 4.5 Average Sums of Number of Nitrogen and Oxygen Atoms of the Final Library Based on Scaffold 3.
In this chapter, we explored the synthesis and further derivatization of the two new spirocyclic 
scaffolds 3 and 4. Both contain three derivatization points and hence could lead to promising
drug-like molecules for the ELF because of their high three-dimensional character as well as 
their high functionalization possibilities.
4.2 Results and Discussion
4.2.1 Synthesis of the Scaffolds
The retrosynthetic analysis for the synthesis of the spiro[piperidine-pyridoindole] and 
spiro[piperidine-pyrrolopyridine] cores is shown in Scheme 4.1. Core structures 7–9 could be 
generated from the protected piperidin-4-ones 10 or 11 and the 2-arylethyl amine moieties (indole 
12 or pyrrole 13) by a Pictet–Spengler cyclization.11
Scheme 4.1 Retrosynthetic Analysis for the Synthesis of Scaffolds 7, 8 and 9.
As described in Chapter 2,6 2-(1H-indol-2-yl)ethan-1-amine (12) and 2-(1H-pyrrol-2-yl)ethan-1-
amine (13) could be prepared from 1H-indole-2-carbaldehyde (14) and 1H-pyrrole-2-
carbaldehyde (15), respectively. However, in this case the synthesis of amine 12 was a crucial step 
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in the synthesis of scaffold 7, because the reaction was meant to be scalable and aldehyde 14 is 
expensive and was needed in large amount. Therefore, we decided to prepare amine 12 following 
the approach depicted in Scheme 4.2.12 Thus, reduction of commercially available and cheap
ethyl 1H-indole-2-carboxylate (16, 9.3 g) with LiAlH4 yielded the corresponding alcohol 17 that 
was subsequently oxidized with MnO2 to afford aldehyde 14.
Scheme 4.2 Synthesis of 2-(1H-Indol-2-yl)ethan-1-amine (12).
Then, amine 12 was synthesized by a base-catalyzed Henry reaction between aldehyde 14 and 
nitromethane in the presence of methylamine hydrochloride and potassium acetate, to give the 
corresponding nitro alkene intermediate (18), which was further reduced with LiAlH4 to afford
amine 12. After these four steps, purification by column chromatography was not necessary so 
that compound 12 was used directly in the next step.13
The same strategy as described in Chapter 2 (Henry reaction, followed by reduction of nitro
alkene 19) was successfully and in high overall yield applied to the synthesis of amine 13 starting
from the commercially available aldehyde 15 (Scheme 4.3).14
Scheme 4.3 Synthesis of 2-(1H-Pyrrol-2-yl)ethan-1-amine (13).
Finally, compounds 7 and 8 were synthesized by a Pictet–Splenger reaction following the 
conditions described in Chapter 2, after condensation of amines 12 and 13 with the Cbz-
protected piperidin-4-one 10, to yield the desired spirocyclic scaffolds 7 and 8, respectively 
(Scheme 4.4). For compound 7, only a SCX-2 column (strong cation exchange column used to 
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extract basic compounds) was performed after five steps of synthesis and a 23% overall yield was 
obtained, whereas compound 8 was obtained in 35% overall yield after three steps.
Scheme 4.4 Synthesis of Scaffolds 7 and 8.
Finally, the synthesis of scaffold 9 started with the deprotection of Boc-protected piperidin-4-
one 20 by TFA to give the corresponding trifluoroacetic salt 21, which was then reacted with allyl 
carbonochloridate to yield the Alloc-piperidin-4-one 11 in 50% yield over two steps. The Pictet–
Spengler reaction of compound 11 and amine 13 afforded the spirocyclic compound 9 in 66%
yield (Scheme 4.5).
Scheme 4.5 Synthesis of Scaffold 9.
4.2.2 Derivatization of the Cbz-Spiro[piperidine-pyridoindole] Scaffold
With the core scaffolds in our hands, we initially focused on the selective derivatization of 
scaffold 7, which presents two unprotected and reactive nitrogen atoms. Preliminary studies 
showed that the amine of the piperidine ring (fused with the indole ring) is sterically hindered so 
the nitrogen of the indole ring would react first with electrophiles under strongly basic
conditions.
Therefore, we treated scaffold 7 with alkylating agents such as allyl bromide and methyl 
2-bromoacetate (Table 4.1, entries 1–5). The deprotonation of the indole was carried out using
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NaH (1.5 equiv; entries 1–3 and 5) or NaHMDS (entry 4) at 0 °C for 30 min, followed by 
addition of the electrophile and increasing the temperature to 21 °C.
Compound 22 was obtained in rather low yields (13 and 11%, entries 1 and 4, respectively) 
when THF was used as solvent.
Although dialkylation could not be avoided in some cases (entries 2 and 3), conditions were 
optimized to obtain the lowest amount of the dialkylated product. A change of the solvent to 
DMF increased the yield of the reaction, affording the final monoalkylated compounds 22 and 
23 in 66 and 70% yields, respectively (entries 3 and 5).
Table 4.1 Conditions for Indole Derivatization.
Entry Product Reagent (equiv) R1 Base Solvent Yield (%)
1 22 AllylBr (1.2) Allyl NaH THF 13
2 22 AllylBr (1.2) Allyl NaH DMF 59a
3 22 AllylBr (1.1) Allyl NaH DMF 66b
4 22 AllylBr (1.1) Allyl NaHMDS THF 11 
5 23 MeO2CCH2Br (1.1) MeO2CCH2 NaH DMF 70 
aDialkylated product was isolated in 29% yield. bDialkylated product was isolated in 14% yield.
Compounds 7, 22 and 23 were derivatized into a small library of ureas by further reacting the 
amine at the piperidine ring (Scheme 4.6).
Thus, compounds 22 and 23 were reacted with alkyl and aryl isocyanates 24 (1.2 equiv) to yield 
compounds 25–27. Interestingly, we encountered compounds 28–30 instead after column 
chromatography. Most probably, these spirocyclic compounds (25, 26c and 27a) underwent an 
elimination reaction to give the non-spirocyclic structures 28–30 (Scheme 4.7).
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Scheme 4.6 Synthesis of Ureas 25–30.
The mechanism of this elimination is likely E1 proceeding via intermediate 31, which finally
aromatizes to the most stable products 28–30.
Scheme 4.7 Rationale Mechanism for the Formation of non-Spirocyclic Compounds 28–30.
Compounds 26–30 (Figure 4.6) were identified after an exhaustive NMR analysis (1H, 13C, 
COSY, HSQC and HMBC).
As can be seen in Figure 4.6, three spirocyclic derivatives 26a, 26b and 27c15 (61% average 
yield), with both ester and allyl groups at the nitrogen of the indole, and three ring-opened 
compounds, an allylic derivative (28c), an ester derivative (29a) and a non-substituted indole (30)
(65% average yield), were obtained. All these compounds were analyzed after column 
chromatography.
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Figure 4.6 Compounds 26–30.
Test reactions were performed and monitored by 1H NMR (after 8, 16, 20 and 72 h of 
reaction) to understand when and why this elimination happened. Reactions were carried out in 
CH2Cl2 at 21 °C using approximately the same concentration in all cases (Table 4.2). Spirocyclic 
compounds 26a, 27a, 27b and 27c were formed at first and the formation of the open form was 
not observed.
Table 4.2 Conditions and Observations Concerning the Elimination Reaction.
Entry SM Products R2 (21) [M] Time (h) Product(s) (ratio)
1 22 26a/28a furfuryl 0.061 
8 
20
26a 
26a/28a (1:1)
2 23 27a/29a furfuryl 0.057 
8 
20
27a 
27a/29aa,b
3 23 27b/29b 2-ClC6H4 0.056 
16 
20
27b 
27b/29bb (3:1)
4 23 27c/29c Et 0.056 
16 
72
27c 
27c/29cb (5:1)
aThe ratio between 27a/29a could not be determined. bAn unidentified compound was present in the 
mixture.
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However, after a certain time, the elimination occurred and compounds 28a, 29a, 29b and 29c
were present in the mixture. For compounds 26a/28a a 1:1 ratio was observed after 20 h (entry 
1), whereas for compounds 27b/29b and 27c/29c the ratios were 3:1 and 5:1, respectively 
(entries 3 and 4). These experiments indicated that the occurrence of this elimination was most 
likely dependent on the reaction time and, secondly, on the structure of the product.
After these results, we also analyzed the reactivity of scaffold 7 under acidic conditions 
(Scheme 4.8). Therefore, we dissolved the Cbz-protected starting material 7 in CH2Cl2, followed 
by the addition of TFA (5.0 equiv). After 8 and 24 h at 21 °C, the reaction was monitored by 
1H NMR and the spirocyclic compound 7 was still the only product present in the reaction
mixture whereas 31 was not observed.
Scheme 4.8 Reactivity of Compound 7 Under Acidic Conditions.
Finally, the deprotection of Cbz-piperidine 26a was carried out using H2 and catalytic Pd/C
(Scheme 4.9). In this particular case not only the amine was deprotected, but also the allyl group 
was reduced to the propyl group.
Scheme 4.9 Deprotection and Elimination of Compound 26a.
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Moreover, the spirocyclic compound 26a performed the elimination to the open structure 32
in 37% yield.16 In this case the presence of the polar solvent MeOH most likely favored the 
elimination process.
Then, we reproduced these conditions (H2, Pd/C) to also deprotect compound 27c, which 
afforded the spirocyclic compound 33 (Scheme 4.10). In this case, compound 27c did not 
eliminate to the open form under the same reaction conditions. Finally, amine 33 was directly 
used in crude form in the next step but the reaction in the presence of TsCl and Et3N resulted in 
the open form compound 34 in 70% yield rather than in the anticipated spirocyclic sulfonamide.
Scheme 4.10 Deprotection of Compound 27c and Synthesis of Compound 34.
With these results, we hypothesized that either MeOH or the triethylammonium salt formed in 
the second step could promote the elimination by forming a hydrogen bond with the carbonyl of 
the urea group, making it a better nucleofuge. The driving force for this elimination could also be 
the back-strain (B-strain) effect, because the spiro[piperidine-pyridoindole]scaffold is highly 
congested.
4.2.3 Derivatization of the Cbz- and Alloc-Spiro[piperidine-pyrrolopyridine] Scaffolds
Following the same strategy as previously discussed for scaffold 7, we decided to derivatize the 
pyrrole nitrogen of scaffold 8. For this reason, test reactions of compound 8 with allyl bromide 
and methyl 2-bromoacetate were performed (Table 4.3). The reaction of 8 with allyl bromide 
(1.1 equiv) and NaH (1.5 equiv) yielded compound 35 in 28% yield after column 
chromatography (entry 1).
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Table 4.3 Conditions for N-Pyrrole Derivatization of 8.
Entry Product Reagent(equiv) R
1 Base
(equiv) 
Time
(h) 
Yield 
(%) 
1 35 AllylBr (1.1) Allyl NaH (1.5) 25 28
2 35 AllylBr (2.5) Allyl NaH (2.0) 42 –
3 36 MeO2CCH2Br (1.2) MeO2CCH2 NaH (1.5) 40 –
As opposed to what was observed in the reactions with compound 7, in this particular case 
1H NMR of the crude material showed a mixture of product 35 and starting material 8 in a 5:2 
ratio alongside a side product (the integration of the aromatic region of the NMR spectra was 
higher than expected). When using more equivalents of allyl bromide and NaH (entry 2) a 5:1 
ratio of 8/35 was obtained, contaminated with the same side product. Unfortunately, we could 
not identify the structure of this side product, but we concluded that a side product derived from 
reaction of the Cbz protecting group was formed. Finally, reaction of 8 with methyl 
2-bromoacetate (entry 3) did not show any conversion into desired product 36 and only starting 
material was recovered.
Simultaneously, the derivatization of the nitrogen in the piperidine ring into ureas was 
attempted as well. Tests reactions were performed using ethyl isocyanate and two aryl 
isocyanates (2,4-difluorophenyl and 2-chlorophenyl). The reactions were performed in CH2Cl2 at 
21 °C and different reaction times depending on the isocyanate used. From these reactions, we 
observed that product 37 was formed in all cases in conversions higher than 91%.
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Scheme 4.11 Synthesis of Compound 37 and Side Reactions after Column Chromatography.
However, we observed that two subsequent reactions occurred (Scheme 4.11, blue and orange
arrows) during purification by column chromatography using 10% of MeOH in CH2Cl2. Firstly, 
the aromatic derivatives (2,4-difluorophenyl and 2-chlorophenyl) mostly underwent the reverse 
reaction of their formation, that is, the elimination of the isocyanate to give back the starting 
material 817 (Scheme 4.11, blue arrows). Secondly, we also observed the formation of the open 
compounds 38 for these two derivatives (Scheme 4.11, orange arrows), but in these cases as
minor species in some of the collected fractions from the column. Finally, the side product 
resulting from reaction of the Cbz protecting group was also formed.18
With these results in hands, we decided to change the Cbz protecting group for the Alloc
group (see Scheme 4.5 for the synthesis of scaffold 9) to see if the formation of the Cbz-derived 
side product could be avoided. We started by alkylating the nitrogen of the pyrrole using the 
conditions previously described (NaH [1.5 equiv] in DMF) in the presence of an electrophile 
(Scheme 4.12). 
Scheme 4.12 N-Pyrrole Akylation of 9 with Allyl Bromide and 4-Fluorobenzyl Bromide.
The reaction of 9 with allyl bromide gave compound 39 in 44% yield whereas the reaction of 
4-fluorobenzyl bromide yielded compound 40 in 62% yield.
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Finally, the selective functionalization of the nitrogen at the piperidine ring was further 
investigated and the results are depicted in Table 4.4. Full conversion was not obtained in any 
case after two or four days of reaction (entries 1–7). Reactions with either Na2CO3 (3.0 equiv) or 
K2CO3 (1.5 equiv) afforded products in low yields (entries 1, 2, 4 and 5).
Table 4.4 N-Piperidine Alkylation of 9 with Allyl Bromide, 4-Fluorobenzyl Bromide and Methyl 2-Bromoacetate.
Entry Product Reagent(equiv) R
1 Base
(equiv) 
Time
(days)
Yield 
(%) 
1a 41 4-FC6H4CH2Br (3.0) 4-FC6H4CH2 Na2CO3 (3.0) 2 27
2 41 4-FC6H4CH2Br (3.0) 4-FC6H4CH2 Na2CO3 (3.0) 4 45
3b 41 4-FC6H4CH2Br (3.0) 4-FC6H4CH2 K2CO3 (3.0) 4 53
4 42 MeO2CCH2Br (1.2) MeO2CCH2 K2CO3 (1.5) 4 32
5 42 MeO2CCH2Br (1.5) MeO2CCH2 K2CO3 (1.5) 4 34
6 42 MeO2CCH2Br (3.0) MeO2CCH2 K2CO3 (3.0) 4 58 
7 43 AllylBr (3.0) Allyl K2CO3 (3.0) 2 58 
aReaction performed in THF. bThe reaction was also performed with NaI, Na2CO3 for 16 h to yield 
compound 41 in 54%. The formation of the dialkylated compound was also observed.
An increase of the equivalents of K2CO3 improved the yields of the reactions, affording 
compound 41 in 53% (entry 3) and compounds 42 and 43 both in 58% yield (entries 6 and 7).
4.3 Conclusion
The synthesis and derivatization of two spiro scaffolds have been developed. A remarkable 
elimination reaction of spiro[piperidine-pyridoindole] containing ureas into pyridinyl-indolyl-
ethyl ureas was observed. As a result, we anticipate that this phenomenon could happen to any 
spiro[piperidine-pyridoindole] derivative when the nitrogen at the piperidine ring is transformed 
into a nucleofuge. This elimination reaction was not as notable for the spiro[piperidine-
pyrrolopyridine] derivatives. The Alloc-protected spiro[piperidine-pyrrolopyridine] framework 
was selectively derivatized at the nitrogen of the pyrrole as well as at the nitrogen of the 
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piperidine ring. These final compounds can be considered as new derivatives of a combination 
of the diazaspiroalkane and tetrahydro-γ-carboline moieties, rendering drug-like compounds that 
might be relevant for the pharmaceutical industry.
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4.5 Experimental Section
For general experimental details, see Section 2.5 (p 51).
Synthesis of Starting Materials 11–14, 17–19 and 21
(1H-Indol-2-yl)methanol 17
A solution of ethyl 1H-indole-2-carboxylate 16 (9.33 g, 51.4 mmol) in THF (64 
mL) was added to a suspension of LiAlH4 (4.11 g, 108.2 mmol) in THF (2.00 
mL) at 0 °C. The resulting mixture was stirred at 21 °C for 2 h. Then, the reaction was carefully 
quenched with H2O (5 mL), diluted with an aqueous saturated solution of potassium sodium 
tartrate (150 mL) and stirred at 21 °C for a minimum of 40 min. The mixture was then extracted 
with CH2Cl2 (5 × 150 mL). The combined organic layers were washed with brine, dried over 
Na2SO4 and concentrated in vacuo. The 1H NMR spectrum was in accordance with the data 
reported in the literature.12 The crude product was used in the next step without further 
purification.
1H-Indole-2-carbaldehyde 14
Manganese dioxide (17.1 g, 197 mmol) was added to a solution of 17 (7.2 g, 49.3 
mmol) in CHCl3 (266 mL) at 21 °C. The resulting mixture was stirred under reflux 
for 16 h. The mixture was then allowed to cool down to 21 °C, filtered over diatomaceous earth 
(eluting with CH2Cl2) and the filtrate was concentrated in vacuo. The 1H NMR spectrum was in 
accordance with the data reported in the literature.12 The crude product was used in the next step 
without further purification.
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2-[(E)-2-Nitrovinyl]-1H-indole 18
Nitromethane (6.7 mL, 7.50 g, 123 mmol) was added to a stirred solution of 
1H-indole-2-carbaldehyde (14; 7.1 g, 49.3 mmol, assumed from the previous 
step), MeNH2·HCl (1.22 g, 39.3 mmol) and KOAc (3.87 g, 39.3 mmol) in EtOH (45 mL) at 
21 °C. The resulting mixture was stirred at 21 °C for 2 h. After completion of the reaction, the 
reaction mixture was quenched with H2O (40 mL) and extracted with CH2Cl2 (3 × 60 mL). The 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo. 
The 1H NMR spectrum was in accordance with the data reported in the literature.19 The crude 
product was used in the next step without further purification.
2-(1H-Indol-2-yl)ethan-1-amine 12
A solution of 2-[(E)-2-nitrovinyl]-1H-indole 18 (9.3 g, 49.3 mmol, assumed 
from the previous step) in THF (260 mL) was added to a suspension of 
LiAlH4 (11.2 g, 295 mmol) in THF (180 mL) at 0 °C. The resulting mixture was stirred at 21 °C 
for 18 h. The reaction was then carefully quenched sequentially with H2O (11 mL), an aqueous 
saturated solution of 6 M NaOH (11 mL) and H2O (22 mL), followed by the addition of CH2Cl2
(150 mL) and MgSO4 (16 g). The mixture was filtered over a mixture of diatomaceous earth with 
sand (eluting with copious amounts of CH2Cl2), the layers were separated and the filtrate was 
concentrated in vacuo. The 1H NMR spectrum was in accordance with the data reported in the 
literature.20 The crude product was used in the next step without further purification.
2-[(E)-2-Nitrovinyl]-1H-pyrrole 19
Nitromethane (5.1 mL, 95.0 mmol), NaOAc (3.9 g, 47.3 mmol) and MeNH2·HCl 
(3.19 g, 47.3 mmol) were added to a solution of pyrrol-2-carbaldehyde 15 (4.5 g, 
47.3 mmol) in dry MeOH (150 mL). The reaction was stirred for 18 h at 21 °C. Then, the solvent 
was removed under vacuo. The crude mixture was dissolved in AcOEt and flushed through a 
silica column with AcOEt until the washings were colorless. Evaporation of the solvent under 
reduced pressure gave alkene 19 (5.48 g, 39.7 mmol) as a brown solid. The 1H NMR spectrum 
was in accordance with the data reported in the literature.21 Yield: 84%.
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2-(1H-Pyrrol-2-yl)ethan-1-amine 13
A solution of 19 (1.2 g, 8.7 mmol) in dry THF (50 mL) was added to a 
suspension of LiAlH4 (4.0 g, 105 mmol) in dry THF (30 mL) at 0 °C. The 
resulting mixture was stirred at 21 °C for 60 h. Then, the reaction was quenched sequentially 
with H2O (2.5 mL), an aqueous saturated solution of 6 M NaOH (0.5 mL) and H2O (5 mL), 
followed by the addition of CH2Cl2 (25 mL) and MgSO4 (3 g). The mixture was filtered over 
diatomaceous earth mixed with sand (eluting with copious amounts of CH2Cl2) and the layers 
were separated. The filtrate was removed under reduced pressure to yield 13 (0.93 g, 8.44 mmol) 
as a brown oil. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.94 (bs, 1 H, NH), 6.68 (td, J = 2.7, 1.6 
Hz, 1 H, 5-CH), 6.13 (q, J = 2.9 Hz, 1 H, 3-CH), 5.95–5.92 (m, 1 H, 4-CH), 2.98 (t, J = 6.3 Hz, 2 
H, NCH2CH2), 2.73 (t, J = 6.3 Hz, 2 H, NCH2CH2). RF: 0.25 (AcOEt/heptane, 1:2). Yield: 
97%.
4-oxopiperidin-1-ium 2,2,2-trifluoroacetate 21
TFA (4.6 mL, 60.2 mmol) was added to a solution of tert-butyl 4-oxopiperidine-1-
carboxylate 20 (3.00 g, 15.1 mmol) in dry CH2Cl2 (20 mL) at 0 °C. The solution 
was stirred for 16 h and the solvent was removed under reduced pressure to yield 
21, which was used directly in the next step.22
Allyl 4-oxopiperidine-1-carboxylate 11
Allyl carbonochloridate (1.81 g, 15.1 mmol) was added to a solution containing 
K2CO3 (14.57 g, 105 mmol) and the ammonium salt 21 (1.49 g, 15.1 mmol) in 
H2O (25 mL) at 0 °C. The reaction was stirred for 2.5 h and gradually warmed up 
to 21 °C. The solution was saturated with NaCl and the product was extracted 
with Et2O (3 × 10 mL). The combined organic layers were washed with cold 5% NH3 in H2O 
(3 × 15 mL). The aqueous layers were then washed with Et2O (3 × 20 mL). The combined 
organic layers were dried over MgSO4 and filtered off. The solvent was removed under reduced 
pressure to yield compound 11 (1.37 g, 7.5 mmol, 50% over two steps) as a light yellow oil. The 
1H NMR spectrum was in accordance with the data reported in the literature.23
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Pictet–Spengler Cyclization: Synthesis of Scaffolds 7, 8 and 9
General Procedure for the Synthesis of Scaffolds 7, 8 and 9
Triethylamine (1.0–1.2 equiv) and Ti(OiPr)4 (1.3–1.6) were added to a solution containing 
amine 12 or 13 and piperidin-4-one 10 or 11 in THF and the reaction was stirred at 21 °C for 
30–60 min. Then, the solution was cooled down to 0 °C and TFA (4.4 equiv) was added to the 
reaction mixture. The reaction was warmed up to 21 °C and stirred for 20 h. The reaction was 
quenched with a saturated aqueous solution of NaHCO3 and the precipitate was removed by 
filtration. The solvent was removed under reduced pressure and the residue was extracted with 
AcOEt (3 ×). The combined organic layers were washed with brine, dried over Na2SO4, filtered 
off and the solvent was removed in vacuo. The crude mixture was purified by column 
chromatography to afford the desired cyclized products 7, 8 and 9.
Benzyl 2',3',4',5'-tetrahydrospiro[piperidine-4,1'-pyrido[4,3-b]indole]-1-carboxylate 7
According to the general procedure, the reaction of a solution of Et3N (6.9 
mL, 49.2 mmol) in THF (67 mL), Ti(OiPr)4 (19.4 mL, 65.6 mmol) in THF (83 
mL), 2-(1H-indol-2-yl)ethan-1-amine 12 (7.90 g, 49.3 mmol) and piperidin-4-
one 10 (9.6 g, 41.0 mmol) in THF (132 mL) afforded the desired cyclized 
product 7 (8.3 g, 22.1 mmol), after SCX-2 chromatography. 1H NMR [400 
MHz, δ (ppm), CD3OD]: 7.45–7.34 (m, 5 H, 2″-CH + 3″-CH + 4″-CH + 5″-CH + 6″-CH), 7.32 
(dd, J = 8.0, 1.1 Hz, 1 H, 9′-CH), 7.28 (dt, J = 8.0, 0.9 Hz, 1 H, 6′-CH), 7.03 (ddd, J = 8.1, 7.1, 
1.1 Hz, 1 H, 7′-CH), 6.94 (ddd, J = 8.1, 7.1, 1.1 Hz, 1 H, 8′-CH), 5.30–5.10 (m, 2 H, OCH2), 
4.13–4.05 (m, 2 H, 2-CHH + 6-CHH), 3.39–3.24 (m, 2 H, 2-CHH + 6-CHH), 3.18 (t, J = 5.8 
Hz, 2 H, 3′-CH2), 2.80 (t, J = 5.8 Hz, 2 H, 4′-CH2), 2.44–2.28 (m, 2 H, 3-CHH + 5-CHH), 1.80–
1.70 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ (ppm), CD3OD]: 157.2 (NC=O), 138.4 
(1″-C), 137.7 (5′a-C), 133.8 (4′a-C), 129.6 (3″-C + 5″-C), 129.1 (4″-C), 128.9 (2″-C + 6″-C), 125.8 
(9′a-C), 121.6 (7′-C), 119.8 (8′-C), 119.4 (9′-C), 114.9 (9′b-C), 112.1 (6′-C), 68.3 (OCH2), 40.9 (2-C
+ 6-C), 39.3 (3′-C), 35.9 (3-C + 5-C), 24.6 (4′-C). FTIR [?̅?𝜈 (cm‒1)]: 3260, 2875, 1696, 1653, 1457, 
1437, 1137, 1026, 744. HRMS [ESI (m/z)] calcd for (C23H25N3O2 + H)+ = 376.20250, found 
376.20279 (|Δ| = 0.76 ppm). Yield: 55%.
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Benzyl 1',5',6',7'-tetrahydrospiro[piperidine-4,4'-pyrrolo[3,2-c]pyridine]-1-carboxylate 8
According to the general procedure, the reaction of Et3N (1.20 mL, 8.61 
mmol), Ti(OiPr)4 (3.40 mL, 11.60 mmol), amine 13 (0.95 g, 8.62 mmol) and 
piperidin-4-one 10 (2.0 g, 8.6 mmol) in THF (50 mL) afforded the desired 
cyclized product 8 (1.22 g, 3.73 mmol) as a black solid, after column 
chromatography (AcOEt→AcOEt/MeOH, 10:0.8). 1H NMR [400 MHz, δ 
(ppm), CDCl3]: 8.21 (bs, 1 H, 5′-NH), 7.40–7.28 (m, 5 H, 2″-CH + 3″-CH + 4″-CH + 5″-CH + 
6″-CH), 6.65 (t, J = 2.8 Hz, 1 H, 6′-CH), 6.01 (t, J = 2.7 Hz, 1 H, 7′-CH), 5.15 (s, 2 H, OCH2), 
3.96–3.81 (m, 2 H, 2-CHH + 6-CHH), 3.74–3.49 (m, 2 H, 2-CHH + 6-CHH), 3.37 (t, J = 6.1 
Hz, 2 H, 3′-CH2), 2.85 (t, J = 6.1 Hz, 2 H, 4′-CH2), 2.04–1.96 (m, 4 H, 3-CH2 + 5-CH2). 13C 
NMR [101 MHz, δ (ppm), CDCl3]: 155.4 (NC=O), 136.8 (1″-C), 128.7 (3″-C + 5″-C), 128.2 (4″-
C), 128.1 (2″-C + 6″-C), 122.3 (4′a-C), 119.5 (7′a-C), 117.9 (6′-C), 104.9 (7′-C), 67.5 (OCH2), 56.2 
(4-C), 39.6 (2-C + 6-C), 38.2 (3′-C) 36.0 (3-C + 5-C), 20.8 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3326, 2942, 
1683, 1434, 1360, 1277, 1231, 1092, 1023, 734, 697. HRMS [ESI (m/z)] calcd for (C19H23N3O2
+ H)+ = 326.18685, found 326.18713 (|Δ| = 0.86 ppm). RF: 0.10 (AcOEt/MeOH, 20:1). Yield: 
43%.
Allyl 1',5',6',7'-tetrahydrospiro[piperidine-4,4'-pyrrolo[3,2-c]pyridine]-1-carboxylate 9
According to the general procedure, the reaction of Et3N (1.04 mL, 7.48 mmol),
Ti(OiPr)4 (3.29 mL, 11.22 mmol), amine 13 (824 mg, 7.48 mmol) and piperidin-
4-one 11 (1.370 g, 7.48 mmol) in dry THF (6 mL) afforded the desired cyclized 
product 9 (1.36 g, 4.9 mmol) as a brown solid, after column chromatography 
(CH2Cl2/MeOH, 20:1→10:1). 1H NMR: [400 MHz, δ (ppm), CDCl3]: 7.85 (bs, 1 H, 5′-NH), 
6.63 (t, J = 2.7 Hz, 1 H, 6′-CH), 6.03–5.89 (m, 2 H, 7′-CH + 2″-CH), 5.31 (dq, J = 17.2, 1.5 Hz, 
1 H, 3″-CHH), 5.21 (dq, J = 10.5, 1.5 Hz, 1 H, 3″-CHH), 4.62 (dt, J = 5.5, 1.5 Hz, 2 H, 1″-CH2), 
4.07–3.84 (m, 2 H, 2-CHH + 6-CHH), 3.38–3.21 (m, 2 H, 2-CHH + 6-CHH), 3.11 (t, J = 5.8 
Hz, 2 H, 3′-CH2), 2.57 (t, J = 5.8 Hz, 2 H, 4′-CH2), 1.93–1.80 (m, 2 H, 3-CHH + 5-CHH), 1.70–
1.60 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 155.3 (NC=O), 133.3 
(2″-C), 124.9 (4′a-C), 124.6 (7′a-C), 117.1 (3″-C), 115.9 (6′-C), 104.4 (7′-C), 65.9 (1″-C), 39.9 (2-C
+ 6-C), 38.7 (3′-C), 37.4 (3-C + 5-C), 24.2 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3319, 2941, 1676, 1436, 1342, 
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1277, 1229, 1137, 1088, 1016, 765, 720. HRMS [ESI (m/z)] calcd for (C15H21N3O2 + H)+ = 
276.17120, found 276.17215 (|Δ| = 3.42 ppm). RF: 0.2 (CH2Cl2/MeOH, 9:1). Yield: 66%.
General Procedure for N-Aromatic Alkylation
Sodium hydride (1.5 equiv) was added portionwise to a solution of protected scaffold 7, 8 or 9
(1 equiv) in dry DMF at 0 °C. The mixture was warmed up to 21 °C and stirred for 30 min for 
compounds 22, 23, 39 and 40 and 2 h for compound 35. Then, the solution was cooled down to 
0 °C and the corresponding bromo alkane derivative (1.2 equiv) was added and the reaction
mixture was stirred for 16 h (for compound 35 the reaction mixture was stirred for 24 h). The 
reaction was slowly quenched with water and the aqueous layer was extracted with CH2Cl2 (3 ×). 
The combined organic layers were washed with brine, dried over Na2SO4, filtered off and 
concentrated in vacuo. The crude mixture was purified by column chromatography using the 
indicated eluent to afford compounds 22, 23, 35, 39 and 40.
Benzyl 5'-allyl-2',3',4',5'-tetrahydrospiro[piperidine-4,1'-pyrido[4,3-b]indole]-1-carboxyl-
ate 22 
According to the general procedure, the reaction of 7 (100 mg, 0.27 mmol), 
NaH (17 mg, 0.40 mmol, 60% suspension mineral oil) and allyl bromide (28 
µL, 0.32 mmol) in dry DMF (5 mL) afforded 22 (82 mg, 0.20 mmol) as a black 
oil, after column chromatography (heptane/AcOEt, 1:4). 1H NMR [400 MHz, 
δ (ppm), CDCl3]: 7.53 (d, J = 7.9 Hz, 1 H, 9′-CH), 7.44–7.30 (m, 5 H, 2″-CH + 
3″-CH + 4″-CH + 5″-CH + 6″-CH), 7.29–7.25 (m, 1 H, 6′-CH), 7.15 (ddd, J = 
8.3, 7.0, 1.2 Hz, 1 H, 7′-CH), 7.06 (ddd, J = 8.1, 7.0, 1.1 Hz, 1 H, 8′-CH), 5.91 (ddt, J = 17.0, 
10.0, 4.8 Hz, 1 H, 2′′′-CH), 5.21 (s, 2 H, OCH2), 5.12 (dq, J = 10.3, 1.6 Hz, 1 H, 3′′′-CHH), 4.88 
(dq, J = 17.3, 1.7 Hz, 1 H, 3′′′-CHH), 4.64 (dt, J = 5.0, 1.8 Hz, 2 H, 1′′′-CH2), 4.24–3.99 (m, 2 H, 
2-CHH + 6-CHH), 3.44–3.25 (m, 2 H, 2-CHH + 6-CHH), 3.19 (t, J = 5.7 Hz, 2 H, 3′-CH2), 2.67 
(t, J = 5.7 Hz, 2 H, 4′-CH2), 2.53–2.30 (m, 2 H, 3-CHH + 5-CHH), 1.74–1.56 (m, 2 H, 3-CHH + 
5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 155.6 (NC=O), 137.2 (1″-C), 136.4 (5′a-C), 
134.2 (4′a-C), 133.5 (2′′′-C), 128.7 (3″-C + 5″-C), 128.1 (4″-C), 128.0 (2″-C + 6″-C), 124.6 (9′a-C), 
120.9 (7′-C), 119.4 (8′-C), 119.2 (9′-C), 116.6 (3′′′-C), 115.9 (9′b-C), 109.4 (6′-C), 67.2 (OCH2), 52.1 
(4-C), 45.2 (1′′′-C), 40.0 (2-C + 6-C), 38.6 (3′-C), 35.8 (3-C + 5-C), 23.8 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 
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2900, 1701, 1685, 1463, 1423, 1238, 1186, 1094, 1074, 739, 967. HRMS [ESI (m/z)] calcd for 
(C26H29N3O2 + H)+ = 416.23380, found 416.23407 (|Δ| = 0.65 ppm). RF: 0.45 
(heptane/AcOEt, 1:4). Yield: 75%.
Benzyl 5'-(2-methoxy-2-oxoethyl)-2',3',4',5'-tetrahydrospiro[piperidine-4,1'-pyrido[4,3-b]-
indole]-1-carboxylate 23
According to the general procedure, the reaction of 7 (100 mg, 0.27 mmol), 
NaH (17 mg, 0.40 mmol, 60% suspension mineral oil) and methyl 2-
bromoacetate (30 µL, 0.32 mmol) in dry DMF (5 mL) afforded 23 (84 mg, 
0.19 mmol) as a black oil, after column chromatography (AcOEt). 1H NMR
[400 MHz, δ (ppm), CDCl3]: 7.54 (dt, J = 7.7, 1.0 Hz, 1 H, 9′-CH), 7.44–7.36 
(m, 4 H, 2″-CH + 3″-CH + 5″-CH + 6″-CH), 7.36–7.31 (m, 1 H, 4″-CH), 7.22 
(ddd, J = 8.2, 1.3, 0.7 Hz, 1 H, 6′-CH), 7.17 (ddd, J = 8.2, 6.9, 1.2 Hz, 1 H, 7′-CH), 7.09 (ddd, J = 
8.1, 6.9, 1.3 Hz, 1 H, 8′-CH), 5.21 (s, 2 H, OCH2), 4.73 (s, 2 H, NCH2), 4.23–3.98 (m, 2 H, 2-
CHH + 6-CHH), 3.73 (s, 3 H, OCH3), 3.46–3.24 (m, 2 H, 2-CHH + 6-CHH), 3.18 (t, J = 5.7 
Hz, 2 H, 3′-CH2), 2.61 (t, J = 5.7 Hz, 2 H, 4′-CH2), 2.51–2.29 (m, 2 H, 3-CHH + 5-CHH), 1.71–
1.57 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 169.2 (OC=O), 155.6 
(NC=O), 137.2 (1″-C), 136.7 (5′a-C), 134.4 (4′a-C), 128.6 (3″-C + 5″-C), 128.0 (4″-C), 128.1 (2″-C 
+ 6″-C), 125.0 (9′a-C), 121.3 (7′-C), 119.7 (8′-C), 119.6 (9′-C), 117.0 (9′b-C), 108.8 (6′-C), 67.1 
(OCH2), 52.7 (OCH3), 51.8 (4-C), 44.4 (NCH2), 40.0 (2-C + 6-C), 38.5 (3′-C), 35.9 (3-C + 5-C), 
23.8 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3650, 2880, 1747, 1691, 1646, 1464, 1437, 1238, 1081, 742. HRMS
[ESI (m/z)] calcd for (C26H29N3O4 + H)+ = 448.22363, found 448.22310 (|Δ| = 1.18 ppm). RF: 
0.21 (AcOEt). Yield: 70%. 
Benzyl 1'-allyl-1',5',6',7'-tetrahydrospiro[piperidine-4,4'-pyrrolo[3,2-c]pyridine]-1-carbox-
ylate 3524
According to the general procedure, the reaction of 8 (51 mg, 0.157 mmol), 
NaH (5.5 mg, 0.23 mmol, 60% suspension mineral oil) and allyl bromide (17 
µL, 0.184 mmol) in dry DMF (3 mL) afforded 35 (16 mg, 0.043 mmol) as a 
light brown oil, after column chromatography (AcOEt→AcOEt/MeOH, 20:1). 
1H NMR [400 MHz, δ (ppm), CDCl3]: 7.40–7.29 (m, 5 H, 2″-CH + 3″-CH + 
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4″-CH + 5″-CH + 6″-CH), 6.52 (d, J = 2.9 Hz, 1 H, 6′-CH), 5.98–5.85 (m, 2 H, 7′-CH + 2′′′-
CH), 5.17–5.15 (m, 2 H, OCH2), 5.09 (dq, J = 10.1, 1.7 Hz, 1 H, 3′′′-CHH), 4.93 (dq, J = 17.0, 1.7 
Hz, 1 H, 3′′′-CHH), 4.36 (dt, J = 5.3 Hz, 1.7 Hz, 2 H, 1′′′-CH2), 3.01–3.79 (m, 2 H, 2-CHH + 6-
CHH), 3.44–3.28 (m, 2 H, 2-CHH + 6-CHH), 3.15 (t, J = 6.1 Hz, 2 H, 3′-CH2), 2.38 (t, J = 6.1 
Hz, 2 H, 4′-CH2), 2.05–1.91 (m, 2 H, 3-CHH + 5-CHH), 1.84–1.70 (m, 2 H, 3-CHH + 5-CHH). 
LRMS [(ESI) m/z] calcd for (C22H27N3O2 + H)+ = 366, found 366. Yield: 28%.
Allyl 1'-allyl-1',5',6',7'-tetrahydrospiro[piperidine-4,4'-pyrrolo[3,2-c]pyridine]-1-carboxyl-
ate 39
According to the general procedure, the reaction of 9 (50 mg, 0.182 mmol), 
NaH (11 mg, 0.27 mmol, 60% suspension mineral oil) and allyl bromide (19 µL, 
0.22 mmol) in dry DMF (5 mL) afforded 39 (24 mg, 0.08 mmol), after column 
chromatography (CH2Cl2→CH2Cl2/MeOH, 10:1). 1H NMR [400 MHz, δ 
(ppm), CDCl3]: 6.50 (d, J = 2.8 Hz, 1 H, 6′-CH), 6.03–5.84 (m, 2 H, 2″-CH + 
2′′′-CH), 5.94 (d, J = 2.9 Hz, 1 H, 7′-CH), 5.31 (dq, J = 17.2, 1.6 Hz, 1 H, 3′′′-CHH), 5.20 (dq, J = 
10.4, 1.4 Hz, 1 H, 3′′′-CHH), 5.15 (dq, J = 10.2, 1.5 Hz, 1 H, 3″-CHH), 4.96 (dq, J = 17.0, 1.7 Hz, 
1 H, 3″-CHH), 4.61 (dt, J = 5.6, 1.6 Hz, 2 H, 1′′′-CH2), 4.35 (dt, J = 5.4, 1.7 Hz, 2 H, 1″-CH2), 
4.07–3.77 (m, 2 H, 2-CHH + 6-CHH), 3.39–3.16 (m, 2 H, 2-CHH + 6-CHH), 3.10 (t, J = 5.8 
Hz, 2 H, 3′-CH2), 2.46 (t, J = 5.8 Hz, 2 H, 4′-CH2), 1.93–1.77 (m, 2 H, 3-CHH + 5-CHH), 1.70–
1.56 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 155.4 (NC=O), 134.4 
(2″-C), 133.5 (2′′′-C), 125.9 (4′a-C), 125.6 (7′a-C), 119.2 (6′-C), 117.2 (3′′′-C), 117.0 (3″-C), 103.5 
(7′-C), 66.0 (OCH2), 51.1 (4-C), 48.9 (NCH2), 40.0 (2-C + 6-C), 38.9 (3′-C), 37.6 (3-C + 5-C), 
23.3 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 2924, 2330, 1695, 1647, 1434, 1419, 1234, 1089, 916, 765. HRMS
[ESI (m/z)] calcd for (C18H25N3O2 + H)+ = 316.20250, found 316.20346 (|Δ| = 3.04 ppm). RF: 
0.35 (CH2Cl2/MeOH, 20:1). Yield: 44%.
Allyl 1'-(4-fluorobenzyl)-1',5',6',7'-tetrahydrospiro[piperidine-4,4'-pyrrolo[3,2-c]pyridine]-
1-carboxylate 40
According to the general procedure, the reaction of 9 (50 mg, 0.182 mmol), 
NaH (11 mg, 0.27 mmol, 60% suspension mineral oil) and 4-fluorobenzyl 
bromide (27 µL, 0.22 mmol) in dry DMF (5 mL) afforded 40 (43 mg, 0.11 
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mmol), after column chromatography (CH2Cl2/AcOEt, 10:3→0:1). 1H NMR [400 MHz, δ 
(ppm), CDCl3]: 7.06–6.89 (m, 4 H, 2″-CH + 3″-CH + 5″-CH + 6″-CH), 6.54 (d, J = 2.9 Hz, 1 H, 
6′-CH), 6.03–5.90 (m, 1 H, 2′′′-CH), 5.97 (d, J = 2.7 Hz, 1 H, 7′-CH), 5.31 (dq, J = 17.4, 1.7 Hz, 1 
H, 3′′′-CHH), 5.21 (dq, J = 10.4, 1.5 Hz, 1 H, 3′′′-CHH), 4.92 (s, 2 H, NCH2), 4.62 (dt, J = 5.6, 1.6 
Hz, 2 H, 1′′′-CH2), 4.08–3.83 (m, 2 H, 2-CHH + 6-CHH), 3.38–3.17 (m, 2 H, 2-CHH + 6-
CHH), 3.07 (t, J = 5.8 Hz, 2 H, 3′-CH2), 2.37 (t, J = 5.8 Hz, 2 H, 4′-CH2), 1.94–1.78 (m, 2 H, 3-
CHH + 5-CHH), 1.70–1.59 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 
162.2 (d, J = 245.9 Hz, 4″-C), 155.4 (NC=O), 133.9 (d, J = 3.2 Hz, 1″-C), 133.5 (2′′′-C), 128.4 (d, 
J = 8.0 Hz, 2″-C + 6″-C), 126.2 (7′a-C), 126.0 (4′a-C), 119.7 (6′-C), 117.2 (3′′′-C), 115.7 (d, J = 
21.6 Hz, 3″-C + 5″-C), 103.9 (7′-C), 66.0 (1′′′-C), 51.1 (4-C), 49.4 (NCH2), 40.0 (2-C + 6-C), 38.8 
(3′-C), 37.6 (3-C + 5-C), 23.5 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 2931, 1692, 1510, 1435, 1337, 1232, 1091, 
820, 766. HRMS [ESI (m/z)] calcd for (C22H26FN3O2 + H)+ = 384.20873, found 384.20979 
(|Δ| = 2.77 ppm). RF: 0.15 (CH2Cl2/AcOEt, 3:7). Yield: 62%.
General Procedure for Urea Formation
The corresponding isocyanate 24 (1.5 equiv) was added to a solution of 7, 22 or 23 (1 equiv) in 
dry CH2Cl2 at 21 °C. The mixture was stirred for 16 h. The reaction was quenched with water, 
and the aqueous layer was extracted with CH2Cl2 (3 ×). The combined organic layers were 
washed with brine, dried over Na2SO4, filtered off and concentrated in vacuo. The crude mixture 
was purified by column chromatography using the indicated eluent.
Benzyl 5'-allyl-2'-[(furan-3-ylmethyl)carbamoyl]-2',3',4',5'-tetrahydrospiro[piperidine-
4,1'-pyrido[4,3-b]indole]-1-carboxylate 26a
According to the general procedure, the reaction of 22 (83 mg, 0.2 
mmol), furfuryl isocyanate (32 µL, 0.3 mmol) in dry CH2Cl2 (3 mL) 
afforded urea 26a (76 mg, 0.14 mmol) as a brown oil, after column 
chromatography (CH2Cl2/AcOEt, 7:3→1:4). 1H NMR [400 MHz, δ 
(ppm), CDCl3]: 7.59 (d, J = 8.0 Hz, 1 H, 9′-CH), 7.42–7.30 (m, 6 H, 
2″-CH + 3″-CH + 4″-CH + 5″-CH + 6″-CH + 5″″-CH), 7.25–7.22 
(m, 1 H, 6′-CH), 7.13 (ddd, J = 8.1, 7.0, 1.1 Hz, 1 H, 7′-CH), 7.04 (ddd, J = 8.1, 7.0, 1.1 Hz, 1 H, 
8′-CH), 6.32 (dd, J = 3.2, 1.9 Hz, 1 H, 4″″-CH), 6.21 (dd, J = 3.2, 0.8 Hz, 1 H, 3″″-CH), 5.90 
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(ddt, J = 17.1, 10.0, 4.8 Hz, 1 H, 2′′′-CH), 5.22 (t, J = 5.6 Hz, 1 H, NH), 5.19 (s, 2 H, OCH2), 
5.11 (dq, J = 10.3, 1.5 Hz, 1 H, 3′′′-CHH), 4.87 (dq, J = 17.1, 1.5 Hz, 1 H, 3′′′-CHH), 4.60 (dt, J = 
4.9, 1.8 Hz, 2 H, 1′′′-CH2), 4.38 (d, J = 5.6 Hz, 2 H, 2″″-CCH2), 4.19–4.00 (m, 2 H, 2-CHH + 6-
CHH), 3.71 (t, J = 5.8 Hz, 2 H, 3′-CH2), 3.31–3.15 (m, 2 H, 2-CHH + 6-CHH), 2.78–2.58 (m, 4 
H, 3-CHH + 5-CHH + 4′-CH2), 2.43–2.28 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ 
(ppm), CDCl3]: 160.9 (HNC=O), 155.8 (NC=O), 152.2 (2″″-C), 142.2 (5″″-C), 137.2 (1″-C), 
136.4 (5′a-C), 133.3 (2′′′-C), 133.0 (4′a-C), 128.6 (3″-C + 5″-C), 128.0 (4″-C), 127.9 (2″-C + 6″-C), 
124.7 (9′a-C), 120.9 (7′-C), 119.5 (8′-C or 9′-C), 119.4 (8′-C or 9′-C), 116.7 (3′′′-C), 115.4 (9′b-C), 
110.6 (4″″-C), 109.5 (6′-C), 107.3 (3″″-C), 67.1 (OCH2), 57.6 (4-C), 45.3 (1′′′-C), 43.8 (3′-C), 40.5 
(2-C + 6-C), 38.1 (2″″-CCH2), 35.4 (3-C + 5-C), 22.0 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3370, 2938, 1685, 
1463, 1425, 1239, 1080, 739. HRMS [ESI (m/z)] calcd for (C32H34N4O4 + H)+ = 539.26583, 
found 539.26613 (|Δ| = 0.55 ppm). RF: 0.41 (CH2Cl2/AcOEt, 2:3). Yield: 71%.
Benzyl 5'-allyl-2'-[(2-chlorophenyl)carbamoyl]-2',3',4',5'-tetrahydrospiro[piperidine-4,1'-
pyrido[4,3-b]indole]-1-carboxylate 26b
According to the general procedure, the reaction of 22 (80 mg, 0.19 
mmol), 2-chlorophenyl isocyanate (35 µL, 0.29 mmol) in dry CH2Cl2 (3 
mL) afforded urea 26b (53 mg, 0.09 mmol) as a brown oil, after 
column chromatography (heptane/AcOEt, 4:1→1:1. 1H NMR [400 
MHz, δ (ppm), CDCl3]: 8.07 (dd, J = 8.3, 1.5 Hz, 1 H, 6″″-CH), 7.62 
(dt, J = 8.0, 0.9 Hz, 1 H, 9′-CH), 7.44–7.31 (m, 6 H, 2″-CH + 3″-CH + 
4″-CH + 5″-CH + 6″-CH + 3″″-CH), 7.30–7.25 (m, 1 H, 6′-CH), 7.25–7.18 (m, 1 H, 5″″-CH), 
7.07 (ddd, J = 8.1, 7.0, 1.1 Hz, 1 H, 8′-CH), 7.18–7.10 (m, 1 H, 7′-CH), 6.98 (ddd, J = 8.1, 7.4, 1.6 
Hz, 1 H, 4″″-CH), 5.92 (ddt, J = 17.1, 10.2, 4.8 Hz, 1 H, 2′′′-CH), 5.21 (s, 2 H, OCH2), 5.13 (dq, 
J = 10.3, 1.6 Hz, 1 H, 3′′′-CHH), 4.89 (dq, J = 17.1, 1.6 Hz, 1 H, 3′′′-CHH), 4.63 (dt, J = 4.8, 1.9 
Hz, 2 H, 1′′′-CH2), 4.25–4.07 (m, 2 H, 2-CHH + 6-CHH), 3.93 (t, J = 5.8 Hz, 2 H, 3′-CH2), 3.41–
3.24 (m, 2 H, 2-CHH + 6-CHH), 2.90–2.82 (m, 2 H, 4′-CH2), 2.83–2.67 (m, 2 H, 3-CHH + 5-
CHH), 2.54–2.35 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 157.8 
(HNC=O), 155.8 (NC=O), 137.1 (1″-C), 136.5 (5′a-C), 135.7 (1″″-C), 133.3 (2′′′-C), 132.7 (4′a-C), 
129.1 (3″″-C), 128.6 (3″-C + 5″-C), 128.1 (4″-C), 128.0 (2″-C + 6″-C), 127.9 (5″″-C), 124.6 (9′a-
C), 123.7 (4″″-C), 122.7 (2″″-C), 121.18 (6″″-C), 121.15 (7′-C), 119.58 (8′-C + 9′-C), 119.56 (8′-C 
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+ 9′-C), 116.8 (3′′′-C), 115.3 (9′b-C), 109.5 (6′-C), 67.2 (OCH2), 58.2 (4-C), 45.4 (1′′′-C), 44.1 (3′-C), 
40.7 (2-C + 6-C), 35.6 (3-C + 5-C), 22.5 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3332, 2956, 2162, 1684, 1441, 
1419, 1280, 1234, 1090, 914. HRMS [ESI (m/z)] calcd for (C33H33N4ClO3 + Na)+ = 591.21389, 
found 591.21185 (|Δ| = 3.44 ppm). RF: 0.44 (heptane/AcOEt, 2:3). Yield: 48%.
Benzyl 2'-(ethylcarbamoyl)-5'-(2-methoxy-2-oxoethyl)-2',3',4',5'-tetrahydrospiro[piperi-
dine-4,1'-pyrido[4,3-b]indole]-1-carboxylate 27c
According to the general procedure, the reaction of 23 (75 mg, 0.17 
mmol), ethyl isocyanate (20 µL, 0.25 mmol) in dry CH2Cl2 (3 mL) 
afforded a 1:1 mixture of rotamers of urea 27c (55 mg, 0.11 mmol) as a 
brown oil, after column chromatography (heptane/AcOEt, 1:4→0:1). 
1H NMR [400 MHz, δ (ppm), CDCl3]: 7.59 (d, J = 8.0 Hz, 2 H, 9′-CH), 
7.43–7.29 (m, 10 H, 2″-CH + 3″-CH + 4″-CH + 5″-CH + 6″-CH), 
7.24–7.17 (m, 2 H, 6′-CH), 7.17–7.12 (m, 2 H, 7′-CH), 7.10–7.04 (m, 2 H, 8′-CH), 5.19 (s, 4 H, 
OCH2), 4.94 (t, J = 5.6 Hz, 2 H, NH), 4.83 (s, 2 H, NCH2), 4.70 (s, 2 H, NCH2), 4.25–3.97 (m, 4 
H, 2-CHH + 6-CHH), 3.74 (s, 3 H, OCH3), 3.73 (s, 3 H, OCH3), 3.72–3.68 (m, 4 H, 3′-CH2), 
3.32–3.14 (m, 8 H, 2-CHH + 6-CHH + CH2CH3), 2.82–2.70 (m, 4 H, 4′-CH2), 2.70–2.49 (m, 4 
H, 3-CHH + 5-CHH), 2.41–2.28 (m, 4 H, 3-CHH + 5-CHH), 1.14 (t, J = 7.2 Hz, 6 H, 
CH2CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 169.1 (OC=O), 168.3 (OC=O), 161.47 
(HNC=O), 161.45 (HNC=O), 155.8 (NC=O), 137.2 (1″-C), 136.8 (5′a-C), 133.3 (4′a-C), 133.2 
(4′a-C), 128.6 (3″-C + 5″-C), 128.1 (4″-C), 128.0 (2″-C + 6″-C), 125.1 (9′a-C), 125.0 (9′a-C), 
121.44 (7′-C), 121.40 (7′-C), 120.0 (8′-C), 119.9 (8′-C), 119.77 (9′-C), 119.76 (9′-C), 116.4 (9′b-C), 
116.2 (9′b-C), 108.84 (6′-C), 108.81 (6′-C), 67.1 (OCH2), 56.99 (4-C), 56.95 (4-C), 52.7 (OCH3), 
52.5 (OCH3), 44.6 (NCH2), 44.4 (NCH2), 43.9 (3′-C), 40.5 (2-C + 6-C), 35.8 (CH2CH3), 35.2 (3-C
+ 5-C), 21.7 (4′-C), 21.6 (4′-C), 15.4 (CH2CH3). FTIR [?̅?𝜈 (cm−1)]: 3338, 2925, 1752, 1701, 1685, 
1543, 1465, 1427, 1239, 1076, 742. HRMS [ESI (m/z)] calcd for (C29H34N4O5 + H)+ = 
519.26074, found 519.26051 (|Δ| = 0.46 ppm). RF: 0.35 (heptane/AcOEt, 3:7). Yield: 63%.
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Benzyl 4-{1-allyl-2-[2-(3-ethylureido)ethyl]-1H-indol-3-yl}-3,6-dihydropyridine-1(2H)-car-
boxylate 28c
According to the general procedure, the reaction of 22 (50 mg, 0.12 
mmol), ethyl isocyanate (14 µL, 0.18 mmol) in dry CH2Cl2 (2 mL) 
afforded urea 28c (36 mg, 0.07 mmol) as a brown oil, after column 
chromatography (CH2Cl2/AcOEt, 2:3→0:1). 1H NMR [400 MHz, δ 
(ppm), CDCl3]: 7.50 (d, J = 7.8 Hz, 1 H, 4′-CH), 7.43–7.29 (m, 5 H, 
2″-CH + 3″-CH + 4″-CH + 5″-CH + 6″-CH), 7.24 (dt, J = 8.3, 0.9 
Hz, 1 H, 7′-CH), 7.16 (ddd, J = 8.2, 7.0, 1.2 Hz, 1 H, 6′-CH), 7.08 (ddd, J = 8.0, 6.9, 1.1 Hz, 1 H, 
5′-CH), 5.95 (ddt, J = 16.9, 10.1, 4.6 Hz, 1 H, 2′′′-CH), 5.72 (bs, 1 H, 5-CH), 5.19 (s, 2 H, OCH2), 
5.11 (dq, J = 10.3, 1.5 Hz, 1 H, 3′′′-CHH), 4.85 (dq, J = 17.2, 1.6 Hz, 1 H, 3′′′-CHH), 4.83–4.80 
(m, 2 H, 1′′′-CH2), 4.69 (bs, 1 H, NH), 4.43 (bs, 1 H, NH), 4.17 (q, J = 2.8 Hz, 2 H, 6-CH2), 3.75 
(t, J = 5.6 Hz, 2 H, 2-CH2), 3.32 (q, J = 6.5 Hz, 2 H, NCH2CH2), 3.15 (qd, J = 7.2, 5.5 Hz, 2 H, 
CH2CH3), 2.95 (t, J = 7.4 Hz, 2 H, NCH2CH2), 2.60–2.42 (m, 2 H, 3-CH2), 1.07 (t, J = 7.2 Hz, 3 
H, CH2CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 158.2 (HNC=O), 155.7 (NC=O), 136.9 
(1″-C), 136.4 (7′a-C), 133.6 (2′-C + 2′′′-C), 131.3 (4-C), 128.6 (3″-C + 5″-C), 128.2 (4″-C), 128.1 
(2″-C + 6″-C), 126.9 (3′a-C), 122.6 (5-C), 121.6 (6′-C), 119.7 (5′-C), 119.2 (4′-C), 116.5 (3′′′-C), 
116.0 (3′-C), 109.8 (7′-C), 67.3 (OCH2), 45.7 (1′′′-C), 43.9 (6-C), 41.3 (2-C), 40.8 (NCH2CH2), 35.4 
(CH2CH3), 30.4 (3-C), 26.5 (NCH2CH2), 15.6 (CH2CH3). RF: 0.39 (CH2Cl2/AcOEt 2:3). Yield: 
61%.
Benzyl 4-(2-{2-[3-(furan-2-ylmethyl)ureido]ethyl}-1-(2-methoxy-2-oxoethyl)-1H-indol-3-
yl)-3,6-dihydropyridine-1(2H)-carboxylate 29a
According to the general procedure, the reaction of 23 (90 mg, 0.2 
mmol), furfuryl isocyanate (32 µL, 0.3 mmol) in dry CH2Cl2 (3 
mL) afforded urea 29a (76 mg, 0.13 mmol) as a brown oil, after 
column chromatography (CH2Cl2/AcOEt, 7:3→1:4). 1H NMR
[400 MHz, δ (ppm), CDCl3]: 7.48 (d, J = 7.8 Hz, 1 H, 4′-CH), 
7.40–7.29 (m, 5 H, 2″-CH + 3″-CH + 4″-CH + 5″-CH + 6″-CH), 
7.24 (dd, J = 1.9, 0.9 Hz, 1 H, 5′′′-CH), 7.20–7.07 (m, 3 H, 5′-CH + 6′-CH + 7′-CH), 6.23 (dd, J = 
3.2, 1.9 Hz, 1 H, 4′′′-CH), 6.14–6.09 (m, 1 H, 3′′′-CH), 5.68 (bs, 1 H, 5-CH), 5.24–5.16 (m, 2 H, 
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NH + NH), 5.15 (s, 2 H, OCH2), 4.91 (s, 2 H, NCH2), 4.26 (d, J = 5.6 Hz, 2 H, 2″″-CCH2), 
4.16–4.08 (m, 2 H, 6-CH2), 3.71 (s, 3 H, OCH3), 3.70 (t, J = 5.6 Hz, 2 H, 2-CH2), 3.28 (q, J = 6.8 
Hz, 2 H, NCH2CH2), 2.91 (t, J = 7.1 Hz, 2 H, NCH2CH2), 2.52–2.42 (m, 2 H, 3-CH2). 13C NMR
[101 MHz, δ (ppm), CDCl3]: 169.9 (OC=O), 158.1 (HNC=O), 155.6 (NC=O), 152.6 (2′′′-C), 
141.9 (5′′′-C), 136.8 (7′a-C or 1″-C), 136.7 (7′a-C or 1″-C), 133.6 (2′-C), 130.8 (4-C), 128.6 (3″-C + 
5″-C), 128.1 (4″-C), 128.0 (2″-C + 6″-C), 127.2 (3′a-C), 123.0 (5-C), 122.0 (6′-C), 120.2 (4′-C or 5′-
C), 119.4 (4′-C or 5′-C), 116.7 (3′-C), 110.4 (4′′′-C), 108.9 (7′-C), 106.9 (3′′′-C), 67.2 (OCH2), 52.7 
(OCH3), 44.9 (NCH2), 43.8 (6-C), 41.1 (2-C), 40.4 (NCH2CH2), 37.3 (2″″-CCH2), 30.1 (3-C), 26.0 
(NCH2CH2). FTIR [?̅?𝜈 (cm−1)]: 3369, 2923, 2174, 1751, 1701, 1681, 1636, 1557, 1466, 1431, 
1235, 1108, 740. HRMS [ESI (m/z)] calcd for (C32H34N4O6 + H)+ = 571.25566, found 
571.25485 (|Δ| = 1.41 ppm). RF: 0.40 (CH2Cl2/AcOEt, 2:3). Yield: 66%.
Benzyl 4-{2-[2-(3-ethylureido)ethyl]-1H-indol-3-yl}-3,6-dihydropyridine-1(2H)-carboxyl-
ate 30
According to the general procedure, the reaction of 7 (25 mg, 0.07 
mmol), ethyl isocyanate (8 µL, 0.1 mmol) in dry CH2Cl2 (1 mL) 
afforded urea 30 (20 mg, 0.04 mmol) as a brown oil, after column 
chromatography (AcOEt). 1H NMR [400 MHz, δ (ppm), CDCl3]: 
9.38 (bs, 1 H, 1′-NH), 7.49 (d, J = 7.6 Hz, 1 H, 4′-CH), 7.42–7.30 
(m, 5 H, 2″-CH + 3″-CH + 4″-CH + 5″-CH + 6″-CH), 7.28 (d, J = 
7.7 Hz, 1 H, 7′-CH), 7.10 (ddd, J = 8.1, 7.6, 1.3 Hz, 1 H, 6′-CH), 7.05 (td, J = 7.6, 1.1 Hz, 1 H, 5′-
CH), 5.66 (bs, 1 H, 5-CH), 5.18 (s, 2 H, OCH2), 5.00 (s, 1 H, NH), 4.68 (s, 1 H, NH), 4.15 (q, 
J = 2.8 Hz, 2 H, 6-CH2), 3.72 (t, J = 5.6 Hz, 2 H, 2-CH2), 3.45 (q, J = 6.5 Hz, 2 H, NCH2CH2), 
3.11 (qd, J = 7.2, 5.4 Hz, 2 H, CH2CH3), 2.92 (t, J = 6.7 Hz, 2 H, NCH2CH2), 2.56–2.41 (m, 2 H, 
3-CH2), 1.03 (t, J = 7.2 Hz, 3 H, CH2CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 158.8 
(HNC=O), 155.8 (NC=O), 136.8 (1″-C), 135.6 (7′a-C), 132.8 (2′-C), 131.1 (4-C), 128.7 (3″-C + 
5″-C), 128.2 (4″-C), 128.0 (2″-C + 6″-C), 127.3 (3′a-C), 122.0 (5-C), 121.5 (6′-C), 119.6 (5′-C), 
119.0 (4′-C), 115.2 (3′-C), 111.1 (7′-C), 67.3 (OCH2), 43.9 (6-C), 41.3 (2-C), 40.1 (NCH2CH2), 35.5 
(CH2CH3), 30.1 (3-C), 28.3 (NCH2CH2), 15.5 (CH2CH3). FTIR [?̅?𝜈 (cm−1)]: 3330, 2969, 1702, 
1645, 1562, 1454, 1237, 1115, 748. HRMS [ESI (m/z)] calcd for (C26H30N4O3 + Na)+ = 
469.22156, found 469.22065 (|Δ| = 1.95 ppm). RF: 0.20 (AcOEt). Yield: 67%.
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1-(Furan-2-ylmethyl)-3-{2-[1-propyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-2-yl]eth-
yl}urea 32
Pd(C) (6 mg, 0.006 mmol, Pd(C) 10%) was added to a solution of 
26a (35 mg, 0.06 mmol) in MeOH (5 mL). The reaction mixture was 
stirred for 10 min and then a flow of hydrogen was passed through. 
After 15 min, the vessel was closed and the reaction was stirred for 
30 min. The reaction was quenched carefully with water, and the 
aqueous layer was extracted with CH2Cl2 (3 ×). The combined 
organic layers were washed with brine, dried over Na2SO4, filtered off and concentrated in vacuo 
to afford compound 32 (9 mg, 0.02 mmol) as a brown oil. 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 7.39 (d, J = 7.8 Hz, 1 H, 4′-CH), 7.29 (d, J = 8.2 Hz, 1 H, 7′-CH), 7.24 (dd, J = 1.8, 0.8 
Hz, 1 H, 5′′′-CH), 7.20–7.12 (m, 1 H, 6′-CH), 7.07 (t, J = 7.5 Hz, 1 H, 5′-CH), 6.21 (dd, J = 3.2, 
1.8 Hz, 1 H, 4′′′-CH), 6.13 (t, J = 6.1 Hz, 1 H, NH), 6.10 (d, J = 3.2 Hz, 1 H, 3′′′-CH), 5.89 (t, J = 
5.6 Hz, 1 H, NH), 5.61 (bs, 1 H, 5-CH), 4.26 (d, J = 5.0 Hz, 2 H, 2‴-CCH2), 4.09 (t, J = 7.5 Hz, 2 
H, 1″-CH2), 3.82–3.74 (m, 2 H, 6-CH2), 3.43–3.31 (m, 4 H, 2-CH2 + NCH2CH2), 2.98 (t, J = 7.0 
Hz, 2 H, NCH2CH2), 2.81–2.71 (m, 2 H, 3-CH2), 1.82 (sx, J = 7.5 Hz, 2 H, 2″-CH2), 0.97 (t, J = 
7.5 Hz, 3 H, 3″-CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 158.7 (HNC=O), 153.2 (2′′′-C), 
141.8 (5′′′-C), 136.1 (7′a-C), 134.7 (2′-C), 132.8 (4-C), 126.6 (3′a-C), 121.5 (6′-C), 119.7 (5′-C), 
118.4 (4′-C), 118.1 (5-C), 114.1 (3′-C), 110.6 (4′′′-C), 110.0 (7′-C), 106.8 (3′′′-C), 45.3 (1″-C), 42.6 
(6-C), 41.6 (2-C), 40.4 (NCH2CH2), 37.3 (2‴-CCH2), 26.9 (3-C), 26.2 (NCH2CH2), 23.7 (2″-C), 
11.7 (3″-C). FTIR [?̅?𝜈 (cm−1)]: 3328, 2963, 2358, 1654, 1559, 1465, 1263, 1021, 806. HRMS [ESI 
(m/z)] calcd for (C24H30N4O2 + H)+ = 407.24470, found 407.24443 (|Δ| = 0.66 ppm). RF: 0.2 
(heptane/AcOEt, 1:4). Yield: 37%.
Methyl 2-{2-[2-(3-ethylureido)ethyl]-3-[1-(4-methylbenzenesulfonyl)-1,2,3,6-tetrahydropyr-
idin-4-yl]-1H-indol-1-yl}acetate 34
Pd(C) (7 mg, 0.007 mmol, Pd(C) 10%) was added to a solution of 27c
(35 mg, 0.07 mmol) in MeOH (5 mL). The reaction mixture was 
stirred for 10 min and then a flow of hydrogen was passed through. 
After 15 min the vessel was closed and the reaction was stirred for 
30 min. The reaction was quenched carefully with water, and the 
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aqueous layer was extracted with CH2Cl2 (3 ×). The combined organic layers were washed with 
brine, dried over Na2SO4, filtered off and concentrated in vacuo to afford compound 33 (11 mg, 
0.03 mmol) as a brown oil. Then, compound 33 (11 mg, 0.03 mmol) was dissolved in CH2Cl2 (2 
mL) and Et3N (4.5 µL, 0.033 mmol) was added to the solution at 0 °C. After 10 min, tosyl 
chloride (5.5 mg, 0.03 mmol) was added and the reaction was allowed to stir at 21 °C for 24 h. 
The reaction was diluted with CH2Cl2 (10 mL), quenched with water (1 mL) and washed with 1N 
HCl solution (20 mL), water (20 mL) and brine (20 mL). The organic layer was dried over 
Na2SO4, filtered off and concentrated in vacuo. The crude mixture was purified by column 
chromatography (heptane/AcOEt, 1:4) to afford compound 34 (10 mg, 0.018 mmol) as a pale-
yellow solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.77–7.69 (m, 2 H, 2″-CH + 6″-CH), 7.39–
7.33 (m, 3 H, 4′-CH + 3″-CH + 5″-CH), 7.16 (ddd, J = 8.1, 6.8, 1.2 Hz, 1 H, 6′-CH), 7.11 (dt, J = 
8.1, 1.1 Hz, 1 H, 7′-CH), 7.06 (ddd, J = 8.0, 6.8, 1.3 Hz, 1 H, 5′-CH), 5.69–5.65 (m, 1 H, 5-CH), 
4.95 (s, 2 H, NCH2), 4.77 (t, J = 6.0 Hz, 1 H, NH), 4.43 (t, J = 5.6 Hz, 1 H, NH), 3.76 (s, 3 H, 
OCH3), 3.79 (q, J = 2.8 Hz, 2 H, 6-CH2), 3.36 (t, J = 5.6 Hz, 2 H, 2-CH2), 3.29 (q, J = 6.6 Hz, 2 
H, NCH2CH2), 3.14 (qd, J = 7.2, 5.6 Hz, 2 H, CH2CH3), 2.91 (t, J = 7.2 Hz, 2 H, NCH2CH2), 
2.61–2.53 (m, 2 H, 3-CH2), 2.46 (s, 3 H, CH3), 1.06 (t, J = 7.2 Hz, 3 H, CH2CH3). 13C NMR [101 
MHz, δ (ppm), CDCl3]: 169.9 (OC=O), 158.3 (HNC=O), 143.9 (4″-C), 136.7 (7′a-C), 133.9 (2′-
C), 133.3 (1″-C), 130.9 (4-C), 129.9 (3″-C + 5″-C), 127.9 (2″-C + 6″-C), 127.2 (3′a-C), 122.1 (5-C), 
122.0 (6′-C), 120.3 (5′-C), 119.2 (4′-C), 116.2 (3′-C), 109.0 (7′-C), 52.8 (OCH3), 45.5 (6-C), 45.1 
(NCH2), 43.5 (2-C), 40.5 (NCH2CH2), 35.4 (CH2CH3), 30.4 (3-C), 26.1 (NCH2CH2), 21.7 (CH3), 
15.6 (CH2CH3). FTIR [?̅?𝜈 (cm−1)]: 3375, 2938, 1751, 1652, 1564, 1466, 1165, 1092, 719. HRMS
[ESI (m/z)] calcd for (C28H34N4O5S + H)+ = 539.23281, found 539.23218 (|Δ| = 1.17 ppm). 
RF: 0.48 (heptane/AcOEt, 4:1). Yield: 70%.
N-Piperidine Alkylation. Synthesis of compounds 41, 42 and 43
Allyl 5'-(4-fluorobenzyl)-1',5',6',7'-tetrahydrospiro[piperidine-4,4'-pyrrolo[3,2-c]pyridine]-1-
carboxylate 41
Sodium iodide (117 mg, 0.78 mmol) was added to a solution of 4-
fluorobenzyl bromide (91 µL, 0.73 mmol) in acetone (2 mL). The 
reaction mixture was stirred for 20 min and then it was filtered off. The 
filtrate was evaporated and added to a suspension of compound 9
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(50 mg, 0.18 mmol) and Na2CO3 (38 mg, 0.36 mmol) in dry THF (4 mL). The reaction was 
stirred for 16 h and it was quenched with H2O. The aqueous layer was extracted with CH2Cl2
(3 ×). The combined organic layers were washed with brine, dried over Na2SO4, filtered off and 
concentrated in vacuo. The crude mixture was purified by column chromatography 
(heptane/AcOEt, 7:3) to afford compound 41 (38 mg, 0.1 mmol). 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 7.91 (s, 1 H, NH), 7.41–7.32 (m, 2 H, 2′′′-CH + 6′′′-CH), 7.06–6.96 (m, 2 H, 3′′′-CH + 
5′′′-CH), 6.67 (t, J = 2.7 Hz, 1 H, 6′-CH), 6.04 (t, J = 2.7 Hz, 1 H, 7′-CH), 6.04–5.92 (m, 1 H, 2″-
CH), 5.33 (dq, J = 17.2, 1.5 Hz, 1 H, 3″-CHH), 5.22 (dq, J = 10.4, 1.5 Hz, 1 H, 3″-CHH), 4.63 
(dt, J = 5.5, 1.5 Hz, 2 H, 1″-CH2), 4.07–3.88 (m, 2 H, 2-CHH + 6-CHH), 3.60 (s, 2 H, NCH2), 
3.50–3.33 (m, 2 H, 2-CHH + 6-CHH), 2.97 (t, J = 6.0 Hz, 2 H, 3′-CH2), 2.50 (t, J = 6.0 Hz, 2 H, 
4′-CH2), 2.17–2.03 (m, 2 H, 3-CHH + 5-CHH), 1.93–1.78 (m, 2 H, 3-CHH + 5-CHH). 
13C NMR [101 MHz, δ (ppm), CDCl3]: 161.9 (d, J = 244.3 Hz, 4′′′-C), 155.6 (NC=O), 136.4 (d, J
= 3.2 Hz, 1′′′-C), 133.6 (2″-C), 129.8 (d, J = 7.8 Hz, 2′′′-C + 6′′′-C), 124.0 (4′a-C), 122.9 (7′a-C), 
117.3 (3″-C), 116.1 (6′-C), 115.3 (d, J = 21.1 Hz, 3′′′-C + 5′′′-C), 104.9 (7′-C), 66.1 (1″-C), 55.2 (4-
C), 48.5 (NCH2), 40.1 (2-C + 6-C), 40.0 (3′-C), 36.0 (3-C + 5-C), 17.3 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 
3336, 2963, 1683, 1508, 1441, 1233, 1022, 836. HRMS [ESI (m/z)] calcd for (C22H26FN3O2 + 
H)+ = 384.20873, found 384.20913 (|Δ| = 1.03 ppm). RF: 0.62 (heptane/AcOEt, 4:1). Yield: 
54%.
General Procedure for compounds 42 and 43
Bromo alkane (2–3 equiv) was added to a solution containing the protected scaffold 9 (1 equiv) 
and K2CO3 (2–3 equiv) in dry CH3CN (2 mL) at 21 °C. The mixture was stirred for 4 days. 
Then, the reaction was quenched with water and the aqueous layer was extracted with AcOEt
(3 ×). The combined organic layers were washed with brine, dried over Na2SO4, filtered off and 
concentrated in vacuo. The crude mixture was purified by column chromatography using the 
indicated eluent to afford compounds 42 and 43.
Allyl 5'-(2-methoxy-2-oxoethyl)-1',5',6',7'-tetrahydrospiro[piperidine-4,4'-pyrrolo[3,2-c]pyr-
idine]-1-carboxylate 42
According to the general procedure, the reaction of 9 (30 mg, 0.11 mmol), 
K2CO3 (45 mg, 0.33 mmol) and methyl 2-bromoacetate (33 µL, 0.33 mmol) 
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afforded compound 42 (22 mg, 0.06 mmol) as a brown oil, after column chromatography 
(heptane/AcOEt, 1:1). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.93 (s, 1 H, NH), 6.62 (t, J = 2.7 
Hz, 1 H, 6′-CH), 6.02–5.97 (m, 1 H, 2′′′-CH), 5.99 (t, J = 2.7 Hz, 2 H, 7′-CH), 5.31 (dq, J = 17.2, 
1.6 Hz, 1 H, 3′′′-CHH), 5.21 (dq, J = 10.5, 1.4 Hz, 1 H, 3′′′-CHH), 4.62–4.58 (m, 2 H, 1′′′-CH2), 
3.96–3.78 (m, 2 H, 2-CHH + 6-CHH), 3.72 (s, 3 H, OCH3), 3.51–3.33 (m, 2 H, 2-CHH + 6-
CHH), 3.31 (s, 2 H, NCH2), 3.21 (t, J = 6.0 Hz, 2 H, 3′-CH2), 2.68–2.52 (m, 2 H, 4′-CH2), 1.99–
1.90 (m, 2 H, 3-CHH + 5-CHH), 1.88–1.74 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ
(ppm), CDCl3]: 172.9 (OC=O), 155.5 (NC=O), 133.5 (2′′′-C), 123.7 (4′a-C), 122.6 (7′a-C), 117.3 
(3′′′-C), 116.2 (6′-C), 105.0 (7′-C), 66.0 (1′′′-C), 55.5 (4-C), 52.0 (OCH3), 48.9 (NCH2), 42.9 (3′-C), 
40.0 (2-C + 6-C), 36.2 (3-C + 5-C), 17.5 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3350, 2951, 2360, 1739, 1688, 
1419, 1281, 1233, 1021, 721. HRMS [ESI (m/z)] calcd for (C18H25N3O4 + H)+ = 348.19233, 
found 348.19286 (|Δ| = 1.51 ppm). RF: 0.69 (heptane/AcOEt, 1:1). Yield: 58%. 
Allyl 5'-allyl-1',5',6',7'-tetrahydrospiro[piperidine-4,4'-pyrrolo[3,2-c]pyridine]-1-carboxyl-
ate 43
According to the general procedure, the reaction of 9 (30 mg, 0.11 mmol), 
K2CO3 (45 mg, 0.33 mmol) and allyl bromide (28 µL, 0.33 mmol) afforded 
compound 43 (20 mg, 0.06 mmol) as a brown oil, after column 
chromatography (heptane/AcOEt, 2:3→0:1). 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 7.90 (s, 1 H, NH), 6.63 (t, J = 2.7 Hz, 1 H, 6′-CH), 6.02–5.86 (m, 3 H, 7′-CH + 2″-CH + 
2′′′-CH), 5.32 (dq, J = 17.2, 1.6 Hz, 1 H, 3′′′-CHH), 5.24–5.17 (m, 2 H, 3″-CHH + 3′′′-CHH), 5.10 
(dq, J = 10.0, 1.5 Hz, 1 H, 3″-CHH), 4.61 (dt, J = 5.5, 1.7 Hz, 2 H, 1′′′-CH2), 4.00–3.75 (m, 2 H, 
2-CHH + 6-CHH), 3.44–3.27 (m, 2 H, 2-CHH + 6-CHH), 3.15 (t, J = 6.0 Hz, 2 H, 3′-CH2), 3.11 
(d, J = 6.4 Hz, 2 H, 1″-CH2), 2.49 (t, J = 6.0 Hz, 2 H, 4′-CH2), 2.04–1.93 (m, 2 H, 3-CHH + 5-
CHH), 1.85–1.69 (m, 2 H, 3-CHH + 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 155.6 
(NC=O), 138.0 (2″-C), 133.5 (2′′′-C), 124.2 (4′a-C), 122.8 (7′a-C), 117.2 (3′′′-C), 116.1 (3″-C), 115.9 
(6′-C), 105.0 (7′-C), 66.0 (1′′′-C), 55.0 (4-C), 48.9 (1″-C), 40.5 (3′-C), 40.1 (2-C + 6-C), 35.9 (3-C + 
5-C), 17.3 (4′-C). FTIR [?̅?𝜈 (cm−1)]: 3332, 2956, 2162, 1684, 1441, 1419, 1280, 1234, 1090, 914. 
HRMS [ESI (m/z)] calcd for (C18H25N3O2 + H)+ = 316.20250, found 316.20328 (|Δ| = 2.48 
ppm). RF: 0.60 (heptane/AcOEt, 1:1). Yield: 58%.
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Chapter 5
Trifluoromethyl Vinyl Sulfide: a Building Block for the 
Synthesis of CF3S-Containing Isoxazolidines
This chapter has been adapted from “Riesco-Domínguez, A.; van de Wiel, J.; Hamlin, T. A.; van 
Beek, B.; Lindell, S. D.; Blanco-Ania, D.; Bickelhaupt, M.; Rutjes, F. P. J. T. J. Org. Chem. 2018, 
83, 1779–1789”.
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ABSTRACT: Trifluoromethyl vinyl sulfide, a potential building block for pharmaceutically and 
agrochemically relevant products, was prepared and used for the first time in high-pressure-mediated 
1,3-dipolar cycloaddition reactions with nitrones to synthesize a library of (trifluoromethyl)sulfanyl 
isoxazolidines.
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5.1 Introduction
The (trifluoromethyl)sulfanyl group (SCF3) represents a privileged substituent in agrochemicals 
and pharmaceuticals because of the strong electron-withdrawing effect and the large Hansch 
lipophilicity parameter (π = 1.44).1 Cefazaflur,2 a first-generation cephalosporin antibiotic, 
toltrazuril,3 an antiprotozoal agent, and a losartan analogue,4 developed as a potential 
hypotensive agent, are prominent examples of biologically active compounds bearing the SCF3
group (Figure 5.1).
Figure 5.1 Bioactive Heterocycles Containing the SCF3 Group. 
CF3S-Containing compounds are considered appealing targets in the agrochemical and 
pharmaceutical fields, and consequently, modern research has focused on efficient 
(trifluoromethyl)sulfanylation methods. The main strategies that have been developed to 
synthesize CF3S-containing compounds have focused on direct C–SCF3 bond formation5 and 
trifluoromethylation of sulfur-containing compounds.6 However, incorporation via simple CF3S-
containing building blocks is still unprecedented so that the use of a CF3S-containing reagent 
could be an alternative strategy to construct CF3S-substituted heterocycles. More specifically, 
trifluoromethyl vinyl sulfide (2) could be an attractive building block to provide straightforward 
access to a wide variety of hetero- and carbocycles via cycloaddition reactions.
Previously reported examples of cycloaddition reactions of alkene 2 are rather scarce: there is a 
single example of a Diels–Alder reaction with 2,3-dimethylbuta-1,3-diene to yield the 
corresponding CF3S-cyclohexene,7 and two cyclopropanation examples with organomercury 
reagents to yield CF3S-substituted cyclopropanes.8
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The potential of this unexplored chemistry and the inherent biological attractiveness of these 
molecules motivated us to further study the reactivity of alkene 2 in cycloaddition reactions.
Thus, we herewith present the study of the first 1,3-dipolar cycloaddition reactions of 2 with 
several nitrones9 to synthesize a novel group of isoxazolidines (Scheme 5.1).
Scheme 5.1 Synthesis of CF3S-Containing Isoxazolidines.
5.2 Results and Discussion
We commenced our investigations by forming alkene 2 in situ. Because of its high volatility,7
we first performed the elimination reactions in deuterated solvents in order to instantly measure 
conversions from commercially available chloro alkane 1 into alkene 2, with no need for further 
treatment or isolation of the alkene. We tested several bases (Et3N, DBU, KOtBu, KOH and 
KOTMS) in the presence of various deuterated solvents (CD2Cl2, THF-d8, CD3OD and DMF-d7; 
see Experimental Section for experimental details) to eventually choose a solution of KOtBu (1.0 
M solution in THF) in THF-d8 at 21 °C for 90 min as the final method for the in situ synthesis 
of alkene 2 with full conversion.
5.2.1 Synthesis of 2,5-Disubstituted Isoxazolidines
Initially, we focused on the synthesis of 2,5-disubstituted isoxazolidines 3 using N-substituted 
hydroxylamines 5 and paraformaldehyde as precursors for the in situ synthesis of the dipoles 
(Table 5.1). The nitrone intermediates were used without isolation in a one-pot process with a 
preformed solution of alkene 2 (3 equiv) and In(OTf)3 (0.06 equiv). In this manner, we obtained 
isoxazolidine 3a in 22% yield after column chromatography. Increasing the concentration of 2
(6 equiv) resulted in a yield of 38% (entry 1). Isoxazolidines 3b–e were synthesized in yields 
between 20 and 30% under the same reaction conditions with different substrates (entries 2–5).
However, yields were rather low after column chromatography in all cases (see Experimental 
Section for experimental details).
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Table 5.1 Synthesis of Isoxazolidines 3a−e.
Entry Compound R Yield (%)
1 3a C6H5 38 
2 3b 3-CF3C6H4 20
3 3c 3,5-Cl2C6H3 22 
4a 3d C6H5CH2 30
5a 3e Cy 23 
aEt3N (1.0 equiv) was used.
5.2.2 Synthesis of 2,3,5-Trisubstituted Isoxazolidines
With these results in hand and because of the low yields in the synthesis of 3a−e, we changed 
our strategy to the synthesis of 2,3,5-trisubstituted isoxazolidines 4, exhibiting a second 
(hetero)aromatic group at the 3-position and introducing consequently a second chiral center in 
the molecule (Scheme 5.2, Table 5.2).
Scheme 5.2 Formation of Compounds 4, 7 and 8.
We first performed the reaction with nitrone 6a (R = C6H5), a catalytic amount of In(OTf)3,
and alkene 2 at 21 °C in THF, but no conversion into the product was observed. When the same 
conditions were applied at 80 °C with nitrone 6c (R = 4-MeC6H4), less than 7% conversion into 
the final product was observed by 1H NMR, presumably because of the low reactivity of this 
alkene and perhaps because of its volatility.
Therefore, we decided to perform these reactions under high-pressure conditions (Table 5.2), 
which is an established and powerful tool to increase the rate of cycloaddition reactions.10 Thus, 
we gratifyingly observed an 83% conversion into isoxazolidines 4c and 7c (regioisomeric ratio 
4c/7c 13:1, diastereomeric ratio [dr] cis-4c/trans-4c 7:2) when 1.3 equiv of 2 at 21 °C under a 15 
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kbar pressure was used (entry 1). Nitrone 6b gave only 56% conversion under the same reaction 
conditions (entry 4), with similar regio- and diastereoisomeric ratios. Conversions of 93 and 75%
into compounds 4c and 4b were obtained, respectively (entries 2 and 5) when the concentration 
of alkene 2 was increased. Finally, an increase of the temperature to 50 °C gave nearly full 
conversion into the desired cis- and trans-products 4c and 4b (entries 3 and 6).
Table 5.2 Optimization Process for the 1,3-Dipolar Cycloaddition Reaction of Nitrones 6 with Alkene 2.
Entry Nitrone R 2 (equiv) t (°C) Scavenger cis-4/trans-4 8a Conversion
a
(yield)b
1 6c 4-MeC6H4 1.3 21 – 76:22 5% 83% (41%)c
2 6c 4-MeC6H4 3 21 – 79:21 22% 93% (–)
3 6c 4-MeC6H4 3 50 – 76:24 6% 96% (85%)c
4 6b 4-FC6H4 1.3 21 – 79:21 7% 56% (35%)c
5 6b 4-FC6H4 3 21 – 79:21 38% 75% (–)
6 6b 4-FC6H4 3 50 – 77:23 17% 91% (79%)c
7 6b 4-FC6H4 3 50 Galvinoxyl (3%) 76:24 0% 100% (78%)
8 6b 4-FC6H4 3 50 Galvinoxyl (1%) 76:24 1% 100% (–)
aCalculated by integration of the 1H NMR signals of the crude mixtures. bIsolated after column chromatography.
ctrans-Isomer contaminated with 7.
Azoxybenzene11 8 was formed in all reactions as a side product (Scheme 5.2) and could not be 
separated in any case from trans-4 by column chromatography. Thus, we used galvinoxyl to 
prevent the formation of compound 8.12 We were pleased to see that when using 3 equiv of 
alkene 2 at 50 °C, in the presence of 1–3 mol % of galvinoxyl as radical scavenger (entries 7 and 
8), not only full conversion into the desired product 4b was obtained, but also the formation of 
the azoxy compound 8 was fully suppressed.
Furthermore, our reactions gave the exo-products as the major diastereoisomers (the cis-
isomers), showing a 3:1 diastereomeric ratio (entries 7 and 8). Having these results in hand, the 
scope of nitrones in this 1,3-dipolar cycloaddition was examined by employing the conditions 
shown in entry 7. We first synthesized a total of 18 nitrones (6a–r) with phenyl (containing both 
electron-donating and electron-withdrawing groups at the 2-, 3- and 4- positions), heterocyclic 
and carbamoyl substituents in excellent yields (see Experimental Section). We then studied the 
scope of the 1,3-dipolar cycloaddition reactions between alkene 2 and nitrones 6a–r (Table 5.3).
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Table 5.3 Scope of the High-Pressure-Promoted 1,3-Dipolar Cycloaddition Reaction.
aCombined yield. bCalculated by integration of the 1H NMR signals of the crude. cGalvinoxyl was not used in 
the reaction. dcis-4o,p/trans-4o,p/(mixture of isomers 7).
As shown in Table 5.3, high and excellent yields (total yields) were observed for compounds 
4a–c, 4f–i, 4l and 4n. In addition, in most of the cases the major product (cis-4) was separated 
from the other isomers by column chromatography in good yields (cis-4a–c, cis-4f–j, cis-4m and 
cis-4q). Unfortunately, in a few cases the isomers 4 were obtained as a mixture that could not be 
separated (4d,e, 4k,l and 4n). For compounds 4o and 4p, the trans-4 isomer and the 
corresponding regioisomers 7 were present as a mixture.13 The assignment of the cis- and trans-
isomers was performed by 2D NMR studies (NOESY).
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The diastereoselectivity was lower for compounds 4o and 4p, which contained an indole and a 
pyrrole substituent, respectively. In these cases, a mixture of cis- and trans-diastereoisomers was 
obtained approximately in a 3:2 ratio. In addition, for compounds 4o and 4p, a 7:3 ratio of a 
mixture cis-7 and trans-7 from the regioisomer 7 was observed. For these two compounds (4o
and 4p), the total yields were significantly lower because of incomplete conversion into the 
products and purification problems. Finally, benzyl amide isoxazolidine 4r was synthesized in 
60% yield when using a non-aromatic nitrone.
The biological assays resulting from the isoxazolidines shown in this chapter were carried out 
by Bayer CropScience and a few analogs exhibited slight activity.
5.2.3 Computational Studies
To evaluate the apparent regioselectivity of the cycloaddition, high-level DFT calculations were 
carried out at the BP86/TZ2P14 level, using the ADF program.15 Tetrahydrofuran was simulated 
using the COSMO solvation model.16 Thermochemical corrections were computed using the 
temperature and pressure under which the experiments were performed (see Computational
Section for computational details). We focused on understanding the regioselectivity of the 
cycloaddition between a simple model nitrone 9 and 2 (Scheme 5.3).
Scheme 5.3 Formation of Compounds 10 and 11.
This reaction proceeds in a concerted and asynchronous manner with a Gibbs free energy 
barrier of 21.3 and 24.0 kcal mol−1 for 10 and 11, respectively (Table 5.4). The ∆∆G‡ of 2.7 kcal 
mol−1 facilitates a high degree of regioselectivity, resulting in a calculated product ratio of 98:2 
for 10/11. Furthermore, the experimentally observed regioisomer 10 is more stable than 11
(∆∆Grxn = 3.9 kcal mol−1).
The calculated product ratio for the model nitrone cycloaddition is in line with experimentally 
observed regioselectivity of reactions involving the majority of the nitrones 6.
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Table 5.4 Computed Activation Barriers, Reaction Energies (kcal mol−1), and Product Distribution Computed at the 
COSMO(THF)-BP86/TZ2P Level of Theory.
Compound ∆E‡ (∆G‡) ∆Erxn (∆Grxn) Product ratioa
10 12.8 (21.3) −17.6 (−6.1) 98 
11 15.0 (24.0) −14.3 (−2.2) 2 
aCalculated at 50 °C and 15 kbar based on the ∆∆G‡ between 10 and 11
(see Computational Section for details).
Insight into why regioisomer 10 is favored over the other (11) is provided by the activation 
strain model (ASM)17 (also known as the distortion-interaction model).18 In this framework, the 
potential energy surface ΔE(ζ) is decomposed along the reaction coordinate ζ into the strain 
ΔEstrain(ζ) associated with deforming the individual reactants plus the actual interaction ΔEint(ζ) 
between the deformed reactants.
ΔE(ζ) = ΔEstrain + ΔEint(ζ) (1)
The ΔEint(ζ) between the reactants is further analyzed by an energy decomposition analysis 
(EDA) in the conceptual framework provided by the Kohn–Sham molecular orbital (KS-MO) 
model19 and is decomposed into three physically meaningful terms:
ΔEint(ζ) = ΔVelstat(ζ) + ΔEPauli(ζ) + ΔEoi(ζ) (2)
The ΔVelstat(ζ) term corresponds to the classical electrostatic interaction between unperturbed 
charge distributions, ΔEPauli(ζ) is responsible for any steric repulsion, and the ΔEoi(ζ) accounts 
for charge transfer (HOMO–LUMO interactions) and polarization.
Applying the ASM along the reaction coordinate defined by the bending of the 1,3-dipole, it is 
revealed that reactivity differences in the reaction between 9 and 2 leading to 10 (blue curve) and 
11 (red curve) are a result of ΔEint (Figure 5.2a). ΔEstrain remains nearly constant for both 
reactions along the reaction coordinate. Next, the EDA terms were analyzed, and the ΔEPauli
dominates and is chiefly responsible for the difference in the interaction energies (Figure 5.2b). 
The more favorable ΔVelstat and ΔEoi curves associated with the reaction leading to 11 are unable 
to overcome for increased steric repulsion associated with this approach. These results highlight 
the fact that the reaction results from the least hindered approach, leaving the SCF3 group far 
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away from the CH2 group. See Computational Section for an ASA and EDA analysis on 6m and 
6p.
Figure 5.2 (a) Activation Strain and (b) Energy Decomposition Analyses of the Cycloaddition Reactions of Nitrone 9
and Alkene 2 up to Their Respective TS (Indicated by the Dot) Computed at the BP86/TZ2P Level. 
5.3 Conclusion
In summary, we have developed the synthesis of a new class of 5-[(trifluoromethyl)-
sulfanyl]isoxazolidines. The reactions utilized for their synthesis were high-pressure-promoted 
1,3-dipolar cycloaddition reactions between trifluoromethyl vinyl sulfide 2 and various easily 
synthesized nitrones. The results of our DFT computations are in harmony with experimental 
results and were leveraged to show that the high regioselectivity of these cycloaddition reactions 
originates from minimizing steric repulsion.
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5.5 Experimental Section
For general experimental details, see Section 2.5 (p 51).
Tetrahydrofuran was used as a solvent after distillation. Potassium tert-butoxide was used as a 
1.0 M solution in tetrahydrofuran. The high-pressure experiments were run in a high-pressure 
apparatus equipped with a one-wall-piston cylinder for pressures up to 15 kbar (1.5 GPa). 
Reactions were performed in 1–1.5 mL PTFE ampules closed by screwed stainless steel 
stoppers. These ampules were inserted into the high-pressure vessel filled with 80–100 petroleum 
ether as transmission medium. The characterization and assignment of isoxazolidines 4a–r were 
done either from isolated compounds or mixtures of isomers.
Optimization for the Synthesis of Trifluoromethyl Vinyl Sulfide 2
Several reaction conditions were attempted for the synthesis of alkene 2 (Table 5.5). All 
reactions were carried out in deuterated solvents and followed by 1H NMR.
Table 5.5 Optimization Process for the Synthesis of Alkene 2.
Entry Solvent Base (equiv) t (°C) Time (h) Ratio 1/2
1 CD2Cl2 DBU (1.0) 21 0.5 4:1 
2 CD2Cl2 DBU (1.0) 37 2 1:1 
3 CD2Cl2 DBU (1.0) 60a 1 0.8:1 
4 THF-d8 KOtBu (1.0)b 21 2.5 0.1:1 
5 CD3OD KOH (1.6) 80a 1 0:1 
6 CD3OD KOtBu (1.1)b 80a 1 0:1 
7 CD3OD KOTMS (1.7) 80a 1 0:1 
8 DMF-d7 KOtBu (1.1)b 21 1 –c
9 CD2Cl2 Et3N (1.0) 21 21 1:0 
10 THF-d8 KOtBu (1.0)d 0–21 1.5 0:1 
aReaction performed under microwave irradiation. bReagent used as a 
solid. cVinyl chloride was present in the mixture. Ratio between 1 and 2
could not be measured. dKOtBu was used as a 1.0 M solution in THF.
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Conditions for the Synthesis of Hydroxylamines 5b and 5c
The hydroxylamines used for the synthesis of compounds 3a–e are shown in Figure 5.3. 
Compounds 5a, 5d and 5e were commercially available and were used directly for the synthesis 
of 3a, 3d and 3e, respectively. Hydroxylamines 5b and 5c were synthesized from their 
corresponding nitrobenzenes 12b and 12c by reduction.
Figure 5.3 Hydroxylamines 5a–e Used for the Synthesis of Isoxazolidines 3a–e.
Firstly, we performed the reaction under the conditions described by Ung et al. in the presence 
of NH4Cl and Zn (dust).20 However, this reaction resulted in the formation of hydroxylamine 5c
alongside azoxybenzene 13c and 3,5-dicloroaniline 14c (ratio 5c/12c/13c/14c 65:19:12:4, 
Scheme 5.4).
Scheme 5.4 Synthesis of N-(3,5-Dichlorophenyl)hydroxylamine (5c).
The reaction of 5c with an excess of H2 and 10% Pd/C resulted into aniline 14c (Scheme 5.5).
Scheme 5.5 Synthesis of 3,5-Dichloroaniline by Reduction with Pd/C and H2.
Then, we investigated the synthesis of compound 5c by screening the use of Rh/C (5%) and Pd/C 
(10%) as catalysts with different reaction conditions (Table 5.6).21
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Table 5.6 Optimization Process for the Synthesis of Hydroxylamine 5c.
Entry Catalyst N2H4·H2O (equiv) t (°C) 5c/12c/13c/14c Yield (%)
1a Rh/C 1.2 0→21 52:47:1:0 31 
2a Pd/C 1.2 0→21 75:23:1:1 39
3b Pd/C 1.6 0 99:0:1:0 84
4b Pd/C 2 0 98:0:2:0 65c
5b Pd/C 2 0 99:0:1:0 89
aConducted at 100 mg scale. bConducted at 1 g scale. cPurified by recrystallization in heptane.
Hydroxylamine 5c was eventually synthesized in 89% by reduction with Pd/C (entry 5). In the 
same way, hydroxylamine 5b was synthesized from 1-nitro-3-(trifluoromethyl)benzene (12b) in 
95%.
Synthesis of Trifluoromethyl Vinyl Sulfide 2
General Procedure for the Synthesis of Trifluoromethyl Vinyl Sulfide 2
2-Chloroethyl trifluoromethyl sulfide (1.0 equiv) was dissolved in distilled THF (0.40 M) under 
inert atmosphere and cooled to 0 °C. Then, KOtBu (1.0 equiv, 1.0 M solution in THF) was 
added slowly, and the mixture was warmed to 21 °C for 90 min. This solution was used for the 
cycloaddition reactions of alkene 2.
1H NMR [400 MHz, δ (ppm), THF-d8]: 6.54 (dd, J = 16.5, 9.4 Hz, 1 H, 1-CH), 
5.72 (dq, J = 9.4, 1.5 Hz, 1 H, 2-CHa), 5.70 (d, J = 16.5, 1 H, 2-CHb). 13C NMR
[101 MHz, δ (ppm), THF-d8]: 129.8 (q, J = 306.5 Hz, SCF3), 124.4 (q, J = 1.0 Hz, 2-C), 121.3 (q, 
J = 3.2 Hz, 1-C). 19F NMR [377 MHz, δ (ppm), THF-d8]: −43.6.7
Synthesis of Hydroxylamines 5b and 5c
General Procedure for the Synthesis of Hydroxylamines 5b and 5c
The corresponding nitrobenzene (12b or 12c; 1 equiv) was added to a flame-dried Schlenk tube 
containing a suspension of Pd/C (0.25 equiv) in dry THF (10 mL). The mixture was cooled to 
0 °C, and N2H4·H2O (2.0 equiv) was added dropwise. The reaction was carefully monitored by 
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TLC until the starting material disappeared. The crude mixture was diluted with THF (10 mL) 
and filtered over a pad of diatomaceous earth. The solvent was evaporated in vacuo and the 
crude mixture was purified by column chromatography using CH2Cl2 under a nitrogen 
atmosphere.
N-[3-(Trifluoromethyl)phenyl]hydroxylamine 5b
According to the general procedure, the reaction of 1-nitro-3-
(trifluoromethyl)benzene 12b (1.0 g, 5.23 mmol) afforded hydroxylamine 5b
(885 mg, 5.00 mmol) as a pale yellow oil. 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 7.41–7.34 (m, 1 H, 5-CH), 7.28–7.26 (m, 1 H, 2-CH), 7.23–7.19 (m, 1 H, 4-CH or 6-
CH), 7.15–7.10 (m, 1 H, 4-CH or 6-CH), 6.74–4.98 (bs, 2 H, NH + OH). RF: 0.31 (CH2Cl2). 
Yield: 95%. NMR spectral data are in accordance with previously reported data.20
N-(3,5-Dichlorophenyl)hydroxylamine 5c
According to the general procedure, the reaction of 1,3-dichloro-5-nitrobenzene 
12c (1.0 g, 5.22 mmol) afforded hydroxylamine 5c (827 mg, 4.65 mmol) as a 
yellow solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 6.93 (t, J = 1.8 Hz, 1 H, 4-
CH), 6.88 (d, J = 1.8 Hz, 2 H, 2-CH + 6-CH), 6.79 (bs, 1 H, OH), 5.31 (bs, 1 H, NH). RF: 0.33 
(CH2Cl2). Yield: 89%. NMR spectral data are in accordance with previously reported data.20
Synthesis of Isoxazolidines 3a–e
General Procedure for the Synthesis of Isoxazolidines 3a–c
A solution of the corresponding hydroxylamine 5 (1 equiv) in THF (0.22 M) was added to a 
solution of paraformaldehyde (3 equiv) in THF (0.22 M) at 0 °C. Then, a cooled solution (0 °C) 
of alkene 2 (6.0 equiv) was subsequently added to the solution containing paraformaldehyde and 
the hydroxylamine. Finally, a solution of In(OTf)3 (0.06 equiv) in dry THF (44 mM) was added to 
the reaction mixture. The reaction mixture was warmed up to 21 °C and stirred for 16 h. Then, 
the reaction mixture was quenched with a saturated aqueous solution of NaHCO3 (10 mL) and 
the aqueous layer was extracted with AcOEt (2 × 10 mL). The combined organic layers were 
dried over MgSO4, filtered off and concentrated in vacuo. The crude mixture was purified by 
column chromatography using the indicated eluent to afford isoxazolines 3a–c.
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2-Phenyl-5-[(trifluoromethyl)sufanyl]isoxazolidine 3a
According to the general procedure, the reaction of N-phenylhydroxylamine 
5a (17.8 mg, 0.163 mmol) afforded isoxazolidine 3a (15.3 mg, 0.163 mmol) as 
a brown solid, after column chromatography (heptane/AcOEt, 19:1→4:1). 
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.34–7.27 (m, 2 H, 3′-CH + 5′-CH), 7.08–7.05 (m, 2 H, 
2′-CH + 6′-CH), 7.03 (tt, J = 7.3, 1.1 Hz, 1 H, 4′-CH), 5.98 (dd, J = 8.1, 4.3 Hz, 1 H, 5-CH), 
3.85–3.71 (m, 1 H, 3-CHH), 3.24 (ddd, J = 9.3, 8.2, 7.6 Hz, 1 H, 3-CHH), 2.91 (dtdq, J = 13.2, 
8.2, 4.0, 0.8 Hz, 1 H, 4-CHH), 2.48–2.28 (m, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), 
CDCl3]: 149.8 (1′-C), 130.1 (q, J = 307.7 Hz, SCF3), 129.0 (3′-C + 5′-C), 123.0 (4′-C), 116.1 (2′-C
+ 6′-C), 81.1 (q, J = 2.2 Hz, 5-C), 52.0 (3-C), 36.0 (q, J = 1.1 Hz, 4-C). 19F NMR [471 MHz, δ 
(ppm), CDCl3]: −39.8. FTIR [?̅?𝜈 (cm−1)]: 3064, 2956, 2860, 1599, 1491, 1295, 1109, 752, 692. 
HRMS [EI (m/z)] calcd for C10H10F3NOS = 249.04352, found for [M+•] = 249.04575 (|Δ| = 
2.23 mmu). RF: 0.56 (heptane/AcOEt, 4:1). Yield: 38%.
2-[3-(Trifluoromethyl)phenyl]-5-[(trifluoromethyl)sulfanyl]isoxazolidine 3b
According to the general procedure, the reaction of hydroxylamine 5b (56.2 
mg, 0.318 mmol) afforded isoxazolidine 3b (23.5 mg, 0.071 mmol) as a 
colorless oil, after column chromatography (heptane/AcOEt/Et3N, 
12.2:1:0.13). 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.41 (ddquint, J = 8.2, 
7.2, 0.8 Hz, 1 H, 5′-CH), 7.29–7.25 (m, 2 H, 2′-CH + 4′-CH), 7.23–7.19 (m, 1 H, 6′-CH), 6.00
(dd, J = 8.0, 4.2 Hz, 1 H, 5-CH), 3.82 (ddd, J = 9.1, 8.2, 4.3 Hz, 1 H, 3-CHH), 3.29 (ddd, J = 9.1, 
8.5, 7.4 Hz, 1 H, 3-CHH), 3.02–2.90 (m, 1 H, 4-CHH), 2.48–2.38 (m, 1 H, 4-CHH). 13C NMR
[126 MHz, δ (ppm), CDCl3]: 150.1 (1′-C), 131.3 (q, J = 32.3 Hz, 3′-C), 129.8 (q, J = 307.9 Hz, 
SCF3), 129.4 (5′-C), 124.0 (q, J = 272.4 Hz, CF3), 119.2 (q, J = 3.8 Hz, 4′-C), 118.9 (6′-C), 112.3 
(q, J = 4.0 Hz, 2′-C), 81.1 (q, J = 2.4 Hz, 5-C), 51.7 (3-C), 35.8 (q, J = 1.2 Hz, 4-C). 19F NMR 
[471 MHz, δ (ppm), CDCl3]: −39.9, −62.8. FTIR [?̅?𝜈 (cm−1)]: 2956, 2925, 2855, 1593, 1455, 1328, 
1020, 795, 698. HRMS [ESI (m/z)] calcd for C11H9F6NOS = 317.03090, found for [M+•] =
317.03252 (|Δ| = 1.61 mmu). RF: 0.44 (heptane/AcOEt, 4:1). Yield: 22%.
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2-(3,5-Dichlorophenyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine 3c
According to the general procedure, the reaction of hydroxylamine 5c (29.3 
mg, 0.166 mmol) afforded isoxazolidine 3c (10.33 mg, 0.033 mmol) as a 
green oil, after column chromatography (heptane/AcOEt/Et3N, 
12.2:1:0.13). 1H NMR [500 MHz, δ (ppm), CDCl3]: 6.99 (t, J = 1.8 Hz, 1 
H, 4′-CH), 6.91 (d, J = 1.8 Hz, 2 H, 2′-CH + 6′-CH), 5.98 (dd, J = 8.0, 4.1 Hz, 1 H, 5-CH), 3.75 
(ddd, J = 8.9, 8.1, 4.4 Hz, 1 H, 3-CHH), 3.27 (ddd, J = 9.2, 8.6, 7.1 Hz, 1 H, 3-CHH), 3.01–2.87 
(m, 1 H, 4-CHH), 2.47–2.36 (m, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 151.6 (1′-
C), 135.4 (3′-C + 5′-C), 129.7 (q, J = 307.9 Hz, SCF3, indirect observation), 122.5 (4′-C), 114.2 (2′-
C + 6′-C), 81.2 (q, J = 2.6 Hz, 5-C), 51.6 (3-C), 35.8 (q, J = 1.1 Hz, 4-C). FTIR [?̅?𝜈 (cm−1)]: 3084, 
2924, 2850, 1587, 1260, 1115, 1051, 796, 668. HRMS [EI (m/z)] calcd for C10H8Cl2F3NOS = 
316.96557, found for [M+•] = 316.96573 (|Δ| = 0.16 mmu). RF: 0.45 (heptane/AcOEt, 4:1). 
Yield: 20%.
General Procedure for the Synthesis of Isoxazolidines 3d and 3e
A solution of hydroxylamine hydrochloride 5d or 5e (1 equiv) in THF (0.22 M) and Et3N 
(1 equiv) was added to a solution of paraformaldehyde (3 equiv) in THF (0.22 M) at 0 °C. Then, 
a cooled solution (0 °C) of alkene 2 (6.0 equiv) was subsequently added to the solution 
containing paraformaldehyde and the hydroxylamine. Finally, a solution of In(OTf)3 (0.06 equiv) 
in dry THF (22 mM) was added to the reaction mixture. The reaction mixture was warmed to 
21 °C and stirred for 16 h. Then, the reaction mixture was quenched with a saturated aqueous 
solution of NaHCO3 (10 mL) and the aqueous layer was extracted with AcOEt (2 × 10 mL). The 
combined organic layers were dried over MgSO4, filtered off and concentrated in vacuo. The 
crude mixture was purified by column chromatography using the indicated eluent to afford 
isoxazolines 3d and 3e.
2-Benzyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 3d
According to the general procedure, the reaction of hydroxylamine 
hydrochloride 5d (26.8 mg, 0.169 mmol) afforded isoxazolidine 3d (13.2 
mg, 0.050 mmol) as a colorless oil, after column chromatography (heptane/AcOEt/Et3N, 
9:1:0.1). 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.40–7.36 (m, 2 H, 2′-CH + 6′-CH), 7.35–7.30 
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(m, 2 H, 3′-CH + 5′-CH), 7.30–7.27 (m, 1 H, 4′-CH), 5.86 (dd, J = 8.3, 4.4 Hz, 1 H, 5-CH), 4.35–
3.82 (m, 2 H, NCH2), 3.34–3.11 (m, 1 H, 3-CHH), 3.11–2.40 (m, 1 H, 3-CHH), 2.83 (dtd, J = 
11.9, 8.0, 3.3 Hz, 1 H, 4-CHH), 2.40–2.18 (m, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), 
CDCl3]: 136.2 (1′-C), 130.3 (q, J = 307.9 Hz, SCF3, indirect observation), 128.9 (2′-C + 6′-C), 
128.4 (3′-C + 5′-C), 127.5 (4′-C), 81.3 (q, J = 2.4 Hz, 5-C), 61.7 (NCH2), 53.3 (3-C), 36.5 (4-C). 
19F NMR [471 MHz, δ (ppm), CDCl3]: −39.9. FTIR [?̅?𝜈 (cm−1)]: 3066, 2924, 2849, 1606, 1497, 
1455, 1117, 755, 698. HRMS [EI (m/z)] calcd for C11H12F3NOS = 263.05917, found for [M+•] = 
263.06036 (|Δ| = 1.20 mmu). RF: 0.41 (heptane/AcOEt, 4:1). Yield: 30%.
2-Cyclohexyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 3e
According to the general procedure, the reaction of hydroxylamine 
hydrochloride 5e (23.1 mg, 0.152 mmol) afforded isoxazolidine 3e (20.4 mg, 
0.080 mmol) as a colorless oil, after column chromatography 
(heptane/AcOEt, 19:1→5:1). 1H NMR [400 MHz, δ (ppm), CDCl3]: 5.82 (dd, J = 8.1, 4.2 Hz, 
1 H, 5-CH), 3.43–3.13 (m, 1 H, 3-CHH), 2.85–2.73 (m, 1 H, 4-CHH), 2.68–2.50 (m, 1 H, 1′-CH), 
2.68–2.18 (m, 1 H, 3-CHH), 2.31–2.18 (m, 1 H, 4-CHH), 1.83–1.69 (m, 2 H, Cy), 1.66–1.52 (m, 
2 H, Cy), 1.39–1.13 (m, 6 H, Cy). 13C NMR [101 MHz, δ (ppm), CDCl3]: 130.4 (q, J = 308.1 Hz, 
SCF3), 80.8 (q, J = 2.2 Hz, 5-C), 65.8 (1′-C), 51.5 (3-C), 36.6 (4-C), 26.0 (Cy), 24.8 (Cy), 24.4 (Cy). 
19F NMR [377 MHz, δ (ppm), CDCl3]: −40.0. FTIR [?̅?𝜈 (cm−1)]: 2924, 2854, 1728, 1455, 1258, 
1082, 1009, 788. RF: 0.44 (heptane/AcOEt, 9:1). Yield: 53%.
Synthesis of Nitrones 6a–r
General Procedure A for the Syntheses of Nitrones 6d–g, 6i, 6j, 6l–r
The corresponding aldehyde (1.0 equiv, dissolved in 1.5 mL of dry EtOH for solid 
compounds) was added to a solution of N-phenylhydroxylamine (1.05 equiv) in dry EtOH 
(1.0 mL) at 21 °C under a nitrogen atmosphere. The reaction mixture was stirred for 16–21 h 
and then the solvent was removed under vacuo. The crude mixture was purified by column 
chromatography using the indicated eluent to afford nitrones 6d–g, 6i, 6j, 6l–r.
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General Procedure B for the Syntheses of Nitrones 6a–c, 6h and 6k
The corresponding aldehyde (1.0 equiv) was added to a solution of N-phenylhydroxylamine
(1.0 equiv) in dry EtOH (1.0 mL) and the flask was wrapped with aluminum foil. The reaction 
mixture was stirred at 21 °C for 16–21 h and then the solvent was removed under vacuo. The 
crude mixture was purified by column chromatography using the indicated eluent to afford 
nitrones 6a–c, 6h and 6k.
(Z)-N,1-Diphenylmethanimine Oxide 6a22
According to the general procedure B, the reaction of benzaldehyde (47.0 µL, 
0.458 mmol) with N-phenylhydroxylamine (50 mg, 0.458 mmol) afforded 
nitrone 6a (71 mg, 0.360 mmol) as a white solid, after column chromatography 
(heptane/AcOEt, 5:1→1:1). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.44–8.36 
(m, 2 H, 2-CH + 6-CH), 7.92 (s, 1 H, N=CH), 7.81–7.74 (m, 2 H, 2′-CH + 6′-CH), 7.53–7.43 
(m, 6 H, 3-CH + 4-CH + 5-CH + 3′-CH + 4′-CH + 5′-CH). Yield: 79%.
(Z)-1-(4-Fluorophenyl)-N-phenylmethanimine Oxide 6b23
According to the general procedure B, the reaction of 4-fluorobenzaldehyde 
(98.0 µL, 0.916 mmol) with N-phenylhydroxylamine (100 mg, 0.916 mmol) 
afforded nitrone 6b (178.5 mg, 0.829 mmol) as a white solid. 1H NMR [400 
MHz, δ (ppm), CDCl3]: 8.49–8.42 (m, 2 H, 2-CH + 6-CH), 7.91 (s, 1 H, 
N=CH), 7.80–7.75 (m, 2 H, 2′-CH + 6′-CH), 7.55–7.44 (m, 3 H, 3′-CH + 4′-CH + 5′-CH), 7.23–
7.14 (m, 2 H, 3-CH + 5-CH). Yield: 91%.
(Z)-N-Phenyl-1-(4-tolyl)methanimine Oxide 6c23
According to the general procedure B, the reaction of 
4-methylbenzaldehyde (163.0 µL, 1.375 mmol) with N-phenylhydroxylamine 
(127 mg, 1.375 mmol) afforded nitrone 6c (267.2 mg, 1.26 mmol) as yellow 
crystals, after column chromatography (heptane/AcOEt, 5:1→1:1). 1H 
NMR [400 MHz, δ (ppm), CDCl3]: 8.34–8.27 (m, 2 H, 2-CH + 6-CH), 7.89 (s, 1 H, N=CH), 
7.81–7.75 (m, 2 H, 2′-CH + 6′-CH), 7.51–7.43 (m, 3 H, 3′-CH + 4′-CH + 5′-CH), 7.33–7.28 (m, 
2 H, 3-CH + 5-CH), 2.42 (s, 3 H, CH3). Yield: 92%.
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(Z)-N-Phenyl-1-[4-(trifluoromethyl)phenyl]methanimine Oxide 6d24
According to the general procedure A, the reaction of 
4-(trifluoromethyl)benzaldehyde (91 mg, 0.523 mmol) with N-
phenylhydroxylamine (60 mg, 0.549 mmol) afforded nitrone 6d (139 mg, 
0.523 mmol) as a yellow solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.54–
8.48 (m, 2 H, 2-CH + 6-CH), 8.00 (s, 1 H, N=CH), 7.83–7.76 (m, 2 H, 2′-CH + 6′-CH), 7.76–
7.70 (m, 2 H, 3-CH + 5-CH), 7.55–7.47 (m, 3 H, 3′-CH + 4′-CH + 5′-CH). Yield: 99%.
(Z)-1-[4-(Pentafluoro-λ6-sulfanyl)phenyl]-N-phenylmethanimine Oxide 6e
According to the general procedure A, the reaction of 4-(pentafluoro-λ6-
sulfanyl)benzaldehyde (120 mg, 0.517 mmol) with N-phenylhydroxylamine 
(59 mg, 0.543 mmol) afforded nitrone 6e (163.3 mg, 0.505 mmol) as a 
white-yellow solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.52–8.45 (m, 2 
H, 2-CH + 6-CH), 8.00 (s, 1 H, N=CH), 7.89–7.81 (m, 2 H, 3-CH + 5-CH), 7.81–7.74 (m, 2 H, 
2′-CH + 6′-CH), 7.58–7.46 (m, 3 H, 3′-CH + 4′-CH + 5′-CH). 13C NMR [101 MHz, δ (ppm), 
CDCl3]: 154.5 (4-C, indirect observation), 149.1 (1′-C), 133.6 (1-C), 132.5 (N=CH), 130.7 (4′-C), 
129.5 (3′-C + 5′-C), 128.9 (2-C + 6-C), 126.5 (quint, J = 4.4 Hz, 3-C + 5-C), 121.9 (2′-C + 6′-C). 
FTIR [?̅?𝜈 (cm−1)]: 3102, 3057, 1594, 1573, 1074, 821, 810, 765. HRMS [ESI (m/z)] calcd for 
(C13H10F5NOS + H)+ = 324.04760, found 324.04815 (|Δ| = 0.06 ppm). RF: 0.45 (CH2Cl2). 
Yield: 98%.
(Z)-1-(4-Methoxyphenyl)-N-phenylmethanimine Oxide 6f25
According to the general procedure A, the reaction of 4-
methoxybenzaldehyde (0.063 mL, 0.514 mmol) with N-
phenylhydroxylamine (59 mg, 0.540 mmol) afforded nitrone 6f (110 mg, 
0.484 mmol) as a yellow-brown solid, after column chromatography 
(CH2Cl2→CH2Cl2/MeOH, 10:0.2). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.44–8.36 (m, 2 H, 2-
CH + 6-CH), 7.84 (s, 1 H, N=CH), 7.79–7.72 (m, 2 H, 2′-CH + 6′-CH), 7.50–7.37 (m, 3 H, 3′-
CH + 4′-CH + 5′-CH), 7.01–6.93 (m, 2 H, 3-CH + 5-CH), 3.86 (s, 3 H, OCH3). Yield: 94%.
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(Z)-1-(3-Fluorophenyl)-N-phenylmethanimine Oxide 6g26
According to the general procedure A, the reaction of 3-fluorobenzaldehyde 
(0.060 mL, 0.564 mmol) with N-phenylhydroxylamine (62 mg, 0.564 mmol) 
afforded nitrone 6g (118 mg, 0.548 mmol) as a light brown solid, after column 
chromatography (heptane/CH2Cl2, 1:4→CH2Cl2/MeOH, 10:1). 1H NMR
[400 MHz, δ (ppm), CDCl3]: 8.44 (ddd, J = 10.6, 2.6, 1.6 Hz, 1 H, 2-CH), 7.94 (s, 1 H, N=CH), 
7.90 (ddt, J = 8.1, 1.6, 0.7 Hz, 1 H, 6-CH), 7.80–7.73 (m, 2 H, 2′-CH + 6′-CH), 7.54–7.47 (m, 3 
H, 3′-CH + 4′-CH + 5′-CH), 7.44 (td, J = 8.1, 5.9 Hz, 1 H, 5-CH), 7.17 (tdd, J = 8.1, 2.6, 1.0 Hz, 
1 H, 4-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 162.8 (d, J = 245.5 Hz, 3-C), 149.1 (1′-C), 
133.5 (N=CH), 132.6 (d, J = 9.1 Hz, 1-C), 130.4 (4′-C), 130.1 (d, J = 8.4 Hz, 5-C), 129.4 (3′-C + 
5′-C), 125.1 (d, J = 3.0 Hz, 6-C), 121.8 (2′-C + 6′-C), 118.0 (d, J = 21.7 Hz, 4-C), 115.3 (d, J = 
24.7 Hz, 2-C). Yield: 97%.
(Z)-N-Phenyl-1-(3-tolyl)methanimine Oxide 6h26
According to the general procedure B, the reaction of 3-methylbenzaldehyde 
(42 µL, 0.458 mmol) with N-phenylhydroxylamine (50 mg, 0.458 mmol) 
afforded nitrone 6h (95.3 mg, 0.451 mmol) as a yellow oil, after column 
chromatography (heptane/AcOEt, 5:1→1:1). 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 8.32 (tq, J = 1.8, 0.7 Hz, 1 H, 2-CH), 8.12 (dddquint, J = 7.8, 1.8, 1.2, 0.7 Hz, 1 H, 4-
CH), 7.89 (s, 1 H, N=CH), 7.81–7.75 (m, 2 H, 2′-CH + 6′-CH), 7.53–7.44 (m, 3 H, 3′-CH + 4′-
CH + 5′-CH), 7.38 (t, J = 7.8 Hz, 1 H, 5-CH), 7.32–7.27 (m, 1 H, 6-CH), 2.43 (s, 3 H, CH3). 13C 
NMR [101 MHz, δ (ppm), CDCl3]: 149.3 (1′-C), 138.5 (3-C), 134.9 (N=CH), 132.0 (6-C), 130.8 
(1-C), 130.0 (4′-C), 129.4 (2-C), 129.3 (3′-C + 5′-C), 128.7 (5-C), 126.6 (4-C), 121.9 (2′-C + 6′-C), 
21.6 (CH3). FTIR [?̅?𝜈 (cm−1)]: 3092, 3056, 2963, 2920, 1652, 1590, 1459, 1088, 781, 692. HRMS
[ESI (m/z)] calcd for (C14H13NO + H)+ = 212.10699, found 212.10847 (|Δ| = 4.39 ppm).
Yield: 98%.
(Z)-1-[3-(Methoxycarbonyl)phenyl]-N-phenylmethanimine Oxide 6i
According to the general procedure A, the reaction of methyl 
3-formylbenzoate (90 mg, 0.548 mmol) with N-phenylhydroxylamine (63 
mg, 0.576 mmol) afforded nitrone 6i (112 mg, 0.439 mmol) as a yellow 
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oil, after column chromatography (CH2Cl2→CH2Cl2/MeOH, 10:1). 1H NMR [400 MHz, δ
(ppm), CDCl3]: 8.88 (dddd, J = 7.9, 1.7, 1.2, 0.5 Hz, 1 H, 6-CH), 8.80 (tt, J = 1.7, 0.5 Hz, 1 H, 2-
CH), 8.13 (ddd, J = 7.9, 1.7, 1.2 Hz, 1 H, 4-CH), 8.01 (d, J = 0.5 Hz, 1 H, N=CH), 7.83–7.75 (m, 
2 H, 2′-CH + 6′-CH), 7.59 (tt, J = 7.9, 0.5 Hz, 1 H, 5-CH), 7.54–7.46 (m, 3 H, 3′-CH + 4′-CH + 
5′-CH), 3.95 (s, 3 H, OCH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 166.5 (C=O), 149.0 (1′-C), 
133.6 (N=CH), 132.6 (6-C), 131.6 (4-C), 131.0 (1-C), 130.6 (3-C), 130.4 (4′-C), 130.2 (2-C), 129.3 
(3′-C + 5′-C), 129.0 (5-C), 121.7 (2′-C + 6′-C), 52.4 (OCH3). FTIR [?̅?𝜈 (cm−1)]: 3064, 2952, 1718, 
1434, 1278, 1187, 1072, 912, 729, 684. HRMS [ESI (m/z)] calcd for (C15H13NO3 + H)+ = 
256.09682, found 256.09840 (|Δ| = 4.02 ppm). RF: 0.07 (CH2Cl2). Yield: 80%.
(Z)-1-(3-Methoxyphenyl)-N-phenylmethanimine Oxide 6j
According to the general procedure A, the reaction of 
3-methoxybenzaldehyde (0.063 mL, 0.514 mmol) with N-
phenylhydroxylamine (59 mg, 0.540 mmol) afforded nitrone 6j (115 mg, 
0.506 mmol) as a yellow oil, after column chromatography 
(CH2Cl2→CH2Cl2/MeOH, 10:0.2). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.38 (dd, J = 2.7, 1.5 
Hz, 1 H, 2-CH), 7.92 (s, 1 H, N=CH), 7.81–7.75 (m, 2 H, 2′-CH + 6′-CH), 7.66 (dddd, J = 7.7, 
1.5, 1.0, 0.5 Hz, 1 H, 6-CH), 7.52–7.44 (m, 3 H, 3′-CH + 4′-CH + 5′-CH), 7.38 (dd, J = 8.3, 7.7 
Hz, 1 H, 5-CH), 7.05 (ddd, J = 8.3, 2.7, 1.0 Hz, 1 H, 4-CH), 3.89 (s, 3 H, OCH3). 13C NMR [101 
MHz, δ (ppm), CDCl3]: 159.7 (3-C), 149.1 (1′-C), 134.7 (N=CH), 131.9 (1-C), 130.0 (4′-C), 129.5 
(5-C), 129.2 (3′-C + 5′-C), 122.3 (6-C), 121.8 (2′-C + 6′-C), 118.1 (4-C), 112.7 (2-C), 55.4 (OCH3). 
FTIR [?̅?𝜈 (cm−1)]: 3060, 3001, 2834, 1553, 1270, 1025, 769, 684. HRMS [ESI (m/z)] calcd for 
(C14H13NO2 + Na)+ = 250.08385, found 250.08567 (|Δ| = 5.07 ppm). RF: 0.06 (CH2Cl2). Yield: 
98%.
(Z)-N-Phenyl-1-[3-(trifluoromethyl)phenyl]methanimine Oxide 6k26
According to the general procedure B, the reaction of 3-
(trifluoromethyl)benzaldehyde (61 µL, 0.458 mmol) with N-
phenylhydroxylamine (50 mg, 0.458 mmol) afforded nitrone 6k (116 mg, 
0.437 mmol) as a white solid, after column chromatography 
(heptane/AcOEt, 5:1→1:1). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.70 (dq, J = 2.3, 1.0 Hz, 1 
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H, 2-CH), 8.59 (dddd, J = 7.9, 1.7, 1.2, 0.6 Hz, 1 H, 6-CH), 8.01 (s, 1 H, N=CH), 7.84–7.75 (m, 
2 H, 2′-CH + 6′-CH), 7.72 (dq, J = 8.5, 1.1 Hz, 1 H, 4-CH), 7.61 (t, J = 7.9 Hz, 1 H, 5-CH), 
7.55–7.48 (m, 3 H, 3′-CH + 4′-CH + 5′-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 149.1 (1′-
C), 133.1 (N=CH), 131.8 (q, J = 1.0 Hz, 6-C), 131.5 (3-C), 131.5 (1-C), 130.5 (4′-C), 129.5 (3′-C + 
5′-C), 129.3 (5-C), 127.3 (q, J = 3.7 Hz, 4-C), 125.7 (q, J = 3.9 Hz, 2-C), 122.6 (CF3, indirect 
observation), 121.9 (2′-C + 6′-C). FTIR [?̅?𝜈 (cm−1)]: 3124, 3065, 1604, 1330, 1120, 1068, 770, 692. 
HRMS [ESI (m/z)] calcd for (C14H10F3NO + H)+ = 266.07873, found 266.07989 (|Δ| = 2.33 
ppm). RF: 0.35 (CH2Cl2). Yield: 95%.
(Z)-N-Phenyl-1-(2-tolyl)methanimine Oxide 6l27
According to the general procedure A, the reaction of 2-methylbenzaldehyde 
(0.061 mL, 0.524 mmol) with N-phenylhydroxylamine (60 mg, 0.551 mmol) 
afforded nitrone 6l (107 mg, 0.508 mmol) as a yellow-brown solid, after column 
chromatography (CH2Cl2→CH2Cl2/MeOH, 10:0.2). 1H NMR [400 MHz, δ
(ppm), CDCl3]: 9.42–9.32 (m, 1 H, 6-CH), 8.07 (s, 1 H, N=CH), 7.81–7.73 (m, 2 H, 2′-CH + 6′-
CH), 7.53–7.44 (m, 3 H, 3′-CH + 4′-CH + 5′-CH), 7.39–7.33 (m, 2 H, 4-CH + 5-CH), 7.28–7.23 
(m, 1 H, 3-CH), 2.46 (s, 3 H, CH3). Yield: 97%.
(Z)-1-(2-Methoxyphenyl)-N-phenylmethanimine Oxide 6m26
According to the general procedure A, the reaction of 2-methoxybenzaldehyde 
(70 mg, 0.514 mmol) with N-phenylhydroxylamine (59 mg, 0.540 mmol) 
afforded nitrone 6m (106 mg, 0.464 mmol) as an orange-brown solid, after 
column chromatography (CH2Cl2→CH2Cl2/MeOH, 10:0.2). 1H NMR [400 
MHz, δ (ppm), CDCl3]: 9.48 (dd, J = 7.9, 1.7 Hz, 1 H, 6-CH), 8.40 (s, 1 H, N=CH), 7.85–7.73 
(m, 2 H, 2′-CH + 6′-CH), 7.53–7.39 (m, 4 H, 4-CH, 3′-CH + 4′-CH + 5′-CH), 7.13–7.06 (m, 1 H, 
5-CH), 6.93 (dd, J = 8.4, 1.1 Hz, 1 H, 3-CH), 3.89 (s, 3 H, OCH3). 13C NMR [101 MHz, δ
(ppm), CDCl3]: 157.6 (2-C), 149.8 (1′-C), 132.3 (4-C), 129.8 (4′-C), 129.4 (N=CH), 129.2 (3′-C + 
5′-C), 128.9 (6-C), 122.0 (2′-C + 6′-C), 121.0 (5-C), 120.1 (1-C), 110.0 (3-C), 55.8 (OCH3). FTIR 
[?̅?𝜈 (cm−1)]: 3058, 3019, 1577, 1288, 1046, 746, 691, 611. RF: 0.07 (CH2Cl2). Yield: 90%.
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(Z)-N-Phenyl-1-(thiophen-3-yl)methanimine Oxide 6n28
According to the general procedure A, the reaction of thiophene-3-carbaldehyde 
(0.047 mL, 0.535 mmol) with N-phenylhydroxylamine (61 mg, 0.562 mmol) 
afforded nitrone 6n (109 mg, 0.535 mmol) as a white-yellow solid, after column 
chromatography (heptane/CH2Cl2, 1:1→heptane/CH2Cl2, 0:1). 1H NMR [400 
MHz, δ (ppm), CDCl3]: 9.16 (ddd, J = 3.1, 1.2, 0.7 Hz, 1 H, 2-CH), 8.06 (d, J = 0.6 Hz, 1 H, 
N=CH), 7.82–7.76 (m, 2 H, 2′-CH + 6′-CH), 7.52–7.46 (m, 3 H, 3′-CH + 4′-CH + 5′-CH), 7.45 
(dd, J = 5.2, 1.2 Hz, 1 H, 4-CH), 7.39 (dd, J = 5.1, 3.0 Hz, 1 H, 5-CH). Yield: 99%.
(Z)-1-(1H-Indol-2-yl)-N-phenylmethanimine Oxide 6o
According to the general procedure A, the reaction of 1H-indole-2-
carbaldehyde (80 mg, 0.551 mmol) with N-phenylhydroxylamine (63 mg, 
0.579 mmol) afforded nitrone 6o (130 mg, 0.551 mmol) as a yellow-brown 
solid. 1H NMR [500 MHz, δ (ppm), CDCl3]: 11.69 (s, 1 H, NH), 8.14 (s, 1 
H, N=CH), 7.87–7.80 (m, 2 H, 2′-CH + 6′-CH), 7.67 (dd, J = 8.1, 1.0 Hz, 1 H, 4-CH), 7.55–7.45 
(m, 4 H, 7-CH + 3′-CH + 4′-CH + 5′-CH), 7.32 (ddd, J = 8.2, 6.9, 1.1 Hz, 1 H, 6-CH), 7.16 
(ddd, J = 8.0, 6.9, 1.0 Hz, 1 H, 5-CH), 6.94 (s, 1 H, 3-CH). 13C NMR [126 MHz, δ (ppm), 
CDCl3]: 147.4 (1′-C), 136.0 (7a-C), 130.2 (4′-C), 129.9 (2-C), 129.4 (3′-C + 5′-C), 127.6 (3a-C), 
126.8 (N=CH), 125.2 (6-C), 121.3 (2′-C + 6′-C), 120.8 (5-C), 112.3 (7-C), 108.6 (3-C). FTIR [?̅?𝜈
(cm−1)]: 3315, 3067, 3052, 1593, 1502, 1345, 1234, 818, 733. HRMS [ESI (m/z)] calcd for 
(C15H12N2O + Na)+ = 259.08418, found 259.08576 (|Δ| = 3.98 ppm). RF: 0.13 (CH2Cl2). Yield: 
99%.
(Z)-N-Phenyl-1-(1H-pyrrol-2-yl)methanimine Oxide 6p
According to the general procedure A, the reaction of 1H-pyrrole-2-
carbaldehyde (52 mg, 0.547 mmol) with N-phenylhydroxylamine (60 mg, 0.550 
mmol) afforded nitrone 6p (62 mg, 0.333 mmol) as a dark brown solid, after 
column chromatography (CH2Cl2→CH2Cl2/MeOH, 10:0.1). 1H NMR [500 
MHz, δ (ppm), CDCl3]: 12.21 (s, 1 H, NH), 7.95 (s, 1 H, N=CH), 7.81–7.73 (m, 2 H, 2′-CH + 6′-
CH), 7.52–7.38 (m, 3 H, 3′-CH + 4′-CH + 5′-CH), 7.07 (td, J = 2.7, 1.3 Hz, 1 H, 5-CH), 6.70 (dt, 
J = 3.6, 1.6 Hz, 1 H, 3-CH), 6.40 (dt, J = 3.9, 2.5 Hz, 1 H, 4-CH). 13C NMR [126 MHz, δ (ppm), 
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CDCl3]: 147.1 (1′-C), 129.5 (4′-C), 129.3 (3′-C + 5′-C), 126.1 (N=CH), 125.3 (2-C), 121.3 (5-C), 
121.0 (2′-C + 6′-C), 115.9 (3-C), 111.3 (4-C). FTIR [?̅?𝜈 (cm−1)]: 3317, 3062, 1580, 1403, 1294, 
1074, 1045, 740, 686. HRMS [ESI (m/z)] calcd for (C11H10N2O + H)+ = 187.08659, found 
187.08851 (|Δ| = 7.33 ppm). RF: 0.45 (heptane/AcOEt, 1:1). Yield: 61%.
(Z)-1-(Furan-2-yl)-N-phenylmethanimine Oxide 6q29
According to the general procedure A, the reaction of furan-2-carbaldehyde 
(0.043 mL, 0.520 mmol) with N-phenylhydroxylamine (60 mg, 0.546 mmol) 
afforded nitrone 6q (97 mg, 0.520 mmol) as a light brown solid, after column 
chromatography (CH2Cl2→CH2Cl2/MeOH, 10:0.2). 1H NMR [400 MHz, δ
(ppm), CDCl3]: 8.16 (s, 1 H, N=CH), 8.01 (dt, J = 3.5, 0.7 Hz, 1 H, 3-CH), 7.83–7.77 (m, 2 H, 2′-
CH + 6′-CH), 7.58 (dd, J = 1.8, 0.7 Hz, 1 H, 5-CH), 7.52–7.44 (m, 3 H, 3′-CH + 4′-CH + 5′-
CH), 6.65 (dd, J = 3.6, 1.8 Hz, 1 H, 4-CH). Yield: 99%.
(Z)-2-(Benzylamino)-2-oxo-N-phenylethan-1-imine Oxide 6r
According to the general procedure A, the reaction of N-benzyl-2-
oxoacetamide (56 mg, 0.343 mmol) with N-phenylhydroxylamine (26 mg, 
0.240 mmol) afforded nitrone 6r (34.5 mg, 0.135 mmol) as a white solid. 
1H NMR [400 MHz, δ (ppm), CDCl3]: 10.39 (s, 1 H, NH), 7.72–7.67 (m, 
2 H, 2′-CH + 6′-CH), 7.66 (s, 1 H, N=CH), 7.58–7.46 (m, 3 H, 3′-CH + 4′-CH + 5′-CH), 7.40–
7.27 (m, 5 H, 2-CH + 3-CH + 4-CH + 5-CH + 6-CH), 4.64 (d, J = 5.9 Hz, 2 H, NCH2). 13C 
NMR [101 MHz, δ (ppm), CDCl3]: 160.8 (C=O), 147.5 (1′-C), 137.8 (1-C), 131.7 (4′-C), 130.3 
(N=CH), 129.7 (3′-C + 5′-C), 128.9 (3-C + 5-C), 128.0 (2-C + 6-C), 127.7 (4-C), 121.6 (2′-C + 6′-
C), 43.3 (NCH2). FTIR [?̅?𝜈 (cm−1)]: 3255, 3121, 2945, 1634, 1516, 1059, 768, 751, 683. HRMS
[ESI (m/z)] calcd for (C15H14N2O2 + Na)+ = 277.09475, found 277.09556 (|Δ| = 0.93 ppm). RF: 
0.68 (CH2Cl2/MeOH, 10:0.2). Yield: 39%.
Synthesis of Isoxazolidines 4a–r, 7o and 7p
General Procedure for the Synthesis of Isoxazolidines 4a, 4b, 4d–r
The solution containing alkene 2 in distilled THF (3 equiv, 1.48 M) at 0 °C was added to a 
PTFE tube containing the corresponding nitrone 6 (1 equiv) and galvinoxyl (0.03 equiv). The 
tube was filled up with distilled THF, closed and brought to 15 kbar at 50 °C for 16 h. Then, the 
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reaction mixture was filtered off and the solvent was removed under vacuo. The crude mixture 
was purified by column chromatography using the indicated eluent to afford isoxazolidines 4a, 
4b, 4d–r.
2,3-Diphenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4a
According to the general procedure, the reaction of nitrone 6a (26 mg, 0.119 mmol) and alkene 2
in a 1 mL PTFE high-pressure tube afforded cis-4a (24.9 mg, 0.77 mmol, 65%) as a white solid 
and a mixture of cis- and trans-4a and regioisomers 7a (12.6 mg, 0.039 mmol, 33%) as a yellow 
oil, after column chromatography (heptane/CH2Cl2, 9:1). Total yield: 98%. 
rac-(3R,5R)-2,3-Diphenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4a
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.52–7.47 (m, 2 H, 2″-CH + 6″-CH), 
7.43–7.37 (m, 2 H, 3″-CH + 5″-CH), 7.35–7.30 (m, 1 H, 4″-CH), 7.24–7.18 
(m, 2 H, 3′-CH + 5′-CH), 7.04–6.99, (m, 1 H, 4′-CH), 6.99–6.95 (m, 2 H, 2′-
CH + 6′-CH), 6.01 (dd, J = 8.1, 4.4 Hz, 1 H, 5-CH), 4.41 (dd, J = 9.0, 7.1 Hz, 
1 H, 3-CH), 3.41 (dddq, J = 13.6, 9.0, 8.1, 0.9 Hz, 1 H, 4-CHH), 2.44–2.31 (m, 1 H, 4-CHH). 13C 
NMR [126 MHz, δ (ppm), CDCl3]: 148.8 (1′-C), 139.8 (1″-C), 130.2 (q, J = 307.7 Hz, SCF3), 
129.3 (3′-C + 5′-C), 128.8 (3′′-C + 5′′-C), 128.3 (4′′-C), 127.2 (2′′-C + 6′′-C), 123.8 (4′-C), 117.6 (2′-
C + 6′-C), 80.5 (q, J = 2.5 Hz, 5-C), 68.3 (3-C), 47.2 (4-C). FTIR [?̅?𝜈 (cm−1)]: 3070, 2963, 2877, 
1598, 1489, 1258, 1114, 1031, 966, 928, 752, 700. HRMS [EI (m/z)] calcd for C16H14F3NOS = 
325.07482, found for [M+•] = 325.07648 (|Δ| = 1.66 mmu). RF: 0.20 (heptane/CH2Cl2, 9:1). 
rac-(3R,5S)-2,3-Diphenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4a
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.50–7.45 (m, 2 H, 2″-CH + 6″-CH), 
7.41–7.36 (m, 2 H, 3″-CH + 5″-CH), 7.35–7.30 (1 H, 4″-CH), 7.25–7.18 (m, 2 
H, 3′-CH + 5′-CH), 7.04–6.98 (m, 2 H, 2′-CH + 6′-CH), 6.98–6.93 (m, 1 H, 4′-
CH), 6.07 (dd, J = 6.8, 3.8 Hz, 1 H, 5-CH), 4.90 (t, J = 7.3 Hz, 1 H, 3-CH), 
3.02–2.92 (m, 1 H, 4-CHH), 2.88 (ddd, J = 13.3, 7.3, 3.8 Hz, 1 H, 4-CHH). 13C NMR [126 MHz, 
δ (ppm), CDCl3]: 151.0 (1′-C), 139.9 (1″-C), 129.9 (q, J = 307.8 Hz, SCF3), 129.2 (3″-C + 5″-C), 
128.8 (3′-C + 5′-C), 128.2 (4″-C), 126.7 (2″-C + 6″-C), 122.4 (4′-C), 115.2 (2′-C + 6′-C), 82.3 (q, J
= 2.0 Hz, 5-C), 68.1 (3-C), 46.3 (4-C). FTIR [?̅?𝜈 (cm−1)]: 3065, 2926, 1598, 1489, 1206, 1108, 
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1049, 842, 796, 665. HRMS [EI (m/z)] calcd for C16H14F3NOS = 325.07482, found for [M+•] = 
325.07503 (|Δ| = 0.21 mmu). RF: 0.11 (heptane/CH2Cl2, 9:1). 
3-(4-Fluorophenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4b
According to the general procedure, the reaction of nitrone 6b (27 mg, 0.125 mmol) and alkene 2
in a 1 mL PTFE high-pressure tube afforded cis-4b (27.6 mg, 0.080 mmol, 64%) as a white solid, 
a mixture of cis- and trans-4b and regioisomers 7b (13.1 mg, 0.038 mmol, 27%) as a yellow oil 
and trans-4b (3.5 mg, 0.010 mmol, 8%) as a pale yellow oil, after column chromatography 
(heptane/CH2Cl2, 9:1). Total yield: 99%.
rac-(3R,5R)-3-(4-Fluorophenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4b
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.49–7.43 (m, 2 H, 2″-CH + 6″-CH), 
7.25–7.19 (m, 2 H, 3′-CH + 5′-CH), 7.11–7.05 (m, 2 H, 3″-CH + 5″-CH), 
7.05–7.01 (m, 1 H, 4′-CH), 6.99–6.93 (m, 2 H, 2′-CH + 6′-CH), 6.01 (dd, J = 
8.1, 4.3 Hz, 1 H, 5-CH), 4.40 (dd, J = 9.0, 7.0 Hz, 1 H, 3-CH), 3.39 (dddq, J
= 13.7, 9.0, 8.1, 0.9 Hz, 1 H, 4-CHH), 2.39–2.28 (m, 1 H, 4-CHH). 13C NMR [126 MHz, δ
(ppm), CDCl3]: 162.6 (d, J = 247.0 Hz, 4″-C), 148.6 (1′-C), 135.4 (d, J = 3.1 Hz, 1″-C), 130.1 (q, J
= 307.8 Hz, SCF3), 128.92 (3′-C + 5′-C), 128.91 (d, J = 7.2 Hz, 2″-C + 6″-C), 124.0 (4′-C), 117.7 
(2′-C + 6′-C), 116.2 (d, J = 21.6 Hz, 3″-C + 5″-C), 80.5 (q, J = 2.3 Hz, 5-C), 67.7 (3-C), 47.1 (4-
C). 19F NMR [471 MHz, δ (ppm), CDCl3]: −39.9. FTIR [?̅?𝜈 (cm−1)]: 3071, 2963, 1597, 1490, 
1455, 1256, 1226, 1110, 1029, 905, 804, 754. HRMS [EI (m/z)] calcd for C16H13F4NOS = 
343.06540, found for [M+•] = 343.06497 (|Δ| = 0.43 mmu). RF: 0.26 (heptane/CH2Cl2, 17:3).
rac-(3R,5S)-3-(4-Fluorophenyl)-2-phenyl-5-[(trifluoromethyl]sulfanyl]isoxazolidine trans-4b
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.44–7.40 (m, 2 H, 2″-CH + 6″-CH), 
7.25–7.20 (m, 2 H, 3′-CH + 5′-CH), 7.10–7.04 (m, 2 H, 3″-CH + 5″-CH), 
6.99–6.92 (m, 3 H, 2′-CH + 4′-CH + 6′-CH), 6.05 (dd, J = 6.8, 3.9 Hz, 1 H, 
5-CH), 4.88 (t, J = 7.2 Hz, 1 H, 3-CH), 2.98–2.90 (m, 1 H, 4-CHH), 2.87 
(ddd, J = 13.3, 7.3, 3.9 Hz, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 162.3 (d, J = 
242.3 Hz, 4″-C, indirect observation), 150.7 (1′-C), 135.6 (1″-C), 128.9 (3′-C + 5′-C), 128.4 (d, J = 
8.3 Hz, 2″-C + 6″-C), 122.6 (4′-C), 116.2 (d, J = 21.7 Hz, 3″-C + 5″-C), 115.3 (2′-C + 6′-C), 81.2 
(5-C), 67.4 (3-C), 46.2 (4-C). The carbon signal of SCF3 was not observed. 19F NMR [471 MHz, 
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δ (ppm), CDCl3]: −39.4. FTIR [?̅?𝜈 (cm−1)]: 3071, 2960, 1686, 1598, 1154, 1052, 937, 693. HRMS
[EI (m/z)] calcd for C16H13F4NOS = 343.06540, found for [M+•] = 343.06763 (|Δ| = 2.23 
mmu). RF: 0.21 (heptane/CH2Cl2, 17:3).
2-Phenyl-3-(4-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4c
The solution containing alkene 2 (3.0 equiv) in distilled THF (500 μL) at 0 °C was added to a 
PTFE tube containing nitrone 6c (1.0 equiv). The tube was filled up with distilled THF, closed 
and brought to 15 kbar at 50 °C for 16 h. Then, the reaction mixture was filtered off and the 
solvent was removed under vacuo. The crude mixture was purified by column chromatography 
(heptane/CH2Cl2, 4:1) to afford isoxazolidine cis-4c (17.1 mg, 0.050 mmol, 50%) as white solid
and trans-4c (12.1 mg, 0.36 mmol, 35%) as a brown oil, contaminated with regioisomers 7c and 
azoxybenzene 8. Total yield: 85%.
rac-(3R,5R)-2-Phenyl-3-(4-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4c
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.40–7.34 (m, 2 H, 2″-CH + 6″-
CH), 7.23–7.16 (m, 4 H, 3′-CH + 5′-CH + 3″-CH + 5″-CH), 7.03–6.95 (m, 
3 H, 2′-CH + 4′-CH + 6′-CH), 6.00 (dd, J = 8.1, 4.3 Hz, 1 H, 5-CH), 4.36 
(dd, J = 9.0, 7.2 Hz, 1 H, 3-CH), 3.38 (dddq, J = 13.7, 9.0, 8.1, 0.9 Hz, 1 H, 
4-CHH), 2.39–2.32 (m, 1 H, 4-CHH), 2.36 (s, 3 H, CH3). 13C NMR [126 MHz, δ (ppm), CDCl3]: 
148.9 (1′-C), 138.1 (4″-C), 136.6 (1″-C), 130.2 (q, J = 307.7 Hz, SCF3), 130.0 (3″-C + 5″-C), 128.8 
(3′-C + 5′-C), 127.1 (2″-C + 6″-C), 123.7 (4′-C), 117.6 (2′-C + 6′-C), 80.5 (q, J = 2.2 Hz, 5-C), 68.1 
(3-C), 47.3 (4-C), 21.3 (CH3). 19F NMR [471 MHz, δ (ppm), CDCl3]: −39.9. FTIR [?̅?𝜈 (cm−1)]: 
3056, 2962, 2886, 1597, 1489, 1257, 1107, 752, 691. HRMS [EI (m/z)] calcd for C17H16F3NOS = 
339.09047, found for [M+•] = 339.08895 (|Δ| = 1.52 mmu). RF: 0.21 (heptane/CH2Cl2, 4:1).
rac-(3R,5S)-2-Phenyl-3-(4-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4c
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.36–7.33 (m, 2 H, 2″-CH + 6″-
CH), 7.25–7.16 (m, 4 H, 3′-CH + 5′-CH + 3″-CH + 5″-CH), 7.02–6.98 (m, 
2 H, 2′-CH + 6′-CH), 6.97–6.92 (m, 1 H, 4′-CH), 6.06 (dd, J = 6.8, 3.8 Hz, 
1 H, 5-CH), 4.85 (t, J = 7.2 Hz, 1 H, 3-CH), 2.95 (dddq, J = 13.2, 7.6, 6.8, 
0.9 Hz, 1 H, 4-CHH), 2.85 (ddd, J = 13.2, 7.2, 3.8 Hz, 1 H, 4-CHH), 2.36 (s, 3 H, CH3). 13C 
NMR [126 MHz, δ (ppm), CDCl3]: 151.0 (1′-C), 137.9 (4″-C), 136.9 (1″-C), 130.1 (q, J = 307.7 
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Hz, SCF3, indirect observation), 129.8 (3″-C + 5″-C), 128.8 (3′-C + 5′-C), 126.6 (2″-C + 6″-C), 
122.2 (4′-C), 115.2 (2′-C + 6′-C), 82.3 (q, J = 2.2 Hz, 5-C), 67.9 (3-C), 46.4 (4-C), 21.3 (CH3). 19F 
NMR [471 MHz, δ (ppm), CDCl3]: −39.3. FTIR [?̅?𝜈 (cm−1)]: 3063, 2925, 2861, 1599, 1487, 1152, 
1053, 756, 686. HRMS [EI (m/z)] calcd for C17H16F3NOS = 339.09047, found for [M+•] =
339.09236 (|Δ| = 1.89 mmu). RF: 0.13 (heptane/CH2Cl2, 4:1).
2-Phenyl-3-[4-(trifluoromethyl)phenyl]-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4d
According to the general procedure, the reaction of nitrone 6d (50 mg, 0.190 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube, containing approximately 300 μL of glass beads, afforded 
a mixture of isoxazolidines cis- and trans-4d and regioisomers 7d (53.1 mg, 0.137 mmol, 73%) as 
a pale yellow solid oil, after column chromatography (heptane/CH2Cl2, 17:3). FTIR [?̅?𝜈 (cm−1)]: 
2959, 2888, 1597, 1490, 1325, 1104, 1051, 850, 754, 692. HRMS [EI (m/z)] calcd for 
C17H13F6NOS = 393.06220, found for [M+•] = 393.06244 (|Δ| = 0.23 mmu). RF: 0.20 
(heptane/CH2Cl2, 17:3). Total yield: 73%.
rac-(3R,5R)-2-Phenyl-3-[4-(trifluoromethyl)phenyl]-5-[(trifluoromethyl)sulfanyl]isoxazoli-
dine cis-4d
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.72–7.55 (m, 4 H, 2″-CH + 3″-
CH + 5″-CH + 6″-CH), 7.25–7.18 (m, 2 H, 3′-CH + 5′-CH), 7.05–7.00 
(m, 1 H, 4′-CH), 6.97–6.93 (m, 2 H, 2′-CH + 6′-CH), 6.00 (dd, J = 8.0, 4.3 
Hz, 1 H, 5-CH), 4.50 (dd, J = 9.1, 6.7, 1 H, 3-CH), 3.43 (dddq, J = 13.7, 
9.1, 8.0, 0.9, 1 H, 4-CHH), 2.33 (ddd, J = 13.7, 6.7, 4.3 Hz, 1 H, 4-CHH). 13C NMR [126 MHz, δ 
(ppm), CDCl3]: 148.4 (1′-C), 144.1 (1″-C), 130.6 (q, J = 32.6 Hz, 4″-C), 130.0 (q, J = 307.8 Hz, 
SCF3), 129.0 (3′-C + 5′-C), 127.4 (2″-C + 6″-C), 126.3 (q, J = 3.8 Hz, 3″-C + 5″-C), 124.09 (q, J = 
272.1 Hz, CF3), 124.05 (4′-C), 117.4 (2′-C + 6′-C), 80.4 (q, J = 2.2 Hz, 5-C), 67.5 (3-C), 46.9 (4-C). 
rac-(3R,5S)-2-Phenyl-3-[4-(trifluoromethyl)phenyl]-5-[(trifluoromethyl)sulfanyl]isoxazoli-
dine trans-4d
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.70–7.56 (m, 4 H, 2″-CH + 3″-
CH + 5″-CH + 6″-CH), 7.27–7.18 (m, 2 H, 3′-CH + 5′-CH), 7.00–6.96 
(m, 3 H, 2′-CH + 4′-CH + 6′-CH), 6.04 (dd, J = 6.3, 4.6 Hz, 1 H, 5-CH), 
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4.97 (t, J = 7.1 Hz, 1 H, 3-CH), 3.01–2.83 (m, 2 H, 4-CH2). 13C NMR [126 MHz, δ (ppm), 
CDCl3]: 150.5 (1′-C), 144.1 (1″-C), 130.5 (q, J = 32.5 Hz, 4″-C), 130.0 (q, J = 307.8 Hz, SCF3, 
indirect observation), 129.0 (3′-C + 5′-C), 127.0 (2″-C + 6″-C), 126.2 (q, J = 3.9 Hz, 3″-C + 5″-
C), 122.7 (4′-C), 115.1 (2′-C + 6′-C), 82.2 (q, J = 2.1 Hz, 5-C), 67.5 (3-C), 45.9 (4-C).
3-[4-(Pentafluoro-λ6-sulfanyl)phenyl]-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4e
According to the general procedure, the reaction of nitrone 6e (37.8 mg, 0.143 mmol) and alkene 
2 in a 1 mL PTFE high-pressure tube afforded a mixture of isoxazolidines cis- and trans-4e and 
regioisomers 7e (41 mg, 0.091 mmol, 72%) as a white solid, after column chromatography 
(heptane/CH2Cl2, 17:3). FTIR [?̅?𝜈 (cm−1)]: 3078, 2963, 1670, 1585, 1261, 1120, 1104, 817, 753, 
584. HRMS [EI (m/z)] calcd for C16H13F8NOS2 = 451.03108, found for [M+•] = 451.03178 
(|Δ| = 0.69 mmu). RF: 0.21 (heptane/CH2Cl2, 17:3). Total yield: 72%.
rac-(3R,5R)-3-[4-(Pentafluoro-λ6-sulfanyl)phenyl]-2-phenyl-5-[(trifluoromethyl)sulfanyl]-
isoxazolidine cis-4e
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.85–7.72 (m, 2 H, 3″-CH + 5″-
CH), 7.64–7.55 (m, 2 H, 2″-CH + 6″-CH), 7.30–7.21 (m, 2 H, 3′-CH + 5′-
CH), 7.09–7.02 (m, 1 H, 4′-CH), 7.02–6.92 (m, 2 H, 2′-CH + 6′-CH), 6.00 
(dd, J = 8.0, 4.3 Hz, 1 H, 5-CH), 4.52 (dd, J = 9.2, 6.6, 1 H, 3-CH), 3.43 
(dt, J = 13.7, 8.6, 1 H, 4-CHH), 2.32 (ddd, J = 13.7, 6.6, 4.3 Hz, 1 H, 4-CHH). 13C NMR [126 
MHz, δ (ppm), CDCl3]: 153.7–153.4 (m, 4″-C), 148.3 (1′-C), 144.0 (1″-C), 130.0 (q, J = 307.9 Hz, 
SCF3), 129.1 (3′-C + 5′-C), 127.3 (2″-C + 6″-C), 127.0 (3″-C + 5″-C), 124.2 (4′-C), 117.3 (2′-C + 
6′-C), 80.4 (q, J = 2.3 Hz, 5-C), 67.1 (3-C), 46.7 (4-C).
rac-(3R,5S)-3-[4-(Pentafluoro-λ6-sulfanyl)phenyl]-2-phenyl-5-[(trifluoromethyl)sulfanyl]-
isoxazolidine trans-4e
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.80–7.74 (m, 2 H, 3″-CH + 5″-
CH), 7.60–7.56 (m, 2 H, 2″-CH + 6″-CH), 7.28–7.21 (m, 2 H, 3′-CH + 5′-
CH), 7.01–6.97 (m, 3 H, 2′-CH + 4′-CH + 6′-CH), 6.03 (dd, J = 5.9, 5.0, 1 
H, 5-CH), 4.97 (t, J = 7.1 Hz, 1 H, 3-CH), 3.01–2.80 (m, 2 H, 4-CH2). 13C 
520586-L-bw-Riesco
Processed on: 8-8-2018 PDF page: 174
Chapter 5
174
NMR [126 MHz, δ (ppm), CDCl3]: 153.7–153.4 (m, 4″-C), 150.4 (1′-C), 143.9 (1″-C), 130.0 (q, J
= 307.9 Hz, SCF3, indirect observation), 129.0 (3′-C + 5′-C), 127.1 (2″-C + 6″-C), 127.0 (3″-C + 
5″-C), 122.8 (4′-C), 115.1 (2′-C + 6′-C), 82.2 (q, J = 2.2 Hz, 5-C), 67.1 (3-C), 45.8 (4-C).
3-(4-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4f
According to the general procedure, the reaction of nitrone 6f (54 mg, 0.238 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube afforded isoxazolidine cis-4f (44.3 mg, 0.125 mmol, 53%), a 
mixture of isoxazolidines cis- and trans-4f (27.3 mg, 0.077 mmol, 32%) and isoxazolidine trans-4f 
mixed with cis-4f and regioisomers 7f (12.4 mg, 0.035 mmol, 15%) as yellow oils, after column 
chromatography (heptane/CH2Cl2, 7:3). Total yield: 99%.
rac-(3R,5R)-3-(4-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 
cis-4f
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.43–7.35 (m, 2 H, 2″-CH + 6″-
CH), 7.23–7.18 (m, 2 H, 3′-CH + 5′-CH), 7.04–6.99 (m, 1 H, 4′-CH), 
6.99–6.95 (m, 2 H, 2′-CH + 6′-CH), 6.94–6.90 (m, 2 H, 3″-CH + 5″-CH), 
6.01 (dd, J = 8.1, 4.3 Hz, 1 H, 5-CH), 4.34 (dd, J = 8.9, 7.3 Hz, 1 H, 3-
CH), 3.82 (s, 3 H, OCH3), 3.37 (dddq, J = 13.8, 8.9, 8.2, 0.9 Hz, 1 H, 4-CHH), 2.46–2.25 (m, 1 
H, 4-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 159.6 (4″-C), 148.8 (1′-C), 131.4 (1″-C), 
130.2 (q, J = 307.8 Hz, SCF3), 128.8 (3′-C + 5′-C), 128.4 (2″-C + 6″-C), 123.8 (4′-C), 117.8 (2′-C
+ 6′-C), 114.6 (3″-C + 5″-C), 80.5 (q, J = 2.2 Hz, 5-C), 68.0 (3-C), 55.4 (OCH3), 47.2 (4-C). 19F 
NMR [471 MHz, δ (ppm), CDCl3]: −39.9. FTIR [?̅?𝜈 (cm−1)]: 3003, 2837, 1614, 1598, 1515, 1298, 
1103, 1031, 816, 773. HRMS [EI (m/z)] calcd for C17H16F3NO2S = 355.08538, found for [M+•] 
= 355.08608 (|Δ| = 0.70 mmu). RF: 0.15 (heptane/CH2Cl2, 4:1).
rac-(3R,5S)-3-(4-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 
trans-4f
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.38–7.35 (m, 2 H, 2″-CH + 6″-
CH), 7.22–7.18 (m, 2 H, 3′-CH + 5′-CH), 7.01–6.98 (m, 2 H, 2′-CH + 6′-
CH), 6.97–6.93 (m, 1 H, 4′-CH), 6.92–6.89 (m, 2 H, 3″-CH + 5″-CH), 
6.06 (dd, J = 6.8, 3.7 Hz, 1 H, 5-CH), 4.87–4.77 (m, 1 H, 3-CH), 3.81 (s, 3 
H, OCH3), 3.00–2.90 (m, 1 H, 4-CHH), 2.84 (ddd, J = 13.2, 7.2, 3.7 Hz, 1 H, 4-CHH). 13C 
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NMR [126 MHz, δ (ppm), CDCl3]: 159.5 (4″-C), 151.0 (1′-C), 131.8 (1″-C), 130.0 (q, J = 307.8 
Hz, SCF3, indirect observation), 128.8 (3′-C + 5′-C), 127.9 (2″-C + 6″-C), 122.4 (4′-C), 115.4 (2′-C
+ 6′-C), 114.5 (3″-C + 5″-C), 82.3 (q, J = 2.3 Hz, 5-C), 67.7 (3-C), 55.5 (OCH3), 46.3 (4-C). 
FTIR [?̅?𝜈 (cm−1)]: 3002, 2961, 1598, 1512, 1489, 1248, 1109, 1030, 794, 693. HRMS [EI (m/z)] 
calcd for C17H16F3NO2S = 355.08538, found for [M+•] = 355.08545 (|Δ| = 0.07 ppm). RF: 0.10 
(heptane/CH2Cl2, 4:1).
3-(3-Fluorophenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4g
According to the general procedure, the reaction of nitrone 6g (52 mg, 0.242 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube afforded isoxazolidine cis-4g (46.6 mg, 0.136 mmol, 56%) 
as a white solid, a mixture of cis- and trans-6g (27.8 mg, 0.081, 34%) as a yellow oil, and 
isoxazolidine trans-6g mixed with cis-6g and regioisomers 7g (8.5 mg, 0.025 mmol, 10%) as a 
yellow solid, after column chromatography (heptane/CH2Cl2, 9:1). Total yield: 99%.
rac-(3R,5R)-3-(3-Fluorophenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4g
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.34 (td, J = 8.1, 5.9 Hz, 1 H, 5″-
CH), 7.28–7.18 (m, 4 H, 3′-CH + 5′-CH + 2″-CH + 6″-CH), 7.06–6.98 (m, 
2 H, 4′-CH + 4″-CH), 6.98–6.93 (m, 2 H, 2′-CH + 6′-CH), 5.98 (dd, J = 8.1, 
4.3 Hz, 1 H, 5-CH), 4.41 (dd, J = 9.1, 6.8 Hz, 1 H, 3-CH), 3.39 (dddq, J = 
13.7, 9.1, 8.1, 0.9 Hz, 1 H, 4-CHH), 2.33 (ddd, J = 13.7, 6.8, 4.3 Hz, 1 H, 4-CHH). 13C NMR
[126 MHz, δ (ppm), CDCl3]: 163.4 (d, J = 247.0 Hz, 3″-C), 148.6 (1′-C), 142.5 (d, J = 7.2 Hz, 1″-
C), 130.9 (d, J = 8.3 Hz, 5″-C), 130.1 (q, J = 307.9 Hz, SCF3), 128.9 (3′-C + 5′-C), 123.9 (4′-C), 
122.7 (d, J = 2.9 Hz, 6″-C), 117.4 (2′-C + 6′-C), 115.3 (d, J = 21.3 Hz, 4″-C), 114.1 (d, J = 22.6
Hz, 2″-C), 80.4 (q, J = 2.4 Hz, 5-C), 67.5 (d, J = 1.9 Hz, 3-C), 46.9 (4-C). 19F NMR [471 MHz, δ 
(ppm), CDCl3]: −39.9. FTIR [?̅?𝜈 (cm−1)]: 3062, 2954, 1594, 1489, 1448, 1258, 1111, 1044, 915, 
833, 752, 690. HRMS [EI (m/z)] calcd for C16H13F4NOS = 343.06540, found for [M+•] =
343.06750 (|Δ| = 2.10 mmu). RF: 0.22 (heptane/CH2Cl2, 17:3).
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rac-(3R,5S)-3-(3-Fluorophenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4g
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.35 (td, J = 8.1, 5.9 Hz, 1 H, 5″-
CH), 7.25–7.20 (m, 4 H, 3′-CH + 5′-CH + 2″-CH + 6″-CH), 7.04–6.94 (m, 4 
H, 2′-CH + 4′-CH + 4″-CH + 6′-CH), 6.05 (dd, J = 6.8, 4.0 Hz, 1 H, 5-CH), 
4.90 (t, J = 7.4 Hz, 1 H, 3-CH), 2.99–2.91 (m, 1 H, 4-CHH), 2.33 (ddd, 
J =13.2, 7.4, 4.0 Hz, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 163.4 (d, J = 247.1 
Hz, 3″-C), 150.6 (1′-C), 142.6 (d, J = 7.2 Hz, 1″-C), 130.7 (d, J = 8.3 Hz, 5″-C), 128.9 (3′-C + 5′-
C), 122.6 (4′-C), 122.2 (d, J = 2.8 Hz, 6″-C), 115.2 (d, J = 21.6 Hz, 4″-C), 115.1 (2′-C + 6′-C), 
113.7 (d, J = 22.7 Hz, 2″-C), 80.2 (q, J = 2.5 Hz, 5-C), 67.4 (d, J =2.1 Hz, 3-C), 46.0 (4-C). 19F 
NMR [471 MHz, δ (ppm), CDCl3]: −39.4. FTIR [?̅?𝜈 (cm−1)]: 3070, 2928, 1593, 1488, 1451, 1256, 
1109, 947, 787, 756, 691. HRMS [EI (m/z)] calcd for C16H13F4NOS = 343.06540, found for 
[M+•] = 343.06665 (|Δ| = 1.25 mmu). RF: 0.15 (heptane/CH2Cl2, 17:3).
2-Phenyl-3-(3-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4h
According to the general procedure, the reaction of nitrone 6h (49 mg, 0.234 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube afforded isoxazolidine cis-4h (46 mg, 0.136 mmol, 57%) as 
an off white solid and isoxazolidine trans-4h and regioisomers 7h (26 mg, 0.077 mmol, 31%) as a 
yellow solid, after column chromatography (heptane/CH2Cl2, 17:3→7:3). Total yield: 88%.
rac-(3R,5R)-2-Phenyl-3-(3-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4h
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.31–7.28 (m, 1 H, 2″-CH), 7.27–
7.24 (m, 2 H, 5″-CH + 6″-CH), 7.22–7.17 (m, 2 H, 3′-CH + 5′-CH), 7.14–
7.10 (m, 1 H, 4″-CH), 7.02–6.94 (m, 3 H, 2′-CH + 4′-CH + 6′-CH), 5.98 
(dd, J = 8.1, 4.4 Hz, 1 H, 5-CH), 4.35 (dd, J = 9.0, 7.2 Hz, 1 H, 3-CH), 
3.37 (dddq, J = 13.6, 9.0, 8.1, 0.9 Hz, 1 H, 4-CHH), 2.38–2.32 (m, 1 H, 4-CHH), 2.36 (s, 3 H, 
CH3). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.9 (1′-C), 139.7 (1″-C), 139.1 (3″-C), 130.2 (q, 
J = 307.7 Hz, SCF3), 129.1 (4″-C), 129.1 (5″-C), 128.8 (3′-C + 5′-C), 127.6 (2″-C), 124.2 (6″-C), 
123.6 (4′-C), 117.5 (2′-C + 6′-C), 80.5 (q, J = 2.2 Hz, 5-C), 68.3 (3-C), 47.2 (4-C), 21.6 (CH3). 
FTIR [?̅?𝜈 (cm−1)]: 3028, 2871, 1599, 1489, 1040, 1001, 839, 737, 724, 692. HRMS [EI (m/z)] 
calcd for C17H16F3NOS = 339.09047, found for [M+•] = 339.09252 (|Δ| = 2.06 ppm). RF: 0.41 
(heptane/CH2Cl2, 4:1).
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rac-(3R,5S)-2-Phenyl-3-(3-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4h
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.31–7.18 (m, 5 H, 3′-CH + 5′-CH
+ 2″-CH + 5″-CH + 6″-CH), 7.14–7.10 (m, 1 H, 4″-CH), 7.03–6.98 (m, 2 
H, 2′-CH + 6′-CH), 6.98–6.91 (m, 1 H, 4′-CH), 6.06 (dd, J = 6.8, 3.7 Hz, 1 
H, 5-CH), 4.85 (t, J = 7.3 Hz, 1 H, 3-CH), 2.95 (dddq, J = 13.2, 7.6, 6.8, 
0.9 Hz, 1 H, 4-CHH), 2.86 (ddd, J = 13.2, 7.3, 3.7 Hz, 1 H, 4-CHH), 2.36 (s, 3 H, CH3). 13C 
NMR [126 MHz, δ (ppm), CDCl3]: 151.2 (1′-C), 139.9 (1″-C), 139.0 (3″-C), 130.0 (q, J = 307.8 
Hz, SCF3), 129.0 (5″-C), 128.9 (4″-C), 128.8 (3′-C + 5′-C), 127.1 (2″-C), 123.7 (6″-C), 122.3 (4′-C), 
115.1 (2′-C + 6′-C), 82.4 (q, J = 2.1 Hz, 5-C), 68.1 (3-C), 46.4 (4-C), 21.6 (CH3). 19F NMR [471 
MHz, δ (ppm), CDCl3]: −39.3. FTIR [?̅?𝜈 (cm−1)]: 3029, 2924, 1598, 1489, 1150, 1111, 1045, 785, 
692. HRMS [EI (m/z)] calcd for C17H16F3NOS = 339.09047, found for [M+•] = 339.09314 (|Δ| 
= 2.67 mmu). RF: 0.34 (heptane/CH2Cl2, 4:1).
Methyl 3-{2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidin-3-yl}benzoate 4i
According to the general procedure, the reaction of nitrone 6i (26 mg, 0.102 mmol) and alkene 2
in a 1 mL PTFE high-pressure tube, containing approximately 150 μL of glass beads, afforded 
isoxazolidine cis-4i (17.3 mg, 0.045 mmol, 44%) as an off white solid and a mixture of 
isoxazolidines cis- and trans-4i and regioisomers 7i (18.2 mg, 0.047 mmol, 47%) as a brown-yellow 
solid, after column chromatography (heptane/CH2Cl2, 3:2). Total yield: 91%.
Methyl-3-{rac-(3R,5R)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidin-3-yl}benzoate 
cis-4i
1H NMR [500 MHz, δ (ppm), CDCl3]: 8.11 (t, J = 1.8 Hz, 1 H, 2″-CH), 
8.01 (dt, J = 7.7, 1.4 Hz, 1 H, 4″-CH), 7.76 (dddd, J = 7.7, 1.8, 1.2, 0.5 
Hz, 1 H, 6″-CH), 7.48 (t, J = 7.7 Hz, 1 H, 5″-CH), 7.24–7.19 (m, 2 H, 
3′-CH + 5′-CH), 7.07–7.00 (m, 1 H, 4′-CH), 6.98–6.94 (m, 2 H, 2′-CH + 
6′-CH), 6.01 (dd, J = 8.0, 4.5 Hz, 1 H, 5-CH), 4.50 (dd, J = 8.9, 7.0 Hz, 1 H, 3-CH), 3.93 (s, 3 H, 
OCH3), 3.43 (dddq, J = 13.6, 8.9, 8.0, 0.9 Hz, 1 H, 4-CHH), 2.42–2.30 (m, 1 H, 4-CHH). 13C 
NMR [126 MHz, δ (ppm), CDCl3]: 166.8 (C=O), 148. 6 (1′-C), 140.4 (1″-C), 131.6 (6″-C), 131.1 
(3″-C), 130.0 (q, J = 307.7 Hz, SCF3), 129.6 (4″-C + 5″-C), 129.0 (3′-C + 5′-C), 128.3 (2″-C), 
124.0 (4′-C), 117.6 (2′-C + 6′-C), 80.4 (q, J = 2.5 Hz, 5-C), 67.9 (3-C), 52.4 (OCH3), 46.9 (4-C). 
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19F NMR [471 MHz, δ (ppm), CDCl3]: −39.9. FTIR [?̅?𝜈 (cm−1)]: 3015, 2962, 1729, 1598, 1489, 
1438, 1301, 1247, 1114, 1025, 786, 692, 674, 526. HRMS [EI (m/z)] calcd for C18H16F3NO3S = 
383.08030, found for [M+•] = 383.08241 (|Δ| = 2.12 mmu). RF: 0.27 (heptane/CH2Cl2, 3:2).
Methyl-3-{rac-(3R,5S)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidin-3-yl}benzoate 
trans-4i
1H NMR [500 MHz, δ (ppm), CDCl3]: 8.12 (t, J = 1.8 Hz, 1 H, 2″-CH), 
8.02–7.98 (m, 1 H, 4″-CH), 7.69 (dt, J = 7.8, 1.6 Hz, 1 H, 6″-CH), 7.47 
(t, J = 7.7, 1 H, 5″-CH), 7.26–7.18 (m, 2 H, 3′-CH + 5′-CH), 7.00–6.98 
(m, 2 H, 2′-CH + 6′-CH), 6.97–6.94 (m, 1 H, 4′-CH), 6.06 (dd, J = 6.7, 
4.0 Hz, 1 H, 5-CH), 4.96 (t, J = 7.3 Hz, 1 H, 3-CH), 3.93 (s, 3 H, OCH3), 3.01–2.94 (m, 1 H, 4-
CHH), 2.91 (ddd, J = 13.3, 7.4, 4.0 Hz, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 
166.8 (C=O), 150.7 (1′-C), 140.5 (1″-C), 131.19 (3″-C), 131.14 (6″-C), 130.0 (q, J = 307.9 Hz, 
SCF3), 129.57 (4″-C or 5″-C), 129.55 (4″-C or 5″-C), 128.9 (3′-C + 5′-C), 127.8 (2″-C), 122.6 (4′-
C), 115.2 (2′-C + 6′-C), 82.3 (q, J = 2.2 Hz, 5-C), 67.6 (3-C), 52.4 (OCH3), 46.1 (4-C). 19F NMR 
[471 MHz, δ (ppm), CDCl3]: −39.4. FTIR [?̅?𝜈 (cm−1)]: 3064, 2954, 1720, 1598, 1489, 1434, 1285, 
1107, 1020, 799, 751, 692. HRMS [EI (m/z)] calcd for C18H16F3NO3S = 383.08030, found for 
[M+•] = 383.08101 (|Δ| = 0.72 mmu). RF: 0.22 (heptane/CH2Cl2, 3:2).
3-(3-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4j
According to the general procedure, the reaction of nitrone 6j (50 mg, 0.190 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube, containing approximately 300 μL of glass beads, afforded 
isoxazolidine cis-4j (33.8 mg, 0.095 mmol, 53%) as a white solid, a mixture of isoxazolidines 
cis- and trans-4j (3 mg, 0.0084 mmol, 5%) as a yellow oil and isoxazolidines trans-4j and 7j (18.2 
mg, 0.051 mmol, 22%) as a yellow oil, after column chromatography (heptane/CH2Cl2, 7:3).
Total yield: 80%.
rac-(3R,5R)-3-(3-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 
cis-4j
1H NMR [400 MHz, δ (ppm), CDCl3]: 7.29 (t, J = 7.9 Hz, 1 H, 5″-CH), 
7.24–7.17 (m, 2 H, 3′-CH + 5′-CH), 7.09–6.95 (m, 5 H, 2′-CH + 4′-CH + 
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6′-CH + 2″-CH + 6″-CH), 6.85 (ddd, J = 8.3, 2.7, 1.1 Hz, 1 H, 4″-CH), 5.99 (dd, J = 8.1, 4.3 Hz, 
1 H, 5-CH), 4.37 (dd, J = 9.1, 7.0 Hz, 1 H, 3-CH), 3.81 (s, 3 H, OCH3), 3.43–3.32 (m, 1 H, 4-
CHH), 2.36 (ddd, J = 13.7, 7.0, 4.3 Hz, 1 H, 4-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 
160.4 (3″-C), 148.9 (1′-C), 141.6 (1″-C), 130.3 (5″-C), 130.2 (q, J = 307.7 Hz, SCF3), 128.8 (3′-C + 
5′-C), 123.6 (4′-C), 119.3 (6″-C), 117.3 (2′-C + 6′-C), 113.8 (4″-C), 112.4 (2″-C), 80.5 (q, J = 2.5 
Hz, 5-C), 68.0 (3-C), 55.4 (OCH3), 47.2 (q, J = 1.2 Hz, 4-C). 19F NMR [377 MHz, δ (ppm), 
CDCl3]: −39.9. FTIR [?̅?𝜈 (cm−1)]: 3006, 2961, 2838, 1599, 1490, 1262, 1117, 757, 694. HRMS
[EI (m/z)] calcd for C17H16F3NO2S = 355.08538, found for [M+•] = 355.08681 (|Δ| = 1.43 
mmu). RF: 0.16 (heptane/CH2Cl2, 7:3).
rac-(3R,5S)-3-(3-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 
trans-4j
1H NMR [400 MHz, δ (ppm), CDCl3]: 7.29 (t, J = 8.1 Hz, 1 H, 5″-CH), 
7.25–7.19 (m, 2 H, 3′-CH + 5′-CH), 7.07–6.92 (m, 5 H, 2′-CH + 4′-CH + 
6′-CH + 2″-CH + 6″-CH), 6.89–6.81 (m, 1 H, 4″-CH), 6.06 (dd, J = 6.8, 
3.8, 1 H, 5-CH), 4.86 (t, J = 7.4 Hz, 1 H, 3-CH), 3.81 (s, 3 H, OCH3), 2.96 
(dddq, J = 13.3, 7.6, 6.8, 0.9 Hz, 1 H, 4-CHH), 2.87 (ddd, J = 13.3, 7.3, 3.8 Hz, 1 H, 4-CHH). 
13C NMR [101 MHz, δ (ppm), CDCl3]: 160.3 (3″-C), 151.0 (1′-C), 141.6 (1″-C), 130.2 (5″-C), 
130.0 (q, J = 307.8 Hz, SCF3), 128.8 (3′-C + 5′-C), 122.3 (4′-C), 118.8 (6″-C), 115.1 (2′-C + 6′-C), 
113.7 (4″-C), 112.0 (2″-C), 82.3 (q, J = 2.3 Hz, 5-C), 68.0 (3-C), 55.5 (OCH3), 46.3 (4-C). 
19F NMR [377 MHz, δ (ppm), CDCl3]: −39.3. FTIR [?̅?𝜈 (cm−1)]: 3064, 2954, 1720, 1598, 1489, 
1347, 1201, 1107, 1020, 799, 750, 692. HRMS [ESI (m/z)] calcd for (C17H16F3NO2S+ H)+ = 
356.09321, found 356.09393 (|Δ| = 2.0 ppm). RF: 0.13 (heptane/CH2Cl2, 7:3).
2-Phenyl-3-[3-(trifluoromethyl)phenyl]-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4k
According to the general procedure, the reaction of nitrone 6k (49 mg, 0.234 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube afforded a mixture of isoxazolidines cis- and trans-4k and 
7k (87.4 mg, 0.222 mmol, 95%) as a white-yellow solid, after column chromatography 
(heptane/CH2Cl2, 17:3→7:3). FTIR [?̅?𝜈 (cm−1)]: 2927, 2856, 1598, 1490, 1263, 1144, 1045. 
HRMS [EI (m/z)] calcd for C17H13F6NOS = 393.06220, found for [M+•] = 393.06386 (|Δ| = 
1.66 ppm). RF: 0.38 (heptane/CH2Cl2, 4:1). Total yield: 95%.
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rac-(3R,5R)-2-Phenyl-3-[3-(trifluoromethyl)phenyl]-5-[(trifluoromethyl)sulfanyl]isoxazoli-
dine cis-4k
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.73–7.69 (m, 2 H, 2″-CH + 6″-
CH), 7.60–7.56 (m, 1 H, 4″-CH), 7.54–7.48 (m, 1 H, 5″-CH), 7.26–7.20 
(m, 2 H, 3′-CH + 5′-CH), 7.05–7.00 (m, 1 H, 4′-CH), 6.98–6.93 (m, 2 H, 
2′-CH + 6′-CH), 5.99 (dd, J = 8.0, 4.5 Hz, 1 H, 5-CH), 4.51 (dd, J = 9.0, 
6.7 Hz, 1 H, 3-CH), 3.41 (dddq, J = 13.6, 9.0, 8.0, 0.8 Hz, 1 H, 4-CHH), 2.37–2.28 (m, 1 H, 4-
CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.6 (1′-C), 141.1 (1″-C), 131.6 (q, J = 32.4 Hz, 
3″-C), 130.4 (q, J = 1.2 Hz, 6″-C), 129.9 (q, J = 308.0 Hz, SCF3), 129.9 (5″-C), 129.0 (3′-C + 5′-
C), 125.2 (q, J = 3.8 Hz, 4″-C), 124.0 (q, J = 272.4 Hz, CF3, indirect observation), 124.1 (4′-C), 
123.9 (q, J = 3.8 Hz, 2″-C), 117.4 (2′-C + 6′-C), 80.4 (q, J = 2.5 Hz, 5-C), 67.8 (3-C), 46.8 (4-C). 
rac-(3R,5S)-2-Phenyl-3-[3-(trifluoromethyl)phenyl]-5-[(trifluoromethyl)sulfanyl]isoxazoli-
dine trans-4k
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.73–7.70 (m, 1 H, 2″-CH), 7.68–
7.64 (m, 1 H, 5″-CH), 7.60–7.56 (m, 1 H, 6″-CH), 7.53–7.48 (m, 1 H, 4″-
CH), 7.26–7.20 (m, 2 H, 3′-CH + 5′-CH), 6.92–6.88 (m, 3 H, 2′-CH + 4′-
CH + 6′-CH), 6.06–6.02 (m, 1 H, 5-CH), 4.96 (t, J = 7.2 Hz, 1 H, 3-CH), 
2.98–2.86 (m, 2 H, 4-CH2). 13C NMR [126 MHz, δ (ppm), CDCl3]: 150.6 (1′-C), 141.1 (1″-C), 
131.6 (q, J = 32.4 Hz, 3″-C), 130.4 (q, J = 1.2 Hz, 6″-C), 129.7 (5″-C), 128.9 (3′-C + 5′-C), 125.1 
(q, J = 4.0 Hz, 4″-C), 123.5 (q, J = 3.8 Hz, 2″-C), 122.7 (4′-C), 115.2 (2′-C + 6′-C), 82.3 (q, J = 2.4 
Hz, 5-C), 67.5 (3-C), 46.0 (4-C).
2-Phenyl-3-(2-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4l
According to the general procedure, the reaction of nitrone 6l (49 mg, 0.234 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube afforded isoxazolidine cis-4l (1.9 mg, 0.0056 mmol; used 
for characterization) as a colorless oil and a mixture of isoxazolidines cis- and trans-4l (79.5 mg, 
0.234 mmol, 99%) as a yellow solid, after column chromatography (heptane/CH2Cl2, 4:1). FTIR 
[?̅?𝜈 (cm−1)]: 3025, 2947, 2920, 1596, 1489, 1258, 1109, 1041, 972, 754, 695. HRMS [EI (m/z)] 
calcd for C17H16F3NOS = 339.09047, found for [M+•] = 339.09231 (|Δ| = 1.84 mmu). RF: 0.23 
(heptane/CH2Cl2, 4:1). Total yield: 99%.
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rac-(3R,5R)-2-Phenyl-3-(2-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4l
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.72 (dd, J = 7.2, 1.7 Hz, 1 H, 6″-CH), 
7.26–7.17 (m, 5 H, 3′-CH + 5′-CH + 3″-CH + 4″-CH + 5″-CH), 7.00 (tt, J = 
7.4, 1.2 Hz, 1 H, 4′-CH), 6.96–6.88 (m, 2 H, 2′-CH + 6′-CH), 6.01 (dd, J = 
8.1, 4.2 Hz, 1 H, 5-CH), 4.61 (dd, J = 9.1, 7.1 Hz, 1 H, 3-CH), 3.44 (dddq, J = 
13.5, 9.1, 8.1, 0.9 Hz, 1 H, 4-CHH), 2.35 (s, 3 H, CH3), 2.25 (ddd, J = 13.5, 7.1, 4.2 Hz, 1 H, 4-
CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.9 (1′-C), 138.0 (1″-C), 134.6 (2″-C), 130.8 (3″-
C), 130.1 (q, J = 307.4 Hz, SCF3), 128.9 (3′-C + 5′-C), 127.8 (4″-C), 127.3 (5″-C), 126.6 (6″-C), 
123.5 (4′-C), 117.2 (2′-C + 6′-C), 80.5 (q, J = 2.2 Hz, 5-C), 64.5 (3-C), 45.6 (4-C), 19.7 (CH3). 19F 
NMR [471 MHz, δ (ppm), CDCl3]: −40.0.
rac-(3R,5S)-2-Phenyl-3-(2-tolyl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4l
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.65–7.62 (m, 1 H, 6″-CH), 7.27–7.15 
(m, 5 H, 3′-CH + 5′-CH + 3″-CH + 4″-CH + 5″-CH), 6.97–6.93 (m, 3 H, 2′-
CH + 4′-CH + 6′-CH), 6.06 (dd, J = 6.7, 3.9 Hz, 1 H, 5-CH), 5.04 (t, J = 7.5 
Hz, 1 H, 3-CH), 2.89 (ddd, J = 13.1, 7.5, 3.9 Hz, 1 H, 4-CHH), 2.80 (dddq, 
J = 13.1, 7.5, 6.7, 0.9 Hz, 1 H, 4-CHH), 2.39 (s, 3 H, CH3). 13C NMR [126 MHz, δ (ppm), 
CDCl3]: 151.1 (1′-C), 137.8 (1″-C), 134.3 (2″-C), 130.8 (3″-C), 128.7 (3′-C + 5′-C), 127.8 (4″-C), 
127.0 (5″-C), 126.2 (6″-C), 122.1 (4′-C), 114.7 (2′-C + 6′-C), 82.2 (q, J = 2.3 Hz, 5-C), 65.3 (3-C), 
44.6 (4-C), 19.4 (CH3).
3-(2-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4m
According to the general procedure, the reaction of nitrone 6m (53 mg, 0.234 mmol) and alkene 
2 in a 1.5 mL PTFE high-pressure tube afforded isoxazolidine cis-4m (35.6 mg, 0.100 mmol, 
43%) as an off white solid and a mixture of isoxazolidines cis- and trans-4m (29.6 mg, 0.083 
mmol, 28%) as a yellow solid, after column chromatography (heptane/CH2Cl2, 7:3). Total yield: 
71%.
rac-(3R,5R)-3-(2-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 
cis-4m
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.65 (dd, J = 7.6, 1.7 Hz, 1 H, 6″-
CH), 7.28 (ddd, J = 8.2, 7.5, 1.8 Hz, 1 H, 5″-CH), 7.25–7.19 (m, 2 H, 3′-CH 
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+ 5′-CH), 7.01–6.94 (m, 4 H, 2′-CH + 4′-CH + 6′-CH + 4″-CH), 6.91 (dd, J = 8.3, 1.0 Hz, 1 H, 
3″-CH), 5.94 (dd, J = 8.0, 4.5 Hz, 1 H, 5-CH), 4.87 (dd, J = 9.1, 6.1 Hz, 1 H, 3-CH), 3.86 (s, 3 H, 
OCH3), 3.40 (dddq, J = 13.6, 9.1, 8.0, 0.9 Hz, 1 H, 4-CHH), 2.30–2.20 (m, 1 H, 4-CHH). 13C 
NMR [126 MHz, δ (ppm), CDCl3]: 156.3 (2″-C), 149.4 (1′-C), 130.3 (q, J = 307.7 Hz, SCF3), 
128.9 (3′-C + 5′-C + 4″-C), 128.4 (1″-C), 127.5 (6″-C), 123.1 (4′-C), 121.3 (5″-C), 116.7 (2′-C + 6′-
C), 110.5 (3″-C), 80.6 (q, J = 2.4 Hz, 5-C), 62.1 (3-C), 55.5 (OCH3), 45.0 (4-C). FTIR [?̅?𝜈 (cm−1)]: 
3075, 2835, 1599, 1490, 1464, 1243, 1106, 1027, 897, 751, 664. HRMS [EI (m/z)] calcd for 
C17H16F3NO2S = 355.08538, found for [M+•] = 355.08749 (|Δ| = 2.11 mmu). RF: 0.19 
(heptane/CH2Cl2, 7:3).
rac-(3R,5S)-3-(2-Methoxyphenyl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 
trans-4m
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.59 (dd, J = 7.6, 1.5 Hz, 1 H, 6″-
CH), 7.31–7.26 (m, 2 H, 3′-CH + 5′-CH), 7.06–7.02 (m, 2 H, 2′-CH + 6′-
CH), 7.00–6.88 (m, 4 H, 3″-CH + 4′-CH + 4″-CH + 5″-CH), 5.99–5.96 (m, 1 
H, 5-CH), 5.26 (dd, J = 7.5, 5.8 Hz, 1 H, 3-CH), 3.88 (s, 3 H, OCH3), 2.90 
(ddd, J = 12.7, 7.5, 5.0 Hz, 1 H, 4-CHH), 2.84–2.76 (m, 1 H, 4-CHH). 13C NMR [126 MHz, δ 
(ppm), CDCl3]: 156.3 (2″-C), 151.2 (1′-C), 128.9 (4″-C), 128.8 (3′-C + 5′-C), 128.1 (1″-C), 127.2 
(6″-C), 122.0 (4′-C), 121.1 (5″-C), 114.9 (2′-C + 6′-C), 110.4 (3″-C), 82.4 (q, J = 2.2 Hz, 5-C), 62.9 
(3-C), 55.5 (OCH3), 43.7 (4-C). The carbon signal of SCF3 was not observed. FTIR [?̅?𝜈 (cm−1)]: 
2962, 2839, 1599, 1490, 1464, 1256, 1106, 1026, 751, 692. HRMS [EI (m/z)] calcd for 
C17H16F3NO2S = 355.08538, found for [M+•] = 355.08624 (|Δ| = 0.86 mmu). RF: 0.15 
(heptane/CH2Cl2, 7:3).
2-Phenyl-3-(thiophen-3-yl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4n
According to the general procedure, the reaction of nitrone 6n (48 mg, 0.234 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube afforded a mixture of isoxazolidines cis- and trans-4n (68.4 
mg, 0.206 mmol, 88%) as a yellow solid, after column chromatography (heptane/CH2Cl2, 3:2). 
FTIR [?̅?𝜈 (cm−1)]: 3095, 2962, 1598, 1489, 1454, 1257, 1163, 1110, 1031, 837, 792, 754, 692. 
HRMS [EI (m/z)] calcd for C14H12F3NOS2 = 331.03124, found for [M+•] = 331.03298 (|Δ| = 
1.7 mmu). RF: 0.19 (heptane/CH2Cl2, 17:3). Total yield: 88%.
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rac-(3R,5R)-2-Phenyl-3-(thiophen-3-yl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4n
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.36 (dd, J = 5.0, 3.0 Hz, 1 H, 5″-
CH), 7.30–7.27 (m, 1 H, 2″-CH), 7.25–7.20 (m, 2 H, 3′-CH + 5′-CH), 7.19 
(dd, J = 5.0, 1.3 Hz, 1 H, 4″-CH), 7.02 (tt, J = 7.4, 1.2 Hz, 1 H, 4′-CH), 7.00–
6.96 (m, 2 H, 2′-CH + 6′-CH), 6.00 (dd, J = 8.2, 4.2 Hz, 1 H, 5-CH), 4.51 (dd, 
J = 8.8, 6.7 Hz, 1 H, 3-CH), 3.36–3.28 (m, 1 H, 4-CHH), 2.38 (ddd, J = 13.6, 6.7, 4.2 Hz, 1 H, 4-
CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.9 (1′-C), 140.4 (3″-C), 130.2 (q, J = 307.7 Hz, 
SCF3), 128.8 (3′-C + 5′-C), 127.3 (5″-C), 126.1 (4″-C), 123.9 (4′-C), 122.7 (2″-C), 117.5 (2′-C + 6′-
C), 80.5 (q, J = 2.5 Hz, 5-C), 64.6 (3-C), 45.9 (4-C). 
rac-(3R,5S)-2-Phenyl-3-(thiophen-3-yl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4n
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.32 (dd, J = 5.0, 3.0 Hz, 1 H, 5″-
CH), 7.30–7.27 (m, 1 H, 2″-CH), 7.26–7.20 (m, 2 H, 3′-CH + 5′-CH), 7.09 
(dd, J = 5.0, 1.4 Hz, 1 H, 4″-CH), 7.06–6.95 (m, 3 H, 2′-CH + 4′-CH + 6′-
CH), 6.03 (dd, J = 7.2, 4.9 Hz, 1 H, 5-CH), 5.01 (t, J = 6.5 Hz, 1 H, 3-CH), 
2.96 (dt, J = 13.0, 6.4 Hz, 1 H, 4-CHH), 2.78 (ddd, J = 12.7, 7.3, 4.7 Hz, 1 H, 4-CHH). 13C 
NMR [126 MHz, δ (ppm), CDCl3]: 150.2 (1′-C), 140.6 (3″-C), 130.2 (q, J = 307.7 Hz, SCF3), 
128.8 (3′-C + 5′-C), 127.0 (5″-C), 125.8 (4″-C), 122.7 (2″-C), 122.4 (4′-C), 115.7 (2′-C + 6′-C), 81.9 
(q, J = 2.2 Hz, 5-C), 64.2 (3-C), 44.6 (4-C).
3-(1H-Indol-2-yl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4o
According to the general procedure, the reaction of nitrone 6o (56 mg, 0.237 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube afforded isoxazolidines cis- and trans-4o (20.3 mg, 0.056 
mmol, 24%; contaminated with 8) as an brown-yellow oil and a mixture of isoxazolidine trans-4o 
and regioisomers 7o (35.6 mg, 0.098 mmol, 41%) as a brown oil, after column chromatography 
(heptane/CH2Cl2, 11:9). FTIR [?̅?𝜈 (cm−1)] of isoxazolidines cis- and trans-4o: 3413, 3060, 2962, 
1599, 1436, 1258, 1110, 1022, 788, 756, 684, 660. FTIR [?̅?𝜈 (cm−1)] of isoxazolidine trans-4o and
regioisomers 7o: 3406, 3059, 2963, 1597, 1489, 1455, 1231, 1107, 1014, 793, 749, 693. Total
yield: 65%.
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rac-(3R,5R)-3-(1H-Indol-2-yl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4o
1H NMR [500 MHz, δ (ppm), CDCl3]: 8.67 (bs, 1 H, NH), 7.61–7.58 (m, 1 
H, 4″-CH), 7.40–7.37 (m, 1 H, 7″-CH), 7.25–7.18 (m, 3 H, 3′-CH + 5′-CH
+ 6″-CH), 7.15–7.12 (m, 1 H, 5″-CH), 7.05–7.02 (m, 3 H, 2′-CH + 4′-CH + 
6′-CH), 6.50 (d, J = 2.0 Hz, 1 H, 3″-CH), 6.07 (dd, J = 8.3, 3.5 Hz, 1 H, 5-
CH), 4.77 (dd, J = 9.4, 5.6 Hz, 1 H, 3-CH), 3.44–3.32 (m, 1 H, 4-CHH), 
2.50 (ddd, J = 13.8, 5.6, 3.5 Hz, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.6 (1′-
C), 136.2 (2″-C), 135.6 (7″a-C), 130.0 (q, J = 306.8 Hz, SCF3, indirect observation), 129.1 (3′-C + 
5′-C), 128.6 (3″a-C), 123.9 (4′-C), 122.6 (6″-C), 120.6 (4″-C), 120.4 (5″-C), 116.7 (2′-C + 6′-C), 
111.5 (7″-C), 100.9 (3″-C), 80.7 (q, J = 2.4 Hz, 5-C), 62.2 (3-C), 44.9 (4-C). RF: 0.51 
(heptane/CH2Cl2, 1:1).
rac-(3R,5S)-3-(1H-Indol-2-yl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4o
1H NMR [500 MHz, δ (ppm), CDCl3]: 8.50 (bs, 1 H, NH), 7.57–7.47 (m, 3 
H, 3′-CH + 5′-CH + 4″-CH), 7.32 (dt, J = 8.2, 0.9 Hz, 1 H, 7″-CH), 7.06–
7.03 (m, 1 H, 6″-CH), 6.98–6.90 (m, 2 H, 4′-CH + 5″-CH), 6.86–6.82 (m, 2 
H, 2′-CH + 6′-CH), 6.40 (d, J = 2.1 Hz, 1 H, 3″-CH), 5.84 (dd, J = 8.3, 4.0 
Hz, 1 H, 5-CH), 4.28 (dd, J = 9.4, 5.7 Hz, 1 H, 3-CH), 2.82 (dt, J = 13.7, 
8.9 Hz, 1 H, 4-CHH), 2.16–2.09 (m, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.5 
(1′-C), 134.4 (7″a-C), 132.7 (2″-C), 129.0 (3′-C + 5′-C), 128.6 (3″a-C), 122.6 (4′-C), 122.5 (6″-C), 
120.6 (4″-C), 119.5 (5″-C), 116.2 (2′-C + 6′-C), 111.3 (7″-C), 100.5 (3″-C), 82.1 (q, J = 2.4 Hz, 5-
C), 59.8 (3-C), 44.6 (4-C). RF: 0.42 (heptane/CH2Cl2, 1:1).
3-(1H-Indol-2-yl)-2-phenyl-4-[(trifluoromethyl)sulfanyl]isoxazolidine 7o
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.64–7.59 (m, 2 H, 4″-CHmajor,minor), 
7.38–6.97 (m, 16 H, Armajor,minor), 6.59–6.55 (m, 2 H, 3″-CHmajor,minor), 5.25 (d, 
J = 8.2 Hz, 1 H, 3-CHmajor), 4.94 (d, J = 4.4 Hz, 1 H, 3-CHminor), 4.67–4.61 (m, 
1 H, 5-CHHmajor), 4.61–4.56 (m, 1 H, 5-CHHminor), 4.31 (q, J = 7.6 Hz, 1 H, 4-
CHmajor), 4.25–4.18 (m, 2 H, 4-CHminor, 5-CHHmajor), 4.11 (dd, J = 9.3, 6.2 Hz, 
1 H, 5-CHHminor). 13C NMR [126 MHz, δ (ppm), CDCl3]: 149.3 (1′-Cminor), 148.9 (1′-Cmajor), 135.9 
(7″a-Cmajor), 135.7 (7″a-Cminor), 135.5 (2″-Cminor), 132.8 (2″-Cmajor), 129.2 (3′-Cmajor + 5′-Cmajor), 
129.2 (3′-Cminor + 5′-Cminor), 128.5 (3″a-Cminor), 127.9 (3″a-Cmajor), 123.4 (4′-Cmajor), 123.2 (4′-Cminor), 
520586-L-bw-Riesco
Processed on: 8-8-2018 PDF page: 185
5
Trifluoromethyl Vinyl Sulfide: a Building Block for the Synthesis of CF3S-Containing Isoxazolidines
185
122.7 (6″-Cmajor), 122.5 (6″-Cminor), 120.8 (4″-Cmajor), 120.6 (4″-Cminor), 120.3 (5″-Cmajor,minor), 115.1 
(2′-Cmajor + 6′-Cmajor), 115.0 (2′-Cminor + 6′-Cminor), 111.3 (7″-Cmajor), 111.2 (7″-Cminor), 103.1 (3″-
Cmajor), 100.6 (3″-Cminor), 73.2 (5-Cmajor), 72.7 (5-Cminor), 70.1 (3-Cminor), 65.6 (3-Cmajor), 52.4 (4-
Cminor), 48.1 (4-Cmajor).
2-Phenyl-3-(1H-pyrrol-2-yl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4p
According to the general procedure, the reaction of nitrone 6p (44 mg, 0.234 mmol) and alkene 2
in a 1.5 mL PTFE high-pressure tube afforded a mixture of isoxazolidines cis- and trans-4p and 
7p (33 mg, 0.105 mmol, 45%) as a brown oil, after column chromatography (heptane/CH2Cl2, 
4:1→CH2Cl2/MeOH, 10:1). FTIR [?̅?𝜈 (cm−1)]: 3421, 3062, 2960, 1597, 1489, 1154, 1109, 1082, 
1029, 756, 722, 693. HRMS [EI (m/z)] calcd for C14H13F3N2OS = 314.07007, found for [M+•] =
314.07058 (|Δ| = 0.51 mmu). RF (unassigned mixture): 0.46, 0.30, 0.24, 0.20 (heptane/CH2Cl2, 
1:1). Total yield: 45%.
rac-(3R,5R)-2-Phenyl-3-(1H-pyrrol-2-yl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4p
1H NMR [400 MHz, δ (ppm), CDCl3]: 8.65 (bs, 1 H, NH), 7.28–7.22 (m, 2 
H, 3′-CH + 5′-CH), 7.08–6.98 (m, 3 H, 2′-CH + 4′-CH + 6′-CH), 6.81–6.77 
(m, 1 H, 5″-CH), 6.21–6.18 (m, 1 H, 4″-CH), 6.15–6.12 (m, 1 H, 3″-CH), 6.03 
(dd, J = 8.3, 3.6 Hz, 1 H, 5-CH), 4.62 (dd, J = 8.9, 5.6 Hz, 1 H, 3-CH), 3.34–
3.17 (m, 1 H, 4-CHH), 2.48–2.36 (m, 1 H, 4-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: δ 
148.9 (1′-C), 130.0 (q, J = 307.9 Hz, SCF3, indirect observation), 129.0 (2″-C), 128.8 (3′-C + 5′-C), 
123.8 (4′-C), 116.8 (2′-C + 6′-C), 115.2 (5″-C), 109.1 (4″-C), 106.7 (3″-C), 80.7 (q, J = 2.3 Hz, 5-
C), 62.5 (3-C), 44.6 (4-C).
rac-(3R,5S)-2-Phenyl-3-(1H-pyrrol-2-yl)-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4p
1H NMR [500 MHz, δ (ppm), CDCl3]: 8.57 (bs, 1 H, NH), 7.31–6.66 (m, 7 
H, Ar), 6.27–6.15 (m, 1 H, Ar), 5.97 (t, J = 6.4 Hz, 1 H, 5-CH), 5.07 (dd, J = 
7.0, 4.4 Hz, 1 H, 3-CH), 3.00 (ddd, J = 12.2, 7.1, 4.4 Hz, 1 H, 4-CHH), 2.68 
(dt, J = 13.1, 6.4 Hz, 1 H, 4-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 
150.0 (1′-C), 129.9, 128.9, 123.8 (4′-C), 118.0, 115.8, 107.2, 106.3, 82.1 (5-C), 62.7 (3-C), 43.2 (4-
C). The carbon signal of SCF3 was not observed.
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2-Phenyl-3-(1H-pyrrol-2-yl)-4-[(trifluoromethyl)sulfanyl]isoxazolidine 7p
1H NMR [400 MHz, δ (ppm), CDCl3]: 8.65 (bs, 1 H, NH), 7.30–7.23 (m, 2 H, 
3′-CH + 5′-CH), 7.06–6.99 (m, 3 H, 2′-CH + 4′-CH + 6′-CH), 6.81–6.77 (m, 1 
H, 5″-CH), 6.27–6.19 (m, 1 H, 4″-CH), 6.19 (m, 1 H, 3″-CH), 5.11 (d, J = 7.8 
Hz, 1 H, 3-CH), 4.66–4.55 (m, 1 H, 5-CHH), 4.22 (q, J = 7.5 Hz, 1 H, 4-CH), 
4.15 (dd, J = 8.6, 6.8 Hz, 1 H, 5-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 149.2 (1′-C), 
129.3 (3′-C + 5′-C), 126.0 (2″-C), 123.4 (4′-C), 118.8 (5″-C), 115.2 (2′-C + 6′-C), 109.0 (4″-C), 
108.8 (3″-C), 73.5 (5-C), 65.3 (3-C), 48.7 (q, J = 1.3 Hz, 4-C). The carbon signal of SCF3 was not 
observed.
2-Phenyl-3-(1H-pyrrol-2-yl)-4-[(trifluoromethyl)sulfanyl]isoxazolidine 7p
1H NMR [500 MHz, δ (ppm), CDCl3]: 8.57 (bs, 1 H, NH), 7.31–6.66 (m, 7 H, 
Ar), 6.27–6.15 (m, 1 H, Ar), 4.82 (d, J = 4.2 Hz, 1 H, 3-CH), 4.65–4.50 (m, 2 H, 
5-CH2), 4.26–4.10 (m, 1 H, 4-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]:
149.6 (1′-C), 129.4, 126.0, 124.1, 118.1, 115.2, 109.1, 108.7, 70.3 (5-C), 65.3 (3-
C), 48.7 (4-C). The carbon signal of SCF3 was not observed.
3-(Furan-2-yl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine 4q
According to the general procedure, the reaction of nitrone 6q (44 mg, 0.234 mmol) in a 1.5 mL 
PTFE high-pressure tube afforded isoxazolidine cis-4q (33.2 mg, 0.105 mmol, 45%) as an off 
white solid and isoxazolidines trans-4q and 7q (24.7 mg, 0.078 mmol, 34%) as a yellow oil, after 
column chromatography (heptane/CH2Cl2, 23:2→heptane/CH2Cl2, 0:1). Total yield: 79%.
rac-(3R,5R)-3-(Furan-2-yl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine cis-4q
1H NMR [400 MHz, δ (ppm), CDCl3]: 7.45 (dd, J = 1.8, 0.9 Hz, 1 H, 5″-CH), 
7.31–7.22 (m, 2 H, 3′-CH + 5′-CH), 7.10–6.98 (m, 3 H, 2′-CH + 4′-CH + 6′-
CH), 6.37 (dd, J = 3.2, 1.8 Hz, 1 H, 4″-CH), 6.35 (d, J = 3.2 Hz, 1 H, 3″-CH), 
6.00 (dd, J = 8.1, 4.5 Hz, 1 H, 5-CH), 4.50 (dd, J = 8.8, 6.5 Hz, 1 H, 3-CH), 
3.23 (dddq, J = 13.5, 8.8, 8.1, 0.9 Hz, 1 H, 4-CHH), 2.63 (ddd, J = 13.5, 6.5, 4.5 Hz, 1 H, 4-
CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 151.0 (2″-C), 148.7 (1′-C), 143.0 (5″-C), 130.2 (q, 
J = 307.7 Hz, SCF3), 128.9 (3′-C + 5′-C), 124.2 (4′-C), 117.5 (2′-C + 6′-C), 110.8 (4″-C), 109.0 (3″-
C), 80.5 (q, J = 2.6 Hz, 5-C), 63.0 (3-C), 42.4 (q, J = 1.2 Hz, 4-C). FTIR [?̅?𝜈 (cm−1)]: 3070, 2922, 
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1683, 1489, 1453, 1254, 1106, 1037, 936, 743, 680. HRMS [EI (m/z)] calcd for C14H12F3NO2S = 
315.05408, found for [M+•] = 315.05378 (|Δ| = 0.31 mmu). RF: 0.48 (heptane/CH2Cl2, 7:3).
rac-(3R,5S)-3-(Furan-2-yl)-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine trans-4q
1H NMR [400 MHz, δ (ppm), CDCl3]: 7.37 (dd, J = 1.8, 0.9 Hz, 1 H, 5″-CH), 
7.27–7.22 (m, 2 H, 3′-CH + 5′-CH), 7.09–7.05 (m, 2 H, 2′-CH + 6′-CH), 6.98 
(tt, J = 7.3, 1.2 Hz, 1 H, 4′-CH), 6.30 (dd, J = 3.3, 1.8 Hz, 1 H, 4″-CH), 6.26 
(dt, J = 3.3, 0.8, 1 H, 3″-CH), 6.11 (dd, J = 7.4, 5.2 Hz, 1 H, 5-CH), 5.00 (dd, J
= 7.7, 4.3, 1 H, 3-CH), 3.17 (dddq, J = 13.7, 7.4, 4.3, 0.8, 1 H, 4-CHH), 2.77–2.67 (m, 1 H, 4-
CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 151.6 (2″-C), 149.2 (1′-C), 142.8 (5″-C), 130.0 (q, J 
= 307.7 Hz, SCF3), 128.8 (3′-C + 5′-C), 123.0 (4′-C), 116.2 (2′-C + 6′-C), 110.6 (4″-C), 108.4 (3″-
C), 81.8 (q, J = 2.5 Hz, 5-C), 61.6 (3-C), 41.6 (q, J = 1.2 Hz, 4-C). FTIR [?̅?𝜈 (cm−1)]: 3003, 2872, 
1599, 1490, 1262, 1118, 1046, 757, 694. HRMS [EI (m/z)] calcd for C14H12F3NO2S = 
315.05408, found for [M+•] = 315.05451 (|Δ| = 0.42 mmu). RF: 0.39 (heptane/CH2Cl2, 7:3).
N-Benzyl-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine-3-carboxamide 4r
According to the general procedure, the reaction of nitrone 6r (25 mg, 0.098 mmol) and alkene 2
in a 1 mL PTFE high-pressure tube afforded isoxazolidine cis-4r (3.2 mg, 0.0084 mmol, 9%; used 
for NMR characterization) as a white solid and a mixture of isoxazolidines cis- and trans-4r (16.1 
mg, 0.042 mmol, 51%) as a yellow-white solid, after column chromatography (heptane/CH2Cl2, 
17:3→CH2Cl2/MeOH, 24:1). FTIR [?̅?𝜈 (cm−1)]: 3385, 3309 3066, 2930, 1668, 1597, 1454, 1261, 
1161, 1029, 757, 697. HRMS [EI (m/z)] calcd for C18H17F3N2O2S = 382.09628, found for [M+•] 
= 382.09640 (|Δ| = 0.3 ppm). Total yield: 60%.
rac-(3R,5R)-N-Benzyl-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine-3-carboxami-
de cis-4r
1H NMR [400 MHz, δ (ppm), CDCl3]: 7.59–7.52 (m, 1 H, NH), 7.37–
7.27 (m, 7 H, 3′-CH + 5′-CH + 2″-CH + 3″-CH + 4″-CH + 5″-CH + 
6″-CH), 7.11–7.03 (m, 1 H, 4′-CH), 7.02–6.97 (m, 2 H, 2′-CH + 6′-CH), 
5.88 (dd, J = 8.1, 4.7 Hz, 1 H, 5-CH), 4.56 (dd, J = 14.8, 6.1 Hz, 1 H, 
NCHH), 4.49 (dd, J = 14.8, 5.9 Hz, 1 H, NCHH), 4.31 (dd, J = 9.6, 3.5 Hz, 1 H, 3-CH), 3.19–
3.07 (m, 1 H, 4-CHH), 2.75–2.65 (m, 1 H, 4-CHH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 
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169.7 (C=O), 148.8 (1′-C), 137.6 (1″-C), 129.6 (q, J = 308.1 Hz, SCF3), 129.5 (3′-C + 5′-C or 3″-C
+ 5″-C), 128.9 (2″-C + 6″-C), 127.9 (3′-C + 5′-C or 3″-C + 5″-C), 127.8 (4″-C), 123.9 (4′-C), 115.1 
(2′-C + 6′-C), 80.3 (q, J = 2.5 Hz, 5-C), 67.6 (3-C), 43.7 (NCH2), 39.4 (4-C). 
rac-(3R,5S)-N-Benzyl-2-phenyl-5-[(trifluoromethyl)sulfanyl]isoxazolidine-3-carboxamide 
trans-4r
1H NMR [500 MHz, δ (ppm), CDCl3]: 7.52–7.43 (m, 1 H, NH), 7.36–
7.23 (m, 7 H, 3′-CH + 5′-CH + 2″-CH + 3″-CH + 4″-CH + 5″-CH + 
6″-CH), 7.11–7.02 (m, 3 H, 2′-CH + 4′-CH + 6′-CH), 5.91 (t, J = 6.8 
Hz, 1 H, 5-CH), 4.54–4.49 (m, 2 H, 3-CH + NCHH), 4.46 (dd, J = 
15.0, 5.6 Hz, 1 H, NCHH), 3.29 (ddd, J = 13.5, 7.3, 3.9 Hz, 1 H, 4-CHH), 2.62 (ddd, J = 13.9, 
8.1, 6.2 Hz, 1 H, 4-CHH). 13C NMR [126 MHz, δ (ppm), CDCl3]: 169.1 (C=O), 149.4 (1′-C), 
137.6 (1″-C), 129.6 (q, J = 308.1 Hz, SCF3), 129.0 (3′-C + 5′-C or 3″-C + 5″-C), 128.8 (3′-C + 5′-
C or 3″-C + 5″-C), 127.7 (4″-C), 127.6 (2″-C + 6″-C), 123.6 (4′-C), 115.1 (2′-C + 6′-C), 82.3 (q, J
= 2.5 Hz, 5-C), 67.1 (3-C), 43.5 (NCH2), 39.0 (4-C).
5.6 Computational Section
The density functional theory (DFT)30 based quantum chemical calculations were carried out 
using the Amsterdam Density Functional (ADF 2017.103) program.15 A generalized gradient 
approximation (GGA) of DFT using the BP86 functional was selected for the calculations.14
Additionally, this exchange and correlation functional reproduces barriers within a few kcal 
mol−1 compared to highly correlated ab initio benchmarks, thus making it a suitable choice for the 
goals of this research.31 Vibrational analysis confirmed stationary points as either energy minima 
(no imaginary frequencies) or transition states (a single imaginary frequency).32 The transition 
states were connected to their associated minima by following the intrinsic reaction coordinate 
(IRC).
The geometries as produced by the IRCs were subsequently analyzed in the framework of the 
activation/strain model (ASM) and the energy decomposition analysis (EDA), with the purpose 
of gaining insight into the origin of reactivity.17,18 The TZ2P basis set used herein is of triple-ξ 
quality and consists of a large uncontracted set of Slater-type orbitals used to construct the 
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molecular orbitals (MOs).14c The basis set was augmented with two sets of polarization 
functions: 2p and 3d on hydrogen, 3d and 4f for carbon, nitrogen, oxygen, fluorine, and sulfur.
The core electrons (carbon, nitrogen, oxygen, fluorine: 1s; sulfur: 1s, 2s and 2p) were treated with
the frozen core approximation.
Following the gas-phase calculations, all stationary points were submitted to a geometry 
reoptimization and vibrational analysis in the solution-phase. These solution-phase calculations 
employ COSMO to simulate solvent effects in tetrahydrofuran (THF) and default parameters in 
ADF were used in addition to a correction for outlying charges.16 The accuracy parameter of 
both the Becke grid integration and ZLMfit were set to GOOD.33 Optimized structures were 
illustrated using CYLview.34
G = Etot + Unuc + pV − T*S  =  Etot + (Utrans + Urot + Uvib) + pV − T*(Strans + Srot + Svib)
The effects of increased temperature and pressure were taken into account for the calculation 
of the thermochemistry (Unuc, pV and T*S), with the assumption that the system acts like an 
ideal gas.35 In this approximation, the work term pV = nRT has a constant contribution to the 
enthalpy and Gibbs free energy that affects absolute barriers of all our model reactions (n = –1) 
to the same extent: Δ(pV) = p∆V = −RT.
1,3-Dipolar Cycloaddition between 6m and 2
To understand the factors giving rise to the high regio- and diastereoselectivity of the reaction 
between 6m and 2, we undertook additional computational studies and summarize our results 
below. Our computed product distribution for this cycloaddition was in excellent agreement with 
the experimentally determined results. Both approaches favored the formation of 4m over regio-
4m (calcd 94:6, exp. 100:0) in addition to showing a preference for cis-4m over trans-4m (calcd
69:25, exp. 81:19; Table 5.7).
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Table 5.7 Computed N-Phenyl Nitrone Activation Barriers for the Reaction between 6m and 2, Reaction Energies 
(kcal mol−1) and Product Ratios, at 50 °C and 15 kbar, Computed at the COSMO(THF)-BP86/TZ2P Level.
Compound Isomer ∆E‡ (∆G‡) ∆Erxn (∆Grxn) Calcd product ratiosa
Exp. product 
ratios
4m 
trans 18.8 (27.9) –10.6 (1.4) 25 19
cis 17.9 (27.3) –9.7 (1.9) 69 81
regio-trans 19.4 (28.9) –7.1 (4.0) 5 0
0 regio-cis 20.2 (29.9) –7.3 (5.9) 1
aCalculated at 50 °C and 15 kbar based on the ∆∆G‡ between the various isomers of 4m.
Analysis of the formation of cis-4m and trans-4m using D/I-ASM and EDA (Figure 5.4) revealed
that cis/trans isomerism is controlled by ΔEint, or more specifically by the more favorable ΔEPauli for 
the cis-4m isomer. The more destabilizing Pauli repulsion associated with the trans-4m isomer 
originates from the orientation of the N-phenyl group. As can be seen further down below in Figure 
5.7, the sterically bulky N-phenyl group is positioned cis with respect to SCF3, which causes an 
unfavorable steric clash between these two functional groups. Though a similar sterically congested 
environment is observed for the cis-4m isomer (where 2-anisyl and SCF3 are cis), the Pauli repulsion 
is less destabilizing here due to the greater distance between these substituents.
Figure 5.4 (a) Distortion/Interaction-Activation Strain and (b) Energy Decomposition Analyses of the Cycloaddition 
Reactions between Nitrone 6m and Alkene 2 up to Their Respective TS (Indicated by the Dot), Resulting in cis-4m and 
trans-4m. All Data Were Computed at the BP86/TZ2P Level. R = 2-Anisyl.
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1,3-Dipolar Cycloaddition between 6p and 2
Now, to rationalize the reason why both regioisomers and all four possible diastereomers are 
experimentally observed for the reaction between 6p and 2, we again turn to DFT computations.
As summarized in Table 5.8, the computational and experimental product ratios for 4p/regio-
4p are in good agreement (calcd 79:21, exp. 71:29), with the same being true also for cis-4p/trans-
4p (calcd 57:22, exp. 47:24). Attempts at experimentally determining the exact regio-cis-4p/regio-
trans-4p product ratios were unsuccessful, currently the only thing known is that both 
regioisomers are present in a ratio of 20:9. Based on our computationally determined product 
ratios (regio-cis-4p: 5, regio-trans-4p: 19) we predict that the 20:9 ratio belongs to regio-trans-
4p/regio-cis-4p.
Table 5.8 Computed N-Phenyl Nitrone Activation Barriers for the Reaction between 6p and 2, Reaction Energies (kcal 
mol−1) and Product Ratios, at 50 °C and 15 kbar, Computed at the COSMO(THF)-BP86/TZ2P Level.
Compound Isomer ∆E‡ (∆G‡) ∆Erxn (∆Grxn) Calcd product ratiosa
Exp. product 
ratios
4p 
trans 21.1 (30.1) –6.3 (4.7) 22 24
cis 20.4 (29.6) –6.5 (4.9) 57 47
regio-trans 21.1 (30.3) –3.9 (7.8) 16 9
regio-cis 21.5 (31.1) –3.4 (8.3) 5 20
aCalculated at 50 °C and 15 kbar based on the ∆∆G‡ between the various isomers of 4p.
To understand the degraded regio- and diastereoselectivity observed for this substrate (6p), 
cis-4p was compared to regio-cis-4p (Figure 5.5) and trans-4p with regio-trans-4p (Figure 5.6). 
Analysis of the EDA reveals that ΔEPauli is, again, the most important term in determining 
regioisomer stability. However, whereas ΔEoi was found to be nearly identical for both 
regioisomers in the previous EDAs of 4m, 10 and 11, it was no longer the case for 4p. This 
additional stabilization due to ΔEoi is enough to lower the barriers of the two regio-4p isomers to 
point where they can be experimentally observed. 
An analysis of the frontier molecular orbitals (FMOs) suggested that this increase in favorable 
orbital interaction is a result of the HOMO of 6p interacting with the LUMO of 2. For regio-4p, 
this combination of FMOs (Figure 5.5 and Figure 5.6) has a smaller energy gap when compared 
to 4p (regio-cis/cis: 1.5/1.7 eV; regio-trans/trans: 1.5/1.6 eV), resulting in a more favorable orbital 
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interaction. In contrast, the interaction between the LUMO of 6p with the HOMO-1 of 2 shows 
an orbital overlap that favors the formation 4p over regio-4p instead. However, due to the larger 
energy gaps (regio-cis/cis: 4.4/4.3 eV; regio-trans/trans: 4.4/4.4 eV) this FMO combination is of 
lesser importance than the previously discussed 6p HOMO/2 LUMO interaction.
In conclusion, we have demonstrated our computational methods are suitable for qualitatively 
predicting regioselectivity and diastereoselectivity of these 1,3-dipolar cycloaddition reactions. 
Furthermore, this general conclusion was shown to be valid for both model system, 9, as well for 
the substrates that were experimentally evaluated (6m, 6p).
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Coordinates of Stationary Points
For Cartesian coordinates (in Å), ADF total energy (Etot, in kcal mol−1), ADF total Gibbs free 
energies (G50 °C; 15 kbar, in kcal mol−1) and the number of imaginary vibrational frequencies (Nimag) 
for the stationary points (R = reactant, TS = transition state, P = product) computed at 
BP86/TZ2P level for the studied cycloadditions in the gas phase and for the studied 
cycloadditions in THF (COSMO), see: J. Org. Chem. 2018, 83, 1779–1789.36
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Synthesis of Ethynyl Trifluoromethyl Sulfide and Its 
Application to the Synthesis of CF3S-Containing Triazoles
Riesco-Domínguez, A.; Hammoudeh, H.; Blanco-Ania, D.; Rutjes, F. P. J. T. Submitted.
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ABSTRACT: The ethynyl trifluoromethyl sulfide building block was described for the first time in the 
literature. CF3S-acetylene was synthesized in a one-pot process from its precursor 2-chloroethyl 
trifluoromethyl sulfide via an elimination, bromination and double elimination sequence.
CF3S-Acetylene reacted with various aromatic and aliphatic azides under copper-catalyzed conditions
to yield 1,4-disbustituted triazoles bearing the SCF3 group (16 examples, up to 86% yield).
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6.1 Introduction
The incorporation of the (trifluoromethyl)sulfanyl group (SCF3) into drug molecules can 
significantly enhance the bioavailability of drugs and allow a more effective transport of 
molecules through lipid membranes (Hansch parameter π = 1.44).1 Consequently, not only is the 
introduction of the SCF3 group into organic molecules relevant for agrochemical and 
pharmaceutical communities for its use in isostere-based drug design,2 but also for the 
development of new synthetic methodologies that can contribute to discoveries in biomedical 
research.3 A few analogues derived from biologically active compounds have been developed 
since the chemistry of the SCF3 group began (Figure 6.1). For example, the SCF3 group has been 
used as an isostere in losartan analogues, used clinically for the treatment of cardiovascular 
diseases.4 Vaniliprole and JKU 0422 were developed as analogues of the insecticide fipronil, a 
compound with a trifluoromethyl sulfoxide.5 Finally, a methionine analogue was developed,
which is of interest for peptide design because of the strong steric and electrostatic requirements 
of the CF3 group.6
Figure 6.1 CF3S-Containing Analogues Derived from Biologically Active Compounds.
The use of building blocks represents one of the major strategies for pharmaceutical and 
agrochemical industries for the construction of compound libraries. Thus, the discovery of new 
CF3S-containing building blocks that can be utilized for the construction of potentially 
biologically active molecules represents nowadays a focus for organic chemists. In this regard, 
the majority of known building blocks bearing the SCF3 group consists of either 
(hetero)aromatic or disubstituted vinylic/acetylenic molecules.7 However, the syntheses of the 
simplest CF3S-ethene/acetylene building blocks (2 and 3) and their applications to the synthesis 
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of heterocycles are unexplored. We recently reported the synthesis of the trifluoromethyl vinyl 
sufide building block 2 from chloro alkane 1 and its application to the synthesis of the new class 
of isoxazolidines 4 by 1,3-dipolar cycloaddition reactions with nitrones (Scheme 6.1; Chapter 5).8
Furthermore, the inherent potential of the building block 29 motivated us to study the synthesis 
of its CF3S-acetylene counterpart 3.
Scheme 6.1 Synthesis of CF3S-Containing Isoxazolidines 4 and Triazoles 5 from Chloro Alkane 1. 
Thus, we report herewith the first synthesis of ethynyl trifluoromethyl sulfide 310, and its use as 
a building block for the synthesis of drug-like CF3S-containing 1,4-disubstituted triazoles 5
(Scheme 6.1).
6.2 Results and Discussion
6.2.1 Synthesis of Ethynyl Trifluoromethyl Sulfide
The synthesis of the CF3S-acetylene 311 started with the preparation of trifluoromethyl vinyl
sulfide 2 from the available chloro alkane 1 (Scheme 6.2). We applied the conditions recently 
reported by our research group (1.3 equiv of KOtBu, 1.0 M solution in THF)8 to afford alkene 2
quantitatively.
Scheme 6.2 Synthesis of Dibromide 6 from Chloro Alkane 1. 
Then, Br2 was added to the solution that contained alkene 2.12 Initial experiments showed that 
the addition of 2.0 equiv of Br2 gave full conversion to dibromide 613 but 4-bromobutan-1-ol 
was formed as a side product from the reaction of dibromine with THF.14 We therefore replaced 
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THF with CH2Cl2 (except for the stock solution of KOtBu in THF), and reduced the amount of 
Br2 to avoid the formation of the side product. Alkene 2 was then prepared from chloro alkane 1
in CH2Cl2 (KOtBu, 1.3 equiv) with full conversion under these conditions. Subsequent addition 
of Br2 (1.1 equiv) afforded dibromide 6 with full conversion and without formation of side 
products (Scheme 6.2). We tried to isolate dibromide 6 by distillation but our attempts resulted in 
the decomposition of 6 when evaporating the solvent.
Finally, the last steps of the synthesis of CF3S-acetylene 3 implied a double elimination reaction 
of compound 6 (Table 6.1). It is worth noting that compounds 2, 6, 7 and 3 were not isolated 
and that the reactions were followed in all cases by 1H and 19F NMR. Preliminary studies using 
1,2-dibromoethyl phenyl sulfide as substrate showed that KOtBu, NaOH and NaNH2 (in excess) 
were not suitable bases for both eliminations to occur. After screening several other bases, we 
concluded that the combination of KOtBu and NaHMDS gave the best results (Table 6.1). The 
reaction of dibromide 6 with NaHMDS (2.0 equiv, entry 1) afforded bromo alkene 7 with full 
conversion after 17 h of reaction time.
Table 6.1 Synthesis of CF3S-Acetylene 3 from Dibromide 6.
Entry Base equiv Time (h) Ratio 7/3
1 NaHMDS 2.0 + 3.0 
17 +
2 
1:0 
disappearance 7
2 NaHMDS 2.0 + 3.0 
1.5 +
8 
1:0 
1:0 
3 KO
tBu +
NaHMDS
1.5 + 
0.6 
1.5 +
1 
4:1 
1:0.9 
4 KOtBu +NaHMDS
1.3 + 
0.7 
1.5 +
1 
7:3 
4:13 
5 KO
tBu +
NaHMDS
1.3 + 
1.7 
1.5 +
1.5
4:1 
0:1a
aThe accurate ratio 7/3 could not be determined, but alkyne 3 was the 
major product in the reaction mixture.
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The addition of one more equivalent revealed the disappearance of alkene 7 by 1H NMR. 
Assuming that alkyne 3 was formed in the reaction, 1-azido-4-nitrobenzene was added and the 
reaction mixture was brought under 15 kbar of pressure. Unfortunately, no product was obtained
and the starting azide was recovered, so we continued investigating the formation of alkyne 3. 
We repeated the same procedure confirming that alkene 7 was formed after 1.5 h and the 
addition of 2.0 equiv of NaHMDS (entry 2). Unfortunately, the addition of one additional 
equivalent of NaHMDS did not result in formation of alkyne 3. When we used KOtBu as the 
base for the first elimination (1.5 equiv, entry 3), we observed not only the formation of alkene 7,
but also alkyne 3 (ratio 7/3 4:1). The subsequent addition of NaHMDS (0.6 equiv) increased the 
formation of alkyne 3, even though alkene 7 was still present in the reaction mixture. When we 
used KOtBu and NaHMDS (1.3 and 0.7 equiv, respectively; entry 4), an increase of alkyne 3 was 
obtained. Finally, the best result was obtained by employing KOtBu (1.3 equiv) and a subsequent
excess of NaHMDS (1.7 equiv), providing alkyne 3 as the sole product in the reaction mixture
(entry 5).
6.2.2 Synthesis of CF3S-Containing Triazoles
With the CF3S-acetylene 3 in hand, we focused our attention on the azide–alkyne cycloaddition 
reaction15 for the synthesis of 1,4-disubstituted triazoles (5) bearing the SCF3 group. Triazoles are 
one of the most exploited structures in heterocyclic chemistry as their structural motif occurs in 
products with a diversity of biological activities, such as antiviral, analgesic, anti-inflammatory, 
anticonvulsant, antimicrobial, anticancer effects and so forth.16
Previous results from our research group revealed the importance of high pressure to promote 
the cycloaddition reaction between alkene 2 and several nitrones for the synthesis of 
CF3S-substituted isoxazolidines.8 Following the same strategy, we studied the high-pressure-
promoted synthesis of CF3S-containing 1,4-disubstituted triazoles 5 (Table 6.2).17 We first 
performed the reaction of azide 8a (R = NO2) and CF3S-acetylene 3 at 21 °C under 15 kbar of 
pressure (entry 1). To our delight, the reaction proceeded smoothly and after 72 h of reaction 
time we isolated triazole 5a in 78% yield. Surprisingly, compound 5a was the only regioisomer
formed,18 representing the first non-catalyzed regioselective azide–alkyne 1,3-dipolar 
cycloaddition reported in the literature.
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Table 6.2 Optimization Process for the Synthesis of CF3S-Containing 1,4-Disubstituted Triazoles 5.
Entry Substrate Product R t (°C) Time (h) Promotor Yield (%)a
1b 8a 5a NO2 21 72 15 kbar 78c
2 8a 5a NO2 21→30 72 – –
3 8b 5b F 21→50d 120 15 kbar 49
4 8c 5c CF3 21→50d 120 15 kbar 38
5 8d 5d Me 21→50e 120 15 kbar –
6 8e 5e OMe 21→50e 120 15 kbar −
7 8a 5a NO2 30 16 Cu(I)f 82
8 8b 5b F 60 16 Cu(I)f 85
aIsolated yield. bReaction performed in THF. c4-Nitroaniline was obtained as a side product. 
dReactions were performed at 21 °C for 96 h and at 50 °C for 24 h. eReactions were performed at 
21 °C for 72 h and at 50 °C for 48 h. fReactions were performed with CuSO4·5H2O (0.01 equiv), 
sodium ascorbate (0.02 equiv), benzoic acid (0.1 equiv) in tBuOH/H2O (1:2).
The reaction of azide 8a did not show any conversion into the desired triazole 5a under 
thermal conditions (30 °C; entry 2) for 72 h. Initially, we refrained from using higher 
temperatures because of the volatility of CF3S-acetylene 3. Reaction times for the reactions with 
azides 8b (R = F, entry 3) and 8c (R = CF3, entry 4) were longer (120 h led to 2:7 and 4:7 ratios
for 5b/8b and 5c/8c, respectively) and yields were considerably low (49% and 38%,
respectively), even when the reaction mixtures were heated up to 50 °C. Applying the same 
reaction conditions to substrates 8d (R = Me, entry 5) and 8e (R = OMe, entry 6), the ratios of 
5d/8d and 5e/8e were 1:6 and 1:15, respectively, after 120 h of reaction time.
As a result, we decided to perform the synthesis of triazoles 5 under copper-catalyzed 
conditions. Thus, the copper-catalyzed reaction of azide 8a with CF3S-acetylene 3; CuSO4·5H2O 
(0.01 equiv), sodium ascorbate (NaAsc, 0.02 equiv) and benzoic acid (0.1 equiv), in a mixture of 
tBuOH/H2O/CH2Cl2 at 30 °C; afforded triazole 5a after 16 h of reaction in 82% yield (entry 7).
Compound 5b was isolated in 85% yield when using azide 8b (R = F) under copper-catalyzed 
conditions at 60 °C (entry 8).
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The copper-catalyzed conditions greatly improved the results as compared to the high-
pressure-promoted reactions and reduced reaction times considerably. Thereby, various azides 
were examined in the copper-catalyzed azide–alkyne cycloaddition reaction19 by employing the 
conditions shown in entries 7 and 8 of Table 6.2.
We used commercially available azides (8b–g), previously prepared azides from our research 
group (8a, 8l and 8m) and freshly synthesized azides 8h–k as substrates. Azides 8h–k were 
synthesized from the corresponding anilines 9h–k (Table 6.3) using the classical conditions20
with NaNO2 and TsOH via the formation of arenediazonium tosylates 10h–k, followed by 
reaction with NaN3, in very good to excellent overall yields (80–97%).
Table 6.3 Synthesis of Aromatic Azides 8h–k from Anilines 9h–k.
Entry 9 R 8 Yield (%)a
1 9h 3-OMe 8h 97 
2 9i 3-CN 8i 95 
3 9j 2-OMe 8j 95 
4 9k 2-CN 8k 80 
aIsolated yield.
A total of 12 aromatic azides (8a–l) with both electron-donating or electron-withdrawing 
groups at the 2-, 3- and 4-positions were used to study the scope of the copper-catalyzed 
cycloaddition reaction with CF3S-acetylene 3 (Table 6.4).
These reactions proceeded at different temperatures and reaction times and in variable yields 
depending on the position and electronic effect of the substituent at the phenyl ring of azides 
8a–l. Yields were moderate to very good (61–86%; 5a–d, 5f, 5g and 5l), except when the phenyl 
ring was substituted with a MeO or CN group (5e, 5h–5k).
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Table 6.4 Scope of the Copper-Catalyzed Cycloaddition Reaction of Azides 8a–l and CF3S-Acetylene 3.
aReaction performed at 30 °C. bReaction performed for 16 h. cIsolated yield. dReaction 
performed at 60 °C. eReaction performed at 50 °C. fReaction performed at 70 °C. 
gReaction performed for 48 h. hReaction performed for 72 h.
Most of the azides reacted at 50 °C yielding triazoles 5c, 5e, 5h–l. Compounds 5a, 5f and 5g
were formed at 30 °C, whereas triazoles 5b and 5d21 required temperatures to 60 and 70 °C, 
respectively. The reaction times also varied with the substrate. The majority of reactions were 
carried out for 48 h (compounds 5d, 5f and 5h–l), whereas reaction rates were accelerated (16 h) 
for compounds 5a–c and 5g.
For compounds 5e, 5h and 5j, bearing a methoxy substituent at the 4-, 3-, and 2-positions in 
the phenyl ring, we identified the formation of the corresponding 1,5-disubstituted regioisomers 
by NMR analysis (1H, 13C and HSQC) in 10:1 to 12:1 ratios.22,23
Finally, we expanded the scope of this reaction to the synthesis of heteroaromatic and aliphatic 
CF3S-containing triazoles (Figure 6.2). In this manner, we were able to synthesize pyridinyl 
triazole 5m after 16 h of reaction time at 70 °C in 65% yield. 
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Moreover, aliphatic triazoles (5n–p) were synthesized in moderate to good yields (40–72%) at 
50 °C for a period of 16–48 h (Figure 6.2). Remarkably, the reaction of azide 8o afforded the 
1,5-disubstituted regioisomer 5o, which was isolated after column chromatography. The 
structure of triazole 5o was confirmed by HMBC studies.
Figure 6.2 CF3S-Containing Heteroaromatic and Aliphatic Triazoles.
aReaction performed at 70 °C. bReaction performed for 16 h. cIsolated yield. dReaction 
performed at 50 °C. eReaction performed for 48 h.
6.3 Conclusion
In summary, we have developed the first synthesis of ethynyl trifluoromethyl sulfide 3, a 
building block for the synthesis of CF3S-containing heterocycles. A one-pot four-step synthesis 
of CF3S-acetylene 3 was developed and applied to synthesize the first class of CF3S-containing 
triazoles by copper-promoted 1,3-dipolar cycloaddition reactions with several (hetero)aromatic 
and aliphatic azides. Currently, the biological properties of these compounds are being evaluated 
in various assays and the reactivity of the CF3S-acetylene 3 is further explored with different 
dipoles.
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6.5 Experimental Section
For general experimental details, see Section 2.5 (p 51).
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Synthesis of Azides 8h–k 
General Procedure for the Synthesis of Aromatic Azides 8h–k
The corresponding aniline 9h–k (1.0 mmol) was added to a solution of TsOH·H2O (1.62 g, 9.0 
mmol) in H2O (9 mL). After stirring for 1 min, anhydrous NaNO2 (0.621 g, 9.0 mmol) was 
added gradually over 5 min. The resulting solution was then stirred for a period between 2–60 
min until the starting amine disappeared (reactions were monitored by TLC). Anhydrous NaN3
(0.104 g, 1.6 mmol) was added to the resulting solution and an immediate emission of N2 was 
observed. The solid aromatic azides (8h and 8i) were filtered off, washed with H2O (50 mL) and 
dried in vacuo whereas the oily azides (8j and 8k) were extracted with AcOEt (3 × 10 mL) and
dried over Na2SO4. The suspension was filtered off and dried under reduced pressure.
1-Azido-3-methoxybenzene 8h24
According to the general procedure, the reaction of aniline 9h (123 mg, 1.0 mmol) 
afforded azide 8h (144.7 mg, 0.97 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.25 
(t, J = 8.1 Hz, 1 H), 6.67 (ddd, J = 8.3, 2.4, 0.8 Hz, 1 H), 6.65 (ddd, J = 8.0, 2.1, 0.9 Hz, 
1 H), 6.55 (t, J = 2.2 Hz, 1 H), 3.80 (s, 3 H). Yield: 97%.
3-Azidobenzonitrile 8i25
According to the general procedure, the reaction of aniline 9i (118.1 mg, 1.0 mmol) 
afforded azide 8i (136.9 mg, 0.95 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.65–
7.56 (m, 2 H), 7.28–7.25 (m, 1 H), 7.22 (td, J = 7.7, 1.0 Hz, 1 H). Yield: 95%.
1-Azido-2-methoxybenzene 8j24
According to the general procedure, the reaction of aniline 9j (123.2 mg, 1.0 mmol) 
afforded azide 8j (141.7 mg, 0.95 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.10 
(td, J = 7.8, 1.7 Hz, 1 H), 7.02 (dd, J = 7.8, 1.7 Hz, 1 H), 6.97–6.88 (m, 2 H), 3.88 (s, 3 H, 
OCH3). Yield: 95%.
2-Azidobenzonitrile 8k26
According to the general procedure, the reaction of aniline 9k (118.1 mg, 1.0 mmol) 
afforded azide 8k (115.3 mg, 0.80 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]:
7.50–7.40 (m, 2 H), 7.30–7.24 (m, 2 H). Yield: 80%.
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Azides 8b–g were commercially available and azides 8a,27 8l28 and 8m29 were previously 
prepared in our research group according to procedures published in the literature.
General Procedure for the Synthesis of Ethynyl Trifluoromethyl Sulfide 3
In a sealed vial under a nitrogen atmosphere, 2-chloroethyl trifluoromethyl sulfide (1; 100 mg, 
0.608 mmol) was dissolved in CH2Cl2 (1 mL). The solution was cooled to 0 °C and subsequently
KOtBu (790 µL, 0.790 mmol, 1.3 equiv, 1.0 M solution in THF) was slowly added. The reaction 
mixture was stirred at 21 °C for 90 min to form trifluoromethyl vinyl sulfide (2). Then, Br2 (34 
µL, 107 mg, 0.668 mmol, 1.1 equiv) in CH2Cl2 (1 mL) and added at 21 °C to the solution
containing alkene 2. The reaction mixture was stirred for 1 h until the orange color of the 
mixture turned to a pale yellow color, to afford the CF3S-dibromo derivative 6. Subsequently, the 
mixture was filtered and the CH2Cl2 was evaporated under reduced pressure in order to reduce 
50% of the volume of the mixture. Then, the reaction mixture was cooled to 
0 °C, KOtBu (790 µL, 0.790 mmol, 1.3 equiv, 1.0 M solution in THF) was slowly added and the 
reaction mixture was stirred at 21 °C for 90 min to afford alkene 7. Finally, NaHMDS (517 µL, 
1.034 mmol, 1.7 equiv, 2.0 M solution in THF) was slowly added and stirred for 1 h, to give 
CF3S-acetylene 3. 1H NMR and 19F NMR were checked after every reaction step and used for 
the final characterization of CF3S-acetylene 3.
Trifluoromethyl Vinyl Sulfide 28
1H NMR [400 MHz, δ (ppm), THF-d8]: 6.54 (dd, J = 16.5, 9.4 Hz, 1 H, 1-CH), 
5.72 (dq, J = 9.4, 1.5 Hz, 1 H, 2-CHa), 5.70 (d, J = 16.5, 1 H, 2-CHb). 13C NMR
[101 MHz, δ (ppm), THF-d8]: 129.8 (q, J = 306.5 Hz, SCF3), 124.4 (q, J = 1.0 Hz, 2-C), 121.3 (q, 
J = 3.2 Hz, 1-C). 19F NMR [377 MHz, δ (ppm), THF-d8]: −43.6.
1,2-Dibromoethyl Trifluoromethyl Sulfide 6
1H NMR [400 MHz, δ (ppm), CDCl3]: 5.46 (dd, J = 7.1, 5.7 Hz, 1 H, 1-CH), 4.00 
(ddq, J = 11.4, 5.8, 0.5 Hz, 1 H, 2-CHH), 3.91 (ddq, J = 11.4, 7.1, 0.6 Hz, 1 H, 2-
CHH). 13C NMR [126 MHz, δ (ppm), CD2Cl2/THF-d8]: 130.4 (q, J = 309.1 Hz, SCF3), 48.3 (1-
C), 37.0 (2-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −40.9.
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1-Bromovinyl Trifluoromethyl Sulfide 7
1H NMR [500 MHz, δ (ppm), CD2Cl2/THF-d8]: 6.56 (d, J = 2.3 Hz, 1 H, 2-CHH), 6.41 
(dq, J = 2.3, 0.8 Hz, 1 H, 2-CHH). 13C NMR [126 MHz, δ (ppm), CD2Cl2/THF-d8]:
138.2 (q, J = 1.3 Hz, 2-C), 130.0 (d, J = 310.5 Hz, SCF3), 112.3 (q, J = 2.9 Hz, 1-C). 19F NMR 
[377 MHz, δ (ppm), CDCl3]: −42.5.
Ethynyl Trifluoromethyl Sulfide 3
1H NMR [400 MHz, δ (ppm), CDCl3]: 3.33 (s, 1 H, CH). 19F NMR [377 MHz, δ 
(ppm), CDCl3]: −43.2.
General Procedure for the Synthesis of 1,4-Disubstituted-1H-1,2,3-Triazoles 5a–p
A solution containing a mixture of CF3S-acetylene 3 (3.0 equiv) and the corresponding azide 8
(1.0 equiv) in CH2Cl2/THF was added to a solution of CuSO4·5H2O (2.5 mg, 0.01 mmol), 
sodium ascorbate (4 mg, 0.02 mmol) and benzoic acid (12 mg, 0.1 mmol) in tBuOH/H2O 
(1:2 v/v, 1.0 mL) in a 4 mL vial. Then, CH2Cl2 was added in order to fill the vial completely. The 
resultant mixture was stirred for the stated time at the indicated temperature for every reaction
(reactions were followed by 1H and 19F NMR). The reaction mixture was then quenched with
H2O (20 mL) and extracted with CH2Cl2 (3 × 15 mL). The combined organic layers were washed 
with H2O and brine, dried over anhydrous Na2SO4, filtered off and concentrated in vacuo. The 
crude product was purified by column chromatography (heptane/AcOEt, 4:1) to afford the 
corresponding triazoles 5a–p.
1-(4-Nitrophenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5a
According to the general procedure, the reaction of 1-azido-4-nitrobenzene
8a (21 mg, 0.13 mmol) with CF3S-acetylene 3 at 30 °C for 16 h afforded 
triazole 5a (46.4 mg, 0.16 mmol) as a yellow-brown solid. 1H NMR [400 
MHz, δ (ppm), CDCl3]: δ 8.51–8.44 (m, 2 H, 3-CH + 5-CH), 8.42 (s, 1 H, CH), 8.05–7.98 (m, 2 
H, 2-CH + 6-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 148.0 (4-C), 140.5 (1-C), 132.0 (C–S, 
indirect observation), 128.33 (CH), 128.32 (q, J = 310.0 Hz, SCF3), 125.9 (3-C + 5-C), 121.1 (2-C
+ 6-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒42.5. FTIR [?̅?𝜈 (cm−1)]: 2924, 1599, 1519, 1348, 
1144, 1102, 907, 733. RF: 0.32 (heptane/AcOEt, 4:1). Yield: 82%.
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1-(4-Fluorophenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5b
According to the general procedure, the reaction of 1-azido-4-fluorobenzene
8b (250 µL, 0.125 mmol, 0.5 M solution in tBuOMe) with CF3S-acetylene 3 at 
60 °C for 16 h afforded triazole 5b (28.0 mg, 0.106 mmol) as a brown solid.
1H NMR [400 MHz, δ (ppm), CDCl3]: 8.26 (s, 1 H, CH), 7.79–7.67 (m, 2 H, 2-CH + 6-CH), 
7.31–7.22 (m, 2 H, 3-CH + 5-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 163.1 (d, J = 250.6 
Hz, 4-C), 132.7 (1-C), 130.8 (C–S), 128.6 (CH), 128.4 (q, J = 309.7 Hz, SCF3), 123.0 (d, J = 8.8 
Hz, 2-C + 6-C), 117.2 (d, J = 23.5 Hz, 3-C + 5-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒42.7
(SCF3). FTIR [?̅?𝜈 (cm−1)]: 3125, 1520, 1243, 1146, 1122, 839. HRMS [ESI (m/z)] calcd for 
(C9H5F4N3S + H)+ = 264.02186, found 264.02227 (|Δ| = 1.59 ppm). RF: 0.42 (heptane/AcOEt, 
4:1). Yield: 85%.
1-[4-(Trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5c
According to the general procedure, the reaction of 1-azido-4-
(trifluoromethyl)benzene 8c (250 µL, 0.125 mmol, 0.5 M solution in 
tBuOMe) with CF3S-acetylene 3 at 50 °C for 16 h afforded triazole 5c (31.3
mg, 0.10 mmol) as a yellow solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.38 (s, 1 H, CH), 
7.97–7.89 (m, 2 H, 2-CH + 6-CH), 7.88–7.82 (m, 2 H, 3-CH + 5-CH). 13C NMR [101 MHz, δ 
(ppm), CDCl3]: 138.8 (1-C), 131.9 (q, J = 33.4 Hz, 4-C), 131.4 (C–S), 128.37 (q, J = 309.9 Hz, 
SCF3), 128.37 (CH), 127.5 (q, J = 3.7 Hz, 3-C + 5-C), 123.5 (q, J = 272.4 Hz, CF3), 120.9 (2-C + 
6-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒42.6 (SCF3), ‒62.8 (CF3). FTIR [?̅?𝜈 (cm−1)]: 3117, 
1335, 1151, 1106, 844. HRMS [ESI (m/z)] calcd for (C10H5F6N3S + H)+ = 314.01866, found 
314.02077 (|Δ| = 2.11 mmu). RF: 0.50 (heptane/AcOEt, 4:1). Yield: 80%.
1-(4-Tolyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5d
According to the general procedure, the reaction of 1-azido-4-
methylbenzene 8d (250 µL, 0.125 mmol, 0.5 M solution in tBuOMe) with 
CF3S-acetylene 3 at 70 °C for 48 h afforded triazole 5d (28.0 mg, 0.108
mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.26 (s, 1 H, CH), 7.64–7.59 (m, 
2 H, 2-CH + 6-CH), 7.38–7.32 (m, 2 H, 3-CH + 5-CH), 2.44 (s, 3 H, CH3). 13C NMR [101
MHz, δ (ppm), CDCl3]: 140.1 (4-C), 134.2 (1-C), 130.6 (3-C + 5-C), 130.3 (C–S), 128.46 (q, J = 
309.7 Hz, SCF3), 128.45 (CH), 120.7 (2-C + 6-C), 21.3 (CH3). 19F NMR [377 MHz, δ (ppm), 
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CDCl3]: ‒42.8. FTIR [?̅?𝜈 (cm−1)]: 2967, 1143, 1119, 1039, 817. HRMS [ESI (m/z)] calcd for 
(C10H8F3N3S + H)+ = 260.04693, found 260.04638 (|Δ| = 2.11 ppm). RF: 0.44 
(heptane/AcOEt, 4:1). Yield: 86%.
1-(4-Methoxyphenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5e
According to the general procedure, the reaction of 1-azido-4-
methoxybenzene 8e (250 µL, 0.125 mmol, 0.5 M solution in tBuOMe) with 
CF3S-acetylene 3 at 50 °C for 72 h afforded triazole 5e (7.0 mg, 0.025
mmol) as a yellow-brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.21 (s, 1 H, CH), 7.67–
7.62 (m, 2 H, 2-CH + 6-CH), 7.10–7.01 (m, 2 H, 3-CH + 5-CH), 3.89 (s, 3 H, OCH3). 13C NMR 
[101 MHz, δ (ppm), CDCl3]: 160.5 (4-C), 130.1 (1-C), 129.7 (C–S), 128.4 (CH), 128.3 (q, J = 
309.6 Hz, SCF3), 122.4 (2-C + 6-C), 115.0 (3-C + 5-C), 55.7 (OCH3). 19F NMR [377 MHz, δ 
(ppm), CDCl3]: ‒42.8. FTIR [?̅?𝜈 (cm−1)]: 2926, 1522, 1261, 1145, 1121, 830. HRMS [ESI (m/z)] 
calcd for (C10H8F3N3OS + H)+ = 276.04184, found 276.04126 (|Δ| = 2.11 ppm). RF: 0.32
(heptane/AcOEt, 4:1). Yield: 20%.
1-Phenyl-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5f
According to the general procedure, the reaction of phenyl azide 8f (250 µL, 
0.125 mmol, 0.5 M solution in tBuOMe) with CF3S-acetylene 3 at 30 °C for 
48 h afforded triazole 5f (22.4 mg, 0.09 mmol) as a brown solid. 1H NMR [400 
MHz, δ (ppm), CDCl3]: 8.30 (s, 1 H, CH), 7.78–7.73 (m, 2 H, 2-CH + 6-CH), 7.61–7.55 (m, 2 H, 
3-CH + 5-CH), 7.54–7.48 (m, 1 H, 4-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 136.2 (1-C), 
130.5 (C–S, indirect observation), 130.2 (3-C + 5-C), 129.8 (4-C), 128.5 (CH), 120.9 (2-C + 6-C).
The carbon signal of SCF3 was not observed. 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.8. 
FTIR [?̅?𝜈 (cm−1)]: 2989, 1141, 1120, 1041, 758. HRMS [ESI (m/z)] calcd for (C9H6F3N3S + H)+
= 246.03128, found 246.03124 (|Δ| = 0.15 ppm). RF: 0.36 (heptane/AcOEt, 4:1). Yield: 73%.
1-(3-Chlorophenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5g
According to the general procedure, the reaction of 1-azido-3-chlorobenzene
8g (200 µL, 0.10 mmol, 0.5 M solution in tBuOMe) with CF3S-acetylene 3 at 
30 °C for 16 h afforded triazole 5g (21.0 mg, 0.075 mmol) as a brown solid. 1H 
NMR [400 MHz, δ (ppm), CDCl3]: 8.32 (s, 1 H, CH), 7.81 (td, J = 1.9, 0.6 Hz, 
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1 H, 2-CH), 7.67 (dt, J = 7.4, 2.0 Hz, 1 H, 6-CH), 7.53 (t, J = 7.7 Hz, 1 H, 5-CH), 7.48 (dt, J = 
8.1, 1.8 Hz, 1 H, 4-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 137.2 (1-C or 3-C), 136.1 (1-C 
or 3-C), 131.2 (5-C), 131.0 (C–S), 129.9 (4-C), 128.43 (CH), 128.39 (q, J = 309.8 Hz, SCF3), 121.1 
(2-C), 118.8 (6-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒42.7. FTIR [?̅?𝜈 (cm−1)]: 3124, 1597, 
1155, 1118, 1040, 784. HRMS [ESI (m/z)] calcd for (C9H5F3N3SCl + H)+ = 279.99231, found 
279.99238 (|Δ| = 0.26 ppm). RF: 0.40 (heptane/AcOEt, 4:1). Yield: 75%.
1-(3-Methoxyphenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5h
According to the general procedure, the reaction of 1-azido-3-methoxybenzene
8h (19 mg, 0.13 mmol) with CF3S-acetylene 3 at 50 °C for 48 h afforded 
triazole 5h (12.9 mg, 0.047 mmol) as a brown solid. 1H NMR [400 MHz, δ 
(ppm), CDCl3]: 8.28 (s, 1 H, CH), 7.45 (t, J = 8.2 Hz, 1 H, 5-CH), 7.35 (t, J = 
2.3 Hz, 1 H, 2-CH), 7.28 (ddd, J = 8.2, 2.1, 0.9 Hz, 1 H, 6-CH), 7.03 (ddd, J = 8.2, 2.6, 0.9 Hz, 1 
H, 4-CH), 3.90 (s, 3 H, OCH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 160.9 (3-C), 137.5 (1-C), 
130.9 (5-C), 130.4 (C–S), 128.6 (CH), 128.5 (q, J = 309.6 Hz, SCF3), 115.6 (4-C), 112.6 (6-C), 
106.7 (2-C), 55.9 (OCH3). 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒42.8. FTIR [?̅?𝜈 (cm−1)]: 2932, 
1612, 1146, 1110, 1032. HRMS [ESI (m/z)] calcd for (C10H8F3N3OS + H)+ = 276.04184, found 
276.04185 (|Δ| = 0.03 ppm). RF: 0.34 (heptane/AcOEt, 4:1). Yield: 36%.
3-{4-[(Trifluoromethyl)sulfanyl]-1H-1,2,3-triazol-1-yl}benzonitrile 5i
According to the general procedure, the reaction of 3-azidobenzonitrile 8i (20 
mg, 0.14 mmol) with CF3S-acetylene 3 at 50 °C for 48 h afforded triazole 5i
(15.1 mg, 0.056 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 8.35 (s, 1 H, CH), 8.10 (t, J = 1.9 Hz, 1 H, 2-CH), 8.05 (ddd, J = 8.1, 
2.3, 1.2 Hz, 1 H, 4-CH), 7.81 (dt, J = 7.8, 1.3 Hz, 1 H, 6-CH), 7.73 (t, J = 7.9 Hz, 1 H, 5-CH).
13C NMR [101 MHz, δ (ppm), CDCl3]: 137.0 (3-C), 133.1 (6-C), 131.36 (5-C), 131.34 (C–S), 
128.2 (CH), 124.8 (4-C), 124.0 (2-C), 117.1 (CN), 114.7 (1-C). The carbon signal of SCF3 was not 
observed. 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒42.5. FTIR [?̅?𝜈 (cm−1)]: 2930, 2235, 1109, 
1032, 755. RF: 0.17 (heptane/AcOEt, 4:1). Yield: 40%.
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1-(2-Methoxyphenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5j
According to the general procedure, the reaction of 1-azido-2-methoxybenzene
8j (19 mg, 0.13 mmol) with CF3S-acetylene 3 at 50 °C for 48 h afforded triazole 
5j (11.0 mg, 0.04 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 8.48 (s, 1 H, CH), 7.86 (dd, J = 7.9, 1.7 Hz, 1 H, 6-CH), 7.47 (ddd, J = 8.3, 7.6, 1.7 Hz, 1 
H, 4-CH), 7.17–7.10 (m, 2 H, 3-CH + 5-CH), 3.93 (s, 3 H, OCH3). 13C NMR [101 MHz, δ 
(ppm), CDCl3]: 150.8 (2-C), 132.4 (CH), 130.8 (4-C), 128.8 (C–S), 128.4 (q, J = 309.7 Hz, SCF3), 
125.6 (1-C), 125.1 (6-C), 121.4 (5-C), 112.3 (3-C), 56.1 (OCH3). 19F NMR [377 MHz, δ (ppm), 
CDCl3]: ‒43.1. FTIR [?̅?𝜈 (cm−1)]: 2939, 1604, 1510, 1285, 1256, 1106, 1026, 754. HRMS [ESI 
(m/z)] calcd for (C10H8F3N3OS + H)+ = 276.04184, found 276.04158 (|Δ| = 0.93 ppm). RF: 
0.38 (heptane/AcOEt, 4:1). Yield: 30%.
2-{4-[(Trifluoromethyl)sulfanyl]-1H-1,2,3-triazol-1-yl}benzonitrile 5k
According to the general procedure, the reaction of 2-azidobenzonitrile 8k (18 
mg, 0.12 mmol) with CF3S-acetylene 3 at 50 °C for 48 h afforded triazole 5k
(9.7 mg, 0.036 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 
8.59 (s, 1 H, CH), 7.95 (dd, J = 8.2, 1.2 Hz, 1 H, 3-CH), 7.91 (dd, J = 7.8, 1.5 Hz, 1 H, 6-CH), 
7.87 (td, J = 7.8, 1.5 Hz, 1 H, 4-CH), 7.68 (td, J = 7.7, 1.3 Hz, 1 H, 5-CH). 13C NMR [101 MHz, 
δ (ppm), CDCl3]: 137.8 (2-C), 134.8 (4-C), 134.6 (6-C), 131.0 (C–S, indirect observation), 130.8 
(CH), 130.5 (5-C), 128.4 (q, J = 309.9 Hz, SCF3), 125.7 (3-C), 115.3 (CN), 106.9 (1-C). 19F NMR
[377 MHz, δ (ppm), CDCl3]: ‒42.6. FTIR [?̅?𝜈 (cm−1)]: 2923, 2853, 1520, 1349, 1146, 1103, 1034, 
853. HRMS [ESI (m/z)] calcd for (C10H5F3N4S + H)+ = 271.02653, found 271.02598 (|Δ| = 
2.00 ppm). RF: 0.14 (heptane/AcOEt, 4:1). Yield: 30%.
1-(2,6-Difluorophenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5l
According to the general procedure, the reaction of 2-azido-1,3-
difluorobenzene 8l (21 mg, 0.14 mmol) with CF3S-acetylene 3 at 50 °C for 48 h 
afforded triazole 5l (23.9 mg, 0.085 mmol) as a brown solid. 1H NMR [400 
MHz, δ (ppm), CDCl3]: 8.18 (s, 1 H, CH), 7.55 (tt, J = 8.6, 6.0 Hz, 1 H, 4-CH), 7.22–7.14 (m, 2 
H, 3-CH + 5-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 156.8 (dd, J = 257.5, 2.7 Hz, 2-C + 6-
C), 133.0 (CH), 132.3 (t, J = 9.7 Hz, 4-CH), 130.0 (C–S), 128.37 (q, J = 309.7 Hz, SCF3), 113.0–
112.7 (m, 3-C + 5-C). The signal of 1-C was not observed. 19F NMR [400 MHz, δ (ppm), 
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CDCl3]: ‒42.8 (SCF3). FTIR [?̅?𝜈 (cm−1)]: 2919, 1480, 1111, 1032, 1014, 788. HRMS [ESI (m/z)] 
calcd for (C9H4F5N3S + H)+ = 282.01243, found 282.01226 (|Δ| = 0.63 ppm). RF: 0.21 
(heptane/AcOEt, 4:1). Yield: 61%.
4-{4-[(Trifluoromethyl)sulfanyl]-1H-1,2,3-triazol-1-yl}pyridine 5m
According to the general procedure, the reaction of 4-azidopyridine 8m (19 
mg, 0.16 mmol) with CF3S-acetylene 3 at 70 °C for 16 h afforded triazole 5m
(25.6 mg, 0.104 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), 
CDCl3]: 9.10–8.60 (m, 2 H, 2-CH + 6-CH), 8.44 (s, 1 H, CH), 7.79–7.72 (m, 2 H, 3-CH + 5-
CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 150.9 (2-C + 6-C), 141.4 (4-C), 130.7 (C–S), 127.2 
(q, J = 310.0 Hz, SCF3), 126.7 (CH), 112.8 (3-C + 5-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒
42.5. FTIR [?̅?𝜈 (cm−1)]: 3113, 1587, 1510, 1150, 1111, 1037, 845, 706. RF: 0.12 (heptane/AcOEt, 
4:1). Yield: 65%.
1-Benzyl-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5n
According to the general procedure, the reaction of (azidomethyl)benzene 8n
(22 mg, 0.17 mmol) with CF3S-acetylene 3 at 50 °C for 16 h afforded triazole 
5n (27.2 mg, 0.105 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.76 (s, 1 H, 
CH), 7.44–7.37 (m, 3 H, 3-CH + 4-CH + 5-CH), 7.31–7.27 (m, 2 H, 2-CH + 6-CH), 5.58 (s, 2 
H, NCH2). 13C NMR [101 MHz, δ (ppm), CDCl3]: 133.7 (1-C), 130.3 (C–S), 130.2 (CH), 129.5 
(3-C + 5-C), 129.4 (4-C), 128.42 (q, J = 309.5 Hz, SCF3), 128.37 (2-C + 6-C), 54.9 (NCH2). 19F 
NMR [377 MHz, δ (ppm), CDCl3]: ‒43.0. FTIR [?̅?𝜈 (cm−1)]: 2362, 1984, 1143, 1129, 1044, 716. 
HRMS [ESI (m/z)] calcd for (C10H8F3N3S + H)+ = 260.04693, found 260.04899 (|Δ| = 2.06 
mmu). RF: 0.28 (heptane/AcOEt, 4:1). Yield: 62%.
4-({5-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazol-1-yl}methyl)benzonitrile 5o
According to the general procedure, the reaction of 4-
(azidomethyl)benzonitrile 8o (130 µL, 0.065 mmol, 0.5 M solution in 
tBuOMe) with CF3S-acetylene 3 at 50 °C for 48 h afforded triazole 5o (7.39 mg, 0.026 mmol) as 
a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.06 (s, 1 H, CH), 7.71–7.60 (m, 2 H, 3-
CH + 5-CH), 7.40–7.32 (m, 2 H, 2-CH + 6-CH), 5.73 (s, 2 H, NCH2). 13C NMR [101 MHz, δ 
(ppm), CDCl3]: 142.8 (CH), 139.0 (1-C), 133.0 (3-C + 5-C), 128.6 (2-C + 6-C), 119.4 (C–S, 
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indirect observation), 118.2 (CN), 113.2 (4-C), 51.7 (NCH2). The carbon signal of SCF3 was not 
observed. 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒42.2. FTIR [?̅?𝜈 (cm−1)]: 2929, 2230, 1604, 
1510, 1285, 1256, 1107, 1048, 756. HRMS [ESI (m/z)] calcd for (C11H7F3N4S + H)+ = 
285.04218, found 285.04248 (|Δ| = 1.08 ppm). RF: 0.24 (heptane/AcOEt, 4:1). Yield: 40%.
1-(Adamantan-1-yl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole 5p
According to the general procedure, the reaction of 1-azidoadamantane 8p (22 mg, 
0.12 mmol) with CF3S-acetylene 3 at 50 °C for 16 h afforded triazole 5p (26.2 mg, 
0.09 mmol) as a pale solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.90 (s, 1 H, 
CH), 2.32–2.23 (m, 9 H, adamantyl), 1.88–1.75 (m, 6 H, adamantyl). 13C NMR [101
MHz, δ (ppm), CDCl3]: 128.4 (q, J = 309.0 Hz, SCF3), 128.2 (C–S), 126.9 (CH), 60.9 (1-C), 42.8 
(2-C), 35.8 (4-C), 29.4 (3-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: ‒43.2. FTIR [?̅?𝜈 (cm−1)]:
2915, 1140, 1109, 1019. HRMS [ESI (m/z)] calcd for (C13H16F3N3S + H)+ = 304.10953, found 
304.11024 (|Δ| = 0.71 mmu). RF: 0.48 (heptane/AcOEt, 4:1). Yield: 72%.
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ABSTRACT: An enantioselective approach towards the synthesis of CF3S-containing isoxazolidines is 
discussed. A screening of Lewis acids was performed to study suitable conditions needed to achieve 
an enantioselective synthesis of CF3S-containing isoxazolidines. The 1,3-dipolar cycloaddition 
reactions of nitrones and trifluoromethyl vinyl sulfide catalyzed by chiral Cu(OTf)2 and Sc(OTf)3
complexes revealed no enantioselectivity.
A further insight in the computational and experimental studies of the 1,3-dipolar cycloaddition 
reactions of trifluoromethyl vinyl sulfide and ethynyl trifluoromethyl sulfide building blocks with 
several dipoles is also described.
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7.1 Introduction
The unprecedented syntheses and applications of trifluoromethyl vinyl sulfide and ethynyl 
trifluoromethyl sulfide building blocks to the synthesis of heterocycles by dipolar cycloaddition 
reactions were described in Chapters 5 and 6. The novelty and the intrinsic value of these
building blocks towards the synthesis of CF3S-containing nitrogenous heterocycles have been 
demonstrated. The significance of this chemistry was proven with the development of two novel 
libraries of compounds containing the SCF3 group, whose biological properties were tested by 
Bayer CropScience.1
The first library of compounds was based on the synthesis of CF3S-containing isoxazolidines 
that were obtained under high-pressure conditions from the reaction of trifluoromethyl vinyl 
sulfide and several nitrones (aliphatic, aromatic and heteroaromatic). The second family of 
compounds was based on the dipolar cycloaddition reaction of ethynyl trifluoromethyl sulfide 
and various azides (aliphatic, aromatic and heteroaromatic) to obtain CF3S-containing 
1,4-disubstituted triazoles.
This section of the dissertation explores an extension of the chemistry of these CF3S-building 
blocks because of their inherent potential in the fields of organic and medicinal chemistry, 
including an insight towards enantioselective versions of their syntheses and the use of 
computational methods to predict their reactivity with different dipoles.
7.2 Results and Discussion
7.2.1 Towards an Enantioselective Synthesis of CF3S-Containing Isoxazolidines
Enantioselective transformations play a significant role in the field of organic chemistry. The 
development of enantioselective methods leading to enantiopure molecules is of vital importance 
because two enantiomers typically possess different biological properties.
In this regard, examples of isoxazolidines produced by catalytic enantioselective 1,3-dipolar 
cycloaddition reactions of nitrones and different kinds of dipolarophiles (electron-rich, neutral 
and electron-poor substrates) have been previously described.2 These reactions implied the use 
of catalysts and, in several cases, a high degree of control of both diastereo- and 
enantioselectivity (enantiomeric excesses up to 99%).3
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The results described in Chapter 5, where 18 new isoxazolidines were obtained as racemates
from the reaction of nitrones and trifluoromethyl vinyl sulfide (2), alongside the literature 
precedent in the field of enantioselective isoxazolidine synthesis, motivated us to study a possible 
enantioselective version of the 1,3-dipolar cycloaddition reaction of trifluoromethyl vinyl sulfide 
(2) with nitrones 1.
Hence, we started our investigations by testing the enantioselective version of the 1,3-dipolar 
cycloaddition reaction of nitrones 1a (R = C6H5) and 1b (R = 4-FC6H4) and alkene 2 in the 
presence of Cu(OTf)2 and bisoxazoline (BOX) ligands (Table 7.1). This catalyst was chosen 
based on the vast number of successful examples reported in the literature.
Table 7.1 Cu(OTf)2/L Catalyzed 1,3-Cycloaddition Reaction of Nitrones 6 and Alkene 2.
Entry 1 La P (bar) t (°C) Galvinoxyl cis-3/trans-3b 4 (%) Conversionb
1 1a L1 1 37 0.03 – 0 0 
2 1a L2 1 60 0.06 – 4 0
3 1a L2 15 × 103 21 0.06 82:18 23 100
4 1b L2 15 × 103 21 0.06 81:19 19 100 
5 1b L1 15 ×103 50 0.06 93:7 83 100
aThe formation of the chiral complex was performed under a nitrogen atmosphere in a Schlenk tube. 
bRatios and conversions were determined by 1H NMR.
The BOX-copper(II) complexes were previously used in reactions of nitrones with electron-
rich and electron-poor alkenes.4 The structure of the BOX ligands used in our experiments 
(L1 and L2) is depicted in Table 7.1.
We first tested if the Cu(OTf)2/L complexes catalyzed the reaction of 1a and 2 at 37 and 60 °C 
and atmospheric pressure (entries 1 and 2, respectively). Unfortunately, no conversion was 
observed at any temperature, which supported the use of high pressure as a key factor for the 
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reaction to take place, even when Cu(OTf)2 was used. Full conversions were obtained when 
15 kbar of pressure was applied (entries 3–5).5
Preliminary results also showed that the use of Cu(OTf)2 favored the formation of azoxy 
compound 4. However, the formation of 4 could not be avoided in any case (entries 3–5) even 
when galvinoxyl (0.06 equiv) was used.6 In addition, a change in the cis-3a,b/trans-3a,b
diastereomeric ratio (dr) under copper catalyzed conditions was observed. As previously 
described in Chapter 5, the uncatalyzed reaction of nitrone 1b yielded the mixture cis-3b/trans-3b
in a dr of 76:24, whereas the copper-catalyzed reaction resulted in the same mixture with dr’s 
81:19 and 93:7 (entries 4 and 5, respectively). Finally, we measured the enantiomeric excess of 
two reactions when nitrones 1a and 1b were used in the presence of L1, but unfortunately no ee 
was observed.
These preliminary results indicated that Cu(OTf)2 led to the formation of the azoxy compound 
4 and to an increase of the dr of cis-3a,b/trans-3a,b. Initial results of the Cu(OTf)2/L complexes
tested in the 1,3-dipolar cycloaddition reaction did not exhibit any enantioselectivity.
7.2.1.1 Screening of Lewis Acids
A screening of several Lewis acids in the 1,3-dipolar cycloaddition reaction of alkene 2 and 
nitrones 1 was performed in order to figure out what Lewis acid could catalyze the reaction itself
and from there select suitable chiral ligands to perform the enantioselective reaction.
The screening of Lewis acids was carried out with the commonest Lewis acids that are used in 
1,3-dipolar cycloaddition reactions with nitrones, such as Yb(OTf)3, Sc(OTf)3, AlMe3, Cu(OTf)2, 
Ti(OiPr)4 and Ni(ClO4)2·6H2O.3 Furthermore, MgCl2·6H2O, In(OTf)3, Zn(ClO4)2·6H2O and 
BF3·OEt2 were tested as potential catalysts (Scheme 7.1).
The reactions of nitrone 1a and alkene 2 in the presence of the Lewis acids (0.25 equiv) were 
carried out at 21 °C and atmospheric pressure; the temperature was gradually increased to 60 °C 
for a total period of 120 h. The screening showed that only the reaction catalyzed by Sc(OTf)3
resulted in 7% conversion to the desired isoxazolidine 3a (determined by 1H NMR), after 48 h of 
reaction time.
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Scheme 7.1 Lewis Acid-Catalyzed 1,3-Cycloaddition Reaction of Nitrone 1a and Alkene 2. 
It is important to note that for all reactions the formation of the azoxy compound 4 was 
observed. As Sc(OTf)3 was the only Lewis acid that catalyzed the reaction of nitrone 1a and 
alkene 2, we focused our studies on enantioselective 1,3-dipolar cycloaddition reactions with 
Sc(OTf)3 complexes.
7.2.1.2 1,3-Dipolar Cycloaddition Reactions Catalyzed by Sc(OTf)3/Ligands
Scandium(III) triflate complexes are mostly formed in combination with pybox ligands
(Sc(III)-pybox) and they have been used in a wide range of reactions, such as enantioselective 
Friedel–Crafts additions,7 asymmetric Diels–Alder reactions,8 syntheses of homopropargylic 
alcohols and dihydrofurans9 and 1,3-dipolar cycloaddition reactions,10 among others. The pybox 
ligands consist of a pyridine ring bearing two oxazoline groups at the 2- and 6-positions.
The structures of the three chiral ligands L3, L4 and L5 used in the 1,3-dipolar cycloaddition 
reaction of nitrones 1a and 1b, and alkene 2 are depicted in Figure 7.1.
Figure 7.1 Pybox Ligands L3–5. 
Firstly, we tested the Sc(OTf)3 catalyzed 1,3-dipolar cycloaddition in the absence of ligands. 
Initial results showed that the reaction of nitrone 1a and alkene 2 in the presence of Sc(OTf)3
(0.25 equiv) at 60 °C and atmospheric pressure, and the same reaction under 5 kbar at 21 °C,
afforded the desired isoxazolidine 3a in approximately 35% conversion.
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When the reaction was brought under 10 kbar, 21 °C and 16 h of reaction time, 93%
conversion to 3a was obtained. Therefore, we decided to apply these final conditions (10 kbar, 
21 °C and 16 h) for the reactions catalyzed by Sc(III)-pybox complexes.
7.2.1.3 Synthesis of the Sc(III)-Pybox Complexes
As the formation of the chiral Sc(III)-pybox complexes is a key step to obtain
enantioselectivity, we confirmed the synthesis of the complexes C3–5 between the Lewis acid 
and pybox ligands by 1H NMR. Thus, we followed the procedure described by Evans et al.7
performing the reaction of L3–5 with Sc(OTf)3 in CD2Cl2 (Scheme 7.2) in a glove-box and in the 
presence of molecular sieves (4 Å).
Scheme 7.2 Synthesis of the Sc(III)-Pybox Complexes C3–5. 
An example of the evidence of the formation of the Sc(III)-pybox complexes is shown in 
Figure 7.2, where a comparison between the 1H NMR spectra of L5 and C5 is presented.
As can be seen in the 1H NMR spectra, the proton at the 4-position of the pyridine ring gets 
clearly affected as a consequence of the coordination of the nitrogen of the pyridine ring with the 
scandium complex, shifting its chemical shift from 7.78 to 8.33 ppm.
After the formation of complexes C3–5 was confirmed, we performed the 1,3-dipolar 
cycloaddition reaction of nitrone 1a and alkene 2 (3.0 equiv) in the presence of C3–5, in order to 
test the enantioselectivity. The results of these reactions are shown in Table 7.2.
Unfortunately, no enantioselectivity was observed in the reactions of nitrone 1a and alkene 2
catalyzed by Sc(III)-Pybox complexes C3–5 (entries 1–3). Further studies to optimize this 
reaction will have to be conducted.
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Figure 7.2 1H NMR Spectra of L5 and the Chiral Sc(III)-Pybox C5 Complex.
Table 7.2 1,3-Dipolar Cycloaddition Reaction of 1a and 2 in the Presence of Sc(III)-Pybox Complexes C3–5.
Entry C cis-3a/trans-3aa Conversion (%)a ee (%)b
1 C3 75:25 64 0 
2 C4 75:25 56 0 
3 C5 73:27 67 0
aRatios and conversions were determined by 1H NMR. bee measured by chiral 
HPLC.
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7.2.2 Computational Studies: A Prediction for 1,3-Dipolar Cycloaddition Reactions
Approximately 50 years ago, computational methods to simulate synthetic chemical reactions 
did not exist. Since then, the discovery of computational principles and algorithms, concurrently 
with the development of fast computers, has resulted in an increase in the accuracy and speed of 
computational methods, being now feasible to model many synthetic reactions in this manner.11
In 2013, the Nobel Prize in Chemistry was awarded to Martin Karplus, Michael Levitt and Arieh 
Warshel for development of multiscale models of complex chemical systems. In addition, 
computational chemistry has recently earned relevance and utility in the field of medicinal 
chemistry.12
Computations can be valuable in combination with experiments, and the synergistic 
computation–experiment approach can lead to a better insight in understanding reactions than 
any of the isolated techniques. In this context, the experimental results can be accompanied by 
the use of computational methods in order to guide our experiments in the development of new
chemistry.13
In this regard, and based on the results described in Chapter 5 where the computational 
methods were in agreement with the experimental results to explain the regio- and 
diastereoselectivity of the 1,3-dipolar cycloaddition reactions of nitrones and trifluoromethyl 
vinyl sulfide (2), we can showcase the capability of computational chemistry to predict and 
emphasize the synergistic power of combining calculations with experiments. In order to do so, 
we applied this methodology to predict the 1,3-dipolar cycloaddition reactions (reactivity, 
regiochemistry and diastereoselectivity) of the trifluoromethyl vinyl sulfide (2) and ethynyl 
trifluoromethyl sulfide (5) building blocks with several dipolarophiles such as nitrones, nitrile 
oxides, diazo compounds and azides. Later on, the reactions could be performed experimentally 
to sustain the results (Figure 7.3).
Initial calculations could be carried out using the bare dipoles (nitrones, nitrile oxides, diazo 
compounds and azides) without any substitution. Afterwards, reactions could be computed with 
more realistic systems (dipoles bearing a substituent), which in addition are experimentally more 
viable.
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Figure 7.3 Scope of 1,3-Dipolar Cycloaddition Reactions of 2 or 5 with Several Dipoles as Predicted by Computation.
This section does not describe the experimental results of these reactions because the project is 
still ongoing; the outcome will be published in the near future.
7.3 Conclusion
An initial study towards the enantioselective 1,3-dipolar cycloaddition reaction of nitrones and 
building block 2 was described. A screening of catalysts was performed and confirmed that 
Sc(OTf)3 and Cu(OTf)2 catalyzed the reaction, reaching almost full conversions when the 
reaction was performed under 10 kbar. Scandium(III)-pybox complexes were prepared and used 
for the 1,3-dipolar cycloaddition reactions of nitrones and alkene 2; however, no 
enantioselectivities were observed. Moreover, the synergistic computation–experiment approach 
to study the 1,3-dipolar cycloaddition reactions of alkene 2 and alkyne 5 with several dipoles is 
being currently studied.
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7.5 Experimental Section
For general experimental details, see Section 2.5 (p 51).
HPLC was performed using a 4.60 mm × 25 cm Lux 3 µm Cellulose-1 column with a flow rate 
of 0.5 µL/min and injection of 1 µL. The samples were dissolved in heptane (compound 3a) or 
propan-2-ol (compound 3b) HPLC grade.
The Cu(OTf)2/L catalyzed reactions (Table 7.1) were performed following the procedure 
described by Jørgensen et al.4b in the presence of Cu(OTf)2 (0.25 equiv) and L1 or L2
(0.287 equiv).
The screening of the ligands (Scheme 7.1) was performed as described in Chapter 5 for the 
1,3-dipolar cycloaddition reaction. Reactions were performed at 21–60 °C, at atmospheric 
pressure for a period of 48–120 h and in the presence of a Lewis acid (0.25 equiv; Yb(OTf)3, 
Sc(OTf)3, AlMe3, Cu(OTf)2, Ni(ClO4)2·6H2O, Ti(OiPr)4, MgCl2·6H2O, Zn(ClO4)2·6H2O,
In(OTf)3 or BF3·OEt2).
The preparation of the complexes was performed in a glove-box following the procedure from 
Evan’s group,7 with Sc(OTf)3 (1.0 equiv) and L3–5 (1.2 equiv) in CD2Cl2.
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Summary
This thesis deals with the synthesis of fluorine-containing nitrogen-based heterocycles as 
potential compounds for agrochemical lead discovery. The development of agrochemicals is vital 
to achieve food security to a society that is projected to become 9–10 thousand million people by 
2050. Therefore, the development of sustainable methods for crop protection is crucial.
In this regard, fluorine-containing compounds have earned a key place in the agrochemical 
sector and nowadays, approximately 52% of commercial pesticides are fluorinated. The effects 
caused by the presence of fluorine in agrochemicals can be attributed to the physicochemical 
effects (steric and electronic effects, stability or lipophilicity among others) of having fluorine in 
biologically active molecules. The incorporation of F, CF3, SF5 and SCF3 groups into potentially 
active molecules is of great interest from an agrochemical point of view and therefore they were 
chosen as the target groups to be incorporated in the majority of the molecules described in this 
thesis.
The presented research is divided in three parts: (1) synthesis of libraries of compounds based 
on derivatives of the piperidin-4-one scaffold that already contain F, CF3 or SF5 groups 
(Chapters 2 and 3), (2) synthesis and selective functionalization of spiro[piperidine-pyridoindole] 
and spiro[piperidine-pyrrolopyridine] drug-like molecules within the European Lead Factory 
Network (Chapter 4) and (3) generation of CF3S-vinylic and acetylenic building blocks to the 
synthesis of CF3S-containing isoxazolidines (Chapter 5) and triazoles (Chapter 6).
The enantiopure piperidin-4-ones 1a–c described in Chapter 2 were synthesized by an 
enantioselective organocatalyzed three-component Mannich reaction, followed by deprotection 
and subsequent intramolecular organocatalyzed Mannich reaction (Scheme 1). Scaffolds 1a–c
were used as starting materials for further derivatization into libraries of compounds.
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Scheme 1 Synthesis of Scaffolds 1a–c. 
Chapter 2 described the derivatization of the ketone into a new library of privileged 
compounds based on the spiro[piperidine-pyridoindole] core via a diastereoselective 
Pictet−Spengler cyclization (Scheme 2). In Chapter 3, the amino group of the three fluorinated 
piperidin-4-ones was derivatized into a library of ureas using flow chemistry. Furthermore, the 
ketone functional group of compound 1c was reduced in flow diastereoselectively and the 
corresponding amino alcohol was also transformed into another family of ureas (Scheme 2).
Scheme 2 Synthesis of Libraries of Compounds Based on Scaffolds 1a–c.
Chapter 4 described the synthesis of tri- and tetracyclic scaffolds based also on the 
spiro[piperidine-pyridoindole] and spiro[piperidine-pyrrolopyridine] cores. The Pictet–Spengler 
products obtained in Chapter 2 were simplified into more drug-like molecules by removing the 
two phenyl groups. Hence, scaffolds 2a and 2b were proposed as frameworks for further 
derivatization into libraries of compounds that were relevant for the European Lead Factory. 
Both scaffolds could be considered as new derivatives of a combination of the diazaspiroalkane 
and tetrahydro-γ-carboline moieties.
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The selective derivatization of the amino groups via N-aromatic alkylation, N-piperidine 
alkylation and N-urea formation of compounds 2a and 2b was achieved in good yields (Scheme 
3). A remarkable elimination of spiro[piperidine-pyridoindole] containing ureas into pyridinyl-
indolyl-ethyl ureas was also observed.
Scheme 3 Spiro[piperidine-pyridoindole], Spiro[piperidine-pyrrolopyridine] and Pyridinyl-indolyl-ethyl Derivatives.
In Chapters 5 and 6, a novel methodology for the incorporation of the SCF3 group via building 
blocks was disclosed. The synthesis of CF3S-vinylic and acetylenic building blocks and their 
application to the synthesis of two families of drug- and agrochemical-like compounds were 
reported. Chapter 5 described the synthesis of trifluoromethyl vinyl sulfide (3) from its 2-
chloroethyl trifluoromethyl sulfide precursor and its use for the first time to the synthesis of 
(trifluoromethyl)sulfanyl isoxazolidines.
The catalytic reaction of trifluoromethyl vinyl sulfide with nitrones gave 5 new 2,5-
disubstituted isoxazolidines in low yields whereas the high-pressure-mediated 1,3-dipolar 
cycloaddition reactions yielded 18 2,3,5-trisubstituted isoxazolidines in high yields in a regio- and 
stereoselective manner (Scheme 4).
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Scheme 4 Synthesis of CF3S-Containing Isoxazolidines and Triazoles from Building Blocks 3 and 4. 
The one-pot synthesis of the building block ethynyl trifluoromethyl sulfide (4) from its 
precursor 2-chloroethyl trifluoromethyl sulfide was disclosed in Chapter 6. Ethynyl 
trifluoromethyl sulfide was synthesized in four steps and was used in copper-catalyzed 1,3-
dipolar cycloaddition reactions with aromatic and aliphatic azides. In this manner, 15 1,4-
disubstituted triazoles bearing the SCF3 group were obtained in up to 86% yields and remarkably, 
a CF3S-containing 1,5-disubstituted triazole was isolated under the same reaction conditions.
Finally, Chapter 7 described an initial study towards the enantioselective 1,3-dipolar 
cycloaddition reaction of nitrones and trifluoromethyl vinyl sulfide (3). Moreover, a further 
insight in the computational and experimental studies of the 1,3-dipolar cycloaddition reactions 
of trifluoromethyl vinyl sulfide (3) and ethynyl trifluoromethyl sulfide (4) building blocks with 
several dipoles was also described.
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Resumen
En esta tesis se describe la síntesis de heterociclos nitrogenados fluorados, con potencial 
interés en el descubrimiento de nuevos compuestos agroquímicos. El desarrollo de agroquímicos 
es de vital importancia para garantizar la seguridad alimentaria a una sociedad que se prevé que 
llegue a 9–10 mil millones de personas en 2050, por lo que el desarrollo de métodos sostenibles,
que sean útiles para la protección de cultivos, es crucial.
En este sentido, el flúor ha ganado un lugar clave en el sector agroquímico y, actualmente, 
aproximadamente el 52% de los plaguicidas comerciales son fluorados. Los efectos causados por 
la presencia de flúor se pueden atribuir a sus efectos físico-químicos (estéricos y electrónicos, 
estabilidad o lipofilia). La introducción de los grupos F, CF3, SF5 y SCF3 en moléculas 
potencialmente activas es de gran interés desde el punto de vista agroquímico y, por lo tanto, se 
eligieron estos grupos para incorporarlos en la mayoría de las moléculas descritas en esta tesis.
La investigación presentada en esta tesis se divide en tres partes: (1) síntesis de quimiotecas de 
compuestos basadas en derivados de piperidin-4-ona con los grupos F, CF3 o SF5 (Capítulos 2 y 
3), (2) síntesis y funcionalización selectiva de los núcleos de espiro[piperidina-piridopiridina] y 
espiro[piperidina-pirrolopiridina] que forman parte del consorcio europeo de la ELF (Capítulo 
4), y (3) síntesis de los fragmentos esenciales vinílico y acetilénico con el grupo SCF3 para 
sintetizar isoxazolidinas y triazoles (Capítulos 5 y 6).
Las piperidin-4-onas enantiopuras 1a–c descritas en el Capítulo 2 se sintetizaron a través de 
una reacción de Mannich multicomponente organocatalizada, seguido de una desprotección y 
una reacción de Mannich intramolecular también organocatalizada (Esquema 1). Los compuestos 
1a–c se utilizaron como sustratos para su posterior derivatización en la construcción de 
quimiotecas de compuestos.
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Esquema 1 Síntesis de los Núcleos Basados en las Piperidin-4-onas 1a–c.
En el Capítulo 2 se describió la derivatización de la cetona para sintetizar una nueva quimioteca 
de compuestos privilegiados basados en el esqueleto de espiro[piperidina-piridoindol] a través de 
una ciclación de Pictet−Spengler diastereoselectiva (Esquema 2). En el Capítulo 3, el grupo 
amino de las tres piperidin-4-onas fluoradas se derivatizó en una quimioteca basada en el grupo 
funcional urea usando química de flujo. Además, la cetona del compuesto 1c se redujo en flujo 
diastereoselectivamente y el amino alcohol resultante se transformó también en otra familia de 
ureas (Esquema 2).
Esquema 2 Síntesis de Quimiotecas de Compuestos Basadas en los Núcleos de Piperidin-4-onas 1a–c.
En el Capítulo 4 se describió la síntesis de estructuras tri- y tetracíclicas basadas también en los 
núcleos de espiro[piperidina-piridoindol] y espiro[piperidina-pirrolopiridina]. Los productos 
Pictet–Spengler obtenidos en el Capítulo 2 se simplificaron eliminando los dos grupos fenilo. 
Los núcleos 2a y 2b se propusieron como estructuras base para su posterior derivatización en 
quimiotecas de compuestos relevantes para la ELF. Ambas estructuras base podrían considerarse 
como una combinación de los núcleos de diazaespiroalcano y tetrahidro-γ-carbolina.
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La derivatización selectiva de los grupos amino a través de la alquilación del nitrógeno
aromático, alquilación del nitrógeno de piperidina y formación de ureas de los compuestos 2a y 
2b se logró con buenos rendimientos (Esquema 3). También se observó una notable reacción de 
eliminación de las ureas con el núcleo de espiro[piperidina-piridoindol] en piridinil-indolil-etil 
ureas.
Esquema 3 Derivados de los Núcleos de Espiro[piperidina-piridoindol], Espiro[piperidina-pirrolopiridina] y Pyridinyl-
indolyl-ethyl Ureas.
En los Capítulos 5 y 6 se describió una metodología nueva basada en la síntesis de los 
fragmentos esenciales vinílico y acetilénico con el grupo SCF3 y sus aplicaciones en las síntesis de 
dos nuevas familias de compuestos con potencial farmacéutico y agroquímico. En el Capítulo 5 
se describió la síntesis del trifluorometil vinil sulfuro (3) a partir de su precursor 2-cloroetil 
trifluorometil sulfuro. El compuesto 3 se usó por primera vez en la síntesis de isoxazolidinas con
el grupo SCF3.
La reacción catalítica del trifluorometil vinil sulfuro con nitronas generó 5 isoxazolidinas 2,5-
disustituidas con bajos rendimientos, mientras que la reacción de cicloadición 1,3-dipolar a alta 
presión generó 18 isoxazolidinas 2,3,5-trisustituidas con rendimientos altos y de manera regio y 
estereoselectiva (Esquema 4).
520586-L-bw-Riesco
Processed on: 8-8-2018 PDF page: 244
Resumen
244
Esquema 4 Síntesis de Isoxazolidinas y Triazoles con el Grupo SCF3 a partir de los Compuestos 3 y 4.
La síntesis del etinil trifluorometil sulfuro (4) a partir de su precursor 2-cloroetil trifluorometil 
sulfuro se describió en el Capítulo 6. El etinil trifluorometil sulfuro se sintetizó en cuatro pasos y 
se utilizó en cicloadiciones 1,3-dipolares catalizadas por cobre con azidas aromáticas y alifáticas.
Siguiendo esta metodología, se obtuvieron 15 triazoles 1,4-disustituidos conteniendo el grupo
SCF3 con rendimientos de hasta un 86%. Por primera vez se aisló un triazol 1,5-disustituido
utilizando las mismas condiciones de reacción.
Por último, en el Capítulo 7 se describió un estudio preliminar basado en cicloadiciones 1,3-
dipolares enantioselectivas con nitronas y el trifluorometil vinil sulfuro (3). Se describió también
un estudio más profundo sobre métodos computacionales y experimentales de cicloadiciones
1,3-dipolares de los fragmentos esenciales trifluorometil vinil sulfuro (3) y etinil trifluorometil 
sulfuro (4) con varios dipolos.
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Samenvatting
Dit proefschrift beschrijft de synthese van fluorbevattende, stikstofgebaseerde heterocyclische 
verbindingen die het potentieel hebben om als agrochemicaliën gebruikt te kunnen worden. De 
ontwikkeling van agrochemicaliën als gewasbeschermers is van cruciaal belang om de 
voedselzekerheid te waarborgen in een maatschappij waarin de wereldwijde populatie razendsnel 
toeneemt. Het is daarom van cruciaal belang dat er duurzame gewasbeschermingsmethodes 
ontwikkeld worden waardoor de voedselzekerheid voor de toekomstige wereldpopulatie (naar 
schatting 9–10 miljard mensen in 2050) gewaarborgd kan worden.
In dit opzicht speelt het gebruik van fluor een sleutelrol in de agrochemische sector, dit 
weerspiegelt zich in het feit dat tegenwoordig 52% van de commercieel verkrijgbare pesticiden
fluoratomen bevatten. Het effect van het inbouwen van fluoratomen in agrochemicaliën kan 
worden toegeschreven aan de fysisch-chemische eigenschappen van deze verbindingen, zoals 
bijvoorbeeld sterische en electrofiele effecten, stabiliteit of vetoplosbaarheid. Vanuit een 
agrochemisch perspectief is het specifiek inbouwen van F, CF3, SF5, en SCF3 in agrochemicaliën
om de activiteit te verhogen enorm veelbelovend. Dit is de reden waarom deze functionele 
groepen in het merendeel van de in dit proefschrift beschreven gesynthetiseerde moleculen zijn 
ingebouwd.
Het onderzoek beschreven in dit proefschrift is onderverdeeld in drie deelstukken: (1) de
synthese van bibliotheken van verbindingen gebaseerd op derivaten van het piperidine-4-on 
kapstokmolecuul (scaffold), die al F, CF3 of SF5 deelgroepen bevatten (hoofdstuk 2 en 3), (2) de 
synthese en selectieve functionalisatie van spiro[piperidine-pyridoindol]- en spiro[piperidine-
pyrrolopyridine]gebaseerde moleculen als geneesmiddelkandidaten binnen het European Lead 
Factory Network (hoofdstuk 4) en (3) de synthese van CF3S-vinylische en CF3S-acetylenische 
bouwstenen voor de synthese van CF3S-bevattende isoxazolidines en triazolen (hoofdstuk 5 en 6).
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Schema 1 Synthese van Scaffolds 1a–c.
De enantiozuivere piperidin-4-ons 1a-c beschreven in hoofdstuk 2 werden gesynthetiseerd via 
een enantiozuivere, organo-gekatalyseerde, driedelige Mannich-reactie, gevolgd door de 
ontscherming en tenslotte door een intramoleculaire, organo-gekatalyseerde Mannich-reactie 
(Schema 1).
Scaffolds 1a-c werden vervolgens gebruikt als startmaterialen voor het samenstellen van 
bibliotheken van verbindingen. Zo is de derivatisering van het keton voor de vorming van een 
nieuwe bibliotheek van bevoorrechte verbindingen gebaseerd op de spiro[piperidine-
pyridoindol]skeletstructuur via een diastereoselectieve Pictet–Spengler-cyclisatie (Schema 2)
beschreven in hoofdstuk 2. Daarnaast werd in hoofdstuk 3 met behulp van flowchemie een 
bibliotheek van urea’s samengesteld door derivatisering van de overeenkomende aminegroepen
van drie fluorbevattende piperidin-4-ons. Verder werd de functionele ketongroep van verbinding 
1c in flow diastereoselectief gereduceerd en werd het overeenkomstige amino-alcohol ook 
getransformeerd tot een bibiliotheek van urea's (Schema 2).
Schema 2 Synthese van Bibliotheken van Verbindingen Gebaseerd op Scaffolds 1a–c.
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In hoofdstuk 4 werd de synthese beschreven van drie- en viervoudige cyclische scaffolds die
zijn gebaseerd op de spiro[piperidine-pyridoindol]- en de spiro[piperidine-
pyrrolopyridine]kernstructuren. De Pictet-Spenglerproducten (verkregen in hoofdstuk 2) werden 
vereenvoudigd tot potentiële geneesmiddelkandidaten door verwijdering van de twee 
fenylgroepen. Vandaar dat in het kader van de European Lead Factory, scaffolds 2a en 2b
werden voorgesteld als basisstructuren voor verdere derivatisering tot bibliotheken van 
verbindingen. Beide scaffolds kunnen namelijk worden beschouwd als nieuwe derivaten van een 
combinatie van diazaspiroalkaan- en tetrahydro-γ-carboline-deelgroepen. De selectieve 
derivatisering van de aminegroepen via N-aromatische alkylering, N-piperidine alkylering en N-
ureavorming van verbindingen 2a en 2b werd verkregen met een goede opbrengst (Schema 3). 
Daarnaast werd er tijdens deze studie een opmerkelijke eliminatie van spiro[piperidine-
pyrodoindol]bevattende urea's tot pyrindyl-indoyl-ethyl-urea's waargenomen.
Schema 3 Spiro[piperidine-pyridoindol]-, Spiro[piperidine-pyrrolopyridine]- en Pyridinyl-indolyl-ethylderivaten.
In hoofdstuk 5 en 6 werd een nieuwe methode beschreven voor het inbouwen van SCF3-
groepen via functionele bouwstenen. Zo werd er in deze hoofdstukken ingegaan op de synthese 
van CF3S-gebaseerde vinylische en acetylenische bouwstenen en de toepassing hiervan in de 
synthese van twee families van potentiële agrochemische en geneesmiddelkandidaten. In 
hoofdstuk 5 werd verder zowel de synthese van trifluormethylvinylsulfide 3 vanuit uitgangsstof 
2-chloor-ethyl-trifluoromethylsulfide beschreven en vervolgens het gebruik van verbinding 3 in 
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de synthese van (trifluormethyl)sulfanyl-isoxazolidines. Hierin werd ontdekt dat de katalytische 
reactie van trifluormethylvinylsulfide met nitronen resulteerde in vijf nieuwe 2,5-
digesubstitueerde isoxazolidines in lage opbrengst, waar onder hoge druk gemedieerde 1,3-
dipolaire cyclo-addities achttien regio- en stereospecifieke 2,3,5-trigesubstitueerde isoxazolidines 
opleverde in hoge opbrengst (Schema 4).
Schema 4 Synthese van CF3S-Bevattende Isoxazolidines en Triazolen vanuit Bouwstenen 3 en 4. 
De éénpotssynthese van de bouwsteen ethynyltrifluormethylsulfide 4 vanuit de uitgangsstof
2-chloor-ethyl-trifluormethylsulfide was beschreven in hoofdstuk 6. Ethyltrifluormethylsulfide 
was gesynthetiseerd in vier stappen en deze is vervolgens gebruikt in kopergekatalyseerde 1,3-
dipolaire cyclo-additie reacties met aromatische en alifatische azides. Op deze manier, zijn vijftien 
1,4-digesubstitueerde SCF3-bevattende triazolen verkregen met opbrengsten tot 86%. 
Opmerkelijk genoeg werd er ook een CF3S-bevattend 1,5-digesubstitueerd triazool geïsoleerd
onder dezelfde reactiecondities.
Tenslotte werd in hoofdstuk 7 in een voorlopige studie de enantioselectieve 1,3-dipolaire cyclo-
additie tussen nitronen en trifluormethylvinylsulfide 3 beschreven. Daarnaast werd in dit 
hoofdstuk dieper ingegaan op de computationele en experimentele studies van de 1,3-dipolaire 
cyclo-addities van de bouwstenen trifluormethylvinylsulfide 3 en ethynyltrifluormethylsulfide 4
met verschillende dipolen.
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